,titleabstract,decision
2815,"Retreatment of recurrent nasopharyngeal carcinoma. Thirty patients with recurrent primary nasopharyngeal carcinoma were reirradiated between 1949 and 1976. Twenty eventually demonstrated recurrence at or near the primary site, involving the nasopharynx in 4 and the central nervous system in 16. Long-term palliation was often achieved, and there were no severe complications except for one patient who died of necrosis of the base of the skull. The most frequent problems were hearing loss and trismus; necrosis of the nasopharynx was seen in only 2 patients. With therapy in the range of 18-25 MeV, significant palliation and an occasional cure can be achieved without excessive risk. Recurrent disease involving the skull may be controlled for several years using current techniques.",Excluded
3311,[Effect of radon baths of different concentration on the gastric function and neurohumoral regulation in patients with gastroduodenal ulcer],Included
3592,"Opioid involvement in TRH-induced antinociception in the rat following intracerebral administration. Thyrotropin-releasing hormone (TRH) has an antinociceptive action in the rat. Antinociception was observed using a thermal stimulus (tail-flick test) after TRH administration into lateral ventricle, nucleus raphe magnus, nucleus reticularis paragigantocellularis and amygdaloid nuclei. This effect was short-lived since it was completely abolished 60 min after intracerebroventricular administration. TRH may interact with the opioid systems as its antinociceptive effect was blocked by pretreatment with naloxone.",Excluded
2683,"Adaptive compensatory brain response to irradiation. [Russian]. In totally irradiated chick and rat embryos, young chicks and rats structural functional activity of the subcellular reparative processes in the brain cortex was studied. The animals were given an irradiation dose of 600 and 1,200 rad. In embryogenesis and in early postnatal period, the adaptive compensatory response is shown after X-ray irradiation to be characterized by subcellular changes and organelle hypertrophy of the neurons in the CNS accompanied by disturbances in metabolic and synthesis processes. Ultrastructural regeneration goes side by side with the destructive processes in them.",Excluded
3230,"Stereotactic radiosurgery in recurrent high grade malignant glioma of the brain. [Spanish]. Purpose: To evaluate in a phase II trial the local control and survival of patients with recurrent high grade brain glioma treated with stereotactic radiosurgery (SRS). Material(s) and Method(s): Fourteen patients, 7 with glioblastoma multiforme and 7 with anaplastic astrocytoma, with a mean tumor volume of 26.5 cc, received SRS employing an average single total dose of 22 Gy (range 11-40 Gy). Result(s): The mean survival time was 14 months, and the 1 and 2 year aditional survival was of 73.8% and 42.2% respectively. Eleven patients (79%) had a local tumor progression, with a progression mean time of 11 months. Conclusion(s): Stereotactic radiosurgery (SRS) is a tolerable alternative treatment modality in patients with recurrent high grade malignant glioma.",Excluded
2695,"DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios. Expanded polyglutamine (polyQ) stretches lead to protein aggregation and severe neurodegenerative diseases. A highly efficient suppressor of polyQ aggregation was identified, the DNAJB6, when molecular chaperones from the HSPH, HSPA, and DNAJ families were screened for huntingtin exon 1 aggregation in cells (Hageman et al. in Mol Cell 37(3):355-369, 2010). Furthermore, also aggregation of polyQ peptides expressed in cells was recently found to be efficiently suppressed by co-expression of DNAJB6 (Gillis et al. in J Biol Chem 288:17225-17237, 2013). These suppression effects can be due to an indirect effect of DNAJB6 on other cellular components or to a direct interaction between DNAJB6 and polyQ peptides that may depend on other cellular components. Here, we have purified the DNAJB6 protein to investigate the suppression mechanism. The purified DNAJB6 protein formed large heterogeneous oligomers, in contrast to the more canonical family member DNAJB1 which is dimeric. Purified DNAJB6 protein, at substoichiometric molar ratios, efficiently suppressed fibrillation of polyQ peptides with 45degreeQ in a thioflavin T fibrillation. No suppression was obtained with DNAJB1, but with the closest homologue to DNAJB6, DNAJB8. The suppression effect was independent of HSPA1 and ATP. These data, based on purified proteins and controlled fibrillation in vitro, strongly suggest that the fibrillation suppression is due to a direct protein-protein interaction between the polyQ peptides and DNAJB6 and that the DNAJB6 has unique fibrillation suppression properties lacking in DNAJB1. Together, the data obtained in cells and in vitro support the view that DNAJB6 is a peptide-binding chaperone that can interact with polyQ peptides that are incompletely degraded by and released from the proteasome.",Excluded
3180,"Physiological roles of Na+/Ca2+ exchange in Limulus ventral photoreceptors. In previous work we have presented evidence for electrogenic Na+/Ca2+ exchange in Limulus ventral photoreceptors (1989. J. Gen. Physiol. 93:473-492). This article assesses the contributions to photoreceptor physiology from Na+/Ca2+ exchange. Four separate physiological processes were considered: maintenance of resting sensitivity, light-induced excitation, light adaptation, and dark adaptation. (a) Resting sensitivity: reduction of [Na+]o caused a [Ca2+]o-dependent reduction in light sensitivity and a speeding of the time courses of the responses to individual test flashes; this effect was dependent on the final value to which [Na+]o was reduced. The desensitization caused by Na+ reduction was dependent on the initial sensitivity of the photoreceptor; in fully dark-adapted conditions no desensitization was observed; in light-adapted conditions, extensive desensitization was observed. (b) Excitation: Na+ reduction in fully dark-adapted conditions caused a Ca2+o-dependent depolarizing phase in the receptor potential that persisted beyond the stimulus duration and was evoked by a bright adapting flash. (c) Light adaptation: the degree of desensitization induced by a bright adapting flash was Na+o dependent, being larger with lower [Na+]o. Na+ reduction enhanced light adaptation only at intensities brighter than 4 x 10(-6) W/cm2. In addition to being Na+o dependent, light adaptation was Ca2+o dependent, being greater at higher [Ca2+]o. (d) Dark adaptation: the recovery of light sensitivity after adapting illumination was Na+o dependent. Dark adaptation after bright illumination in voltage-clamped and in unclamped conditions was faster in normal-Na+ saline than in reduced Na+ saline. The final sensitivity to which photoreceptors recovered was lower in reduced-Na+ saline when bright adapting illumination was used. The results suggest the involvement of Na+/Ca2+ exchange in each of these physiological processes. Na+/Ca2+ exchange may contribute to these processes by counteracting normal elevations in [Ca2+]i.",Excluded
2878,"Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis. BACKGROUND: The primary dose-limiting toxicity of stereotactic radiosurgery (SRS) is radiation necrosis (RN), which occurs after approximately 5% to 10% of treatments. This adverse event may worsen neurologic deficits, increase the frequency and cost of imaging, and necessitate prolonged treatment with steroids or antiangiogenic agents. Previous investigations have primarily identified lesion size and dosimetric constraints as risk factors for RN in small populations. We hypothesized that disease histology, receptor status, and mutational status are associated with RN.METHODS AND MATERIALS: All patients presenting with brain metastasis between 1997 and 2015 who underwent SRS and subsequent radiographic follow-up at a single tertiary-care institution were eligible for inclusion. The primary outcome was the cumulative incidence of radiographic RN. Multivariate competing risks regression was used to identify biological risk factors for RN.RESULTS: 1939 patients (5747 lesions) were eligible for inclusion; 285 patients (15%) experienced radiographic RN after the treatment of 427 (7%) lesions. After SRS, the median time to RN was 7.6 months. After multivariate analysis, graded prognostic assessment, renal pathology, lesion diameter, and the heterogeneity index remained independently predictive of RN in the pooled cohort. In subset analyses of individual pathologies, HER2-amplified status (hazard ratio [HR] 2.05, P=.02), BRAF V600+ mutational status (HR 0.33, P=.04), lung adenocarcinoma histology (HR 1.89, P=.04), and ALK rearrangement (HR 6.36, P<.01) were also associated with RN.CONCLUSIONS: In the present investigation constituting the largest series of RN, several novel risk factors were identified, including renal histology, lung adenocarcinoma histology, HER2 amplification, and ALK/BRAF mutational status. These risk factors may be used to guide clinical trial design incorporating biological risk stratification or dose escalation. Future studies determining the optimal timing of targeted therapies are warranted to further define the risk of RN.",Excluded
2787,"Efficient production of high specific activity 64Cu using a biomedical cyclotron. Copper-64 (T 1/2 = 12.7 h) is an intermediate-lived positron-emitting radionuclide that is a useful radiotracer for positron emission tomography (PET) as well as a promising radiotherapy agent for the treatment for cancer. Currently, copper-64 suitable for biomedical studies is produced in the fast neutron flux trap (irradiation of zinc with fast neutrons) at the Missouri University Research Reactor. Access to the fast neutron flux trap is only possible on a weekly basis, making the availability of this tracer very limited. In order to significantly increase the availability of this intermediate-lived radiotracer, we have investigated and developed a method for the efficient production of high specific activity Cu-64 using a small biomedical cyclotron. It has been suggested that it may be possible to produce Cu-64 on a small biomedical cyclotron utilizing the 64Ni(p,n)64Cu nuclear reaction. We have irradiated both natural nickel and enriched (95% and 98%) Ni-64 plated on gold disks. Nickel has been electroplated successfully at thicknesses of approximately 20-300 mm and bombarded with proton currents of 15-45 microA. A special water-cooled target had been designed to facilitate the irradiations on a biomedical cyclotron up to 60 microA. We have shown that it is possible to separate Cu-64 from Ni-64 and other reaction byproducts rapidly and efficiently by using ion exchange chromatography. Production runs using 19-55 mg of 95% enriched Ni-64 have yielded 150-600 mCi of Cu-64 (2.3-5.0 mCi/microAh) with specific activities of 94-310 mci/microgram Cu. The cyclotron produced Cu-64 had been used to radiolabel PTSM [pyruvaldehyde bis-(N4-methylthiosemicarbazone), used to quantify myocardial, cerebral, renal, and tumor blood flow], MAb 1A3 [monoclonal antibody MAb to colon cancer], and octreotide. A recycling technique for the costly Ni-64 target material has been developed. This technique allows the nickel eluted off the column to be recovered and reused in the electroplating of new targets with an overall efficiency of greater than 90%.",Excluded
2417,"Potential Improvements in Brain Dose Estimates For Internal Emitters. BACKGROUND: Element-specific biokinetic models are used to reconstruct doses to systemic tissues from internal emitters. Typically, a systemic model for a radionuclide explicitly depicts only its dominant repositories. Remaining tissues and fluids are aggregated into a pool called Other tissue in which the radionuclide is assumed to be uniformly distributed. In the systemic biokinetic models used in radiation protection, the brain usually is addressed as an implicit mass fraction of Other tissue rather than an explicitly depicted repository. Due to increasing interest in radiation effects on the brain, efforts are underway to improve brain dosimetry for internal radiation sources.METHODS: We assessed potential improvements in brain dosimetry for internal emitters by explicitly modelling brain kinetics rather than treating the brain as a mass fraction of Other tissue. We selected ten elements for which brain kinetics can be modeled using published biokinetic data. Injection dose coefficients were calculated for a relatively long-lived radioisotope of each element using each of two versions of the ICRP's latest systemic biokinetic model for each element, the original version and a modified version differing only in the treatment of brain. If the ICRP model contained an explicit brain pool, the modified version depicted brain instead as a mass fraction of Other tissue. If the ICRP model included brain in Other tissue, the modified version included an explicit brain pool with kinetics based on best available brain-specific data.RESULTS: The result for a given radionuclide is expressed as a ratio A:B, where A and B are the dose coefficients based on the versions of the model with and without an explicit brain pool, respectively. The following ratios A:B were obtained for the 10 radionuclides addressed here: 241Am, 0.13; 207Bi, 0.57; 234U, 0.81; 239Pu, 0.96; 203Hg (vapor), 1.4; 134Cs, 1.5; 54Mn, 1.7; 210Po, 1.7; 226Ra, 1.9; 210Pb, 3.3. These ratios indicate that a dose estimate for brain based on a biokinetic model with brain implicitly contained in Other tissue may substantially underestimate or substantially overestimate a dose estimate that reflects best available brain-specific biokinetic data. Of course, the reliability of the latter estimate depends on the quality of the underlying biokinetic data.CONCLUSIONS: Where feasible, the brain should be depicted explicitly in biokinetic models used in epidemiological studies addressing adverse effects of ionizing radiation.",Excluded
3573,"Dosimetric, radiobiological and secondary cancer risk evaluation in head-and-neck three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric modulated arc therapy: A phantom study. This analysis estimated secondary cancer risks after volumetric modulated arc therapy (VMAT) and compared those risks to the risks associated with other modalities of head-and-neck (H&N) radiotherapy. Images of H&N anthropomorphic phantom were acquired with a computed tomography scanner and exported via digital imaging and communications in medicine (DICOM) standards to a treatment planning system. Treatment plans were performed using a VMAT dual-arc technique, a nine-field intensity-modulated radiation therapy (IMRT) technique, and a four-field three-dimensional conformal therapy (3DCRT) technique. The prescription dose was 66.0 Gy for all three techniques, but to accommodate the range of dosimeter responses, we delivered a single dose of 6.60 Gy to the isocenter. The lifetime risk for secondary cancers was estimated according to National Council on Radiation Protection and Measurements (NCRP) Report 116. VMAT delivered the lowest maximum doses to esophagus (23 Gy), and normal brain (40 Gy). In comparison, maximum doses for 3DCRT were 74% and 40%, higher than those for VMAT for the esophagus, and normal brain, respectively. The normal tissue complication probability and equivalent uniform dose for the brain (2.1%, 0.9%, 0.8% and 3.8 Gy, 2.6 Gy, 2.3 Gy) and esophagus (4.2%, 0.7%, 0.4% and 3.7 Gy, 2.2 Gy, 1.8 Gy) were calculated for the 3DCRT, IMRT and VMAT respectively. Fractional esophagus OAR volumes receiving more than 20 Gy were 3.6% for VMAT, 23.6% for IMRT, and 100% for 3DCRT. The calculations for mean doses, NTCP, EUD and OAR volumes suggest that the risk of secondary cancer induction after VMAT is lower than after IMRT and 3DCRT. Copyright Â© 2018 Journal of Medical Physics Published by Wolters Kluwer - Medknow.",Excluded
3586,"The relationship between mood symptoms and neuropsychological function in breast cancer survivors. Objective: Breast cancer survivors show neuropsychological deficits in domains such as language and memory that are suspected to be a result of the harmful effects of cancer treatments. Mood symptoms may exacerbate these problems, however, little is known about the exact relationship between these variables. Participants and Methods: We examined a group of 87 breast cancer survivors, mean age 58.7 years, who had received diagnoses of breast cancer 2-22 years prior (mean 6.1 years). Participants completed a battery of neuropsychological tests that assessed intellectual function, executive function, and memory, and several self-report questionnaires that assessed mood, fatigue, and quality of life. Result(s): Pearson analyses demonstrated significant negative correlations between scores on the Beck Depression Inventory-II (BDI-II; Beck, Steer & Brown, 1996) and the Full Scale IQ,VerbalComprehension Index, and Processing Speed Index scores of theWechsler Adult Intelligence Scale-III(Wechsler, 1997). BDI-II scores also showed significant negative correlations with some measures of executive function, but not with measures of memory. Analysis of variance showed that breast cancer survivors who had been treated with chemotherapy reported more symptoms of depression than individuals who had not been treated with chemotherapy, F = 9.51, p = .003. A similar pattern was not found for individuals who had been treated with radiation. Patients' history of chemotherapy and radiation treatment did not show any relationship to subsequent neuropsychological function. Conclusion(s): Results suggest that elevated mood symptoms may be related to problems in some domains of neuropsychological performance in breast cancer survivors. Individuals who had received chemotherapy appeared more likely to experience subsequent mood problems. Further investigation is needed to determine if mood changes may increase susceptibility to the cognitive deficits experienced by breast cancer survivors. Acknowledgement: Study funded by Susan G. Komen for the Cure.",Excluded
2614,"The medial septum mediates impairment of prepulse inhibition of acoustic startle induced by a hippocampal seizure or phencyclidine. The involvement of the septohippocampal system on the impaired sensorimotor gating induced by phencyclidine (PCP) or by an electrically induced hippocampal seizure was examined in behaving rats. An impaired sensorimotor gating, measured by prepulse inhibition (PPI) of the acoustic startle response, was observed following a hippocampal afterdischarge (AD) or systemic injection of PCP and was accompanied with an increase in hippocampal gamma waves (30-70 Hz). The medial septum infusion with muscimol (0.25 microg), a GABA(A) receptor agonist, 15 min prior to PCP or a hippocampal AD, prevented the impairment of sensorimotor gating and the increase in gamma waves. By itself, muscimol (0.25 microg) injection into the medial septum did not affect PPI, although it significantly suppressed spontaneous gamma waves. In order to identify subpopulations of neurons mediating the sensorimotor gating deficit and the hippocampal gamma wave increase, 0.14-0.21 microg of p75 antibody conjugated to saporin (192 IgG-saporin) was injected into the medial septum to selectively lesion the septohippocampal cholinergic neurons. Neither the PPI deficit nor the gamma wave increase induced by PCP or a hippocampal AD was affected by 192 IgG-saporin lesion of the medial septum. It is concluded that increase in neural activity in the medial septum participates in the impairment of sensorimotor gating and the increase in hippocampal gamma waves induced by PCP or a hippocampal AD. It is suggested that the GABAergic but not the cholinergic septohippocampal neurons mediate the sensorimotor gating deficit.",Excluded
3346,Carcinoma of maxillary antrum: the role of pre-operative irradiation,Included
2563,"Asynchronous inputs and NMDA conductances predict excitatory responses in the cortical-cA1 pathway of the hippocampus. In the hippocampus, CA1 place cells are driven by a substantial input from CA3. There is a second pathway to CA1 from the entorhinal cortex. The mode of action of cortex on CA1 through this pathway is not known. The pathway supports CA1 place field activity after CA3 has been lesioned, yet stimulation of the pathway in rat slices results in strong feedforward inhibition that prevents pyramidal cell action potentials. We use a detailed conductance-based model of this pathway to simulate the response to cortical stimulation in slice experiments and in vivo spatial exploration. We find that the presence of NMDA conductances enable CA1 pyramidal cells to integrate cortical inputs over a time scale longer than that which is effective in recruiting the inhibitory response that can suppress action potentials. We then show that this asynchronous response mode supports place field formation in response to experimentally constrained spatially modulated cortical activity. Within this model, the inclusion of GABAB conductances and the hyperpolarisation activated current I(h) reduces the strength of the GABAA inputs required to balance the excitatory inputs, and this facilitates place field formation by reducing variability in the inhibitory inputs.",Excluded
2940,"CT dose audit 2009-2014: Pre-and post Arpansa NDRL. Introduction Since the inception of NDRL in Australia in 2011, CT dose optimisation continues to be a key focus in patient dose management. At Austin Health, we decided to perform a CT dose audit to review the CT dose trend and the effect NDRL has had at this practice. Method Retrospective data collection of CTDIvol and DLP values of procedures for 2 years prior to NDRL and 3 years post NDRL were taken. The following non-contrast procedures were audited, CT brain, CT chest, CT abdomen/pelvis and CT chest/abdomen/pelvis scans. Data was collected across 4 CT scanners and their median of the spread per year was taken as the facility reference level (FRL) as defined in the Arpansa National Diagnostic Reference Level Service Fact Sheet. The FRL was then compared with the NDRL values. Results Preliminary results indicate a dose reduction over time since 2009 for most procedures, which may be attributed to dose optimisation, CT technology and the establishment of NDRL as a benchmark for CT dose comparison. Conclusion Regular CT dose audits are useful in managing dose trends and dose optimisation. It can be seen that since the implementation of the NDRL in 2011, there has been a positive trend towards lowering radiation dose associated with CT at this facility.",Excluded
3473,"Steroid responsive migratory brain lesions causing intractable epilepsy in multiple myeloma. Objective: Description of a patient with multiple myeloma presenting with intractable epilepsy, steroid responsive, and recurrent abnormal T2 signal on brain magnetic resonance imaging (MRI). Background(s): Paraneoplastic epilepsy has been described in association with multiple malignancies and has been related to the presence of various antibodies, and/or malignancy spread to the central nervous system (CNS). Here we describe a unique presentation of refractory epilepsy associated with steroid responsive CNS lesions in the setting of multiple myeloma. Design/Methods: N/A Results: A 64 year old man presented with episodic expressive aphasia. His medical history was significant for IgA Kappa multiple myeloma with metastases to the spine since 2013; treated with radiation, chemotherapy, and autologous hematopoietic stem cell transplant. MRI showed abnormal T2 hyperintense signal on juxtacortical white matter and cortex with no restricted diffusion or contrast enhancement. Seizures seen on EEG were treated. Paraneoplastic, infectious, and malignancy work up was negative, except for >5 oligoclonal bands in serum and CSF suggesting systemic inflammation with secondary CNS involvement. Two weeks later the symptoms reoccurred. MRI showed progression and intravenous solumedrol (IVSM) treatment lead to clinical and radiological improvement. Follow up MRI four months later showed resolution of findings. However, a few weeks later, he presented with status epilepticus (SE). MRI showed multiple new lesions; he received IVSM, which provided a satisfactory response. He was discharged on prednisone. MRI two months later showed marked improvement and prednisone was reduced to 20mg/day. In July, symptoms reoccurred so he was treated again for SE and his MRI showed extensive new lesions. Despite aggressive treatment with anticonvulsants, IVSM and intravenous immunoglobulin, clinical, electrographic and radiographic progression persisted. Family opted for comfort care. Conclusion(s): Better recognition and management of different presentations of various paraneoplastic syndromes represent new challenges in the management of patients with malignancies. Further studies in paraneoplastic syndromes are needed.",Excluded
3531,Hormonal changes following low-dosage irradiation of pituitary and ovaries in anovulatory women; further studies,Included
3396,"KCNQ/Kv7 channel regulation of hippocampal gamma-frequency firing in the absence of synaptic transmission. Synchronous neuronal firing can be induced in hippocampal slices in the absence of synaptic transmission by lowering extracellular Ca2+ and raising extracellular K+. However, the ionic mechanisms underlying this nonsynaptic synchronous firing are not well understood. In this study we have investigated the role of KCNQ/Kv7 channels in regulating this form of nonsynaptic bursting activity. Incubation of rat hippocampal slices in reduced (<0.2 mM) [Ca2+]o and increased (6.3 mM) [K+]o, blocked synaptic transmission, increased neuronal firing, and led to the development of spontaneous periodic nonsynaptic epileptiform activity. This activity was recorded extracellularly as large (4.7 +/- 1.9 mV) depolarizing envelopes with superimposed high-frequency synchronous population spikes. These intraburst population spikes initially occurred at a high frequency (about 120 Hz), which decayed throughout the burst stabilizing in the gamma-frequency band (30-80 Hz). Further increasing [K+]o resulted in an increase in the interburst frequency without altering the intraburst population spike frequency. Application of retigabine (10 microM), a Kv7 channel modulator, completely abolished the bursts, in an XE-991-sensitive manner. Furthermore, application of the Kv7 channel blockers, linopirdine (10 microM) or XE-991 (10 microM) alone, abolished the gamma frequency, but not the higher-frequency population spike firing observed during low Ca2+/high K+ bursts. These data suggest that Kv7 channels are likely to play a role in the regulation of synchronous population firing activity.",Excluded
3378,"Radiosurgical treatment of trigeminal neuralgia: evaluating quality of life and treatment outcomes. PURPOSE: To assess the safety, efficacy, and quality of life (QOL) associated with radiosurgical treatment for trigeminal neuralgia (TN).METHODS AND MATERIALS: Between June 1996 and June 2001, 112 patients with TN refractory to medical or surgical management were treated with gamma knife radiosurgery (GKRS) at the University of Maryland Medical Center. A median prescription dose of 75 Gy (range: 70-80 Gy) was delivered to the involved trigeminal nerve root entry zone. Treatment outcomes were assessed through patient self-reports of pain control and medication usage during follow-up visits. In addition, patients responded to a standard questionnaire containing the Barrow Neurologic Institute Pain Scale (BNI) and selected sections of the McGill Pain Scale. Treatment outcomes and objective quality of life measures were also addressed.RESULTS: Ninety-six patients (86%) completed questionnaires for a median follow-up of 30 months (range: 8-66 months). Seventy-four patients (77%) reported pain relief occurring after a median of 3 weeks (range: 0-24 weeks) after GKRS. A decrease in medication usage was noted in 66% of patients. Actuarial analysis demonstrated 1-year, 2-year, and 3-year recurrence rates of 23%, 33%, and 39%, respectively. Response to treatment was associated with lack of prior surgical treatment (p = 0.03) and less than 50 months' pain duration before GKRS (p = 0.04). Patients who described their TN pain as more severe than their worst non-TN headache pain (McGill Pain Scale IV-V vs. I-III) were also more likely to respond to treatment (p < 0.001). Seven (7.3%) patients reported new or increased trigeminal dysfunction; however, only 3.1% reported these symptoms as bothersome (BNI III-IV). Patients with sustained pain relief reported an average of 100% improvement in their QOL as a direct result of pain relief after GKRS, and 100% believed that the procedure was successful. Furthermore, among those patients with temporary pain relief and subsequent recurrence, 65% felt their treatment was a success with an average of 80% improvement in their QOL.CONCLUSIONS: GKRS provides significant pain relief and improves QOL in the majority of patients treated for TN, with few bothersome side effects. Patients with both temporary and sustained responses to treatment realized significant improvements in QOL after GKRS, and considered their treatment successful. Longer follow-up of these patients may reveal additional recurrences highlighting the importance of studies evaluating repeat GKRS and optimization of current treatment techniques and patient selection.",Excluded
2971,"Carp experiment in space microgravity--a visual-vestibular sensory conflict model. In the 8-d flight mission of Spacelab-J (STS-47) conducted in 1992, behavior of the dorsal light response (DLR) and EEG activity of the cerebellum were intermittently examined for two carp, normal and otolith-removed. The latter carp had immobilization trouble caused by twisting of the EEG cable on day 2 inflight. The problem continued for the remainder of the experiment. Analyses made on the normal carp provided additional evidence in fish for sensory-motor disorder and readjustment during early phase of microgravity, thus supporting the sensory conflict hypothesis for space motion sickness. In the present report, why and how this space experiment was conducted were reviewed with a brief summary of the results.",Excluded
3544,"Mechanisms of disease: DNA repair defects and neurological disease. In this Review, familial and sporadic neurological disorders reported to have an etiological link with DNA repair defects are discussed, with special emphasis placed on the molecular link between the disease phenotype and the precise DNA repair defect. Of the 15 neurological disorders listed, some of which have symptoms of progeria, six - spinocerebellar ataxia with axonal neuropathy-1, Huntington's disease, Alzheimer's disease, Parkinson's disease, Down syndrome and amyotrophic lateral sclerosis - seem to result from increased oxidative stress, and the inability of the base excision repair pathway to handle the damage to DNA that this induces. Five of the conditions (xeroderma pigmentosum, Cockayne's syndrome, trichothiodystrophy, Down syndrome, and triple-A syndrome) display a defect in the nucleotide excision repair pathway, four (Huntington's disease, various spinocerebellar ataxias, Friedreich's ataxia and myotonic dystrophy types 1 and 2) exhibit an unusual expansion of repeat sequences in DNA, and four (ataxia-telangiectasia, ataxia-telangiectasia-like disorder, Nijmegen breakage syndrome and Alzheimer's disease) exhibit defects in genes involved in repairing double-strand breaks. The current overall picture indicates that oxidative stress is a major causative factor in genomic instability in the brain, and that the nature of the resulting neurological phenotype depends on the pathway through which the instability is normally repaired.",Excluded
2907,"Radiotherapy of painful vertebral hemangiomas: the single center retrospective analysis of 137 cases. PURPOSE: An evaluation of dose-response relationship and an attempt to define predictive factors.METHODS AND MATERIALS: A total of 137 cases of painful vertebral hemangioma irradiations (101 patients). Fraction dose (fd) varied from 2 to 15 Gy (123 fractionated and 14 radiosurgical treatments), and total dose (TD) from 8 to 30 Gy (111 cases irradiated with fd of 2 GY to TD of 24 Gy). We evaluated pain relief, changes in analgesic requirements, and reossification.RESULTS: Means of pain relief 1, 6, 12, and 18 months after radiotherapy (defined as a decrease of primary pain level expressed in percent) were 60.5%, 65.4%, 68.3%, and 78.4%, respectively. Proportion of patients with no need for analgesics and patients using tramadol were 39%, 40%, 44%, 57%, and 20%, 17%, 22%, and 11% in these times. The proportion of patients experiencing complete/partial pain relief changed from 36/48% 1 month, to 64/22% 1.5 years after radiotherapy. No impact of radiotherapy on reossification was found. The positive impact of fd and TD increase for analgesics uptake reduction and pain relief was found. An increase of the fd by 1 Gy results in 27% chance of analgesics uptake reduction and 3.8% reduction of pain, whereas 14% analgesics uptake reduction and 2.2% of pain reduction in case of the TD. The predictive factors improving results were found: female gender, older age, better performance states (the chance of the lower analgesic treatment decreases over 2.5 times in comparison to the higher Zubrod degree), bigger Hb concentration, shorter symptoms duration and lower analgesics uptake before radiotherapy.CONCLUSIONS: The obtained data support the efficacy of radiotherapy in improving pain secondary to vertebral hemangioma, with the degree of pain amelioration being related to increasing fd and TD. The positive predictive factors were defined: female gender, older age, better performance status, increased Hb concentration, shorter symptoms duration, and lower analgesics uptake before radiotherapy.",Excluded
2949,"Comparison of the extent of hippocampal sparing according to the tilt of a patient's head during WBRT using linear accelerator-based IMRT and VMAT. In this paper, we report the results of our investigation into whole brain radiotherapy (WBRT) using linear accelerator-based intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in lung cancer patients with a high risk of metastasis to the brain. Specifically, we assessed the absorbed dose and the rate of adverse effects for several organs at risk (OAR), including the hippocampus, according to the tilt of a patient's head. We arbitrarily selected five cases where measurements were made with the patients' heads tilted forward and five cases without such tilt. We set the entire brain as the planning target volume (PTV), and the hippocampi, the lenses, the eyes, and the cochleae as the main OAR, and formulated new plans for IMRT (coplanar, non-coplanar) and VMAT (coplanar, non-coplanar). Using the dose-volume histogram (DVH), we calculated and compared the effective uniform dose (EUD), normal tissue complication probability (NTCP) of the OAR and the mean and the maximum doses of hippocampus. As a result, if the patient tilted the head forward when receiving the Linac-based treatment, for the same treatment effect in the PTV, we confirmed that a lower dose entered the OAR, such as the hippocampus, eye, lens, and cochlea. Moreover, the damage to the hippocampus was expected to be the least when receiving coplanar VMAT with the head tilted forward. Accordingly, if patients tilt their heads forward when undergoing Linac-based WBRT, we anticipate that a smaller dose would be transmitted to the OAR, resulting in better quality of life following treatment.",Excluded
3087,"Imaging neuronal pathways with 52Mn PET in rats. Objectives: We aimed at applying <sup>52</sup>Mn for PET imaging of neuronal pathways in rats, and testing potential toxicity of the tracer to the dopaminergic neurons. Method(s): <sup>52</sup>Mn was produced by proton irradiation of natCr. We have elaborated the purification procedure and the tracer was prepared for intracerebral administration in Na ascorbate-buffered saline. Rats were stereotactically injected into the ventral tegmental area (VTA) or striatum (STR) with app. 170kBq and scanned 24 h later. Behavioral (rotameter test) and histological (TH-staining) evaluation was performed after 4 weeks. Another group of rats was injected with a reduced radioactivity dose and the same toxicity evaluation took place at three time points. The influence of the radiation dose on the DNA integrity was tested with gH2AX-staining in a separate experiment. Finally, gradual transport of <sup>52</sup>Mn along the dopaminergic pathways was imaged continuously for 6 h in additional animals. Result(s): <sup>52</sup>Mn transport along the mesolimbic and nigrostriatal pathways was clearly visible in PET images of the VTA-injected rats, as well as along the striatonigral tracts following the intrastriatal administration. Quantitative analysis of the PET data confirmed the tracer distribution in expected brain regions. Impaired motor control and dopaminergic lesion were found in some animals treated with the high radioactivity dose. This effect was completely abolished by reducing the dose to 20+/-5 kBq. There was also no increase in the double strand DNA breaks in the brain tissues treated with the lower dose as compared to the controls. Gradual <sup>52</sup>Mn transport along the mesolimbic pathway could be observed in dynamic PET images. Conclusion(s): <sup>52</sup>Mn traces neuronal pathways which can be imaged with PET. The optimized experimental protocol prevents lesioning dopaminergic neurons and affecting the rotation behavior up to 4 weeks post-injection in rats. Stages of the progressive movement of the tracer along the dopaminergic pathway can be visualize.",Excluded
3064,Regional changes in brain serotonin after head x-irradiation and its significance in the potentiation of barbiturate hypnosis,Included
3595,"Posture, locomotion, spatial orientation, and motion sickness as a function of space flight. This article summarizes a variety of newly published findings obtained by the Neuroscience Laboratory, Johnson Space Center, and attempts to place this work within a historical framework of previous results on posture, locomotion, motion sickness, and perceptual responses that have been observed in conjunction with space flight. In this context, we have taken the view that correct transduction and integration of signals from all sensory systems is essential to maintaining stable vision, postural and locomotor control, and eye-hand coordination as components of spatial orientation. The plasticity of the human central nervous system allows individuals to adapt to altered stimulus conditions encountered in a microgravity environment. However, until some level of adaptation is achieved, astronauts and cosmonauts often experience space motion sickness, disturbances in motion control and eye-hand coordination, unstable vision, and illusory motion of the self, the visual scene, or both. Many of the same types of disturbances encountered in space flight reappear immediately after crew members return to earth. The magnitude of these neurosensory, sensory-motor and perceptual disturbances, and the time needed to recover from them, tend to vary as a function of mission duration and the space travelers prior experience with the stimulus rearrangement of space flight. To adequately chart the development of neurosensory changes associated with space flight, we recommend development of enhanced eye movement systems and body position measurement. We also advocate the use of a human small radius centrifuge as both a research tool and as a means of providing on-orbit countermeasures that will lessen the impact of living for long periods of time with out exposure to altering gravito-inertial forces.",Excluded
2699,"Simulated Microgravity and Low-Dose/Low-Dose-Rate Radiation Induces Oxidative Damage in the Mouse Brain. Microgravity and radiation are stressors unique to the spaceflight environment that can have an impact on the central nervous system (CNS). These stressors could potentially lead to significant health risks to astronauts, both acutely during the course of a mission or chronically, leading to long-term, post-mission decrements in quality of life. The CNS is sensitive to oxidative injury due to high concentrations of oxidizable, unsaturated lipids and low levels of antioxidant defenses. The purpose of this study was to evaluate oxidative damage in the brain cortex and hippocampus in a ground-based model for spaceflight, which includes prolonged unloading and low-dose radiation. Whole-body low-dose/low-dose-rate (LDR) gamma radiation using (57)Co plates (0.04 Gy at 0.01 cGy/h) was delivered to 6 months old, mature, female C57BL/6 mice (n = 4-6/group) to simulate the radiation component. Anti-orthostatic tail suspension was used to model the unloading, fluid shift and physiological stress aspects of the microgravity component. Mice were hindlimb suspended and/or irradiated for 21 days. Brains were isolated 7 days or 9 months after irradiation and hindlimb unloading (HLU) for characterization of oxidative stress markers and microvessel changes. The level of 4-hydroxynonenal (4-HNE) protein, an oxidative specific marker for lipid peroxidation, was significantly elevated in the cortex and hippocampus after LDR + HLU compared to controls (P < 0.05). The combination group also had the highest level of nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) expression compared to controls (P < 0.05). There was a significant decrease in superoxide dismutase (SOD) expression in the animals that received HLU only or combined LDR + HLU compared to control (P < 0.05). In addition, 9 months after LDR and HLU exposure, microvessel densities were the lowest in the combination group, compared to age-matched controls in the cortex (P < 0.05). Our data provide the first evidence that prolonged exposure to simulated microgravity and LDR radiation is associated with increased oxidative stress biomarkers that may increase the likelihood of brain injury and reduced antioxidant defense. NOX2-containing nicotinamide adenosine dinucleotide phosphate (NADPH oxidase) may contribute to spaceflight environment-induced oxidative stress.",Included
3050,"Dark light, rod saturation, and the absolute and incremental sensitivity of mouse cone vision. Visual thresholds of mice for the detection of small, brief targets were measured with a novel behavioral methodology in the dark and in the presence of adapting lights spanning ~8 log(10) units of intensity. To help dissect the contributions of rod and cone pathways, both wild-type mice and mice lacking rod (Gnat1(-/-)) or cone (Gnat2(cpfl3)) function were studied. Overall, the visual sensitivity of mice was found to be remarkably similar to that of the human peripheral retina. Rod absolute threshold corresponded to 12-15 isomerized pigment molecules (R*) in image fields of 800 to 3000 rods. Rod ""dark light"" (intrinsic retinal noise in darkness) corresponded to that estimated previously from single-cell recordings, 0.012 R* s(-1) rod(-1), indicating that spontaneous thermal isomerizations are responsible. Psychophysical rod saturation was measured for the first time in a nonhuman species and found to be very similar to that of the human rod monochromat. Cone threshold corresponded to ~5 R* cone(-1) in an image field of 280 cones. Cone dark light was equivalent to ~5000 R* s(-1) cone(-1), consistent with primate single-cell data but 100-fold higher than predicted by recent measurements of the rate of thermal isomerization of mouse cone opsins, indicating that nonopsin sources of noise determine cone threshold. The new, fully automated behavioral method is based on the ability of mice to learn to interrupt spontaneous wheel running on the presentation of a visual cue and provides an efficient and highly reliable means of examining visual function in naturally behaving normal and mutant mice.",Excluded
3534,"Multiple myeloma with extramedullary dissemination to lung: A rare cause of pancoast syndrome. Introduction: Extramedullary plasmacytomas constitute 3% of plasma cell malignancies, and majority of which primarily occur in the head and neck. The occurrence of extramedullary disease in multiple myeloma is less common. We report a case of multiple myeloma which presented as Pancoast syndrome due to extramedullary dissemination to lung. Case report: A 76-year-old man presented to the Emergency Department with worsening of right shoulder pain for 2 days. He gave a 6 month history of sharp, persistent, right shoulder pain, radiating to medial aspect of arm and forearm associated with numbness and tingling. He subsequently underwent carpal tunnel release and ulnar nerve reposition surgeries. Examination revealed a hard, non mobile mass in the right supraclavicular fossa. Chest radiograph revealed a soft tissue density in the right lung apex and an extrapulmonary mass along the right lower chest wall (Image 1a). CT chest (Image 1b) and MRI spine (Image 1c) revealed multiple masses adjacent to the pleura on the right side and a large right apical lung mass involving the supraclavicular fossa, right posterior cervical space, prevertebral musculature with osseous and epidural invasion. A ultrasound guided biopsy of supraclavicular portion of the lung mass demonstrated neoplastic plasma cells (Image 2a). Serum and urine electrophoresis revealed monoclonal spike with IgG Lambda chains. A bone marrow biopsy confirmed multiple myeloma (Image 2b) and he was diagnosed with an unusual case of Pancoast syndrome caused by multiple myeloma with extramedullary dissemination to lung. He completed a course of palliative radiation to the right lung mass and is currently on bortezomib and prednisone. Discussion(s): Pancoast tumors are primarily non-small cell lung cancers. Multiple myeloma presenting as Pancoast syndrome is less common. The prognosis of these patients is poor. The typical thoracic manifestation of multiple myeloma is bony involvement of the thoracic cage. Other manifestations are pneumonia, mediastinal lymphadenopathy, reticulonodular shadows, interstitial pattern and intrapulmonary calcification. Pancoast tumors, by their close vicinity to neurovascular structures like brachial plexus and subclavian vessels, often present with musculoskeletal pain and distal neurologic symptoms resulting in referral to orthopedicians or physiotherapists. Patients are initially treated for arthritis and bursitis of shoulder and a delay of 6-9 months have been reported in many cases before the tumor was discovered. We are reporting this case to emphasize the importance of including multiple myeloma in the work up of Pancoast syndrome. (Figure Presented).",Excluded
3076,Post-mortem observation of glioma and/or brain tissue compared to C-T scan findings after irradiation. [Japanese]. C-T scan findings in glioma and brain tissue after irradiation were histopathologically analyzed with the post-mortem examination of 4 patients. High density of contrast enhancement observed in gliomas mainly corresponded to proliferation of irregular blood vessels and hypodensity reflected less cellular area or necrotic foci in the tumor tissue. A mottled lesion with high density margin in C-T of radionecrosis of the brain tissue observed in a non-glioma patient was formed by coagulation necrosis showing marked proliferation of telangiectatic blood vessels in periphery of lesion and acellular area in the center. It is occasionally impossible to differentiate the findings between delayed radionecrosis of brain and recurrence of glioma using the C-T criteria alone.,Excluded
3409,"Light-induced Egr-1 expression in the striate cortex of the opossum. In the present study, immunocytochemistry was used to assess the expression of Egr-1 nuclear protein across selected regions of the opossum visual system. In light-deprived (LD) animals, only a few scattered cell nuclei were found throughout the striate cortex (V1). Exposure to light promoted a significant increase in the density of Egr-1 labeled nuclei in V1. Laminar distribution of immunoreactive nuclei in light-stimulated animals (LS) tended to vary with topography: the lateral region, which corresponds to the central representation of the visual field, appeared to have higher density of cells expressing protein in the supragranular layers, as compared to the medial region, which corresponds to the representation of the peripheral field of vision. Finally, LS animals displayed a narrow band of labeled cell nuclei in the intergeniculate leaflet (IGL) and throughout the anteroposterior extent of the superior colliculus (SC). In contrast, almost no Egr-1 immunolabeling was found in the IGL and SC of LD animals. Our report is the first demonstration of light-regulated expression of the Egr-1 gene in the opossum visual system and provides evidence that the expression of an activity-dependent gene related to neural plasticity is evolutionarily conserved in the visual cortex of the mammalian lineage.",Excluded
2400,"Casticin inhibits growth and enhances ionizing radiation-induced apoptosis through the suppression of STAT3 signaling cascade. Casticin (CTC), one of the major components of Vitex rotundifolia L., has been reported to exert significant beneficial pharmacological activities and can function as an antiprolactin, anticancer, anti-inflammatory, neuroprotective, analgesic, and immunomodulatory agent. This study aimed at investigating whether the proapoptotic effects of CTC may be mediated through the abrogation of signal transducers and activators of transcription-3 (STAT3) signaling pathway in a variety of human tumor cells. We found that CTC significantly decreased cell viability in a concentration-dependent manner and suppressed cell proliferation in 786-O, YD-8, and HN-9 cells. CTC also induced programmed cell death that was found to be mediated via caspase-3 activation and induction of poly(ADP-ribose) polymerase cleavage. Interestingly, CTC repressed both constitutive and interleukin-6-induced STAT3 activation in 786-O and YD-8 cells but only affected constitutive STAT3 phosphorylation in HN-9 cells. Moreover, CTC could potentiate ionizing radiation-induced apoptotic effects leading to the downregulation of STAT3 activation and thus may be used in combination with radiation against diverse malignancies.",Excluded
3231,"Neuronal activity in vivo enhances functional myelin repair. In demyelinating diseases such as Multiple Sclerosis (MS), demyelination of neuronal fibers impairs impulse conduction and causes axon degeneration. While neuronal activity stimulates oligodendrocyte production and myelination in normal conditions, it remains unclear whether the activity of demyelinated axons restores their loss-of-function in a harmful environment. To investigate this question, we established a model to induce a moderate optogenetic stimulation of demyelinated axons in the corpus callosum at the level of the motor cortex in which cortical circuit activation and locomotor effects were reduced in adult freely moving mice. We demonstrate that a moderate activation of demyelinated axons enhances the differentiation of oligodendrocyte precursor cells onto mature oligodendrocytes, but only under a repeated stimulation paradigm. This activity-dependent increase in the oligodendrocyte pool promotes an extensive remyelination and functional restoration of conduction, as revealed by ultrastructural analyses and compound action potential recordings. Our findings reveal the need of preserving an appropriate neuronal activity in the damaged tissue to promote oligodendrocyte differentiation and remyelination, likely by enhancing axon-oligodendroglia interactions. Our results provide new perspectives for translational research using neuromodulation in demyelinating diseases.",Excluded
2893,"Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. PURPOSE: Radiotherapy (RT) and chemotherapy may prolong survival in older patients (age >=70 years) with glioblastoma multiforme (GBM), although the survival benefits remain poor. This Phase II multicenter study was designed to evaluate the efficacy and safety of an abbreviated course of RT plus concomitant and adjuvant temozolomide (TMZ) in older patients with GBM.PATIENTS AND METHODS: Seventy-one eligible patients 70 years of age or older with newly diagnosed GBM and a Karnofsky performance status >=60 were treated with a short course of RT (40 Gy in 15 fractions over 3 weeks) plus TMZ at the dosage of 75 mg/m(2) per day followed by 12 cycles of adjuvant TMZ (150-200 mg/m(2) for 5 days during each 28-day cycle). The primary endpoint was overall survival (OS). Secondary endpoints included progression-free survival and toxicity.RESULTS: The Median OS was 12.4 months, and the 1-year and 2-year OS rates were 58% and 20%, respectively. The median and 1-year rates of progression-free survival were 6 months and 20%, respectively. All patients completed the planned programme of RT. Grade 3 or 4 adverse events occurred in 16 patients (22%). Grade 3 and 4 neutropenia and/or thrombocytopenia occurred in 10 patients (15%), leading to the interruption of treatment in 6 patients (8%). Nonhematologic Grade 3 toxicity was rare, and included fatigue in 4 patients and cognitive disability in 1 patient.CONCLUSIONS: A combination of an abbreviated course of RT plus concomitant and adjuvant TMZ is well tolerated and may prolong survival in elderly patients with GBM. Future randomized studies need to evaluate the efficacy and toxicity of different schedules of RT in association with chemotherapy.",Excluded
3242,"Dosimetric comparison of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) in total scalp irradiation: A single institutional experience. Purpose: Total scalp irradiation (TSI) is a rare but challenging indication. We previously reported that non-coplanar intensitymodulated radiotherapy (IMRT) was superior to coplanar IMRT in organ-at-risk (OAR) protection and target dose distribution. This consecutive treatment planning study compared IMRT with volumetric-modulated arc therapy (VMAT). Material(s) and Method(s): A retrospective treatment plan databank search was performed and 5 patient cases were randomly selected. Cranial imaging was restored from the initial planning computed tomography (CT) and target volumes and OAR were redelineated. For each patients, three treatment plans were calculated (coplanar/non-coplanar IMRT, VMAT; prescribed dose 50 Gy, single dose 2 Gy). Conformity, homogeneity and dose volume histograms were used for plan. Result(s): VMAT featured the lowest monitor units and the sharpest dose gradient (1.6 Gy/mm). Planning target volume (PTV) coverage and homogeneity was better in VMAT (coverage, 0.95; homogeneity index [HI], 0.118) compared to IMRT (coverage, 0.94; HI, 0.119) but coplanar IMRT produced the most conformal plans (conformity index [CI], 0.43). Minimum PTV dose range was 66.8%- 88.4% in coplanar, 77.5%-88.2% in non-coplanar IMRT and 82.8%-90.3% in VMAT. Mean dose to the brain, brain stem, optic system (maximum dose) and lenses were 18.6, 13.2, 9.1, and 5.2 Gy for VMAT, 21.9, 13.4, 14.5, and 6.3 Gy for non-coplanar and 22.8, 16.5, 11.5, and 5.9 Gy for coplanar IMRT. Maximum optic chiasm dose was 7.7, 8.4, and 11.1 Gy (non-coplanar IMRT, VMAT, and coplanar IMRT). Conclusion(s): Target coverage, homogeneity and OAR protection, was slightly superior in VMAT plans which also produced the sharpest dose gradient towards healthy tissue. Copyright Â© 2016. The Korean Society for Radiation Oncology.",Excluded
2519,"Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trial. BACKGROUND: Obesity is a risk factor for coronary artery disease (CAD), but adiposity may mimic symptoms of CAD and reduce the accuracy of diagnostic testing.METHODS: Patients from the PROMISE trial (n=8889) were classified according to body mass index (BMI). We assessed relationships between BMI, physician's preference of functional test, test positivity, and results of invasive coronary angiography (Cath) using logistic regression models.RESULTS: Nearly half (48%) of the patients had BMI>=30kg/m<sup>2</sup>, and 20% had BMI>=35. Providers were more likely to prefer nuclear myocardial perfusion imaging (MPI) over other functional tests as BMI increased. The rate of test positivity with coronary computed tomographic angiography (CTA) was not different (10% vs. 12%) in patients with BMI >=35 vs. < 35. The same was true for stress echocardiogram and stress electrocardiogram (positivity 8-13%, P>0.8 for both). In contrast, MPI was significantly more likely to be positive in those with BMI >=35 vs. <35 (18% vs. 13%; P=0.001). The likelihood of obstructive CAD at Cath did not differ with BMI >=35 vs. <35 in patients having CTA (52% vs. 59%, P=0.22), but among MPI patients, Cath positivity was only 29% with BMI >=35 vs. 48% with BMI <35 (P=0.005). Radiation exposure increased with higher BMI in both MPI and CTA groups.CONCLUSIONS: Increasing levels of obesity adversely affect the diagnostic yield of MPI more than CTA. The degree of obesity should be considered when choosing evaluation strategies for patients with chest pain.CLINICAL TRIAL REGISTRATION: PROMISE ClinicalTrials.gov number, NCT01174550.",Excluded
2741,"Corticotropin-releasing hormone-mediated pathway of leptin to regulate feeding, adiposity, and uncoupling protein expression in mice. To examine the functional role of CRH in the regulation of energy homeostasis by leptin, we measured the effects of the CRH antagonist, alpha-helical CRH 8-41 (alphaCRH) on a number of factors affected by leptin activity. These included food intake, body weight, hypothalamic c-fos-like immunoreactivity (c-FLI), weight and histological characterization of white adipose tissue, and mRNA expressions of uncoupling protein (UCP) in brown adipose tissue (BAT) in C57Bl/6 mice. Central infusion of leptin into the lateral cerebroventricle (icv) caused significant induction of c-FLI in the paraventricular nucleus (PVN), ventromedial hypothalamic nucleus (VMH), dorsomedial hypothalamic nucleus, and arcuate nucleus. In all these nuclei, the effect of leptin on expression of cFLI in the PVN and VMH was decreased by treatment with alphaCRH. Administration of leptin markedly decreased cumulative food intake and body weight with this effect being attenuated by pretreatment with alphaCRH. In peripheral tissue, leptin up-regulated BAT UCP1 mRNA expression and reduced fat depositions in this tissue. Those changes in BAT were also decreased by treatment with alphaCRH. As a consequence of the effects on food intake or energy expenditure, treatment with alphaCRH attenuated the leptin-induced reduction of body adiposity, fat cell size, triglyceride contents, and ob mRNA expression in white adipose tissue. Taken together, these results indicate that CRH neurons in the PVN and VMH may be an important mediator for leptin that contribute to regulation of feeding, adiposity, and UCP expression.",Excluded
3504,"Effects of whole body <sup>56</sup>Fe radiation on contextual freezing and Arc-positive cells in the dentate gyrus. The space radiation environment contains high-energy charged particles such as <sup>56</sup>Fe, which could pose a significant hazard to hippocampal function in astronauts during and after the mission(s). The mechanisms underlying impairments in cognition are not clear but might involve alterations in the percentage of neurons in the dentate gyrus expressing the plasticity-related immediate early gene Arc. Previously, we showed effects of cranial <sup>56</sup>Fe irradiation on hippocampus-dependent contextual freezing and on the percentage of Arc-positive cells in the enclosed, but not free, blade. Because it is unclear whether whole body <sup>56</sup>Fe irradiation causes similar effects on these markers of hippocampal function, in the present study we quantified the effects of whole body <sup>56</sup>Fe irradiation (600MeV, 0.5 or 1Gy) on hippocampus-dependent and hippocampus-independent cognitive performance and determined whether these effects were associated with changes in Arc expression in the enclosed and free blades of the dentate gyrus. Whole body <sup>56</sup>Fe irradiation impacted contextual but not cued fear freezing and the percentage of Arc-positive cells in the enclosed and free blades. In mice tested for contextual freezing, there was a correlation between Arc-positive cells in the enclosed and free blades. In addition, in mice irradiated with 0.5Gy, contextual freezing in the absence of aversive stimuli correlated with the percentage of Arc-positive cells in the enclosed blade. In mice tested for cued freezing, there was no correlation between Arc-positive cells in the enclosed and free blades. In contrast, cued freezing in the presence or absence of aversive stimuli correlated with Arc-positive cells in the free blade. In addition, in mice irradiated with 1Gy cued freezing in the absence of aversive stimuli correlated with the percentage of Arc-positive neurons in the free blade. These data indicate that while whole body <sup>56</sup>Fe radiation affects contextual freezing and Arc-positive cells in the dentate gyrus, the enclosed blade might be more important for contextual freezing while the free blade might be more important for cued freezing. Â© 2013 Elsevier B.V.",Included
3199,Radiotherapy for brain metastases: quo vadis?,Excluded
3479,Response of central neurons of the edible snail to exposure to laser radiation of different wavelengths. [Russian],Excluded
3361,"Role of GDNF in the modulation of SGSCs radiation response; regeneration or senescence?. Purpose or Objective Secretory function restoration is a challenge for regenerative therapy of radiation-damaged salivary glands. Recently, stem cell therapy has been proposed to allow such a functional regeneration. It has been suggested that glial-cell-derived neurotrophic factor (GDNF) promotes survival of mice salivary gland stem cells (mSGSCs). GDNF-treatment in combination with stem cell based regenerative therapy could represent a promising treatment for radiation-induced hyposalivation and consequential xerostomia. However, the role of GDNF on SGSC survival and proliferation after therapeutic irradiation is still an enigma. The purpose of this study was to investigate the role of GDNF in the modulation of SGSC response to irradiation. Material and Methods Salivary gland organoid derived cells of Gdnf hypermorphic (Gdnf<sup>wt/hyper</sup>) and wild-type mice (Gdnfwt/wt) were irradiated (IR) with gamma-rays at 0, 1, 2, 4 and 8Gy. mSGSC survival and stemness were assessed by calculating stem cell surviving fraction measured as post- IR organoid forming potential and population doublings. Flow cytometry was used to determine the CD24<sup>hi</sup>/CD29<sup>hi</sup> stem cell (SC) population. qPCR and immunofluorescence were used to detect GDNF expression. Six-day-old salivary gland organoids were irradiated with 7 Gy of yrays, IR induced organoids senescence were confirmed by SA-s-Gal and P16 staining. Results Exogenously added GDNF or increase expression of GDNF in hypermorphic mice SGSC induced an increase in secondary organoids formation efficiency when compared to wild-type mice/untreated SG (p<0.05). However, neither endogenous nor exogenous GDNF increased the CD24<sup>hi</sup>CD29<sup>hi</sup> stem cell-like population. Organoids IR surviving fraction (OSF) of mSGSCs were similar albeit resulted in larger spheres and an increased cell number in the Gdnf<sup>wt/hyper</sup> compared to Gdnfwt/wt group. Indeed, mSGSC of Gdnf<sup>wt/hyper</sup> mice showed high sphere forming efficiency upon replating. Cell cycle distribution of SGSC after irradiation had no difference with or without GDNF. Interestingly, GDNF expression was highly upregulated after irradiation both in vitro (p=0.008) and in vivo (p<0.05) but normalized in vivo after mSGSC transplantation-related regeneration. Receptor tyrosine kinase (RET) expression was strongly related to OSF (r=0.842, p=0.002) and co-localized with GDNF in salivary gland striated ducts. More than 90% IR induced senescence located in striated ducts where GDNF colocalized with senescence marker p16 and SA-s-Gal. Interestingly, senescence cells were detected in organoids after IR. Conclusion GDNF does not protect mSGSCs against irradiation but seems to promote mSGSCs proliferation through the GDNF-RET signaling pathway. Post-transplantation stimulation of GDNF/RET pathway may enhance the regenerative potential of mSGSCs. IR induced upregulation of GDNF may be involved in IR induced senescence.",Included
3187,"Cerenkov luminescence imaging with PET probes for brain function analysis. Objectives Optical imaging has advantages in its easy-to-use feature. However, brain imaging is not easy in optical molecular imaging, since the molecular sizes of fluorescent probes are usually too large to penetrate the bloodbrain- barrier. On the other hands, PET imaging is superior in quantitative analysis, and many brain imaging probes are available. Cerenkov radiation is electromagnetic radiation emitted when a charged particle (such as a positron) passes through a dielectric medium at a speed greater than the phase velocity of light in that medium. Here, we evaluated the feasibility of CLI for the analysis of brain functions using [<sup>18</sup>F]FDG, [<sup>11</sup>C]raclopride and [<sup>11</sup>C]beta-CFT. Methods For [<sup>18</sup>F]FDG imaging, the mice were separated into two groups. For one group, the hair of the mice were shaved (w/o hair), and for other group, the skull was additionally removed (w/o hair & skull). [<sup>18</sup>F]FDG (3 MBq, iv) was injected to each group of the mice, and PET imaging was performed from 30 to 60 min after the injection. Then, Cerenkov luminescence imaging (CLI) was done for 10 min from just after the PET imaging. After in vivo CLI, the brain was removed and ex vivo CLI was performed. Then, the radioactivity of the brain was measured by a gamma-counter. Various fasting times were set for each mouse in order to produce various blood sugar levels. For [<sup>11</sup>C]raclopride imaging, the mice (w/o hair) were injected with 7.4 MBq of the tracer, and sequential 8-min CLI (followed by 2-min interval) was performed from 8-10 min after the injection. In vivo blocking study was done by treating the mice with haloperidol. Also, the images were obtained by [<sup>11</sup>C]beta-CFT. Results In [<sup>18</sup>F]FDG studies, there was a good relationship between the radioactivity and CLI signal in removed brains (r=0.93). The good correlation was observed in w/o hair & skull group (r=0.92). The correlation was weaker in w/o hair group (r=0.74), but it thought to be acceptable for the analysis in mice. The striatum was successfully visualized by [<sup>11</sup>C]raclopride and [<sup>11</sup>C]beta-CFT. Luminescence in the striatum was decreased by haloperidol treatment. Since the brain uptake of [<sup>11</sup>C]beta-CFT was higher than [<sup>11</sup>C]raclopride, [<sup>11</sup>C]beta-CFT produced more clearer images in CLI. Conclusions Optical imaging was possible with PET imaging probes. Although both quantitativity and sensitivity are inferior to PET imaging, it is possible to use CRI for brain function analysis in mice.",Excluded
3221,"[Complication of irradiation in brain tumors]. Examination by questionnaire throughout the country revealed 97 cases of radiation brain necrosis (RN). Of the above 97 cases, histologically confirmed 39, having received one course of radiation therapy received an average dose of 62 +/- 10.6 Gy. Minimal total dose provocative of RN is estimated statistically to be 40.6 Gy. Safety fractionation for total dose is regarded as standard in case of 1.8 Gy per once by 22 fractionations for a total dose of 40 Gy and of 1.4 Gy per once by 36 fractionations for a total dose of 50 Gy. After left frontotemporal craniotomy for pituitary adenoma, postoperative opposing 2 fields irradiation brought about right RN on the right side. Examination by means of PET is useful for the differentiation RN from recurrence of malignant glioma. The appearance of foam cells in tunica intima arteriole in substance alba and subsequent luminal narrowing are interesting histological findings in RN.",Excluded
3384,A new interpretation of the mechanism underlying visual anomalies of astronauts,Excluded
3379,"Reduced-dose radiosurgery for vestibular schwannomas. OBJECTIVE: To evaluate tumor control and complications associated with low-dose radiosurgery for vestibular schwannomas. METHOD(S): Between December 1993 and January 2000, 47 patients with vestibular schwannomas were treated at our center with gamma knife radiosurgery. The marginal tumor doses ranged from 7.5 to 14.0 Gy (median, 12.0 Gy) for patients treated after microsurgery and from 10.0 to 15.0 Gy (median, 12.0 Gy) for patients in whom radiosurgery was the primary treatment. The median maximum tumor diameter was 18 mm (range, 3-50 mm). Evaluation included audiometry, neurological examination, and serial imaging tests. A survey was conducted at the time of analysis. RESULT(S): Follow-up data were available for 45 patients and ranged from 1 to 7 years (median, 3.6 yr). In 43 patients (96%), tumor control (no radiographic progression or surgical resection) was observed. All 33 previously untreated patients had tumor control. Transient facial weakness, experienced in two patients (4%), had resolved completely within 6 months. No patient developed trigeminal neuropathy. Hearing was diminished from baseline in 12% of patients with useful hearing (Gardner-Robertson Class III). However, all patients with pretreatment hearing Gardner-Robertson Class I or II maintained testable hearing (Class I to III) at the most recent examination. CONCLUSION(S): Low-dose radiosurgery in this series provided comparable local control and decreased incidences of complications in relation to other reports. Additional follow-up will allow more definitive conclusions to be reached regarding the ultimate rates of tumor control and hearing preservation. Nevertheless, the current dose used for vestibular schwannomas at the University of Maryland Medical Center is 12.0 Gy to the tumor periphery.",Excluded
2668,"GLIOGENE - An international consortium to understand familial glioma. Evidence for familial aggregation of glioma has been documented in both case-control and cohort studies and occurs apart from the well-described rare inherited genetic syndromes involving glioma: neurofibromatosis type 1 and 2, tuberous sclerosis, Turcot's syndrome, and Li-Fraumeni syndrome. Nonsyndromic glioma families have been studied but no genes have been identified in the two published linkage studies of familial glioma probably due to the small number of families. Because glioma is a rare but devastating cancer, and a family history of glioma has been observed in ~5% of the cases, we initiated an international consortium to identify glioma families not affected by syndromes to better understand the inherited factors related to this disease. The international consortium GLIOGENE is an acronym for ""glioma gene"" and includes 15 research groups in North America, Europe, and Israel to study familial glioma. The overarching goal is to characterize genes in glioma families using a genome-wide single-nucleotide polymorphism approach and conducting linkage analysis to identify new genomic regions or loci that could harbor genes important for gliomagenesis. Here, we review the rationale for studying familial glioma and our proposed strategy for the GLIOGENE study. Copyright Â© 2007 American Association for Cancer Research.",Excluded
3412,"Radiation-induced optic neuropathy 4 years after radiation: report of a case followed up with MRI. We report a case of radiation-induced optic neuropathy in a 32-year-old man with Cushing's disease and a recurrent tumour of the left cavernous sinus. The patient experienced rapid, painless loss of vision 4 years after treatment without recurrence of tumour or other visual disorder. MRI showed enlargement and contrast enhancement of the optic chiasm. A year later the patient was almost blind and MRI showed atrophy and persistent contrast enhancement of the chiasm.",Excluded
2559,"[Sensitivity to glare before and after Nd:YAG capsulotomy. Comparison between small and large capsulotomy]. AIM OF THE STUDY: The aim of this study was to determine whether capsulotomy size influences visual performance.PATIENTS AND METHODS: Twenty eyes were included in this study and were divided into two groups: 10 eyes had small central capsulotomies without dilating the pupil, and 10 eyes had large capsulotomies through dilated pupils. We measured both, visual acuity and glare due to forward light scatter using a computer system.RESULTS: Following treatment both groups had equally significant (< 0.001) improvements in visual acuity. However, a significant (p < 0.001) improvement of glare due to forward light scatter was only observed in the eyes with a large size capsulotomy.CONCLUSIONS: Our study showed that measurements of forward light scatter are more sensitive than visual acuity testing in demonstrating loss of visual performance in patients with media opacities. It is recommended that pupils are dilated prior to Nd:YAG capsulotomy if forward light scatter from capsule remnants and the subsequent glare disability are to be minimised.",Excluded
3093,"Biopsy of enlarging lesions after stereotactic radiosurgery for brain metastases frequently reveals radiation necrosis. Background: Stereotactic radiosurgery (SRS) offers excellent local control for brain metastases (BM) with low rates of toxicity. Radiation necrosis (RN) may occur after treatment and is challenging to distinguish from local recurrence (LR). We evaluated enlarging brain lesions following SRS that were subsequently biopsied to differentiate RN versus LR.Methods: This study reviewed patients receiving SRS for BM between 2008 and 2012 who underwent a biopsy for suspicion of RN versus LR on MRI. Data collection included demographics, radiation parameters, imaging findings, and post-biopsy pathology. Kaplan-Meier methods determined overall survival. Fisher's exact test assessed for association between lesion biopsy result and variables of interest.Results: Thirty-four patients with 35 biopsied BM were included. Lesions were biopsied a median of 8.8 months after SRS. Most patients had primary lung cancer (11; 31.4%). Eleven (31.4%) biopsies were positive for LR and 24 (68.6%) showed RN only. Median overall survival was longer for patients with RN (31.0 mo) than for patients with LR (14.5 mo; P = 0.135). Time from SRS to biopsy was significantly different between RN and LR groups; 10 lesions (52.5%) biopsied <=9 months after SRS showed LR, whereas 1 lesion (6.3%) biopsied >9 months after SRS showed LR (P = 0.004). For 16 (65.7%) lesions, management was changed or directed by the biopsy results.Conclusions: Stereotactic biopsy for accessible enlarging lesions after SRS appears diagnostically valuable in patients with few lesions and changes clinical management. RN should be suspected in patients with an enlarging lesion more than 9 months post-SRS.",Excluded
3058,"Initial clinical experience of a prototype ultra-high-resolution CT for assessment of small intracranial arteries. Purpose: Diagnostic and neurosurgical procedures require the precise localization of small intracranial arteries, but this may be difficult using conventional computed tomography angiography (CTA). This study was conducted to evaluate the quality of CTA images acquired using a prototype ultra-high-resolution computed tomography (U-HRCT) system compared with those acquired using a conventional computed tomography (C-CT) system. Material(s) and Method(s): From July through September 2015, 10 adult patients (6 women and 4 men) previously scanned by C-CT were examined using U-HRCT to locate and assess cerebral aneurysms. The bilateral ophthalmic artery (Opth A), anterior choroidal artery (Acho A), and thalamoperforating arteries (TPAs) were visually evaluated in randomly presented CTA images. Images were graded on a 5-point scale, and differences in scores between U-HRCT and C-CT were evaluated by the Wilcoxon signed-rank test. A p value < 0.05 was considered statistically significant. Result(s): Visual evaluation scores for images of the Opth A, Acho A, and TPAs were significantly higher for U-HRCT than for C-CT. U-HRCT images achieved good visualization (score > 3) for C-CT images with poor visualization (score < 3) in 66.7-100% of all the small arteries. Conclusion(s): U-HRCT is superior to C-CT for detecting and evaluating clinically significant small intracranial arteries. Copyright Â© 2019, Japan Radiological Society.",Excluded
2511,"Radiation tolerance of normal temporal bone structures: implications for gamma knife stereotactic radiosurgery. Popular current thought states that hearing loss and facial weakness after radiosurgery of vestibular schwannomas is a function of cranial nerve damage. Although this may be true in some cases, the middle and inner ear contain rich networks of other sensitive structures that are at risk after radiotherapy and that may contribute to toxicity afterward. We reviewed the limited reported data regarding radiation tolerance of external, middle, and inner ear structures, and perspectives for therapy with gamma knife stereotactic radiosurgery are addressed. [References: 32]",Excluded
2924,"Effects of near-infra-red laser irradiation on adenosine triphosphate and adenosine diphosphate contents of rat brain tissue. Low-power, near-infra-red laser irradiation has been used to relieve patients from various kinds of pain, though the precise mechanisms of such biological actions of the laser have not yet been resolved. To investigate the cellular mechanisms by near-infra-red laser on the nervous system, we examined the effect of 830-nm laser irradiation on the energy metabolism of the rat brain. The diode laser was applied for 15 min with an irradiance of 4.8 W/cm(2). Tissue adenosine triphosphate (ATP) content of the irradiated area in the cerebral cortex was 19% higher than that of the non-treated area, whereas the adenosine diphosphate (ADP) content showed no significant difference. Laser irradiation at another wavelength (652 nm) had no effect on either ATP or ADP contents. The temperature of the tissue was increased by 4.4-4.7 degrees C during the irradiation of both wavelengths. These results suggest that the increase in tissue ATP content did not result from the thermal effect, but from a specific effect of the laser operated at the 830-nm wavelength.",Excluded
2526,"[Analysis of prognostic factors in NSCLC patients with brain metastases diagnosed by constrast-enhanced MRI after whole brain radiotherapy]. BACKGROUND AND OBJECTIVE: Brain metastases are a common complication of lung cancer, occurring in 20%-40% of patients. The aim of this study is to explore prognostic factors in non-small cell lung cancer (NSCLC) in patients with brain metastases diagnosed by constrast-enhanced MRI after whole brain radiotherapy.METHODS: TA retrospective review of clinical data from 241 NSCLC patients with brain metastases received whole brain radiotherapy from April 2007 to October 2008 was performed. A number of potential factors that might affect prognosis after irradiation were evaluated. The significance of prognostic variables in the survival resulted from univariate analysis by Kaplan-Meier combining with Log-rank test, and the multivariate analysis was obtained by Cox regression model.RESULTS: Median follow-up time for the survivors was 19.1 months. For all patients, the median survival time (MST) was 8.7 months. By univariate analysis, female patients with KPS>70, no symptom when diagnosed with brain metastases, tumor controlled in the chest, and received more than 3 cycles of chemotherapy and combined target therapy were the important factors for overall survival. By multivariate analysis, female, tumors controlled in the chest, and combined target therapy were independent prognostic factors for NSCLC patients with brain metastases. Tumor controlled in the chest was the most important independent prognostic factor.CONCLUSIONS: Gender, local tumor controlled, and combined target therapy significantly influenced NSCLC brain metastases diagnosed by constrast-enchanced MRI survival after whole brain radiotherapy.eciated patient subsets and is a useful method for dissecting complex clinical situations. Moreover, CART can be used to identify homogeneous patient populations in clinical practice and future clinical trials.",Excluded
2458,"Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. PURPOSE: To examine the relationship between neurocognitive function (NCF) and quality of life (QOL) in patients with brain metastases after whole-brain radiotherapy.PATIENTS AND METHODS: A total of 208 patients from the whole-brain radiotherapy arm of a Phase III trial (PCI-P120-9801), who underwent regular NCF and QOL (ADL [activities of daily living] and FACT-Br [Functional Assessment of Cancer Therapy-Brain-specific]) testing, were analyzed. Spearman's rank correlation was calculated between NCF and QOL, using each patient's own data, at each time point. To test the hypothesis that NCF declines before QOL changes, the predictive effect of NCF from previous visits on QOL was studied with a linear mixed-effects model. Neurocognitive function or QOL deterioration was defined relative to each patient's own baseline. Lead or lag time, defined as NCF deterioration before or after the date of QOL decline, respectively, was computed.RESULTS: At baseline, all NCF tests showed statistically significant correlations with ADL, which became stronger at 4 months. A similar observation was made with FACT-Br. Neurocognitive function scores from previous visits predicted ADL (p < 0.05 for seven of eight tests) or FACT-Br. Scores on all eight NCF tests deteriorated before ADL decline (net lead time 9-153 days); and scores on six of eight NCF tests deteriorated before FACT-Br (net lead time 9-82 days).CONCLUSIONS: Neurocognitive function and QOL are correlated. Neurocognitive function scores from previous visits are predictive of QOL. Neurocognitive function deterioration precedes QOL decline. The sequential association between NCF and QOL decline suggests that delaying NCF deterioration is a worthwhile treatment goal in brain metastases patients.",Excluded
3315,"Effects of Photons Irradiation on <sup>18</sup>F-FET and <sup>18</sup>F-DOPA Uptake by T98G Glioblastoma Cells. The differential diagnosis between brain tumors recurrence and early neuroinflammation or late radionecrosis is still an unsolved problem. The new emerging magnetic resonance imaging, computed tomography, and positron emission tomography diagnostic modalities still lack sufficient accuracy. In the last years, a great effort has been made to develop radiotracers able to detect specific altered metabolic pathways or tumor receptor markers. Our research project aims to evaluate irradiation effects on radiopharmaceutical uptake and compare the kinetic of the fluorinate tracers. T98G glioblastoma cells were irradiated at doses of 2, 10, and 20 Gy with photons, and <sup>18</sup>F-DOPA and <sup>18</sup>F-FET tracer uptake was evaluated. Activity and cell viability at different incubation times were measured. <sup>18</sup>F-FET and <sup>18</sup>F-DOPA are accumulated via the LAT-1 transporter, but <sup>18</sup>F-DOPA is further incorporated, whereas <sup>18</sup>F-FET is not metabolized. Therefore, time-activity curves (TACs) tend to plateau with <sup>18</sup>F-DOPA and to a rapid washout with <sup>18</sup>F-FET. After irradiation, <sup>18</sup>F-DOPA TAC resembles the <sup>18</sup>F-FET pattern. <sup>18</sup>F-DOPA activity peak we observed at 20 min might be fictitious, because earlier time points have not been evaluated, and a higher activity peak before 20 min cannot be excluded. In addition, the activity retained in the irradiated cells remains higher in comparison to the sham ones at all time points investigated. This aspect is similar in the <sup>18</sup>F-FET TAC but less evident. Therefore, we can hypothesize the presence of a second intracellular compartment in addition to the amino acidic pool one governed by LAT-1, which could explain the progressive accumulation of <sup>18</sup>F-DOPA in unirradiated cells.",Excluded
3330,"Differential inhibition of chromatic and achromatic perception by transcranial magnetic stimulation of the human visual cortex. The magnocellular visual pathway is devoted to low-contrast achromatic and motion perception whereas the parvocellular pathway deals with chromatic and high resolution spatial vision. To specifically separate perception mediated by these pathways we have used low-contrast Gaussian filtered black-white or coloured visual stimuli. By use of transcranial magnetic stimulation (TMS) over the visual cortex inhibition of magnocellular stimuli was achieved distinctly earlier by about 40 ms compared with parvocellular information. A nonspecific inhibition of all stimuli could be seen peaking at 75-90 ms, significantly higher for magnocellular stimuli. The particular vulnerability of magnocellular stimuli to TMS is correlated with distinct physiological properties of this pathway such as faster conduction velocity and non-linear stimulus encoding.",Excluded
3153,"Does iterative reconstruction lower CT radiation dose: evaluation of 15,000 examinations. PURPOSE: Evaluation of 15,000 computed tomography (CT) examinations to investigate if iterative reconstruction (IR) reduces sustainably radiation exposure.METHOD AND MATERIALS: Information from 15,000 CT examinations was collected, including all aspects of the exams such as scan parameter, patient information, and reconstruction instructions. The examinations were acquired between January 2010 and December 2012, while after 15 months a first generation IR algorithm was installed. To collect the necessary information from PACS, RIS, MPPS and structured reports a Dose Monitoring System was developed. To harvest all possible information an optical character recognition system was integrated, for example to collect information from the screenshot CT-dose report. The tool transfers all data to a database for further processing such as the calculation of effective dose and organ doses. To evaluate if IR provides a sustainable dose reduction, the effective dose values were statistically analyzed with respect to protocol type, diagnostic indication, and patient population.RESULTS: IR has the potential to reduce radiation dose significantly. Before clinical introduction of IR the average effective dose was 10.1+/-7.8mSv and with IR 8.9+/-7.1mSv (p*=0.01). Especially in CTA, with the possibility to use kV reduction protocols, such as in aortic CTAs (before IR: average14.2+/-7.8mSv; median11.4mSv /with IR:average9.9+/-7.4mSv; median7.4mSv), or pulmonary CTAs (before IR: average9.7+/-6.2mSV; median7.7mSv /with IR: average6.4+/-4.7mSv; median4.8mSv) the dose reduction effect is significant(p*=0.01). On the contrary for unenhanced low-dose scans of the cranial (for example sinuses) the reduction is not significant (before IR:average6.6+/-5.8mSv; median3.9mSv/with IR:average6.0+/-3.1mSV; median3.2mSv).CONCLUSION: The dose aspect remains a priority in CT research. Iterative reconstruction algorithms reduce sustainably and significantly radiation dose in the clinical routine. Our results illustrate that not only in studies with a limited number of patients but also in the clinical routine, IRs provide long-term dose saving.",Excluded
2503,"Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients. During the last two decades, there has been a trend to use low-dose I-131 ablation therapy in patients with thyroid carcinoma without metastases. However, information regarding the incidence of acute adverse reactions in patients after low-dose radioiodine therapy has not been reported. In this study, the acute radiation effects after low-dose radioiodine ablation therapy in postsurgical differentiated thyroid cancer patients was evaluated. Fifty-six patients with differentiated thyroid cancer were prospectively evaluated. None of these patients had evidence of a distant metastasis. All patients received 40 mCi (1480 MBq) I-131 MIBG orally and were evaluated for symptoms and signs by a physician on the second and seventh days after therapy. Xerostomia and nausea were the most common complaints with the same incidence rate of 5.35%. Gastralgia occurred at a frequency of 3.57%. Pain in the thyroid bed, tenderness over a parotid gland, submandibular glands, change in taste, and vomiting all were found at a frequency of 1.78%. Maximum reactions generally occurred 24-48 hours after therapy. All the symptoms except for xerostomia resolved completely in most patients within a week. In comparison with high-dose ablation therapy published in the literature, the incidence of radiation reactions in low-dose radioiodine therapy was much lower. It was concluded that in patients without lymph node or distant metastases, low-dose I-131 MIBG therapy may be recommended to avoid the high incidence of local complications after high-dose treatment.",Excluded
3522,"A prospective evaluation of the effects of chronic proton pump inhibitor use on plasma biomarker levels in humans. Introduction: Proton pump inhibitors (PPIs) are used primarily to treat gastroesophageal reflux disease. PPI-induced achlorhydria increases circulating gastrin and chromogranin A (CGA). CGA is a widely used biomarker for the diagnosis and follow-up for gut-based neuroendocrine tumors (NETs). PPI-induced increases in CGA or gastrin may falsely suggest the presence of a NET when none exists. Pancreastatin, a fragment of CGA, is also commonly used to diagnose and follow NETs. Aim(s): We hypothesized that chronic PPI use would increase circulating plasma gastrin, CGA and pancreastatin levels. Material(s) and Method(s): Thirty patients who used PPIs for six months or more (mean duration 3.1 +/-2.5 years) and a separate control group of thirty patients who never used antacid medications were prospectively evaluated with plasma gastrin, CGA and pancreastatin determinations. Result(s): Chronic PPI use resulted in significant increases in CGA (15.1+/-11 vs. 131+/-207 ng/ml, p=0.005) and significant increases in gastrin (34.8+/-22.3 vs. 167.8+/-136.2 pg/ml, p=0.001) compared to controls. In contrast, pancreastatin level in non-users and chronic PPI users were identical (81.6+/-36.4 vs.89.4+/-43.4 pg/ml, p=0.46). Conclusion(s): Pancreastatin levels do not change with chronic PPI use and normal pancreastatin levels may be used to distinguish between druginduced changes in biomarkers and tumor-related increases in circulating biomarkers.",Excluded
3337,[Prevention of leukemia of the central nervous system. Results of different therapeutic methods and toxic effects],Included
3519,Isolated congenital hemianopia caused by prenatal injury to the optic radiation. Isolated congenital hemianopias are typically caused by developmental abnormalities of the occipital lobe cortex. We describe two patients with an incidental partial hemianopia associated with unilateral periventricular leukomalacia that was acquired prenatally. Magnetic resonance imaging scans suggest a late second or early third trimester unilateral cerebral ischemic event.,Excluded
3553,"Extremely low frequency magnetic field induced changes in motor behaviour of gerbils submitted to global cerebral ischemia. The purpose of this study was to evaluate behavioural effects of an extremely low frequency magnetic field (ELF-MF) in 3-month-old Mongolian gerbils submitted to global cerebral ischemia. After 10-min occlusion of both common carotid arteries, the gerbils were placed in the vicinity of an electromagnet and continuously exposed to ELF-MF (50Hz, 0.5mT) for 7 days. Their behaviour (locomotion, stereotypy, rotations, and immobility) was monitored on days 1, 2, 4, 7, and 14 after reperfusion for 60min in the open field. It was shown that the 10-min global cerebral ischemia per se induced a significant motor activity increase (locomotion, stereotypy and rotations), and consequently immobility decrease until day 4 after reperfusion, compared to control gerbils. Exposure to ELF-MF inhibited development of ischemia-induced motor hyperactivity during the whole period of registration, but significantly in the first 2 days after reperfusion, when the postischemic hyperactivity was most evident. Motor activity of these gerbils was still significantly increased compared to control ones, but only on day 1 after reperfusion. Our results revealed that the applied ELF-MF (50Hz, 0.5mT) decreased motor hyperactivity induced by the 10-min global cerebral ischemia, via modulation of the processes that underlie this behavioural response.",Excluded
3395,"Dye-induced photolesion in the mammalian retina: glial and neuronal reactions. Irradiation in the presence of a dye applied to the extracellular space is known to produce degenerative features in irradiated neurones and fibers. In the present study, we confirmed the potential use of this procedure as a lesion technique by showing the removal of degenerating elements as part of the glial reaction to the lesion. The dye Rose Bengal was applied to the vitreous body of a rat eye and a T-shaped irradiation pattern was projected onto the retina within the absorption band of the dye. Degenerative features were restricted to the irradiated area, which could be readily identified from its shape. Retinae examined after various survival times showed that macrophages invaded the damaged area within 1 day, and that mitotic activity of reactive glial cells subsequently occurred in the vicinity of the wound. Both cell types were identified by their structural features. Macrophages were also revealed by a staining technique using the dye Nile Red, whereas reactive glial cells were immunolabeled with an antibody directed against the glial fibrillary acidic protein. Reactive glial cells helped the macrophages to gradually remove injured cells and damaged processes. Their main task, however, appeared to be in scar formation, since their processes seemed to suture the lips of the wound together and restore the limiting membrane at the inner retina. After 2 months' survival time, the parent ganglion cells of most disrupted axon bundles had retrogradely degenerated, but regenerating ganglion cell axons were also observed. These results provide some new data about healing processes in the retina. They demonstrate that the dye-induced photolesion technique can be used to either remove or axotomize selected neurones in neural networks which have been made optically accessible.",Excluded
2611,"The effect of exposure to 60Co accelerated electrons and gamma quanta on the activity of oxidative and hydrolytic enzymes in the rat brain. [Russian]. In experiments with 112 male Wistar rats it was shown that accelerated electrons (85 Gy) caused a significant increase in activities of succinate dehydrogenase (SDG) by 15.8% and lactate dehydrogenase (LDG) by 17.0%, and a decrease in activities of alkaline phosphatase (AP) and monoamine oxidase (MAO) by 10.6 and 7.8% respectively within the sensorimotor region of the cerebral cortex immediately after irradiation. Activity of SDG and MAO decreased (by 16.4% and 7.8% respectively) in the caudate nucleus over the same period of time. An increase in the accelerated electron dose from 85 to 500 Gy did not change the direction and the rate of the radiation response of the enzymes. Exposure of rats to 60Co gamma quanta (75 Gy) increased SDG and LDG activity (by 21.4 and 17.3% respectively) within the sensorimotor cortex as late as 10 min after irradiation. A repeated significant increase in SDG and LDG activity was observed 2 hr after irradiation.",Included
3576,"Type-specific photoreceptor loss in pigeons after disruption of parasympathetic control of choroidal blood flow by the medial subdivision of the nucleus of Edinger-Westphal. The medial part of the nucleus of Edinger-Westphal (EWM) in birds mediates light-regulated adaptive increases in choroidal blood flow (ChBF). We sought to characterize the effect of loss of EWM-mediated ChBF regulation on photoreceptor health in pigeons housed in either moderate intensity diurnal or constant light (CL). Photoreceptor abundance following complete EWM destruction was compared to that following a lesion in the pupil control circuit (as a control for spread of EWM lesions to the nearby pupil-controlling lateral EW) or following no EW damage. Birds were housed post-lesion in a 12 h 400 lux light/12 h dark light cycle for up to 16.5 months, or in constant 400 lux light for up to 3 weeks. Paraformaldehyde-glutaraldehyde fixed eyes were embedded in plastic, sectioned, slide-mounted, and stained with toluidine blue/azure II. Blinded analysis of photoreceptor outer segment abundance was performed, with outer segment types distinguished by oil droplet tint and laminar position. Brains were examined histologically to assess lesion accuracy. Disruption of pupil control had no adverse effect on photoreceptor outer segment abundance in either diurnal light or CL, but EWM destruction led to 50-60% loss of blue/violet cone outer segments in both light conditions, and a 42% loss of principal cone outer segments in CL. The findings indicate that adaptive regulation of ChBF by the EWM circuit plays a role in maintaining photoreceptor health and mitigates the harmful effect of light on photoreceptors, especially short wavelength-sensitive cone photoreceptors.",Excluded
3086,"Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs. BACKGROUND: Radiogenetic therapy is a novel approach in the treatment of cancer, which employs genetic modification to alter the sensitivity of tumor cells to the effect of applied radiation.AIM: To select a potent radiation inducible promoter in the context of brain tumors and to investigate if CArG radio responsive motifs or other elements in the promoter nucleotide sequences can correlate to its response to radiation.METHODS: To select initial candidates for promoter inducible elements, the levels of mRNA expression of six different promoters were assessed using Quantitative RTPCR in D54 MG cells before and after radiation exposure. Recombinant Ad/reporter genes driven by five different promoters; CMV, VEGF, FLT-1, DR5 and survivin were constructed. Glioma cell lines were infected with different multiplicity of infection of the (promoter) Ad or CMV Ad. Cells were then exposed to a range of radiation (0-12 Gy) at single fraction. Fluorescent microscopy, Luc assay and X-gal staining was used to detect the level of expression of related genes. Different glioma cell lines and normal astrocytes were infected with Ad survivin and exposed to radiation. The promoters were analyzed for presence of CArG radio-responsive motifs and CCAAT box consensus using NCBI blast bioinformatics software.RESULTS: Radiotherapy increases the expression of gene expression by 1.25-2.5 fold in different promoters other than survivin after 2 h of radiation. RNA analysis was done and has shown an increase in copy number of tenfold for survivin. Most importantly cells treated with RT and Ad Luc driven by survivin promoter showed a fivefold increase in expression after 2 Gy of radiation in comparison to non-irradiated cells. Presence or absence of CArG motifs did not correlate with promoter response to radiation. Survivin with the best response to radiation had the lowest number of CCAAT box.CONCLUSION: Survivin is a selective potent radiation inducible promoter for glioblastoma viral gene therapy and this response to radiation could be independent of CArG motifs.",Excluded
2661,"[Post-irradiation lesions of the brachial plexus]. A series of 60 cases in which a departure was made from the usual chronological distribution of preoperative radiation doses for breast cancer is presented. Tardive lesions were noted in the brachial plexus in 33 cases. Their incidence was higher in patients who had received larger dose fractions over a shorter total period. The progress of these lesions was barely influenced by medical and physical management. The underlying pathogenetic problems are examined, with particular reference to the radiotherapeutic technique and dose fractionation. Agreement is expressed with the opinion of other workers that the risk of such lesions can be kept down by employing a scrupulously careful technique, and employing total doses of 4.500-5.500 rads in 5-6 weeks. The conventional pattern of 5 weekly sessions should not be too widely departed from.",Excluded
3463,Choline acetyltransferase level in cyclic AMP and x-ray induced morphologically differentiated neuroblastoma cells in culture,Excluded
3334,"Gold Nanorod-assisted Optical Stimulation of Neuronal Cells. Recent studies have demonstrated that nerves can be stimulated in a variety of ways by the transient heating associated with the absorption of infrared light by water in neuronal tissue. This technique holds great potential for replacing or complementing standard stimulation techniques, due to the potential for increased localization of the stimulus and minimization of mechanical contact with the tissue. However, optical approaches are limited by the inability of visible light to penetrate deep into tissues. Moreover, thermal modelling suggests that cumulative heating effects might be potentially hazardous when multiple stimulus sites or high laser repetition rates are used. The protocol outlined below describes an enhanced approach to the infrared stimulation of neuronal cells. The underlying mechanism is based on the transient heating associated with the optical absorption of gold nanorods, which can cause triggering of neuronal cell differentiation and increased levels of intracellular calcium activity. These results demonstrate that nanoparticle absorbers can enhance and/or replace the process of infrared neural stimulation based on water absorption, with potential for future applications in neural prostheses and cell therapies.",Excluded
2937,[Clinical application of positron emission tomography and 18FDG to brain tumor],Excluded
2547,"Central nervous system burkitt variant post-transplant lymphopro life rative disorder (PTLD). Learning Objective #1: Recognize that PTLD as part of the differential when post transplant individuals present with unexplained pain, fever, or organ dysfunction. Learning Objective #2: Burkitt Lymphoma subtype as well as CNS involvement represent more aggressive manifestations of PTLD and should be managed more aggressively. CASE: 72 year-old man with end stage renal disease secondary to diabetic nephropathy status post living donor renal transplant on tacro-limus presents with headache, diplopia, and blurry vision found to have CNIII palsy on neurologic examination. Facial CT and Gadolinium enhanced Brain MRI showed complete bilateral maxillary sinus opacification and leptomeningeal enhancement. He was started on broad spectrum antibiotics, but given continuous headache and concern for meningitis a lumbar puncture was performed. CSF studies showed atypical lymphocytes of predominantly monoclonal B cells. CSF FISH showed rearrangement of c-myc oncogene negative for rearrangement of bcl6 or bcl2. Serum LDH was elevated and peripheral EBV PCR was positive. Bone marrow biopsy was negative for malignancy. Further CT imaging revealed thickening of the small bowel and mesenteric lymph-adenopathy. Patient was started on dexamethasone, intrathecal metho-trexate, and R-Hyper CVAD with interval regression of abdominal LAD, mass, improvement in ptosis, and decrease in LDH. IMPACT: The case represents an uncommon manifestation of an rare variant of disease that should warrant a different approach to diagnosis and treatment. DISCUSSION: PTLD is a well recognized, heterogenous group of disorders. The mechanism of PTLD involves EBV-induced B cell proliferation and antigen mediated T cell activation which upregulate pro-growth factors such as c-Myc. The result of which ranges from early mononucleosis-like illness, polyclonal lymphoid infiltrates, to lymphomas. Therapy involves immune reconstitution, local surgical excision, corticosteroids, antiviral agents, radiation and chemotherapy. Burkitt Lymphoma (BL) is a distinct form of PTLD. BL is an aggressive, mature B cell lymphoma composed of a monomorphic population of lymphoid cells with high mitotic and proliferation rates. Monoclonality is shown as isolated c-myc rearrangement as opposed to rear-rangements in c-myc, bcl6, and bcl2 seen in diffuse large B cell lymphoma, the most common form of PTLD. BL represents a distinct monomorphic PTLD and should be managed more aggressively with lymphoma specific chemotherapy rather than simply decreasing immunosuppression. CNS involvement of PTLD is rare, reportedly in 7-15% of all PTLD, when present is predictive of inferior survival. Compared to non-PCNS PTLD, primary CNS PTLD has a higher incidence of monomorphic EBV related disease, and late involvement with poor survival. Prior kidney transplant were also more frequent in primary CNS PTLD compared to other forms of PTLD. As a parallel, in systemic non hodgkins lymphoma, renal localization is also associated with high rates of CNS involvement.",Excluded
2808,"Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Magnetic resonance imaging (MRI) is the neuroimaging method of choice for the noninvasive monitoring of patients with brain tumors due to the enormous amount of information it yields regarding the morphologic features of the lesion and surrounding parenchyma. Over the past decade, proton magnetic resonance spectroscopy (<sup>1</sup>H-MRS), which uses the same technology as MRI and can be performed during a routine clinical imaging examination, has been used to glean information about the metabolic status of the brain. Accurate interpretation of <sup>1</sup>H-MRS data from individual patients requires an understanding of the various techniques for acquiring the data, the physiologic basis of the metabolic signatures obtained from different types of tumors, and the specificity of the technique. This review covers the basic physics of <sup>1</sup>H-MRS, the spectral and physiological characteristics of the metabolites that are typically measured in various types of brain tumors, and the clinical utility of <sup>1</sup>H-MRS with respect to diagnosis, therapeutic planning, and the assessment of response to treatment. Â© 2004 Elsevier Inc. All rights reserved.",Excluded
3047,"Laser energy reaching the posterior pole during transscleral cyclophotocoagulation. OBJECTIVE: To measure scattered laser energy reaching the posterior pole during transscleral cyclophotocoagulation.METHODS: Transscleral cyclophotocoagulation was performed on 4 cadaver eyes with Nd:YAG noncontact, Nd:YAG contact, and diode contact lasers. Energy was measured with a photodiode through a 7-mm trephined hole in the posterior pole. Average percentage power, average power, and average energy transmission were calculated. American Conference of Governmental Industrial Hygienists (ACGIH) guidelines were used to calculate allowable energy exposures for each laser.RESULTS: All 3 lasers transmitted 3% to 5% of the power to the posterior pole. The average energy transmission was 240 to 260 mJ for all lasers. The contact lasers had an average power transmission of 120 mW. The noncontact Nd:YAG laser, with shorter pulse duration, had an average power transmission of 13,000 mW, significantly greater than that of the other lasers. The ACGIH guidelines for allowable energy exposures were 93 mJ for the noncontact Nd:YAG laser, 1300 mJ for the contact Nd:YAG laser, and 440 mJ for the contact diode laser.CONCLUSIONS: Three percent to 5% of laser power delivered during cyclophotocoagulation reaches the posterior pole. Exposure energies may approach or exceed ACGIH guidelines. The clinical significance of these findings remains to be shown.",Excluded
3255,"Evaluation of absorbed dose in respiratory-gated radiotherapy using a phantom system that simulates patient respiration. [Japanese]. Respiratory-gated (RG) radiotherapy is useful for minimizing the irradiated volume of normal tissues resulting from the shifting of internal structures caused by respiratory movement. In this technique, although improvement in the dose distribution of the target can be expected, the actual absorbed dose distribution is not clearly determined. Therefore, it is important to clarify the absorbed dose at the tumor and at the evaluation points according to the patient's respiration. We have developed a phantom system that simulates patient respiration (TNK Co., Ltd.), to evaluate the absorbed dose and ensure precise RG radiotherapy. Actual patient respiratory signals were obtained using a respiratory synchronization and gating system (AZ-733V, Anzai Medical). The acquired data were then transferred to a phantom system driven by a ball screw to simulate the shifting of internal structures caused by respiratory movement. We measured the absorbed dose using a micro-ionization chamber dosimeter and the dose distribution using the film method for RG irradiation at expiratory phase by using Linac (PRIMUS, Toshiba Medical Systems Corp.) X-rays. When the distance of phantom movement was set to the average patient respiratory movement distance of 1.5 cm, we first compared absorbed dose with RG irradiation with a gating signal of 50% or less, and without RG irradiation. The absorbed dose at the iso-center was improved by 6.0% and 4.4% at a field size of 4x4 cm2, and by 1.3% and 0.7% at a field size of 5x5 cm2 with an X-ray energy of 6 MV and 10 MV, respectively. There was, however, no dose change at a field size of 10x10 cm2 and 15x15 cm2. When the gating signal was reduced to 25% and 10%, absorbed dose was also improved. With regard to the flatness of the dose profile, no changes in dose distribution were observed in the lateral direction, e.g., beam flatness was within 1.4% and 1.6% at field sizes of 5x5 cm2 and 10x10 cm2, respectively, with an X-ray energy of 6 MV. In the cranial-caudal direction, the dose profile was relatively large even if a gating signal of 50% was applied, i.e., 8.1% and 10.4% at field sizes of 5x5 cm2 and 10x10 cm2, respectively. Beam flatness without RG was much worse, i.e., 37.8% and 38.2%, at field sizes of 5x5 cm2 and 10x10 cm2, respectively. In both cases, the dose was insufficient in the expiratory direction. Although RG radiotherapy is quite useful, the margins in the inspiratory and expiratory phases should be considered based on the level of gating signal and field size in order to formulate appropriate radiotherapy planning in terms of the shifting of internal structures. To ensure accurate radiotherapy, the characteristics of the RG irradiation technique and the radiotherapy equipment must be clearly understood when this technique is to be employed in clinical practice.",Excluded
2649,"Radiation in the management of pancreatic neuroendocrine tumors. Background: Radiation therapy (RT) has not historically been incorporated into multidisciplinary management of pancreatic neuroendocrine tumors (PNTs). We provide a two-institution series of patients with PNTs who were treated with external beam RT either neoadjuvantly to attempt down-staging for surgery, or in the setting of post-surgical recurrence. Our objective was to assess treatment response and outcomes in this cohort of patients. Method(s): We identified eleven patients with a pathologic diagnosis of PNT from 2006-2011 who received external beam RT to the primary tumor or resection bed. Each institution's electronic medical record was used to evaluate patient demographics, disease characteristics, treatment regimens and tolerance, radiographic response, and survival. Result(s): Our series consists of eleven patients (6 men, 5 women) with a mean age of 57 years (range 37-72 years). All had biopsy proven PNT and were clinically T3 (n=3) or T4 (n=8), M0. Five patients were clinically node positive. All patients received RT to the primary tumor or resection bed to a median dose of 50.4 Gy. Seven patients received concurrent chemotherapy with capecitabine at a median dose of 1000mg/m<sup>2</sup> bid. Nine patients were treated definitively for locally advanced disease, two of whom subsequently underwent surgical resection. Two patients were treated to palliate post-resection recurrence. Initial radiographic response to RT included 2 complete responses (CR), 2 partial responses (PR), 4 stable disease, 3 progressive disease (PD). Two patients were classified as PD due to the development of distant metastases less than 2 months after completing RT. Two grade 3 toxicities were documented (one early, one late). At a median follow-up of 30.4 months, three patients had died with evidence of PD, two had died without evidence of PD, three were alive with metastases, and three were alive without evidence of disease progression (1 stable, 1 PR, 1 CR). From the start of RT, median overall survival was 32.1 months; progression free survival was 14.6 months. Conclusion(s): RT may have the potential to convert PNTs from locally-advanced to resectable. RT may also increase local control of PNTs. Consideration should be given to the use of RT in prospective trials of PNT treatment.",Excluded
2847,[Respiratory system activity in laser irradiation of brain structures]. It has been shown that the low-level laser radiation with the wave-length in the red part of spectrum changes greatly the activity of the respiratory center under the direct influence on the rats' brain structure. The influence of light may have activating or inhibitory character; sometimes symmetry in the respiratory center activity is disturbed. The difference of the effects under the radiation of the sensomotor area of the cerebral cortex hemispheres and the area of the bulbar respiratory center has been found out. It is supposed that one of the reasons of the functional state of the respiratory center variations is the metabolism change in its structures.,Excluded
2477,"[Changes of leg compliance during weightlessness or simulated weightlessness]. Weightlessness or simulated weightlessness causes increase of leg compliance. It leads to more blood pooling in the legs and less blood returning to the heart during orthostatic test, which may partly explain the occurrence of orthostatic intolerance induced by weightlessness or simulated weightlessness. This article is a review covering published materials about the methods of measurement, mechanisms and countermeasures of the increase of leg compliance during weightlessness or simulated weightlessness. [References: 22]",Excluded
2909,"Detecting Pneumonia using Convolutions and Dynamic Capsule Routing for Chest X-ray Images. An entity's existence in an image can be depicted by the activity instantiation vector from a group of neurons (called capsule). Recently, multi-layered capsules, called CapsNet, have proven to be state-of-the-art for image classification tasks. This research utilizes the prowess of this algorithm to detect pneumonia from chest X-ray (CXR) images. Here, an entity in the CXR image can help determine if the patient (whose CXR is used) is suffering from pneumonia or not. A simple model of capsules (also known as Simple CapsNet) has provided results comparable to best Deep Learning models that had been used earlier. Subsequently, a combination of convolutions and capsules is used to obtain two models that outperform all models previously proposed. These models-Integration of convolutions with capsules (ICC) and Ensemble of convolutions with capsules (ECC)-detect pneumonia with a test accuracy of 95.33% and 95.90%, respectively. The latter model is studied in detail to obtain a variant called EnCC, where n = 3, 4, 8, 16. Here, the E4CC model works optimally and gives test accuracy of 96.36%. All these models had been trained, validated, and tested on 5857 images from Mendeley.",Excluded
3225,"Multi cranial neuropathy secondary to primary glioblastoma of trigeminal nerve: Case report. Objective: To report a rare case of glioblastoma arising from trigeminal nerve with leptomeningeal spread of disease, and discuss the origin of this tumor. Background(s): Glioblastoma (GB) is a WHO Grade IV tumor typically arising in the supratentorial compartment of the brain. Gliomas arising from cranial nerves (CN) are extremely rare. Design/Methods: A 77 year old gentleman presented with four month history of numbness over the right side of his face and progressive bilateral hearing loss. One week prior to presentation, he also developed left facial weakness, left eye ptosis, diplopia and lower back pain. On examination, he was found to have loss of sensation in a V1-V3 distribution on the right, a left pupil sparing third nerve palsy, bilateral sensironeural hearing loss, and a left peripheral VII CN palsy Results: MRI brain showed a cisternal mass infiltrating the right CN V with extensive enhancement and thickening of bilateral CN including III, V, VII, and VIII. MRI of the spine showed nodular enhancement at the level of the cauda equina. CSF cytology was negative for malignant cells. Biopsy of the right CN V mass showed this to be glioblastoma. Conclusion(s): Leptomeningeal dissemination of glioblastoma is rare, occurring in about 4% of cases. In most of these cases, a parenchymal component is present that eventually disseminates along the ependymal lining of the brain to involve the leptomeninges. We here describe a unique presentation of a GB most likely arising from a CN followed by widespread leptomeningeal dissemination. The root entry zone (either the glial segment or the transition segment) of the cranial nerve is thought to be the anatomical point of origin for gliomas arising from CNs. Unfortunately despite being treated with radiation and chemotherapy, the patient passed away 3 months after presentation denoting the very poor prognosis associated with leptomeningeal spread of GB.",Excluded
3271,"Membrane current of retinal rods of Caudiverbera caudiverbera (Amphibia: Leptodactylidae): dark noise, spectral and absolute light sensitivity. We investigated the photocurrents from isolated rods of the South American anuran, Caudiverbera caudiverbera. Rod outer segments were on average 66.4 +/- 11.2 microm (mean +/- S.D., n = 104) in length and 6.6 +/- 0.9 microm (mean +/- S.D.) in diameter: 40 +/- 22 photoisomerizations (mean +/- S.D., range 10-99, n = 16) were required for eliciting a half-saturating photocurrent response. The time-to-peak was 911 +/- 217 ms (mean +/- S.D., n = 14, 20 degrees C) in the linear range of the response and the integration time of the current response was 1744 +/- 451 ms (mean +/- S.D., n = 14). The time-to-peak appears to be slower and the integration time shorter in Caudiverbera than in Ambystoma tigrinum, Rana pipiens or Xenopus laevis rods under similar experimental conditions. The a-band of rod spectral sensitivity has a lambda(max) at 520 +/- 2.1 nm (mean +/- S.D., range 516-525 nm, n = 24) and the bandwidth fits a porphyropsin visual pigment. The single-event response amplitude ranges from 0.31-0.51 pA, depending on the calculation method. The intrinsic dark current (variance at dark minus variance under bright light) was 0.045 +/- 0.040 pA2 (mean +/- S.D., n = 24). Our results support the presence of a dark-noise component below 1 Hz, with kinetics similar to the single-photon evoked response and a rate of 0.006 events s(-1) (n = 9).",Excluded
2915,"Activation of ATM and phosphorylation of p53 by heat shock. p53 protein is phosphorylated in response to various stresses. Here we examined phosphorylation of p53 protein in normal human diploid cells after heat shock at 43 degrees C for 2 h. We found that heat shock stimulates phosphorylation of p53 at Ser15 but not at Ser20, while X-irradiation at 4 Gy and 10 J/m(2) of UV induces phosphorylation of p53 at Ser15 and less significantly at Ser20. Increased phosphorylation of Ser15 was also observed in heat shocked GM638, the SV40-transformed human fibroblast cell line. Although X-ray irradiation induced phosphorylation of Ser6, 9, 20, and 37 in GM638 cells, heat shock did not affect the phosphorylation level of these serines. We observed little or no phosphorylation of p53 at Ser15 in two primary ataxia telangiectasia fibroblast cells, that are defective in ATM. Using an in vitro kinase assay, we confirmed that immunoprecipitated ATM from both heat-shocked and X-irradiated normal human diploid cells can phosphorylate p53 at Ser15 to a similar extent. These results indicate that heat shock induces phosphorylation of p53, especially at Ser15, and its phosphorylation is mediated by ATM kinase.",Excluded
2639,"New concept of a submillimetric pixellated Silicon detector for in vivo brain studies in freely moving rodents. In neuroscience, well established techniques such as magnetic resonance imaging (MRI), functional MRI and positron-emission tomography (PET) suffer from technical limitations for the in vivo investigation of brain processes in rodents, such as low sensitivity and the need of animal restraining during image acquisition. To address the lack of adapted neuroimaging methods for awake and freely moving animals a miniature portable PET scanner directly held by the rat head has been developed recently allowing for some freedom of the rat movements when operated together with a mobility system. However, the remaining weight of such bulk apparatus may still impair the animal movements. In order to preserve the animal from any impediment to their motion activity during behavioral analysis, we propose a novel fully autonomous setup with a miniaturized beta+ radiosensitive microprobe implantable in rodent brain. The detector will permit high sensitivity local time activity measurements of radiotracers in a volume of a few mm3 while drastically limiting stress induced in the animals during acquisition. The principal architecture of the measurement setup is based on two mechanically independent parts. The first part is the head socket (Figure 1: A), it carries a pixellated 1700 mum long Silicon needle with its sensitive part implanted into the brain by stereotaxic surgery and a specific ASIC for the parallel signal processing of each pixel. It is fixed on the skull and connected via a cable to the second part, a back-board (Figure 1: B) that can be worn by the animal. This part supports the components required to drive the ASIC, those used to deliver a radio-frequency telemetric signal to the acquisition board on a PC and the power supply. The assembly is sufficiently light and small to prevent any interference with the motions of the animal during the experiments. To design the sensor, Monte-Carlo simulations have been carried out, which showed that 200 mum thick high resistivity Silicon pixels with an area of 200 mum x 500 mum are optimized in terms of beta+ sensitivity versus relative transparency to the gamma background. Several probe geometries have been investigated with simulations using technology computer-assisted design (TCAD) to determine a specific pattern of guard rings enhancing the electronic stabilization of the sensor and ensuring the electrical isolation of the pixels. Finally, two designs with two and three guard rings (total probe width of 690 and 800 mum) were implemented and the prototypes have been proved to be stable and fully operational in probe station analysis. Despite its mechanical fragility, even the only 690 mum wide, less invasive prototype showed sufficient stability for implantation in brain tissue. The physical characterization of both geometries was carried out with dedicated radioactive sources and ratio-tracer solutions. Their beta detection efficiency, their transparency to gamma rays as well as the influence of environmental parameters were determined and results compared to Monte- Carlo simulations reproducing exact probe geometries and experimental setup. (Figure presented).",Excluded
3603,"Comet assay as a useful tool to assess brain damage. DNA damage could be defined as any modification of DNA that changes its coding properties. There are two main mechanisms inducing damage to the structure of DNA: (1) spontaneous damage caused by sources within a cell and (2) damage caused by external sources such as chemicals and radiation. Protracted oxidative, hydrolytic, deamination or alkylation reactions can modify DNA bases, or even sometimes cause a complete loss of bases within DNA, resulting in strand breakage. In the same way, cellular DNA can be damaged by external sources such as ultraviolet or ionizing radiation and a variety of chemical substances can induce interstrand and intrastrand cross-links, DNA-protein cross-links, bulky DNA adducts, single strand breaks (SSBs) and double strand breaks (DSBs). The human genome is constantly exposed to many classes of genotoxins and the central nervous system is sensitive to oxidative damage. Deficiency in repair of nuclear and mitochondrial DNA damage has been linked to several neurodegenerative disorders. DNA damage measurement in any cell or tissue is a significant indicator of a stable or unstable nature of the genomic apparatus, which would reveal physiological health status of a single cell and a whole organism. A number of techniques to detect DNA damage have been used to identify substances with genotoxic activity. The most useful approach to assess DNA damage seems to be the single-cell gel (SCG) or also named Comet assay. This is a simple, rapid, and sensitive technique for the analysis of DNA damage in all cell types, which combine DNA gel electrophoresis with fluorescence microscopy to visualize the migration of DNA strands from individual agarose-embedded cells. Determination of the relative amount of DNA that migrates provided an easy way to evaluate the number of DNA breaks in an individual cell. Since its development in 1984, the Comet assay has been modified at various steps to make it suitable for assessing various kinds of damage in different cells. It is now a tool used extensively to assess DNA damage and repair. Since the introduction of the Alkaline Comet assay, in 1988, the extent of applications and the number of investigators using this technique have increased almost exponentially. This assay has developed into a vital tool for use by investigators interested in research areas ranging from human and environmental biomonitoring to DNA repair processes and genetic toxicology. The Comet assay has been used as a test to predict the risk of development of some diseases related to a higher susceptibility of the individual to DNA damage. This chapter reviews critically the use of the Comet assay to evaluate brain damage. Â© Nova Science Publishers, Inc.",Excluded
2402,"Neurotoxicity in long-term survivors of small cell lung cancer. Chronic central nervous system neurotoxicity was studied in 38 long-term survivors (greater than or equal to 3 years) of small cell lung cancer who were treated at the University of Texas M. D. Anderson Hospital and Tumor Institute at Houston between 1971 and 1980. All but one patient received combination chemotherapy with or without chest irradiation. Twenty-four patients received whole brain irradiation (Group I), 22 for ""elective"" and two for therapeutic purposes, while 14 did not (Group II). Abnormalities in computed tomographic (CT) scans of the brain were more frequently observed in Group I than in Group II (70% vs. 0%, p less than 0.01). Clinical central nervous system neurotoxicity developed in three patients in Group I, while none developed in patients in Group II (p less than 0.05). Patients who received methotrexate and procarbazine after whole brain irradiation were at a higher risk for clinical central nervous system neurotoxicity (p less than 0.05), and for development of periventricular white matter changes in CT brain scans (p less than 0.05) than were patients in Group II. Impaired methylation of the myelin sheath is proposed as a possible underlying pathogenic mechanism.",Excluded
2910,"Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging alpha(v)beta(3) integrin levels. PURPOSE: To assess the safety, biodistribution, and dosimetric properties of the positron emission tomography (PET) radiopharmaceutical agent fluorine 18 ((18)F) FPPRGD2 (2-fluoropropionyl labeled PEGylated dimeric RGD peptide [PEG3-E{c(RGDyk)}2]), which is based on the dimeric arginine-glycine-aspartic acid (RGD) peptide sequence and targets alpha(v)beta(3) integrin, in the first volunteers imaged with this tracer.MATERIALS AND METHODS: The protocol was approved by the institutional review board, and written informed consent was obtained from all participants. Five healthy volunteers underwent whole-body combined PET-computed tomography 0.5, 1.0, 2.0, and 3.0 hours after tracer injection (mean dose, 9.5 mCi +/- 3.4 [standard deviation] [351.5 MBq +/- 125.8]; mean specific radioactivity, 1200 mCi/mmol +/- 714 [44.4 GBq/mmol +/- 26.4]). During this time, standard vital signs, electrocardiographic (ECG) readings, and blood sample values (for chemistry, hematologic, and liver function tests) were checked at regular intervals and 1 and 7 days after the injection. These data were used to evaluate tracer biodistribution and dosimetric properties, time-activity curves, and the stability of laboratory values. Significant changes in vital signs and laboratory values were evaluated by using a combination of population-averaged generalized estimating equation regression and exact paired Wilcoxon tests.RESULTS: The administration of (18)F-FPPRGD2 was well tolerated, with no marked effects on vital signs, ECG readings, or laboratory values. The tracer showed the same pattern of biodistribution in all volunteers: primary clearance through the kidneys (0.360 rem/mCi +/- 0.185 [0.098 mSv/MBq +/- 0.050]) and bladder (0.862 rem/mCi +/- 0.436 [0.233 mSv/MBq +/- 0.118], voiding model) and uptake in the spleen (0.250 rem/mCi +/- 0.168 [0.068 mSv/MBq +/- 0.046]) and large intestine (0.529 rem/mCi +/- 0.236 [0.143 mSv/MBq +/- 0.064]). The mean effective dose of (18)F-FPPRGD2 was 0.1462 rem/mCi +/- 0.0669 (0.0396 mSv/MBq +/- 0.0181). With an injected dose of 10 mCi (370 MBq) and a 1-hour voiding interval, a patient would be exposed to an effective radiation dose of 1.5 rem (15 mSv). Above the diaphragm, there was minimal uptake in the brain ventricles, salivary glands, and thyroid gland. Time-activity curves showed rapid clearance from the vasculature, with a mean 26% +/- 17 of the tracer remaining in the circulation at 30 minutes and most of the activity occurring in the plasma relative to cells (mean whole blood-plasma ratio, 0.799 +/- 0.096).CONCLUSION: (18)F-FPPRGD2 has desirable pharmacokinetic and biodistribution properties. The primary application is likely to be PET evaluation of oncologic patients-especially those with brain, breast, or lung cancer. Specific indications may include tumor staging, identifying patients who would benefit from antiangiogenesis therapy, and separating treatment responders from nonresponders early.",Excluded
3468,"Disorder in Pixel-Level Edge Directions on T1WI Is Associated with the Degree of Radiation Necrosis in Primary and Metastatic Brain Tumors: Preliminary Findings. BACKGROUND AND PURPOSE: Co-occurrence of local anisotropic gradient orientations (COLLAGE) is a recently developed radiomic (computer extracted) feature that captures entropy (measures the degree of disorder) in pixel-level edge directions and was previously shown to distinguish predominant cerebral radiation necrosis from recurrent tumor on gadolinium-contrast T1WI. In this work, we sought to investigate whether COLLAGE measurements from posttreatment gadolinium-contrast T1WI could distinguish varying extents of cerebral radiation necrosis and recurrent tumor classes in a lesion across primary and metastatic brain tumors.MATERIALS AND METHODS: On a total of 75 gadolinium-contrast T1WI studies obtained from patients with primary and metastatic brain tumors and nasopharyngeal carcinoma, the extent of cerebral radiation necrosis and recurrent tumor in every brain lesion was histopathologically defined by an expert neuropathologist as the following: 1) ""pure"" cerebral radiation necrosis; 2) ""mixed"" pathology with coexistence of cerebral radiation necrosis and recurrent tumors; 3) ""predominant"" (>80%) cerebral radiation necrosis; 4) predominant (>80%) recurrent tumor; and 5) pure tumor. COLLAGE features were extracted from the expert-annotated ROIs on MR imaging. Statistical comparisons of COLLAGE measurements using first-order statistics were performed across pure, mixed, and predominant pathologies of cerebral radiation necrosis and recurrent tumor using the Wilcoxon rank sum test.RESULTS: COLLAGE features exhibited decreased skewness for patients with pure (0.15 +/- 0.12) and predominant cerebral radiation necrosis (0.25 +/- 0.09) and were statistically significantly different (P < .05) from those in patients with predominant recurrent tumors, which had highly skewed (0.42 +/- 0.21) COLLAGE values. COLLAGE values for the mixed pathology studies were found to lie between predominant cerebral radiation necrosis and recurrent tumor categories.CONCLUSIONS: With additional independent multisite validation, COLLAGE measurements might enable noninvasive characterization of the degree of recurrent tumor or cerebral radiation necrosis in gadolinium-contrast T1WI of posttreatment lesions.",Excluded
2542,"Comparison of four scatter correction methods using Monte Carlo simulated source distributions. UNLABELLED: Scatter correction in SPECT is important for improving image quality, boundary detection and the quantification of activity in different regions. This paper presents a comparison of four scatter correction methods, three using more than one energy window and one convolution-subtraction correction method using spatial variant scatter line-spread functions.METHODS: The comparison is based on Monte Carlo simulated data for point sources on- and off-axis, hot and cold spheres of different diameters, and a clinically realistic source distribution simulating brain imaging. All studies were made for a uniform cylindrical water phantom. Since the nature of the detected photon is known with Monte Carlo simulation, separate images of primary and scattered photons can be recorded. These can then be compared with estimated scatter and primary images obtained from the different scatter correction methods. The criteria for comparison were the normalized mean square error, scatter fraction, % recovery and image contrast.RESULTS: All correction methods significantly improved image quality and quantification compared to those obtained with no correction. Quantitatively, no single method was observed to be the best by all criteria for all the source distributions. Three of the methods were observed to perform the best by at least one of the criteria for one of the source distributions. For brain imaging, the differences between all the methods were much less than the difference between them and no correction at all.CONCLUSION: It is concluded that performing scatter correction is essential for accurate quantification, and that all four methods yield a good, but not perfect, scatter correction. Since it is hard to distinguish the methods consistently in terms of their performance, it may be that the choice should be made on the basis of ease of implementation.",Excluded
3626,"A model for assessing cognitive impairment after fractionated whole-brain irradiation in nonhuman primates. To investigate the effect of fractionated whole-brain irradiation on nonhuman primates, 6-9-year-old male rhesus monkeys were irradiated with 40 Gy delivered as two 5-Gy fractions/week for 4 weeks. Cognitive function was assessed 5 days/week for 4 months prior to fractionated whole-brain irradiation and for 11 months after irradiation using a Delayed-Match-to-Sample (DMS) task at both low and high cognitive loads. Local rates of cerebral glucose metabolism were measured prior to and 9 months after irradiation using [(18)F]-2-deoxy-2-fluoro-d-glucose positron emission tomography. Low cognitive load trials did not reveal a significant reduction in performance until 7 months after irradiation; performance then declined progressively. In high cognitive load trials, the initial impairment was observed ~1 month after irradiation. This was followed by a transient recovery period over the next 1-2 months, after which performance declined progressively through 11 months after irradiation. Nine months after irradiation, glucose uptake during the DMS task was decreased in the cuneate and prefrontal cortex and was increased in the cerebellum and thalamus compared with the levels prior to irradiation. Results from this pilot study suggest that the radiation-induced changes in cognition and brain metabolism observed in rhesus monkeys may be similar to those observed in brain tumor patients receiving brain irradiation.",Included
2396,"Age, Sex, and Repeated Measures Effects on NASA's ""Cognition"" Test Battery in STEM Educated Adults. <b>BACKGROUND:</b> Cognition is a neurocognitive test battery created at the University of Pennsylvania and adapted by the National Aeronautics and Space Administration (NASA). It comprises 10 neurocognitive tests that examine multiple domains, and has been validated in a normative sample of STEM-educated adults and compared to NASA's WinSCAT battery. <b>METHODS:</b> The purpose of this study was to follow the original sample to assess Cognition and WinSCAT's test-retest reliability and age, sex, and test-retest interval effects on performance. <b>RESULTS:</b> Performance on both Cognition and WinSCAT decreased with age but improved with repeated administration due to practice effects, and men had higher scores than women on tasks that required vigilant attention, spatial reasoning, and risk-taking behaviors. Assessment of test-retest reliability showed intraclass coefficients for efficiency ranging from 0.417 to 0.810, reflecting the broad nature of constructs assessed by Cognition. <b>DISCUSSION:</b> Results largely matched predictions, with some counter-intuitive results for test-retest reliability interval. <b>Lee G, Moore TM, Basner M, Nasrini J, Roalf DR, Ruparel K, Port AM, Dinges DF, Gur RC. Age, sex, and repeated measures effects on NASA's ""Cognition"" Test Battery in STEM educated adults. Aerosp Med Hum Perform. 2020; 91(1):18-25.</b>",Excluded
3159,"Treatment of motion sickness in parabolic flight with buccal scopolamine. Treatment of acute motion sickness induced by parabolic flight with a preparation of scopolamine placed in the buccal pouch was investigated. Twenty-one subjects flew aboard a KC-135 aircraft operated by the National Aeronautics and Space Administration (NASA) which performed parabolic maneuvers resulting in periods of 0-g, 1-g, and 1.8-g. Each subject flew once with a tablet containing scopolamine and once with a placebo in a random order, crossover design. Signs and symptoms of motion sickness were systematically recorded during each parabola by an investigator who was blind to the content of the tablet. Compared with flights using placebo, flights with buccal scopolamine resulted in significantly lower scores for nausea (31%-35% reduction) and vomiting (50% reduction in number of parabolas with vomiting). Side effects of the drug during flight were negligible. We conclude that buccal scopolamine is more effective than a placebo in treating ongoing motion sickness.",Excluded
3044,"Brain MRI reveals white matter tract abnormalities in patients with idiopathic fecal incontinence. Objective: The pathophysiological mechanisms behind idiopathic fecal incontinence (IFI) is still partially unknown, however abnormalities within the central nervous system (CNS) have been proposed as part of the pathogenesis. The current study aimed to examine gray matter volume and cortical thickness characteristics as well as white matter (WM) tract characteristics in patients with IFI and healthy controls. Method(s): We enrolled 21 female patients with IFI (60.3+/-10.9 years) and 15 healthy controls (55.5+/-9.45 years). All subjects underwent a structural MRI and diffusion tensor imaging (DTI). We performed voxel-based morphometry analysis to investigate grey matter volume and surface-based morphometry analysis investigate cortical thickness. Additionally, we used tract-based-spatial statistics (TBSS) to characterize WM microstructure. Finally, associations between MRI based brain characteristics and previously collected latencies of rectal sensory evoked electroencephalography potentials were determined. Result(s): Compared to healthy controls, IFI patients had significantly reduced fractional anisotropy (FA) values, implicating reduced integrity of fiber tracts, in the left hemisphere. Particularly in the superior longitudinal fasciculus (SLF) (P=.042), posterior thalamic radiation (PTR) (P=.047), and middle frontal gyrus (MFG) (P=.049), see Figure 1. No differences were observed in gray matter volume or in cortical thickness between the groups. The reduced FA values in the superior longitudinal fasciculus and middle frontal gyrus were negatively associated with prolonged latencies of cortical potentials evoked by rectal stimuli (all P<.05). (Figure Presented) Conclusion(s): IFI patients have no macrostructural brain abnormalities, but reduced integrity of left WM tracts that are relevant for sensory processing when compared to healthy controls. The clinical relevance of the microstructural findings is supported by their associations with functional changes expressed as prolonged latencies of cortical potentials evoked by rectal stimulation. Our findings support the theories of CNS changes as a central part of the pathogenesis in IFI.",Excluded
3054,[Radiosensitivity of membranes of isolated nuclei of nerve and glial cells],Included
3341,"Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. BACKGROUND: Quality of life (QOL) outcomes become critical for survivors of head and neck cancer. Most QOL studies were based on <5-year outcomes and very few addressed >5-year outcomes. This study focused late complications and >5-year outcomes and also compared the 2 standard treatments.METHODS: The long-term problems were identified through mail surveys. The 2 treatment arms were compared for differences.RESULTS: Seventy-three of 234 possible survivors were identified as still living. Forty-seven returned responses were analyzed to determined problems and QOL. Fifty-three percent reported delayed complications which occurred after 5 years. When the 2 treatments were compared, no statistically significant differences were noted. The survivors in the chemoradiotherapy (CRT) group reported greater difficulties with swallowing, sticky saliva, feeding tube, and weight gain. The survivors in the surgery and postoperative radiation therapy (SRT) group reported more problems with trismus.CONCLUSION: Some complications do not occur until after 5 years. The CRT group tended to have more problems.",Excluded
3436,"Incidence and management of late adverse radiation effects after arteriovenous malformation radiosurgery. Background: Late adverse radiation effects (ARE) typically occur many years after stereotactic radiosurgery (SRS) of intracranial arteriovenous malformations (AVM). They are characterized by perilesional edema or cyst formation and are distinct from radiationinduced changes (RIC) noted in the first 1 to 2 years after AVM SRS and radiation necrosis. Objective(s): To determine the incidence of late ARE after AVM SRS. Method(s): Retrospective review of 233 AVM patients having SRS from 1990 to 2009. Patients had sporadic AVM, no prior radiation, and a minimum of 5 years of magnetic resonance imaging (MRI) follow-up. The median MRI follow-up after SRS was 9.8 years (range, 5-24.2). Result(s): Late ARE were observed in 16 patients (6.9%) at a median of 8.7 years after SRS (range, 2.0-16.1). The 5-, 10-, and 15-year incidence of late ARE was 0.4%, 7.7%, and 12.5%, respectively. Eight patients (3.4%) were symptomatic at the time of ARE detection. Three of 8 patients who were initially asymptomatic had documented cyst progression (at 11, 40, and 42 months), for an overall symptomatic rate of 4.7%. Five patients with asymptomatic ARE have been observed for a median of 9.3 years (range, 2.0-14.1) without progression. Patients having early RIC (hazard ratio [HR] = 2.11, P < .001), patients having obliteration (HR=1.24, P=.02), and patients having SRS before April 1997 (HR=1.12, P=.02) weremore likely to develop late ARE. Conclusion(s): Late ARE are common in AVM patients who develop early RIC after SRS. Resection of the thrombosed AVM and the adjacent damaged tissue is effective at eliminating the mass effect and improving patients' neurological condition. Copyright Â© 2017 by the Congress of Neurological Surgeons.",Excluded
2740,"Differential longitudinal decline of white matter integrity in frontotemporal lobar degeneration and Alzheimer's disease. Objective: To identify imaging biomarkers of disease progression in frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD) that can be used in longitudinal assessments. Background(s): Recent years have witnessed the emergence of treatment trials for FTLD and AD, creating a need for sensitive biomarkers of disease progression. Cross-sectional studies have shown that white matter integrity, measured via diffusion tensor imaging (DTI), is affected by both AD and FTLD. Few studies have quantified or compared the rates of change in white matter integrity in these disorders. Method(s): Diffusion weighted 3T MRIs from a cohort of 60 FTLD patients (27 behavioral-variant, 19 semantic-variant, 14 progressive non-fluent aphasia), 19 AD, and 69 healthy controls were acquired at baseline and 1-year on average follow up. Images were processed using a longitudinal DTI pipeline implemented in SPM12 to identify annualized changes in fractional anisotropy (FA). Result(s): Compared to controls, FTLD showed more reduction in FA over 1-year in the corpus callosum (CC), superior longitudinal fasciculus, inferior longitudinal fasciculus, the uncinate, and anterior portions of the internal capsule and corona radiata. In AD, FA reductions were seen in the splenium and posterior portions of the thalamic radiation. Conclusion(s): Decline in white matter integrity in FTLD and AD is measurable over 1 year and reflects established patterns of brain pathology in these two disorders. This suggests that changes in white matter integrity can provide a viable surrogate marker in both FTLD and AD for future clinical trials. In addition, similar to previous clinical and volumetric studies, white matter is shown to degrade nearly twice as rapidly in FLTD compared to AD.",Excluded
3407,Stereotactic techniques in neurosurgery,Excluded
3421,Changes in the central nervous system in malignant lymphoma--clinical and therapeutic problems. [Polish],Excluded
2826,Fractionation considerations for boron neutron capture therapy: the perspective of a clinician,Excluded
3249,"Neuromagnetic responses to chords are modified by preceding musical scale. Previous psychological studies have shown that musical chords primed by Western musical scale in a tonal and modal schema are perceived in a hierarchy of stability. We investigated such priming effects on auditory magnetic responses to tonic-major and submediant-minor chords preceded by major scales and tonic-minor and submediant-major chords preceded by minor scales. Musically trained subjects participated in the experiment. During MEG recordings, subjects judged perceptual stability of the chords. The tonic chords were judged to be stable, whereas the submediant chords were judged to be unstable. Dipole moments of N1m response originating in the auditory cortex were larger in the left hemisphere for the submediant chords than for the tonic chords preceded by the major but not minor scales. No difference in the N1m or P2m moment was found for the chords presented without preceding scales. These results suggest priming effects of the tonal schema, interacting with contextual modality, on neural activity of the auditory cortex as well as perceptual stability of the chords. It is inferred that modulation of the auditory cortical activity is associated with attention induced by tonal instability and modality shift, which characterize the submediant chords.",Excluded
2857,"Optical coherence tomography in a case of Bietti's crystalline dystrophy. PURPOSE: To demonstrate the cross-sectional morphology in crystalline retinopathy.METHODS: A 24-year-old woman with Bietti's crystalline dystrophy (BCD) and bilaterally decreased vision and nyctalopia was examined by optical coherence tomography (OCT).RESULTS: Fundus examination demonstrated numerous reflective, yellow-white crystalline deposits scattered throughout the posterior pole and midperipheral retina. Optical coherence tomography disclosed an abnormally level of high reflectivity in red to orange colours throughout the entire neuroretina, retinal pigment epithelium (RPE) and choroid. The RPE-choriocapillaris complex was thickened and hyper-reflective, corresponding with dense crystalline deposits.CONCLUSION: The observed uncommon hyper-reflectivity in BCD relates to the deposition of numerous infiltrates. In vivo investigations by OCT confirmed histological studies that a crystalline retinopathy corresponds with numerous infiltrates in the retina, RPE and choroid. The RPE and choroid have intensive hyper-reflection and may be the primary location of the disease.",Excluded
2709,"Anticonvulsant action of three neurosteroids against cortical epileptic afterdischarges in immature rats. Neurosteroids exhibit anticonvulsant action probably by positive modulatory influence on GABA-A receptors. The action of three neurosteroids was tested against cortical epileptic afterdischarges in immature rats with implanted electrodes. Afterdischarges (ADs) were elicited by rhythmic electrical stimulation (biphasic pulses at 8 Hz frequency for 15s) of sensorimotor cortical region with a slightly suprathreshold current intensity. Drugs were administered intraperitoneally after the first afterdischarge and stimulation was repeated five more times with the same intensity. Allopregnanolone in doses of 20 and 30 mg/kg i.p. was found to be active in 12-day-old rats; there was no effect in 18-day-old rats and only a tendency in 25-day-old ones. Therefore, the effects of pregnanolone and a new derivative THDOC-conjugate (20 and 40 mg/kg) were compared with those of allopregnanolone (40 mg/kg) only in 12- and 25-day-old rats in the second part of study. All three neurosteroids blocked progressive prolongation of repeated ADs seen in control 12-day-old rats. In addition, pregnanolone was able to shorten the ADs. In contrast, duration of ADs in 25-day-old animals was significantly shorter than the duration of the first, predrug AD only after administration of the 40 mg/kg dose of pregnanolone; if corresponding ADs in the control and drug groups were compared, pregnanolone and THDOC-conjugate led to significantly shorter ADs, changes after allopregnanolone administration were statistically significant only in the fourth AD. None of the studied neurosteroids was able to suppress movements directly bound to stimulation as well as clonic seizures accompanying afterdischarges. Among the three drugs studied, pregnanolone was found to be the most potent one. As developmental changes are concerned, the youngest animals exhibited the highest sensitivity to anticonvulsant action of neurosteroids.",Excluded
3446,"Dosimetric and clinical impact of 3D vs. 2D planning in palliative radiotherapy for bone metastases. PURPOSE: The incorporation of three-dimensional (3D) planning for the treatment of bone metastases has been embraced in many North American practices with assumed superior tumor targeting, sparing of normal structures, and improvement in patient outcomes. The goal of our project was to evaluate the dosimetric and clinical impact of 3D vs. two-dimensional (2D) planning for patients who require simple palliative radiotherapy techniques (<= 2 beams) for bone metastases.METHODS: Patients undergoing palliative radiation therapy for bone metastases were eligible. The study oncologists first documented the intended treatment target, defined the treatment target/field using digital radiographs (2D), followed by using full 3D planning computerized tomography volumetric datasets. Treatment plans were compared dosimetrically, and patient-reported outcomes (pain, fatigue, anorexia, and nausea) were compared against a historical cohort treated with 2D plans.RESULTS: Eighty-five patients were enrolled in the study group. Review of the 3D datasets led to changes in the target area of interest in 44/85 (52 %) of cases, of which 21/85 (25 %) were clinically significant. 3D plans resulted in superior target coverage and normal tissue sparing. There was no significant difference in patient-reported outcomes however.CONCLUSION: 3D radiotherapy planning resulted in superior treatment plans but we were unable to demonstrate a significant benefit in clinical outcomes. Prospective study designs are needed to describe the contemporary expectation of palliative radiotherapy for bone metastases in the modern era of 3D planning.",Excluded
2533,"Substantia nigra stimulation influences monkey superior colliculus neuronal activity bilaterally. The inhibitory drive arising from the basal ganglia is thought to prevent the occurrence of orienting movements of the eyes, head, and body in monkeys and other mammals. The direct projection from the substantia nigra pars reticulata (SNr) to the superior colliculus (SC) mediates the inhibition. Since the original experiments in the SNr of monkeys the buildup or prelude neuron has been a focus of SC research. However, whether the SNr influences buildup neurons in SC is unknown. Furthermore, a contralateral SNr-SC pathway is evident in many species but remains unexplored in the alert monkey. Here we introduced electrical stimulation of one or both SNr nuclei while recording from SC buildup neurons. Stimulation of the SNr reduced the discharge rate of SC buildup neurons bilaterally. This result is consistent with activation of an inhibitory drive from SNr to SC. The time course of the influence of ipsilateral SNr on the activity of most SC neurons was longer (approximately 73 ms) than the influence of the contralateral SNr (approximately 34 ms). We also found that the variability of saccade onset time and saccade direction was altered with electrical stimulation of the SNr. Taken together our results show that electrical stimulation activates the inhibitory output of the SNr that in turn, reduces the activity of SC buildup neurons in both hemispheres. However, rather than acting as a gate for saccade initiation, the results suggest that the influence of SNr inhibition on visually guided saccades is more subtle, shaping the balance of excitation and inhibition across the SC.",Excluded
2929,"Ultrasound-guided piriformis injection in patients with piriformis muscle syndrome. Objectives: Piriformis muscle syndrome is caused due to the excessive contraction of the piriformis muscle with sciatica-like symptoms. PMS is associated with paresthesias and pain in the hips, buttocks and lower part of body, while ultrasound-guided piriformis injections has several advantages compared prevalent and common approaches, such as well-set shape, availability, direct imaging of neurovascular structures and lack of exposing to ionizing radiation Methods: Fifteen patients (5 male and 10 female; average age, 55.6 years; range, 21-75 years) were diagnosed with PMS based on clinical history, electromyography, straight leg raising (SLR) and Pace signs. First the injection of Methyl Prednisone was applied under guidance of a Micromaxx ultrasound machine and using a 5-10 MHz, 38-mm broadband linear probe. For piriformis injection under ultrasonographic guidance, a linear ultrasound probe is positioned with its lateral side medial to the greater trochanter and its medial side lateral to the ischial tuberosity. The sciatic nerve is then followed cephalad until it courses beneath the piriformis. Ultrasound probe is directed parallel to piriformis. Needle is inserted in lateral third of piriformis. The therapeutic effect was assessed before and a month after injection via Visual Analogue Scale (VAS) as three groups: improvement, partial improvement, or failure depending on the degree of symptom Results: According to the results, 7 patients (46.6%) showed improvement, 4 (26.6%) showed partial improvement and 4 (26.6%) failed to respond to the initial treatment. Conclusion(s): Ultrasound-guided piriformis injection may be a suitable treatment strategy to reduce the symptoms in patients with Piriformis muscle syndrome.",Excluded
2880,"Routine use of approximately 60 Gy once-daily thoracic irradiation for patients with limited-stage small-cell lung cancer. PURPOSE: To review the outcome of patients with limited-stage small-cell lung cancer receiving daily thoracic irradiation (RT) to approximately 60 Gy.METHODS AND MATERIALS: The records of patients treated with RT for limited-stage small-cell lung cancer between 1991 and 1999 at Duke University were retrospectively reviewed. Sixty-five patients were identified who had received continuous course once-daily 1.8-2 Gy fractions to approximately 60 Gy (range 58-66). All patients received chemotherapy (CHT); 32 received concurrent RT/CHT and 33 sequential CHT and then RT. Prophylactic cranial RT was administered to 17 patients. The time from diagnosis to local failure, tumor progression, and death was assessed using actuarial methods. The median follow-up for all patients was 16.7 months and for surviving patients was 29.6 months. The median age was 64 years (range 36-83), and the median Karnofsky performance status was 80 (range 50-100).RESULTS: The 3-year actuarial rate of local failure, progression-free survival, and overall survival was 40%, 25%, and 23%, respectively. One case of acute Grade 3 esophagitis developed. Ten late complications occurred: four pulmonary, two esophageal, two infectious, one leukemia, and one retinal toxicity with prophylactic cranial RT. Six were mild and resolved with treatment.CONCLUSION: CHT plus approximately 60 Gy of once-daily RT for limited-stage small-cell lung cancer was generally well tolerated. The survival rates were less than have been reported using 45 Gy in 1.5-Gy twice-daily fractions (2-year overall survival rate 47% compared with 30% in this study), but may be comparable because fewer than one-half our patients received concurrent CHT/RT and only 26% received prophylactic cranial RT. The relatively low rate of normal tissue morbidity in our patients supports the use of conventional once-daily fractionation to > or = 60 Gy. A randomized trial would be required to compare the outcomes after maximally tolerated dose twice-daily RT vs. maximally tolerated dose daily RT.",Excluded
2882,"Focused ultrasound-mediated suppression of chemically-induced acute epileptic EEG activity. BACKGROUND: Epilepsy is a common neurological disorder, which is attributed to uncontrollable abnormal hyper-excitability of neurons. We investigated the feasibility of using low-intensity, pulsed radiation of focused ultrasound (FUS) to non-invasively suppress epileptic activity in an animal model (rat), which was induced by the intraperitonial injection of pentylenetetrazol (PTZ).RESULTS: After the onset of induced seizures, FUS was transcranially administered to the brain twice for three minutes each while undergoing electroencephalographic (EEG) monitoring. An air-backed, spherical segment ultrasound transducer (diameter: 6 cm; radius-of-curvature: 7 cm) operating at a fundamental frequency of 690 KHz was used to deliver a train of 0.5 msec-long pulses of sonication at a repetitive rate of 100 Hz to the thalamic areas of the brain. The acoustic intensity (130 mW/cm2) used in the experiment was sufficiently within the range of safety guidelines for the clinical ultrasound imaging. The occurrence of epileptic EEG bursts from epilepsy-induced rats significantly decreased after sonication when it was compared to the pre-sonication epileptic state. The PTZ-induced control group that did not receive any sonication showed a sustained number of epileptic EEG signal bursts. The animals that underwent sonication also showed less severe epileptic behavior, as assessed by the Racine score. Histological analysis confirmed that the sonication did not cause any damage to the brain tissue.CONCLUSIONS: These results revealed that low-intensity, pulsed FUS sonication suppressed the number of epileptic signal bursts using acute epilepsy model in animal. Due to its non-invasiveness and spatial selectivity, FUS may offer new perspectives for a possible non-invasive treatment of epilepsy.",Excluded
3298,"Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas. PURPOSE: To compare temporal lobe dose delivered by three pituitary macroadenoma irradiation techniques: three-field three-dimensional conformal radiotherapy (3D-CRT), three-field intensity-modulated radiotherapy (3F IMRT), and a proposed novel alternative of five-field IMRT (5F IMRT).METHODS AND MATERIALS: Computed tomography-based external beam radiotherapy planning was performed for 15 pituitary macroadenoma patients treated at New York University between 2002 and 2007 using: 3D-CRT (two lateral, one midline superior anterior oblique [SAO] beams), 3F IMRT (same beam angles), and 5F IMRT (same beam angles with additional right SAO and left SAO beams). Prescription dose was 45 Gy. Target volumes were: gross tumor volume (GTV) = macroadenoma, clinical target volume (CTV) = GTV, and planning target volume = CTV + 0.5 cm. Structure contouring was performed by two radiation oncologists guided by an expert neuroradiologist.RESULTS: Five-field IMRT yielded significantly decreased temporal lobe dose delivery compared with 3D-CRT and 3F IMRT. Temporal lobe sparing with 5F IMRT was most pronounced at intermediate doses: mean V25Gy (% of total temporal lobe volume receiving >=25 Gy) of 13% vs. 28% vs. 29% for right temporal lobe and 14% vs. 29% vs. 30% for left temporal lobe for 5F IMRT, 3D-CRT, and 3F IMRT, respectively (p < 10(-7) for 5F IMRT vs. 3D-CRT and 5F IMRT vs. 3F IMRT). Five-field IMRT plans did not compromise target coverage, exceed normal tissue dose constraints, or increase estimated brain integral dose.CONCLUSIONS: Five-field IMRT irradiation technique results in a statistically significant decrease in the dose to the temporal lobes and may thus help prevent neurocognitive sequelae in irradiated pituitary macroadenoma patients.",Excluded
2801,"Effects of combined immune and radiation cancer therapy on inflammatory environment in the brain of a mouse model. Purpose/Objective(s): Cancer patients often report behavioral and cognitive changes following cancer treatment. These can include difficulty concentrating, memory impairment, and increased anxiety. Though changes are often associated with cytotoxic chemotherapy and/or cranial irradiation, these effects are also seen in patients who receive peripheral but no cranial irradiation and no chemotherapy. A proinflammatory environment in the brain may mediate these effects. Neuroinflammation mediates cognitive impairments in other neurological disorders. Its role in cancer-related neurological dysfunction is likely relevant given novel treatments combining peripheral radiotherapy (RT) with immune activation. However, little is known about how these treatments might affect the brain, in individuals with or without tumors. Our preliminary research has identified an association between treatments combining immune activation and RT and impairments in cognitive measures. Here, we investigate the role of neuroinflammation in these effects. We hypothesize that cognitive impairments following treatment with immunotherapy and RT will be associated with increased expression of neuromodulatory inflammatory cytokines. Materials/Methods: Our project utilizes anti-CTLA4 checkpoint inhibitor immunotherapy preceding precision CT-guided peripheral RT to closely model clinical treatment. C57BL/6J mice with or without injected hind flank 3LL lung carcinoma were used. Mice received sham, RT-only, anti-CTLA4-only, or RT+anti-CTLA4 treatment. Mice were exposed to two identical objects and 24 hours later reintroduced to one familiar object and one novel object. Mice that recognize the familiar object will spend more time exploring the novel object. The percent time exploring the novel object out of the total time exploring both objects is calculated to determine object recognition. Following cognitive testing, brain tissue was harvested and used in an inflammatory cytokine and chemokine 20-plex (GM-CSF, TNF-a, IL-2, IL-1b, IL-4, MIG, KC, VEGF, IL-17, MIP-1a, IL-12, IL-10, IL-6, IL-5, FGF-Basic, IL-1a, IFN-g, IL-13, MCP-1, and IP-10). Result(s): In the animals that did not receive tumors, object recognition was seen in control mice and mice receiving either RT or anti-CTLA-4 alone, but not in mice receiving both treatments. In mice receiving tumors, only the mice that received RT alone showed novel object recognition. Conclusion(s): While combining immune activation and RT optimizes tumor control, it is associated with cognitive impairments. Data from 20-plex are currently being analyzed. We will determine how levels of cytokines and chemokines might be altered by the various treatments and whether they are associated with behavioral and cognitive performance. These results will be presented at the meeting.",Included
3022,"Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy. Modern radiotherapy has achieved substantial improvement in tumour control and toxicity rates by escalating the total dose to the target volume while sparing surrounding normal tissues. It has therefore become necessary to precisely track tumour position in order to minimise geometrical uncertainties due to setup errors and organ motion. We conducted this prospective evaluation of prostate cancer patients treated with image-guided conformal radiation therapy at our institution. We implanted three fiducial markers (gold seeds) within the prostatic gland in order to quantify daily target displacements and to generate specific margins around the clinical target volume (CTV) to create an appropriate planned target volume (PTV). Between April and December 2009, ten patients affected with localised prostate cancer were transrectally implanted with three radio-opaque markers. Each patient underwent a computed tomography (CT) scan for planning purposes following proper bladder and rectum preparation. During treatment two orthogonal images were acquired daily and compared with previously generated digitally reconstructed radiographs. After manual localisation, comparison between the position of the gold seeds on the portal and reference images was carried out, and a set of extrapolated lateral-lateral (LL), anterior-posterior (AP) and cranial-caudal (CC) shift corrections was calculated and recorded. Couch corrections were applied with a threshold of 3 mm displacement. Systematic and random errors for each direction were calculated either as measured according to displacement of the gold seeds prior to any couch movement and after couch position correction according to the radio-opaque markers. For skin marks, mean systematic and random errors were 0.12+2.94 mm for LL, 1.04+3.37 mm for AP, -1.14+2.71 mm for CC, whereas for seed markers, mean and systematic errors were 0.6+1.5 mm for LL, 0.51+2.45 mm for AP and -0.25+2.51 mm for CC. A scatter plot generated on all measurements after couch repositioning according to gold-seed displacement suggested a confidence range of shift distributions within 5 mm for LL, 8 mm for CC, and 7 mm for AP. The total systematic and random components were then used to calculate proper PTV in patients receiving conventional treatment (7 mm for LL and 9 mm for both AP and CC). Prostate positional variability during a course of radiation treatment is strongly influenced by setup and organ motion. Organ tracking through fiducial markers and electronic portal imaging is able to reduce the spread of displacements, significantly contributing to improve the ballistic precision of radiation delivery.",Excluded
3116,"A rhodopsin in the brain functions in circadian photoentrainment in Drosophila. Animals partition their daily activity rhythms through their internal circadian clocks, which are synchronized by oscillating day-night cycles of light. The fruitfly Drosophila melanogaster senses day-night cycles in part through rhodopsin-dependent light reception in the compound eye and photoreceptor cells in the Hofbauer-Buchner eyelet. A more noteworthy light entrainment pathway is mediated by central pacemaker neurons in the brain. The Drosophila circadian clock is extremely sensitive to light. However, the only known light sensor in pacemaker neurons, the flavoprotein cryptochrome (Cry), responds only to high levels of light in vitro. These observations indicate that there is an additional light-sensing pathway in fly pacemaker neurons. Here we describe a previously uncharacterized rhodopsin, Rh7, which contributes to circadian light entrainment by circadian pacemaker neurons in the brain. The pacemaker neurons respond to violet light, and this response depends on Rh7. Loss of either cry or rh7 caused minor defects in photoentrainment, whereas loss of both caused profound impairment. The circadian photoresponse to constant light was impaired in rh7 mutant flies, especially under dim light. The demonstration that Rh7 functions in circadian pacemaker neurons represents, to our knowledge, the first role for an opsin in the central brain.",Excluded
3296,"A Computational Model of the Electric Field Distribution due to Regional Personalized or Nonpersonalized Electrodes to Select Transcranial Electric Stimulation Target. OBJECTIVE: A procedure to personalize the electrode to stimulate specific cortical regions by transcranial electric stimulations has been recently proposed. This study aims to assess the distribution of the electric field (E) induced by tES via the personalized (RePE) and the nonpersonalized (ReNPE) electrode.METHODS: We used two anatomical models on which we shaped and placed the RePE, based on brain anatomy, and the ReNPE to target the bilateral primary motor (M1) or somatosensory cortex (S1) with the reference on the occipital area in both cases. The effect of shifts of the ReNPE position has been also evaluated.RESULTS: The RePE induced higher E peak and median values than the ReNPE along the bilateral primary motor sensory cortices, up to their lateral regions, on a great percentage of volume of these cortices along all their extent. The shift of the ReNPE electrode toward the inion still induced higher E peak and median values than the ReNPE not shifted, but less than the RePE, mainly in the central region and, in a lower percentage of volume, in the lateral regions of these cortices.CONCLUSION: The E distributions induced for both targets (M1 and S1) by the RePE are different from the ones due to the ReNPE, along the whole extent of the bilateral primary sensorimotor cortices. The shift in the ReNPE positioning can modify the E distributions mainly in the more central region of these cortices.SIGNIFICANCE: These results strengthen the suitability of personalized electrodes in targeting extended cortical regions.",Excluded
2593,[Phenomenology and genesis of changes in the total bioelectrical activity of the brain in response to electromagnetic radiation]. A review of the date on phenomenology and genesis of changes in overall activity of brain in response to electromagnetic radiation is presented. It is validated the nonspecific synchronizing influence of the considered factor. This influence can be a reason of epileptoid class convulsions under growth of its biological significance as an irritant of central nervous system. [References: 59],Excluded
3505,"Effects of Proton and Combined Proton and (56)Fe Radiation on the Hippocampus. The space radiation environment contains protons and (56)Fe, which could pose a significant hazard to space flight crews during and after missions. The space environment involves complex radiation exposures, thus, the effects of a dose of protons might be modulated by a dose of heavy-ion radiation. The brain, and particularly the hippocampus, may be susceptible to space radiation-induced changes. In this study, we first determined the dose-response effect of proton radiation (150 MeV) on hippocampus-dependent cognition 1 and 3 months after exposure. Based on those results, we subsequently exposed mice to protons alone (150 MeV, 0.1 Gy), (56)Fe alone (600 MeV/n, 0.5 Gy) or combined proton and (56)Fe radiations (protons first) with the two exposures separated by 24 h. At one month postirradiation, all animal groups showed novel object recognition. However, at three months postirradiation, mice exposed to either protons or combined proton and (56)Fe radiations showed impaired novel object recognition, which was not observed in mice irradiated with (56)Fe alone. The mechanisms in these impairments might involve inflammation. In mice irradiated with protons alone or (56)Fe alone three months earlier, there was a negative correlation between a measure of novel object recognition and the number of newly born activated microglia in the dentate gyrus. Next, cytokine and chemokine levels were assessed in the hippocampus. At one month after exposure the levels of IL-12 were higher in mice exposed to combined radiations compared with sham-irradiated mice, while the levels of IFN-gamma were lower in mice exposed to (56)Fe radiation alone or combined radiations. In addition, IL-4 levels were lower in (56)Fe-irradiated mice compared with proton-irradiated mice and TNF-alpha levels were lower in proton-irradiated mice than in mice receiving combined radiations. At three months after exposure, macrophage-derived chemokine (MDC) and eotaxin levels were lower in mice receiving combined radiations. The levels of MDC and eotaxin correlated and the levels of MDC, but not eotaxin, correlated with the percentage of newly born activated microglia in the blades of the dentate gyrus. Finally, hippocampal IL-6 levels were higher in mice receiving combined radiations compared with mice receiving (56)Fe radiation alone. These data demonstrate the sensitivity of novel object recognition for detecting cognitive injury three months after exposure to proton radiation alone, and combined exposure to proton and (56)Fe radiations, and that newly-born activated microglia and inflammation might be involved in this injury.",Included
3416,"Radio-neuroprotective effect of a phosphatidylcholine derivative in a rat model of irradiation. Ionizing radiation playsmajor role in the treatment of brain tumours, but side-effects may restrict the efficiency of therapy. In the present study, our goals were to detect the functional and morphological changes that result in the administration of l-alpha glycerylphosphorylcholine (GPC), a deacylated derivative of phosphatidylcholine, in a rodent model of hippocampus irradiation. Anaesthetized SPRD rats were subjected to 40-Gy irradiation of one hemisphere of the brain, with or without GPC treatment (50 mg/kg per os). After the irradiation the rats received GPC or the vehicle at the same time every second day at 5 days per week. The effects of partial rat brain irradiation on the spatial orientation and learning ability of rats were assessed in the Morris water maze (MWM) test, which was performed once before and two times after the irradiation. At the same time morphological changes were detected by MRI to define the time-point for histological examinations. Irradiation of 40-Gy resulted in moderate neurological deficit both at the level of cognitive function and morphology after 4 weeks of irradiation. The MWM test was found to be a highly sensitive tool for the detection of neurofunctional impairment. We found that the place navigational function of the ratswas impaired by the irradiation and the treatment with GPC could prevent this damage. Marked protective effect of the GPC was detected as concerns of the histopathological findings. Targeted brain irradiation induced notable changes in the central nervous system. GPC supplementation provides significant protection against irradiation-caused functional and morphological disturbances.",Included
3016,"Indirect adaptive soft computing based wavelet-embedded control paradigms for WT/PV/SOFC in a grid/charging station connected hybrid power system. This paper focuses on the indirect adaptive tracking control of renewable energy sources in a grid-connected hybrid power system. The renewable energy systems have low efficiency and intermittent nature due to unpredictable meteorological conditions. The domestic load and the conventional charging stations behave in an uncertain manner. To operate the renewable energy sources efficiently for harvesting maximum power, instantaneous nonlinear dynamics should be captured online. A Chebyshev-wavelet embedded NeuroFuzzy indirect adaptive MPPT (maximum power point tracking) control paradigm is proposed for variable speed wind turbine-permanent synchronous generator (VSWT-PMSG). A Hermite-wavelet incorporated NeuroFuzzy indirect adaptive MPPT control strategy for photovoltaic (PV) system to extract maximum power and indirect adaptive tracking control scheme for Solid Oxide Fuel Cell (SOFC) is developed. A comprehensive simulation test-bed for a grid-connected hybrid power system is developed in Matlab/Simulink. The robustness of the suggested indirect adaptive control paradigms are evaluated through simulation results in a grid-connected hybrid power system test-bed by comparison with conventional and intelligent control techniques. The simulation results validate the effectiveness of the proposed control paradigms. Copyright Â© 2017 Mumtaz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",Excluded
2754,Hypofractionated radiation therapy for large brain metastases,Included
2645,"Novel functional imaging technique from brain surface with optical coherence tomography enabling visualization of depth resolved functional structure in vivo. Mapping of the activity of brain by optical intrinsic signal imaging (OISI) provides a two-dimensional activation pattern of visual cortical areas at a resolution of a few hundred microns. However, integration of the intrinsic signal over depth results in loss of finer information about functional organization across the depth. Here, we report the first successful implementation of optical coherence tomography (OCT) at around 30 microm depth resolution to investigate cortical functions of a cat brain in vivo. This technique, named functional OCT (fOCT) provided visually evoked changes in the OCT signal. The fOCT signal shows stimulus specificity that correlates well with that of the intrinsic signals and provides depth resolved layer specific functional information.",Excluded
2837,"Formulation optimization of smart thermosetting lamotrigine loaded hydrogels using response surface methodology, box benhken design and artificial neural networks. The aim of this research was to develop lamotrigine containing thermosetting hydrogel for intranasal administration to manage and treat generalized epilepsy. Thermosetting hydrogels were prepared using different ratios of poloxamer 407 (L127), poloxamer 188 (L68) and Carbopol<sup></sup> 974 P NF (C974) using the cold production process. The in situ thermosetting hydrogel was optimized using Box Behken design. Co-solvency approach was used to increase the solubility of lamotrigine by dissolving it in propylene glycol and polyethylene glycol 400 (0.2: 0.8) and the resultant solution was incorporated in the hydrogel to manufacture an LTG hydrogel. The presence of a higher amount of L127 resulted in higher viscosity at 22 degreeC and 34 degreeC and decreased the overall release of LTG. An increase in the amount of C974 resulted in a decrease in the pH of the hydrogel. The results show that formulations F10, F12, F13, F14, F15, F16 and F17 exhibited acceptable thermosetting behavior, pH and released adequate Lamotrigine above the minimum effective concentration to treat generalized epilepsy. The optimized formulation exhibited acceptable thermosetting behavior, pH and lamotrigine release but formed a stiff gel at 22 degreeC. The average LTG content of the optimized hydrogel was 5.00 +/- 0.0225 mg/ml with % recovery of 99.17%. The amount of LTG released at 12 h from the optimized hydrogel was 3.21 +/- 0.0155 mg and will be therapeutically effective in the brain after absorption via the olfactory region in the nasal cavity. Copyright Â© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",Excluded
3089,Effect of whole body gamma irradiation on tissue lipids of rats & the effect of S-beta-aminoethylisothiouronium bromide hydrobromide,Included
2510,The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. The intensity dependence of the auditory evoked N1 ERP component (IDAP) has been suggested as an indicator of central serotonergic neurotransmission with relevance to pharmacological treatment. We report the results of a study evaluating the IDAP in 16 in-patients fulfilling DSM-IV criteria for major depressive episode in the course of treatment with the SSRI Citalopram. Our data revealed a significant correlation between the intensity slopes of the N1 amplitude prior to Citalopram treatment and treatment response: patients with higher intensity slopes of N1 amplitude showed a significantly stronger decrease of HDRS-Score after Citalopram treatment than patients within the lower intensity slope ranges. Our results indicate an association of N1 amplitude intensity dependence with response to antidepressant treatment with Citalopram.,Excluded
3622,"Avoidance of radiation induced alopecia en whole brain radiotherapy treatments with simultaneous integrated boost. Purpose/Objective: Radiation-induced alopecia in hypofractionated whole brain radiation therapy with simultaneous integrated boost (WBRT+SIB) is an understudied issue, even in RTOG 9508. However, this effect has a significant impact on the quality of life of patients. We have currently found a technical solution to this problem. Our current protocol for WBRT+SIB is presented and described, incluiding a retrospective review of the results in relation to radiation-induced alopecia. Material(s) and Method(s): The protocol already implemented in our department is based on a frame-less procedure compatible with masks of type 35764/2MA/M (Orfit Industries N.V., Wijnegem, Belgium), submasks of eXaSkin (Anatomical Geometry S.L., Sevilla, Spain) and a resonance compatible frame eXaFrame (Anatomical Geometry S.L., Sevilla, Spain). CT and MR studies of 1mm slice thickness are acquired with similar length, position and inmovilization. The whole procedure and the resulting high quality fussion is ensured by the eXaFrame system. Treatments were designed using VMAT in Treatment System Planning Pinnacle V.9.2 (Philips N.V, Koninklijke Holland) with multiple arcs, and delivered with a linear accelerator Elekta Synergy (Elekta A.B., Stockholm, Sweden). The dose scheme used is the one reported by Lagerwaard: [WBRT(20Gy) + SIBmts (40Gy)]/5 fr. Patient positioning is verified daily using IGRT with Elekta XVI, before and after treatment. Before optimization is performed, some auxiliary volumes are created: a 3mm ring around calota,called Follicles, and a volume contracted 12mm from the outer one, called CPE. Two CCW VMAT arcs (178degree to 60degree and 300degree to 182degree) are added, with the following objectives: Follicles (EQD2max = 16 Gy, weight = 20; EQD2max = 5 Gy, weight = 1), brain-CPE (D<inf>max</inf>= 21 Gy, weight = 100 and D<inf>min</inf>= 20 Gy, weight = 50), eyes(D<inf>max</inf>= 10 Gy, weight = 1). Thereafter, we work separately on the metastases blocking the optimization of the prophylaxis and creating three structures: VI1 = PTV (MTS1)+ 5 mm, VI2 = PTV (MTS2)+ 5 mm, Epx = brain-VI1-VI2. Objectives were: PTVI (D<inf>max</inf>= 44 Gy, weight = 100 and D<inf>min</inf>= 40 Gy weight = 50), Epx (D<inf>max</inf>= 30 Gy) ,brain stem (D<inf>max</inf>= 23 Gy) and Follicles (EQD2max = 16 Gy, weight = 20; EQD2max = 5 Gy, weight = 20). Result(s): We have treated 14 patients until now. Fusion images have shown differences less than 1mm while mean IGRT correction has been 1.34mm. No acute toxicity have been observed, including neither alopecia nor temporal depilation. Conclusion(s): This protocol has been designed and developed in our hospital, considering the alopecia as toxicity in VMAT optimization. It produces excellent cosmetic results, avoiding alopecia in practically all cases, which has a direct impact on patient quality of life. As a general consideration, we would like to point out that that it should be considered mandatory to use all advanced tools available on modern radiotherapy to minimize toxicity in radiation treatments.",Excluded
3170,"Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. PURPOSE: To evaluate the feasibility of [(11)C]-methionine positron emission tomography (MET PET) in radiotherapy (RT) treatment planning and long-term follow-up in patients with low-grade glioma.PATIENTS: Thirteen patients with low-grade astrocytoma and 1 with anaplastic astrocytoma underwent sequential MET PET and magnetic resonance imaging (MRI) before and 3, 6, 12, and 21-39 months after RT, respectively. Ten patients were studied after initial debulking surgery or biopsy and 4 in the recurrence phase.METHODS: A total of 58 PET scans were performed. After transmission scanning, a median dose of 425 MBq of MET was injected intravenously and emission data was acquired 20 min after injection for 20 min. The uptake of MET in tumor area was measured as standardized uptake value (SUV) and tumor-to-contralateral brain SUV ratios were generated to assess irradiation effects on tumor metabolism. Functional imaging with PET was compared with concurrent MRI in designing the RT planning volumes and in assessment of response to RT during a median follow-up time of 33 months.RESULTS: In 12 patients (86%), tumor area was clearly discernible in the baseline PET study. In the remaining 2 patients with a suspected residual tumor in MRI, PET showed only a diffuse uptake of MET interpreted as negative in the original tumor area. In the dose planning of RT, MET PET was helpful in outlining the gross tumor volume in 3 of 11 cases (27%), whereas PET findings either coincided with MRI (46%) or were less distinctive (27%) in other cases. In quantitative evaluation, patients with a low tumor SUV initially had significantly better prognosis than those with a high SUV. Tumor-to-contralateral brain uptake ratios of MET discriminated well patients remaining clinically stable from those who have since relapsed or died of disease.CONCLUSION: Quantitative MET PET has prognostic value at the time of initial treatment planning of low-grade glioma. Some patients may benefit of RT volume definition with MET PET, which seems to disclose residual tumor better than MRI in selected cases. Stable or decreasing uptake of MET in tumor area after RT during follow-up seems to be a favorable sign.",Excluded
3150,"Overestimating the role of environment in cancers. In a recent article, Wuand colleagues (Nature 2016;529:43-47) review previous studies and present new estimates for the contribution of extrinsic factors to cancer development. The new estimates are generally close to 100%, even for bone and brain cancers that have no known associations with lifestyle and are typically not considered to be preventable. We find that the results of Wu and colleagues are incompatible with previous estimates derived from epidemiological and genetic data.Wefurther argue that their methods are fundamentally flawed because they overlook important effects of tissue type on cancer risk. We therefore conclude that their results give a misleading view of cancer etiology and preventability. Copyright Â© 2016 American Association for Cancer Research.",Excluded
2448,"Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines. It has been reported that the p53 gene mediates an ionizing radiation-induced G1 arrest in mammalian cells. To further characterize this important phenomenon, a panel of seven human diploid fibroblast cell strains and 14 human tumor cell lines from a variety of sources with both wild-type and mutant p53 status were assayed for their susceptibility to G1 arrest after gamma-ray irradiation by a continuous labeling [3H]thymidine incorporation technique. An irreversible G1-block involving 20-70% of the cell population was observed in diploid fibroblasts irradiated with 4 Gy. The block was abolished by transfection with the Human Papilloma Virus E6 gene and in an ataxia telangiectasia (AT) cell line, indicating a role for the AT and p53 genes respectively in this process. In contrast to wild-type normal fibroblast cell strains, the G1-block in all tumor cell lines was significantly reduced, irrespective of their p53 status. None of the nine human tumor cell lines with mutant p53 genes showed a significant G1-block following irradiation with 4 Gy. Among the five tumor cell lines expressing wild-type p53, two showed no apparent G1-block. The remaining three showed a G1-block involving only 8-15% of the cell population, a block much smaller in magnitude than that seen in diploid fibroblasts. Finally, a diploid fibroblast cell strain and a tumor cell line, both showing a normal p53 and p21/WAF1 expression pattern, were examined for pRb phosphorylation before and after irradiation. The diploid fibroblast cell strain showed a significant G1-arrest and a clear inhibition of pRb phosphorylation by irradiation whereas the tumor cells showed no G1-arrest and no inhibition of pRb phosphorylation. These results suggest that (1) multiple genetic factors may modulate the occurrence and magnitude of the G1-arrest induced by exposure to ionizing radiation, (2) the capacity for p53 to mediate a radiation-induced G1 arrest is significantly reduced in tumor cells, (3) the disruption of G1-block modulating factor(s) other than p53 may be an important step in carcinogenesis.",Excluded
2719,"Radiosurgery is not ""standard of care"" for solitary brain metastases: regarding Flickinger et al., IJROBP 28:797-802; 1994",Excluded
2899,[The effect of local irradiation on the cerebellum and cervical area of the spinal cord],Included
3516,Aortic arch injection with C-arm cone beam CT for radiosurgery treatment planning of cerebral arteriovenous malformations: Technical note. Background: C-arm cone beam CT (CBCT) with selective intra-arterial contrast injection combined with digital subtraction angiography (DSA) is currently used for the evaluation and treatment planning of cerebral arteriovenous malformations (AVMs). In some instances an AVM will derive its blood supply from more than one main cervical artery (carotid and/or vertebral artery) and a single-vessel injection will not adequately demonstrate the entire AVM nidus. Method(s): Three patients with cerebral AVM in whom the entire nidus could not be visualized by injection of a single cervical artery are reported. CBCT dataset acquisition was performed by intra-arterial contrast injection in the ascending thoracic aorta through a 5 F pigtail catheter. The injection of diluted iodinated contrast agent (35%) lasted 22 s at a rate of 8 ml/s for a total volume of 176 ml (61.6 ml of contrast agent). The dataset was then processed using standard reconstruction methods. Result(s): Contrast injection in the ascending aorta during a single CBCT acquisition provided a volumetric dataset adequate for subsequent radiosurgical treatment planning. Conclusion(s): This is a safe and effective angiographic technique for the acquisition of volumetric datasets using CBCT that are suitable for treatment planning of intracranial AVMs deriving their blood supply from more than one major cervical artery. This technique allows imaging of the entire AVM nidus during a single CBCT acquisition.,Excluded
2866,"Location of glioblastoma intersectiing white matter tracts predict patient prognosis and response to bevacizumab prior to therapy. INTRODUCTION: Brain tumors are known to invade healthy brain along white matter tracts. We therefore hypothesized that specific white matter tracts would be associated with poorer prognosis based on their connection to primitive brain regions necessary for essential life functions. We also hypothesized that tumors in these regions treated with bevacizumab would alter patient survival. METHOD(S): 109 subjects with primary GBM tumors were retrospectively included in this study. Voxel-wise survival analyses were performed to test for spatial and treatment dependence of GBM survival prognosis. An intersection analysis was first performed between an enhancing tumor mask and template-space diffusion tensor imaging (DTI) derived tractography which highlighted voxels with tumor-intersecting white matter tracts. Maps of voxels with these tracts were made for each patient. A voxel-wise Kaplan-Meier test was performed comparing the survival times of patients with and without a tumor-intersecting white matter tract in that voxel. The same analysis was implemented to compare survival of participants with and without bevacizumab. This highlighted regions where survival was effected due to anti-VEGF treatment. A Monte Carlo simulation was performed to validate the observed survival differences induced by bevacizumab considering inconsistencies in treatment regimens seen in the patient population. RESULT(S): Glioblastoma patients with tumors intersecting the right anterior thalamic radiation, right inferior fronto-occipital fasciculus, bilateral corticospinal tracts, and corpus callosum have decreased survival compared to those with tumors intersecting elsewhere. Patients treated with bevacizumab and who also had tumors intersecting the corpus callosum, corticospinal tract, or the thalamic radiations were found to be at a survival advantage when compared to those who did not receive bevacizumab. CONCLUSION(S): Patient prognosis is associated with the location of tumor intersecting WM tracts. A survival advantage was found in tumors intersecting specific WM tracts treated with bevacizumab.",Excluded
3005,"Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms. Histone deacetylase (HDAC) inhibitors can radiosensitize cancer cells. Radiation is critical in high-risk neuroblastoma treatment, and combinations of HDAC inhibitor vorinostat and radiation are proposed for neuroblastoma trials. Therefore, we investigated radiosensitizing effects of vorinostat in neuroblastoma. Treatment of neuroblastoma cell lines decreased cell viability and resulted in additive effects with radiation. In a murine metastatic neuroblastoma in vivo model vorinostat and radiation combinations decreased tumor volumes compared to single modality. DNA repair enzyme Ku-86 was reduced in several neuroblastoma cells treated with vorinostat. Thus, vorinostat potentiates anti-neoplastic effects of radiation in neuroblastoma possibly due to down-regulation of DNA repair enzyme Ku-86.",Excluded
3564,"Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. PURPOSE: To report toxicity and overall survival (OS) in patients with newly diagnosed glioblastoma multiforme (GBM) treated with hypofractionated intensity-modulated radiotherapy (hypo-IMRT) with concurrent and adjuvant temozolomide (TMZ).METHODS AND MATERIALS: Patients with newly diagnosed GBM after biopsy or resection and with adequate performance status and organ or bone marrow function were eligible for this study. Patients received postoperative hypo-IMRT to the surgical cavity and residual tumor seen on T1-weighted brain MRI with a 5-mm margin to a total dose of 60 Gy in 10 fractions (6 Gy/fraction) and to the T2 abnormality on T2-weighted MRI with 5-mm margin to 30 Gy in 10 fractions (3 Gy/fraction). Concurrent TMZ was given at 75 mg/m(2)/day for 28 consecutive days. Adjuvant TMZ was given at 150 to 200 mg/m(2)/day for 5 days every 28 days. Toxicities were defined using Common Terminology Criteria for Adverse Events version 3.0.RESULTS: Twenty-four patients were treated, consisting of 14 men, 10 women; a median age of 60.5 years old (range, 27-77 years); and a median Karnofsky performance score of 80 (range, 60-90). All patients received hypo-IMRT and concurrent TMZ according to protocol, except for 2 patients who received only 14 days of concurrent TMZ. The median number of adjuvant TMZ cycles was 6.5 (range, 0-14). With a median follow-up of 14.8 months (range, 2.7-34.2 months) for all patients and a minimum follow-up of 20.6 months for living patients, no instances of grade 3 or higher nonhematologic toxicity were observed. The median OS was 16.6 months (range, 4.1-35.9 months). Six patients underwent repeated surgery for suspected tumor recurrence; necrosis was found in 50% to 100% of the resected specimens.CONCLUSION: In selected GBM patients, 60 Gy hypo-IMRT delivered in 6-Gy fractions over 2 weeks with concurrent and adjuvant TMZ is safe. OS in this small cohort of patients was comparable to that treated with current standard of care therapy.",Excluded
2651,"Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. We aimed to evaluate the feasibility and tolerability of the newly developed thermotherapy using magnetic nanoparticles on recurrent glioblastoma multiforme. Fourteen patients received 3-dimensional image guided intratumoral injection of aminosilane coated iron oxide nanoparticles. The patients were then exposed to an alternating magnetic field to induce particle heating. The amount of fluid and the spatial distribution of the depots were planned in advance by means of a specially developed treatment planning software following magnetic resonance imaging (MRI). The actually achieved magnetic fluid distribution was measured by computed tomography (CT), which after matching to pre-operative MRI data enables the calculation of the expected heat distribution within the tumor in dependence of the magnetic field strength. Patients received 4-10 (median: 6) thermotherapy treatments following instillation of 0.1-0.7 ml (median: 0.2) of magnetic fluid per ml tumor volume and single fractions (2 Gy) of a radiotherapy series of 16-70 Gy (median: 30). Thermotherapy using magnetic nanoparticles was tolerated well by all patients with minor or no side effects. Median maximum intratumoral temperatures of 44.6degreeC (42.4-49.5degreeC) were measured and signs of local tumor control were observed. In conclusion, deep cranial thermotherapy using magnetic nanoparticles can be safely applied on glioblastoma multiforme patients. Â© Springer Science+Business Media B.V. 2006.",Excluded
3458,"[Changes in the ultrastructure of neuromuscular synapses in rats under the effects of space flight factors]. The influence of a 7-day space flight on board the biosputnik ""Kosmos-1669"" on the neuro-muscular synapses (NMS) of soleus, gastrocnemius and diaphragm muscles distinct in their functions has been studied. The synapse restructuring on the basis of destructive- regenerative process has been discovered. It is manifested to a great extent in the soleus muscle, to a lesser extent in the gastrocnemius muscle and the least of all in the diaphragm muscle. The changes observed in synapses may be caused by the attenuation of their function in weightlessness.",Included
2430,"Selective 5-HT receptor inhibition of glutamatergic and GABAergic synaptic activity in the rat dorsal and median raphe. The dorsal (DR) and median (MR) raphe nuclei contain 5-hydroxytryptamine (5-HT) cell bodies that give rise to the majority of the ascending 5-HT projections to the forebrain. The DR and MR have differential roles in mediating stress, anxiety and depression. Glutamate and GABA activity sculpt putative 5-HT neuronal firing and 5-HT release in a seemingly differential manner in the MR and DR, yet isolated glutamate and GABA activity within the DR and MR has not been systematically characterized. Visualized whole-cell voltage-clamp techniques were used to record excitatory and inhibitory postsynaptic currents (EPSC and IPSC) in 5-HT-containing neurons. There was a regional variation in action potential-dependent (spontaneous) and basal [miniature (m)] glutamate and GABAergic activity. mEPSC activity was greater than mIPSC activity in the DR, whereas in the MR the mIPSC activity was greater. These differences in EPSC and IPSC frequency indicate that glutamatergic and GABAergic input have distinct cytoarchitectures in the DR and MR. 5-HT(1B) receptor activation decreased mEPSC frequency in the DR and the MR, but selectively inhibited mIPSC activity only in the MR. This finding, in concert with its previously described function as an autoreceptor, suggests that 5-HT(1B) receptors influence the ascending 5-HT system through multiple mechanisms. The disparity in organization and integration of glutamatergic and GABAergic input to DR and MR neurons and their regulation by 5-HT(1B) receptors may contribute to the distinction in MR and DR regulation of forebrain regions and their differential function in the aetiology and pharmacological treatment of psychiatric disease states.",Excluded
2530,"Gamma knife surgery for cavernous hemangiomas: an analysis of 125 patients. OBJECT: The authors sought to determine the value of gamma knife surgery (GKS) in the treatment of cavernous hemangiomas (CHs).METHODS: Between 1993 and 2002, a total of 125 patients with symptomatic CHs were treated with GKS. Ninety-seven patients presented with bleeding and 45 of these had at least two bleeding episodes. Thirteen patients presented with seizures combined with hemorrhage, and 15 patients presented with seizures alone. The mean margin dose of radiation was 12.1 Gy and the mean follow-up time was 5.4 years. In the 112 patients who had bled the number of rebleeds after GKS was 32. These rebleeds were defined both clinically and based on magnetic resonance imaging for an annual rebleeding rate of 32 episodes/492 patient-years or 6.5%. Twenty-three of the 32 rebleeding episodes occurred within 2 years after GKS. Nine episodes occurred after 2 years; thus, the annual rebleeding rate after GKS was 10.3% for the first 2 years and 3.3% thereafter (p = 0.0038). In the 45 patients with at least two bleeding episodes before GKS, the rebleeding rate dropped from 29.2% (55 episodes/188 patient-years) before treatment to 5% (10 episodes/197 patient-years) after treatment (p < 0.0001). Among the 28 patients who presented with seizures, 15 (53%) had good outcomes (Engel Grades I and II). In this study of 125 patients, symptomatic radiation-induced complications developed in only three patients.CONCLUSIONS: Gamma knife surgery can effectively reduce the rebleeding rate after the first symptomatic hemorrhage in patients with CH. In addition, GKS may be useful in reducing the severity of seizures in patients with CH.",Excluded
2514,Systemic and regional neuroimmune processes in focal CNS lesions. [Russian],Excluded
3017,"Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus. BACKGROUND: Multimodal treatment with neoadjuvant chemoradiation followed by surgery (nCRT + S) is the treatment of choice for patients with locally advanced or node-positive esophageal squamous cell carcinoma (E-SCC). Those who are unsuitable or who decline surgery can be treated with definitive chemoradiation (dCRT). This study compares the oncologic outcome of nCRT + S and dCRT in E-SCC patients.METHODS: Between 2011 and 2017, 95 patients with E-SCC were scheduled for dCRT or nCRT+ S with IMRT at our department. Patients undergoing dCRT received at least 50 Gy and those undergoing nCRT + S received at least 41.4 Gy. All patients received simultaneous chemotherapy with either carboplatin and paclitaxel or cisplatin and 5-fluoruracil. We retrospectively compared baseline characteristics and oncologic outcome including overall survival (OS), progression-free survival (PFS) and site of failure between both treatment groups.RESULTS: Patients undergoing dCRT were less likely to have clinically suspected lymph node metastases (85% vs. 100%, p = 0.019) than patients undergoing nCRT + S and had more proximally located tumors (median distance from dental arch to cranial tumor border 20 cm vs. 26 cm, p < 0.001). After a median follow up of 25.6 months for surviving patients, no significant differences for OS and PFS were noticed comparing nCRT + S and dCRT. However, the rate of local tumor recurrence was significantly higher in patients treated with dCRT than in those treated with nCRT + S (38% vs. 10%, p = 0.002). Within a multivariate Cox regression model, age, tumor location, and tumor grading were the only independent parameters affecting OS and PFS. In addition to that, proximal tumor location was the only parameter independently associated with an increased risk for local treatment failure.CONCLUSION: In E-SCC patients treated with either dCRT or nCRT + S, a higher rate of local tumor recurrence was seen in patients treated with dCRT than in patients treated with nCRT + S. There was at least a trend towards an improved OS and PFS in patients undergoing nCRT + S. However, this should be interpreted with caution, because proximal tumor location was the only parameter independently affecting the risk of local tumor recurrence.",Excluded
2525,"[Timing of Whole Brain Radiotherapy on Survival of Patients with EGFR-mutated Non-small Cell Lung Cancer and Brain Metastases]. BACKGROUND: There is no high-level evidence for the time of whole brain radiotherapy (WBRT) for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) and brain metastases. The aim of this study is to assess the appropriate timing of WBRT for patients with EGFR-mutated NSCLC and brain metastases (BM).METHODS: There were 78 patients diagnosed with EGFR-mutated NSCLC and BM in Beijing Chest Hospital between August 2009 and May 2015. 48 untreated patients who received both WBRT and EGFR-tyrosine kinase inhibitors (TKIs) therapy. Prognostic factors of intracranial progression-free survival (PFS) and overall survival (OS) were identified by Cox proportional hazards modeling.RESULTS: Intracranial objective response rate was 81.3% and disease control rate was 93.8%. Median intracranial PFS was 10 months. Median OS was 18 months. Multivariate analysis of intracranial PFS revealed that Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1 (HR=30.436, 95%CI: 4.721-196.211, P<0.001) and early WBRT (HR=3.663, 95%CI: 1.657-8.098, P=0.001) had a better intracranial PFS. Multivariate analysis of OS revealed that PS 0-1 (HR=57.607, 95%CI: 6.135-540.953, P<0.001), early WBRT (HR=2.757, 95%CI: 1.140-6.669, P=0.024), and stereotactic radiosurgery (HR=5.964, 95%CI: 1.895-18.767, P=0.002) were independent prognostic factors of OS.CONCLUSIONS: Early WBRT combined with EGFR-TKIs can improve outcomes of patients with EGFR-mutated NSCLC and BM, but it needs to be confirmed by large-sample-size and multicenter prospective clinical trials.",Excluded
2761,"Acoustic radiation effects on bone conduction threshold measurement. UNLABELLED: Acoustic radiation is the sound energy escape from a bone vibrator that may be detected by air conduction mechanisms. The presence of acoustic radiation may result in an unreal bone conduction threshold, promoting an unreal air/bone gap in the high frequencies.AIM: aim to analyze the acoustic radiation effect on the extension of air/bone gap at 2,000, 3,000 and 4,000 Hz.MATERIALS AND METHOD: our clinical and experimental study had a sample of 101 individuals, who matched inclusion criteria: to have an air/bone gap higher than 10 dB in the frequencies of 2,000; 3,000 and 4,000 Hz. All of them had their bone conduction threshold measured in two conditions: open ear canal and closed ear canal.RESULTS: we found that major differences between the two conditions evaluated occurred at the 4,000 Hz; data analysis showed significant difference in the extension for the air/bone gap; analysis of the number of cases of mixed hearing loss that changed to sensorineural was significant too.CONCLUSION: These studies concluded that when the MAE is occluded, the acoustic radiation phenomenon is controlled or avoided, enabling bone measures at the frequencies of 3,000 and 4,000Hz to be more accurate.",Excluded
2824,"Correlation of visual field, treatment fields, and dose in helium ion irradiation of uveal melanoma. We correlated predicted radiation distributions in 29 patients with uveal melanoma (treated with 5,000 to 8,000 rads of helium ion therapy) with fundus photography and visual field deficits. The tumor was entirely within the treatment region in all patients. The fraction of the predicted high-dose and low-dose regions corresponding with an absolute scotoma was fitted by a linear regression model (r2 = .721) with three independent variables: dose region, initial condition, and time since therapy. The defect in the maximum-dose region increased at an average rate of 0.270/year. This differed (P = .002) from the rate in the penumbra region: (0.104/year). The rate in the penumbra differed (P = .01) from that in the predicted low-dose region, where scotoma did not increase with time. The pattern and time course of visual field loss in the different radiation dose regions tended to support the conclusion that isodose calculations are accurate. The data were consistent with the hypothesis that visual loss secondary to irradiation results primarily from radiation vasculopathy and not from direct damage to photoreceptors or ganglion cells. Development of an absolute scotoma may require a dose in excess of 5,000 rads.",Excluded
2466,"Temporal modulation of sodium current kinetics in neuron cells by near-infrared laser. Near-infrared laser provides a novel nerve stimulation modality to regulate the cell functions. Understanding its physiological effect is a prerequisite for clinic laser therapy applications. Here, the whole-cell sodium (Na) channel kinetics of neuron cell was employed to determine the temporal roles of infrared laser. The Na currents were elicited by electrical pulses that were synchronized at the rising and falling edges of the 980 nm laser pulses, respectively, to investigate the different infrared effect on cell functions. The time constants of activation (tau(m)) and inactivation (tau(h)) kinetics were extracted from fitting of the Na current (m(3)h) according to the Hodgkin-Huxley (HH) model. By comparing the time constants without and with the laser irradiation, we obtained that laser pulses changed the Na current kinetics by accelerating tau(h)-phase and slowing down tau m-phase at the beginning of the laser pulse, whereas both phases were accelerated at the end of the pulse. After relating the ratios of the time constants to the temperature characteristics of Na channel by Q10, we found that the accelerating in Na current kinetics could be related to the average temperature of extracellular solution in the corresponding time span by choosing Q10 = 2.6. The results of this study demonstrated that there was a positive correlation between the acceleration of the Na current kinetics and increases in temperature of the extracellular solution.",Excluded
2602,"<sup>11</sup>C-ORM-13070, a novel PET ligand for brain alpha<inf>2C</inf>-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men. Methods: Radiometabolism was studied in a test-retest setting in six healthy men. After intravenous injection of <sup>11</sup>C-ORM-13070, blood samples were drawn over 60 min. Plasma samples were analysed by radio-HPLC for intact tracer and its radioactive metabolites. Metabolite-corrected plasma time-activity curves were used for calculation of pharmacokinetics. In a separate group of 12 healthy men, the whole-body distribution of <sup>11</sup>C-ORM-13070 and radiation exposure were investigated by dynamic PET/CT imaging without blood sampling. Purpose: <sup>11</sup>C-labelled 1-[(S)-1-(2,3-dihydrobenzo[1,2]dioxin-2-yl)methyl]-4-(3-methoxy-methylpyridin-2-yl)-piperazine (<sup>11</sup>C-ORM-13070) is a novel PET tracer for imaging of alpha<inf>2C</inf>-adrenoceptors in the human brain. Brain alpha<inf>2C</inf>-adrenoceptors may be therapeutic targets in several neuropsychiatric disorders, including depression, schizophrenia and Alzheimer's disease. To validate the use of <sup>11</sup>C-ORM-13070 in humans, we investigated its radiometabolism, pharmacokinetics, whole-body distribution and radiation dose. Results: Two radioactive metabolites of <sup>11</sup>C-ORM-13070 were detected in human arterial plasma. The proportion of unchanged <sup>11</sup>C-ORM-13070 decreased from 81 +/- 4 % of total radioactivity at 4 min after tracer injection to 23 +/- 4 % at 60 min. At least one of the radioactive metabolites penetrated into red blood cells, while the parent tracer remained in plasma. The apparent elimination rate constant and corresponding half-life of unchanged <sup>11</sup>C-ORM-13070 in arterial plasma were 0.0117 +/- 0.0056 min<sup>-1</sup> and 73.6 +/- 35.8 min, respectively. The organs with the highest absorbed doses were the liver (12 muSv/MBq), gallbladder wall (12 muSv/MBq) and pancreas (9.1 muSv/MBq). The mean effective dose was 3.9 muSv/MBq, with a range of 3.6 - 4.2 muSv/MBq. Conclusion: <sup>11</sup>C-ORM-13070 was rapidly metabolized in human subjects after intravenous injection. The effective radiation dose of <sup>11</sup>C-ORM-13070 was in the same range as that of other <sup>11</sup>C-labelled brain receptor tracers. An injection of 500 MBq of <sup>11</sup>C-ORM-13070 would expose a subject to 2.0 mSv of radiation. This supports the use of <sup>11</sup>C-ORM-13070 in repeated PET scans, for example, in receptor occupancy trials with novel drug candidates. Copyright Â© 2014, Springer-Verlag Berlin Heidelberg.",Excluded
2551,"Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation. PURPOSE: To determine whether phosphatidylinositol-3-kinase (PI3K) mutations confer suboptimal local control after radiation therapy (RT) for brain metastases.METHODS AND MATERIALS: We retrospectively reviewed 259 patients with brain metastases treated with RT during the period 2004 to 2017 for whom tumor genetic data (MSK-IMPACT) were available for primary or metastatic lesions. Associations between clinical factors, PI3K mutations status, and local failure (LF) were evaluated with univariate and multivariate competing risks regression.RESULTS: A total of 112 patients received whole brain radiation therapy (WBRT) to a median dose of 30 Gy in 10 fractions, and 147 patients received stereotactic radiosurgery (SRS) to 338 lesions; 276 lesions were treated with single fraction SRS (median dose 21 Gy) and 76 lesions over 3 to 5 fractions SRS (median dose 30 Gy). PI3K mutations were present in 36 WBRT patients (32%) and 44 SRS patients (30%). For WBRT, patients with PI3K mutations (hazard ratio 2.67, P < .001) were found to be at higher risk for LF on multivariable analysis, and the 1-year cumulative incidence of LF was 50% (95% confidence interval [CI] 32%-65%) for patients with PI3K mutations versus 26% (95% CI 17%-37%) for patients without PI3K mutations. For SRS lesions, while PI3K mutations positivity was not statistically significantly associated with LF, higher rate of LF was observed: 1-year LF cumulative incidence of 11% (95% CI 6%-17%) for patients with PI3K mutations versus 5% (95% CI 3%-9%) for patients without PI3K mutations.CONCLUSION: Patients with PI3K mutations are at higher risk for LF for brain metastases after RT. Novel therapeutic strategies to improve treatment outcomes in these patients should be considered.",Excluded
2627,"Use of 99mTc-EDDA/HYNIC-TOC (TEKTROTYD) for radioguided surgery of gastroenteropancreatic neuroendocrine tumors: A feasibility study. Purpose: Surgical resection of primary tumor and involved lymph nodes in patients with gastroenteropancreatic neuroen-docrine tumors (GEP-NETs) has a significant prognostic impact. Aim of this study was to evaluate feasibility of radioguided surgical nodal staging using <sup>99M</sup>Tc-EDDA/HYNIC-TOC(TEKTROTYD) in GEP-NETs. Subjects and methods: Patients with histologically proven GEP-NET eligible to radical or palliative surgery showing avid tumor uptake on <sup>99M</sup>Tc-EDDA/HYNIC-TOC scintigraphy and SPECT/CT were prospectively enrolled. Approximately 4h before surgery, 185 MBq of <sup>99M</sup>Tc-EDDA/HYNIC-TOC were i.v. administered. Intraoperative localization of primary tumor and radioactive lymph nodes was performed using a hand-held gamma-probe set on <sup>99M</sup>Tc energy peak. Radioactive lymph nodes were localized and excised before proceeding to regional lymphadenectomy. Extra-regional lymphatic basins were also investigated. Resected specimens were re-evaluated ex vivo with the gamma-probe after macroscopic lymph node isolation. Result(s): Since February 2017, fve GEP-NET patients were enrolled (3 pts had G1-G2 ileal NET, 1 pt G2 rectal NET and 1 pt gastric NEC). All primary lesions seen on pre-operative scin-tigraphy were successfully localized with gamma-probe and completely excised. Mean in-vivo tumor count-rate was 399 counts-per-second/cps (range 80-496). Histological examination confrmed pre-operative diagnosis in all cases. A total of 107 lymph nodes was resected (mean number per patient 21, range 14-40), including 35 radioactive lymph nodes (mean number 7, range 3-12). Mean in-vivo nodal count-rate was 185 cps (range 14-722). 20/35 radioactive lymph nodes were meta-static at histologic examination (mean number 4, range 1-11). No metastatic involvement of ""cold"" lymph nodes was reported. Notably, ex-vivo count-rate of metastatic lymph nodes showed no significant variation from in-vivo gamma-probe evaluation, whereas non-involved nodes showed generally a sharp decrease in ex-vivo count-rate. In one patient, radioguided nodal evaluation determined the localization of a metastatic node in a extra-regional district. Median follow-up after surgery was 11 months (range 5-13). Clinical and instrumental follow-up evaluation showed stable disease in every patient, with no evidence of nodal disease recurrence. Conclusion(s): This pilot study con-frmed feasibility of radioguided nodal staging in GEP-NET patients. The use of <sup>99M</sup>Tc-EDDA/HYNIC-TOC allowed manageable surgical scheduling, limiting radiation exposure of patients and medical staf. Moreover, this procedure can be performed using a standard gamma-probe routinely used for sentinel lymph node biopsy. Preliminary results on false-negative rate suggest that this could represent a reliable approach for surgical nodal staging with a clinical impact on prognosis.",Excluded
3351,"Magnetic resonance imaging associates with differences in neurocognitive performance for cancer survivors complaining of cognitive deficits following brain irradiation. BACKGROUND: Following brain irradiation, roughly 50% of cancer survivors develop some higher-order neurocognitive impairment that does not resolve and can decline further into dementia. However, predicting those who will develop cognitive impairment following therapy is not currently possible. Magnetic resonance imaging (MRI) markers from clinical scans may provide candidate biomarkers related to cognitive performance. METHOD(S): Baseline MRI scans and neurocognitive scores were collected from 198 participants enrolled in CCWFU91105 (NCT#00369785) prior to randomization. Subjects self-reported cognitive difficulties and were at least 6 months post-therapy. At minimum, a T1-weighted MRI pre- and post-gadolinium contrast was requested to confirm stable disease in all participants. Additional scans, including fluid-attenuated inversion recovery (FLAIR), diffusion-weighted, perfusion-weighted, and T2-weighted MRI scans, were available for analysis in subgroups of participants. Significance was assessed using statistical parametric mapping (SPM8) with a family-wise error correction of p < 0.05. RESULT(S): Because of the vast variability in scan protocols, consistent whole-brain imaging (ie, no skip) was found in 50% of post-contrast T1-weighted scans. From these, local gray and white matter volumes were determined. Increased processing speed was associated with increased volume of white matter in the Muratoff bundle (i.e., subcallosal fasciculus), whereas increased verbal fluency was associated with increased white matter in the corpus callosum, left frontal horn, and bilateral cerebellum. Subgroup analysis of other modality scans (as available: FLAIR and diffusion-weighted) supported these findings. Perfusion of gray matter did not correlate with neurocognitive function in the sub-group receiving pulse arterial spin labeling scans. CONCLUSION(S): Variance in brain structure correlated with performance differences on several neurocognitive tests and indicated a strong association between white matter integrity and maintenance of cognitive function in cancer survivors following brain irradiation. Whether a prospective trial from a pretreatment baseline will find white matter integrity to be predictive of postradiotherapy cognitive function remains to be seen.",Excluded
2624,"Locally advanced nasopharyngeal carcinoma: Delivering neoadjuvant chemotherapy prior to concurrent chemoradiation therapy. Purpose/Objective(s): The standard of care for locally advanced nasopharyngeal carcinoma (NPC) is concurrent chemoradiation therapy (CRT). Patients with large tumors at presentation which are close to dose-limiting structures such as the optic chiasm and brain stem may pose a challenging clinical problem. Neoadjuvant chemotherapy (NC) prior to CRT can be used to shrink the tumor and may therefore be a valuable strategy to optimize treatment planning. Studies in Asia have reported favorable outcomes with NC for NPC. The goal of this study was to characterize the patterns of use of NC for NPC at a Canadian center. Materials/Methods: We conducted a retrospective analysis of locally advanced NPC patients treated between 2000 and 2013. Patients who received NC with the intention to downsize locally advanced tumors prior to CRT were included. Baseline demographics, chemotherapy, radiation therapy treatments, and follow-up data were obtained from institutional databases and chart review and analyzed with SPSS. Overall survival (OS), disease-specific survival (DSS), progression-free survival (PFS), local regional relapse-free survival (LRFS), and distant metastasis-free survival (DMFS) were analyzed using Kaplan-Meier survival functions. Result(s): Forty-six patients were identified. The median age at diagnosis was 47 (range 18-75). Eighty percent of patients were male, 74% were of Asian ethnicity, and 87% had an ECOG performance status 0 or 1. Ninetyfour percent of patients had T3 or T4 tumors; 80% were node positive; 26% stage III, 67% IVA, 4% IVB. NC regimens included cisplatin/gemcitabine 87%, cisplatin/fluorouracil 6%, and cisplatin/etoposide 6%. The total neoadjuvant dose of cisplatin received ranged from 24mg/m<sup>2</sup> to 325 mg/m<sup>2</sup> with a median dose of 160mg/m<sup>2</sup>. The most common dose fractionations prescribed were 70 Gy in 35fractions for 67% of cases and 66 Gy in 33 fractions for 13%. Forty-two of the 46 patients went on to receive CRT, and the total concurrent cisplatin dose delivered was <200 mg/m<sup>2</sup> for 21 patients (46%) and >200 mg/m<sup>2</sup> for 25 patients (54%). In multivariate analysis of the 42 patients who received concurrent chemotherapy, the ability to deliver over 200 mg/m<sup>2</sup> concurrent chemotherapy with radiation was not impacted by the dose of neoadjuvant chemotherapy, age, sex, ECOG, or ethnicity. Median follow-up was 2.6 years (0.17-10.6 years). Twenty-three percent of patients had a local recurrence, 13% developed distant metastases, and there were 7 deaths, 6 deaths due to NPC. The 3- year PFS was 67%, LRFS 74%, DMFS 86%, DSS 86%, and OS was 83%. Conclusion(s): NPC patients have been treated with NC at this center with favorable outcomes. Most patients tolerated CRT after NC, and half of patients received 5 or more concurrent cycles. The dose of NC given did not lower the dose concurrent chemotherapy later tolerated. This institution is currently evaluating the volumetric impact of NC on tumor size while we await the results of ongoing randomized trials of NC followed by CRT in this patient population.",Excluded
3216,"Radiation injury & mercury deposits in internal organs as a result of thallium-201 chloride intravenous injection for SPECT imaging; additional biochemical information obtained in the images of organs from SPECT or PET scans; & potential injury due to radiation exposure during long distance flights. In order to study functional as well as anatomical aspects of various internal organs, SPECT (Single Photon Emission Computerized Tomography) has been used extensively for evaluation of these organs. For SPECT study, intravenous injection of radioactive substances such as technetium-99m (20 millicuries) & thallium-201 chloride (3 millicuries) is commonly used. Although the physical half-life of thallium-201 chloride is 73 hours, its biological half-life is often more than 3.5 times that. Following intravenous injection of thallium-201 chloride it is concentrated in the heart, liver, kidneys, pancreas, thyroid gland, testes or ovaries, and then eventually decays to mercury. Because of its relatively long physical & biological half-lives, thallium-201 chloride may produce mild radiation injury while it remains radioactive. Similar injuries may be induced by technetium-99m (often used for brain SPECT), which radiates Gamma rays (140 KeV), but since its physical half-life is only 6 hours, the side effects are not as significant as those of thallium-201 chloride. Since the main component of thallium-201 chloride radiation is X-ray (68-82 KeV), which consists of photons with a very short wavelength and a high penetrating power, prolonged exposure can induce electromagnetic field-induced injury. As a previous study of the principal author on electromagnetic field exposure indicated, electromagnetic field-induced injury causes the change of L-amino acids to D-amino acids. 2 days after SPECT study of the heart with intravenous injection of thallium-201 chloride, the principal author experienced shortness of breath, loss of appetite, dizziness, fever, and general malaise within the week, and found a progressively significant increase in D-glutamic acid and decrease in L-glutamic acid peaking 2 weeks after the initial injection but lasting for many weeks after in organs such as the heart, liver, kidneys, pancreas, thyroid gland & testes, where radioactive substances had accumulated and radiation was at an average of about 400 counts/min. Even 2 months after the initial injection, the abnormal ratio of D-amino acids and L-amino acids had not returned to normal (in the radiation exposed heart, L-amino acids: 6 mg/dl with D-amino acids: 5 mg/dl; normal tissue, L-amino acids: 10 mg/dl with D-amino acids < 1 mg/dl). The principal author tried to find a safe method of reducing possible radiation injury and accelerating the elimination of the already deposited mercury.(ABSTRACT TRUNCATED AT 400 WORDS)",Excluded
2903,Evolution of supraoptical and paraventricular nuclei (son and PVN) after X-rays irradiation and subsequent thiamine treatment in white rats,Included
3321,"Long-Term Deficits in Behavior Performances Caused by Low- and High-Linear Energy Transfer Radiation. Efforts to protect astronauts from harmful galactic cosmic radiation (GCR) require a better understanding of the effects of GCR on human health. In particular, little is known about the lasting effects of GCR on the central nervous system (CNS), which may lead to behavior performance deficits. Previous studies have shown that high-linear energy transfer (LET) radiation in rodents leads to short-term declines in a variety of behavior tests. However, the lasting impact of low-, medium- and high-LET radiation on behavior are not fully defined. Therefore, in this study C57BL/6 male mice were irradiated with 100 or 250 cGy of gamma rays (LET ~0.3 KeV/mum), 10 or 100 cGy of <sup>1</sup>H at 1,000 MeV/n (LET ~0.2 KeV/mum), <sup>28</sup>Si at 300 MeV/n (LET ~69 KeV/mum) or <sup>56</sup>Fe at 600 MeV/n (LET of ~180 KeV/mum), and behavior metrics were collected at 5 and 9 months postirradiation to analyze differences among radiation qualities and doses. A significant dose effect was observed on recognition memory and activity levels measured 9 months postirradiation, regardless of radiation source. In contrast, we observed that each ion species had a distinct effect on anxiety, motor coordination and spatial memory at extended time points. Although <sup>28</sup>Si and <sup>56</sup>Fe are both regarded as high-LET particles, they were shown to have different detrimental effects on behavior. In summary, our findings suggest that GCR not only affects the CNS in the short term, but also has lasting damaging effects on the CNS that can cause sustained declines in behavior performance.",Included
3066,Recovery of central nervous system functions impaired by lethal head x-irradiation,Included
2733,"125Iodine implants as an adjuvant to surgery and external beam radiotherapy in the management of locally advanced head and neck cancer. 125Iodine seeds either individually placed or inserted into absorbable Vicryl suture carriers were utilized in conjunction with surgery and external beam radiotherapy in an attempt to increase local control rates in patients with (1) advanced oropharyngeal and laryngopharyngeal cancers (T3-T4, N2-N3), (2) massive cervical lymphadenopathy (N3) and an unknown primary site and (3) locally recurrent head and neck cancers. Forty-eight patients were treated with 55 implants. The carotid artery was implanted in 15 patients, while seven patients had seeds inserted into the base of the skull region, and another three patients had implants near cranial nerves. Eighteen of the 48 patients were treated for cure. The actuarial survival at five years in this subgroup was 50%. The overall local control in the head and neck area was 58%. In this group no patients to date have had a local failure in the implanted volume. Seventeen patients with comparable stage of disease treated prior to 1974 with curative intent without 125I implants were analyzed retrospectively for comparison with the implanted patients. The actuarial survival of these patients was 18% and the overall head and neck control was 21%. These differences are statistically significant at a P value of 0.01 and 0.007, respectively. Seventeen patients received implants for local recurrence. The local control in the head and neck area was 50%; however, the 2.5 year actuarial survival was only 17%. The complication rate was 11% (six of 55 implants). The improved survival, the high local control, and the minimal complication rates in this series makes the intraoperative implantation of 125I seeds and effective adjunctive treatment to surgery and external beam irradiation.",Excluded
2540,"Preclinical radiotherapy at the Australian Synchrotron's Imaging and Medical Beamline: instrumentation, dosimetry and a small-animal feasibility study. Therapeutic applications of synchrotron X-rays such as microbeam (MRT) and minibeam (MBRT) radiation therapy promise significant advantages over conventional clinical techniques for some diseases if successfully transferred to clinical practice. Preclinical studies show clear evidence that a number of normal tissues in animal models display a tolerance to much higher doses from MRT compared with conventional radiotherapy. However, a wide spread in the parameters studied makes it difficult to make any conclusions about the associated tumour control or normal tissue complication probabilities. To facilitate more systematic and reproducible preclinical synchrotron radiotherapy studies, a dedicated preclinical station including small-animal irradiation stage was designed and installed at the Imaging and Medical Beamline (IMBL) at the Australian Synchrotron. The stage was characterized in terms of the accuracy and reliability of the vertical scanning speed, as this is the key variable in dose delivery. The measured speed was found to be within 1% of the nominal speed for the range of speeds measured by an interferometer. Furthermore, dose measurements confirm the expected relationship between speed and dose and show that the measured dose is independent of the scan direction. Important dosimetric parameters such as peak dose, valley dose, the collimator output factor and peak-to-valley dose ratio are presented for 5 mm x 5 mm, 10 mm x 10 mm and 20 mm x 20 mm field sizes. Finally, a feasibility study on three glioma-bearing rats was performed. MRT and MBRT doses were prescribed to achieve an average dose of 65 Gy in the target, and magnetic resonance imaging follow-up was performed at various time points after irradiation to follow the tumour volume. Although it is impossible to draw conclusions on the different treatments with such a small number of animals, the feasibility of end-to-end preclinical synchrotron radiotherapy studies using the IMBL preclinical stage is demonstrated.",Excluded
3374,"MRI-Guided Ultrafocal HDR Brachytherapy for Localized Prostate Cancer: Median 4-Year Results of a feasibility study. PURPOSE: For the treatment of localized prostate cancer, focal therapy has the potential to cure with fewer side effects than traditional whole-gland treatments. We report an update on toxicity, quality of life (QoL), and tumor control in our magnetic resonance imaging (MRI)-guided ultrafocal high-dose-rate brachytherapy cohort.METHODS AND MATERIALS: Disease status was evaluated by systematic biopsies and 3T multiparametric MRI. The brachytherapy implant procedure under fused transrectal ultrasound/MRI guidance was followed by a 1.5 T MRI for contour adjustments and catheter position verification. A single dose of 19 Gy was delivered to the tumor with a margin of 5 mm. Genitourinary (GU) toxicity, gastrointestinal (GI) toxicity, and erectile dysfunction (ED) were graded with the Common Terminology Criteria for Adverse Events version 4.0. QoL was measured with RAND-36, European Organisation for Research and Treatment of Cancer QLQ-C30 and PR25. International Prostate Symptom Scores and International Index of Erectile Function scores were obtained. Prostate-specific antigen level was monitored, with biochemical recurrence defined as nadir + 2 ng/mL (Phoenix).RESULTS: Thirty patients with National Comprehensive Cancer Network low- (13%) to intermediate-risk (87%) prostate cancer were treated between May 2013 and April 2016. Median follow-up was 4 years. Median age was 71 years (interquartile range, 68-73) and median initial prostate-specific antigen level was 7.3 ng/mL (5.2-8.1). Maximum Gleason score was 4 + 3 = 7 (in 2 patients). All tumors were radiologic (MRI) stage T2. No grade >2 GU or >1 GI toxicity occurred. International Prostate Symptom Scores only deteriorated temporarily. Mild pretreatment ED deteriorated to moderate/severe ED in 50% of patients. Long-term clinically relevant QoL deterioration was seen in sexual activity and tiredness, whereas emotional and cognitive functioning improved. At 4 years, biochemical disease-free survival was 70% (95% confidence interval, 52%-93%), metastases-free survival was 93% (85%-100%), and overall survival was 100%. Of intraprostatic recurrences, 7 of 9 were out of field.CONCLUSIONS: Ultrafocal high-dose-rate brachytherapy conveys minimal GU or GI toxicity and has a marginal effect on QoL. An early decline in erectile function was seen. Tumor control outcomes are poor (biochemical disease-free survival of 70% [52%-93%] at 4 years), most likely as a result of poor patient selection.",Excluded
3137,[Local injuries and necroses of cerebral tissue after radiation therapy and stereotactic radiosurgery of intracranial mass lesions],Included
3456,"Palliative irradiation of bone metastases. Painful bone metastases is a common feature in patients with advanced cancer. The application of radiotherapy is often used as palliative treatment. A review of available data from the literature reveals that irrespective of the primary diagnosis palliation is achieved in 70-100% of cases. The biological basis of pain and the effects of radiotherapy is discussed. Treatment schedules for patients with single-bone lesions are reviewed. It is concluded that single-shot treatment in doses ranging from 5 to 8 Gy is as effective as multi-fractionated treatment. In addition, the possible role of radiotherapy in relation to patients with multiple lesions, and the use of combined surgery and radiotherapy in patients with impending and manifest fractures are discussed. It is concluded that the literature does not allow a definitive conclusion concerning an optimal use of radiotherapy. [References: 41]",Excluded
3557,"Orbital radiation for the ocular changes of Graves' disease. The authors review the records of 37 patients who received orbital radiation for ocular changes of Graves' disease. Signs of orbital congestion improved in many patients. Proptosis, extraocular muscle involvement, and corneal involvement were not appreciably altered. The best response was found in patients with optic nerve involvement. Radiation therapy is recommended as an initial therapeutic attack for the optic neuropathy of Graves' disease.",Excluded
2609,"The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy. INTRODUCTION: GBM has a poor survival despite surgery and chemoradiotherapy. Cytoreduction and PDT have postulated to afford better local GBM-control. However, the interaction of PDT with newer novel therapies had not been fully investigated. This study reviewed the impact of PDT in conjunction with intraoperative radiotherapy.METHODS: Case note review of prospectively collected data of GBMs treated surgically by the senior author (SE). Patients received standard therapy (ST), ST+PDT or ST+PDT+IORT. ST involved maximum safe resection, PDT involved intracavity 100 J/cm2 630 nm laser and IORT involved intracavity 10-15 Gys using the PRS400 R. Patients were followed up clinically and radiologically till death.RESULTS: There were 73 patients included in this analysis (42 males). The average age was 59years. Thirty received PDT and 43 did not. The mean survival of PDT-patients was significantly longer than those had ST alone (62.9 weeks vs. 20.6 weeks) (p=0.001). Patients < 65 year of age survived longer than those >= 65 year (p=0.033). IORT on its own did not make a significant difference to survival (p=0.111). However the average survival for patients who received PDT+IORT was substantially higher than those who received PDT alone (79 weeks vs. 39.7 weeks). Using a Cox regression covariant analysis, demonstrated that PDT was the only therapy to make a statistically significant difference to survival (p=0.018).CONCLUSIONS: PDT in high grade glioma was statistically significant therapeutic modality and its effects were further improved by IORT.",Excluded
3006,"Design and evaluation of learning strategies for a group of radiographers in radiostereometric analysis (RSA). Introduction The purpose of this study was to design and evaluate a radiostereometric analysis (RSA) program aimed at radiographers in order to increase their cognitive and practical skills, thereby increasing image quality and minimizing exposure repetition. Methods and materials Twenty radiographers were randomized into two identically sized study groups. Training consisted of a theoretical and practical workshop using a phantom. Tests were performed to compare the effect of training to nontraining, and the effect of time duration on the maintenance of RSA skills. The effect of training was measured by a written test and three defined parameters influencing image quality. Results Group A reduced significantly (p < 0.001) by 31.3 mm (21-31%) the distance between the centrum of the prosthesis (CP) and the centrum of the calibration field (CCF) and increased the number of beads (NB) visible by 3.6 (out of 18). A further significant reduction of 5.1 mm (p = 0.023), 1.0 bead more (p < 0.001) and a 2.1 (p = 0.022) point better rotation of the prosthesis (RP) was registered two months later. Group B was tested twice without training and no significant improvement was registered. One month after training group B had experienced overall significant improvement on a par with group A. Conclusion It is realistic to implement an RSA X-ray training program where radiographers significantly improve their theoretical and practical skills in centering the CP closer to the CCF, NB and RP. A duration of up to two months after training does not influence the quality of participants' performance. Copyright Â© 2017 The College of Radiographers",Excluded
3101,"Diffusion imaging biomarkers for predicting brain normal tissue radiation necrosis. Purpose/Objective(s): Dose-based predictive models of brain radiation necrosis have limited accuracy. We examined whether diffusion tensor imaging changes in a representative white matter structure (corpus callosum splenium) can contribute additional predictive value to a dose-based normal tissue complication probability model. Materials/Methods: Twenty-nine glioblastoma patients received six weeks of intensity modulated radiation therapy (RT) with concurrent temozolomide on a dose-escalation protocol. Patients underwent diffusion tensor imaging before RT, at week 3 during RT, and 1, 3, and 6 months after completing RT. The diffusion indices axial diffusivity (a marker of axonal degradation) and radial diffusivity (a marker of demyelination) were measured in the corpus callosum splenium. Diffusion indices were measured in dose threshold subvolumes of the splenium, defined by 10 Gy isodose lines. A support vector machine was used to classify cases with and without radiation necrosis using the whole brain generalized equivalent uniform dose (gEUD), and percentage changes in diffusion indices from before RT. Significant variables were used to develop a normal tissue complication probability model using binary logistic regression. Result(s): Seven patients developed radiation necrosis between 4 and 8 months after RT. Mean change of radial diffusivity at week 3 during RT was significantly greater in patients that would eventually develop radiation necrosis (+4% vs >=6%, p = 0.037). Mean change of radial diffusivity continued to increase at later time points among patients who developed radiation necrosis, but remained near zero in patients without complications. Whole brain gEUD alone was a weak predictor of radiation necrosis (p = 0.068). Predictive modeling was most accurate with the combination of gEUD and change in radial diffusivity at week 3 during RT in the subvolumes of the splenium receiving >= 30 Gy and >= 40 Gy (p = 0.006). Conclusion(s): This hypothesis-generating study suggests that percentage change in radial diffusivity can contribute predictive value to a dose-based normal tissue complication probability model, even before the course of radiation is complete. Diffusion tensor imaging has potential to guide patient selection in dose-escalation protocols and should be further explored.",Excluded
2789,"RADIANS: A Multidisciplinary Central Nervous System Clinic Model for Radiation Oncology and Neurosurgery Practice. BACKGROUND: Radiation therapy for central nervous system disease commonly involves collaboration between Radiation Oncology and Neurosurgery. We describe our early experience with a multidisciplinary clinic model.METHODS: In 2016, the novel RADIANS (RADIation oncology And NeuroSurgery) clinic model was initiated at a community hospital. Disease and treatment demographics were collected and analyzed. Patient satisfaction was assessed via a blinded survey questionnaire.RESULTS: Forty-two patients have been seen since the inception of RADIANS. The median age was 65; and the median patient distance from RADIANS was 42.7 miles (mean = 62.6; range = 0.7-285). Half of the patients traveled >50 miles to receive care, and >80% were seen for central nervous system metastases. Of the patients receiving radiation, 75% received stereotactic radiosurgery/stereotactic body radiation therapy. The mean overall satisfaction from 0 (not satisfied) to 5 (very satisfied) was 4.8.CONCLUSIONS: The RADIANS clinic model has proved viable and well-liked by patients in a community setting, with the majority of radiation therapy administered being stereotactic radiosurgery/stereotactic body radiation therapy rather than conventional fractionation.",Excluded
3078,"[The protocol of dose reduction in liver perfusion computed tomography]. Cerebral perfusion computed tomography (CT) has been widespread, but abdominal perfusion CT has not been very popular because there has been a problem with regard to the limit of irradiation range and respiratory effects. Recently, it became easy to perform perfusion of abdominal organs because the use of multi detector row CT (MDCT) has been extensive. Along with it, the number of hospitals that perform liver perfusion CT has increased. However, patient dose of the liver perfusion CT is very high, making it very important to reduce patient dose. We created the virtual data that reduced the number of irradiation by partly reducing the data obtained on the liver perfusion CT. We compared the analysis results of all data with that of the partly reduced. It is possible to reduce the patient dose by reducing the number of irradiation because there was no significant difference in the analysis results.",Excluded
2832,"Using biologically based objectives to optimize boost intensity-modulated radiation therapy planning for brainstem tumors in dogs. Irradiated brain tumors commonly progress at the primary site, generating interest in focal dose escalation. The aim of this retrospective observational study was to use biological optimization objectives for a modeling exercise with simultaneously-integrated boost IMRT (SIB-IMRT) to generate a dose-escalated protocol with acceptable late radiation toxicity risk estimate and improve tumor control for brainstem tumors in dogs safely. We re-planned 20 dog brainstem tumor datasets with SIB-IMRT, prescribing 20 x 2.81 Gy to the gross tumor volume (GTV) and 20 x 2.5 Gy to the planning target volume. During the optimization process, we used biologically equivalent generalized equivalent uniform doses (gEUD) as planning aids. These were derived from human data, calculated to adhere to normal tissue complication probability (NTCP) <=5%, and converted to the herein used fractionation schedule. We extracted the absolute organ at risk dose-volume histograms to calculate NTCP of each individual plan. For planning optimization, gEUD<sub>(a = 4) </sub> = 39.8 Gy for brain and gEUD<sub>(a = 6.3) </sub> = 43.8 Gy for brainstem were applied. Mean brain NTCP was low with 0.43% (SD +/-0.49%, range 0.01-2.04%); mean brainstem NTCP was higher with 7.18% (SD +/-4.29%, range 2.87-20.72%). Nevertheless, NTCP of < 10% in brainstem was achievable in 80% (16/20) of dogs. Spearman's correlation between relative GTV and NTCP was high (rho = 0.798, P < .001), emphasizing increased risk with relative size even with subvolume-boost. Including biologically based gEUD values into optimization allowed estimating NTCP during the planning process. In conclusion, gEUD-based SIB-IMRT planning resulted in dose-escalated treatment plans with acceptable risk estimate of NTCP < 10% in the majority of dogs with brainstem tumors. Risk was correlated with relative tumor size.",Excluded
2920,"The effects of the g-quadruplex ligand telomestatin to human brain tumor stem cell survival and growth. Glioblastoma multiforme (GBM) is the leading cause of death among primary brain tumors in adults and the current therapies have only palliative effect on prognosis of patients. Recently, stem cell-like cells in GBM (brain tumor stem-like cells; BTSC) have gained substantial attention as a potential therapeutic target. Hallmarks of BTSC include their self-renewal capacity and highly migratory potential. In this study, we demonstrate that treatment of patient-derived BTSC with a G-quadruplex ligand, telomestatin (TMS), inhibits BTSC self-renewal and maintenance of their stem cell state, and induces their apoptosis in vitro and in vivo. In contrast, both normal precursors and non-stem tumor cells from the matched samples are relatively resistant to TMS treatment. Treatment with a lower dose of TMS specifically inhibits BTSC migration into normal brain. Immunofluorescence in situ hybridization with TMS-treated GBM cells displays both telomeric and non-telomeric DNA damage in BTSC but not in non-stem tumor cells. cDNA microarray analysis identifies a proto-oncogene, c-Myb, as a target of TMS in BTSC, and the pharmacodynamic analysis with TMS-treated tumor-bearing mouse brains demonstrates reduction of c-Myb expression in tumors. An elevated c-Myb expression is found in surgical specimens of GBM compared to normal brain tissues. Lastly, TMS treatment of BTSC-derived mouse intracranial tumors reduces tumor sizes in vivo without any noticeable apoptotic cells in the normal brain, and a combined treatment of TMS with radiation or temozolomide results in additive inhibitory effects on GBM sphere growth in vitro. Collectively, these data indicate a potential avenue toward BTSC-directed therapeutic strategy using TMS via telomeric DNA damage and inhibition of c-Myb, which may offer a novel therapeutic approach for GBM.",Excluded
3214,"Transdermal patches loaded with L-cysteine HCL as a strategy for protection from mobile phone emitting electromagnetic radiation hazards. Mobile phone usage has been increased in the last few years emitting electromagnetic radiation (EMR), which disturbs normal cellular processes via oxidative stress. L-cysteine, a glutathione precursor, prevents oxidative damage. Transdermal patches (TDPs) loaded with L-cysteine hydrochloride (L-CyS-HCL) were fabricated by dispersion of L-CyS-HCL 5% w/w and different concentrations of sorbitol as a plasticizer in room-temperature vulcanizable synthetic silicone matrices (RTV-Si). The effect of sorbitol on patch physicochemical parameters was assessed; in-vitro L-CyS-HCL release profiles and ex-vivo permeation were studied. Pharmacokinetic parameters of endogenous synthetized in-vivo glutathione, after receiving IV bolus dose of L-CyS-HCl and L-CyS-HCl-RTV-Si-TDPs were studied in rat model. The influence of L-CyS-HCL-RTV-Si-TDPs against damaging effects of mobile phone EMR on rats' blood and brain tissues was studied. The results revealed that patch plasticity, intensity reflections, surface porosity, L-CyS-HCL release rate and skin permeation increased with increasing sorbitol concentration. Pharmacokinetic profile for IV dose and L-CyS-HCl-RTV-Si-TDPs revealed that the L-CyS-HCl-RTV-Si-TDPs provided a sustained glutathione plasma concentration-time profile over entire patch application. High significant differences in biological parameters (blood and brain samples) were observed for radiated rats using the patch in study compared with positive control rats. Promising long-term strategy for protection against mobile phone hazards was obtained. Copyright Â© 2018 The Authors",Excluded
2580,"Primary central nervous system lymphoma. Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal non-Hodgkin lymphoma (NHL), confined to the brain, eyes, spinal cord or leptomeninges without systemic involvement. Overall prognosis, diagnosis and management of PCNSL differ from other types of NHL. Prompt diagnosis and initiation of treatment are vital to improving clinical outcomes. PCNSL is responsive to radiation therapy, however whole-brain radiotherapy (WBRT) inadequately controls the disease when used alone and its delayed neurotoxicity causes neurocognitive impairment, especially in elderly patients. High-dose methotrexate (HD-MTX)-based induction chemotherapy with or without autologous stem cell transplantation (ASCT) or reduced-dose WBRT leads to durable disease control and less neurotoxicity. The optimal treatment has yet to be defined, however HD-MTX-based induction chemotherapy is considered standard for newly diagnosed PCNSL. Ongoing randomized trials address the role of rituximab, and of consolidative treatment using ASCT or reduced-dose WBRT. Despite high tumor response rates to initial treatment, many patients have relapsing disease with very poor prognosis. The optimal treatment for refractory or relapsed PCNSL is poorly defined. The choice of salvage treatment depends on age, previous treatment and response, performance status and comorbidities at the time of relapse. Novel therapeutics targeting underlying tumor biology include small molecule inhibitors of B-cell receptor, cereblon, and mammalian target of rapamycin signaling, and immunotherapy programmed cell death 1 receptor inhibitors and chimeric antigen receptor T cells. Copyright Â© The Author(s), 2018.",Excluded
2414,"Influence of white matter conductivity anisotropy on electric field strength induced by electroconvulsive therapy. The goal of this study is to investigate the influence of white matter conductivity anisotropy on the electric field strength induced by electroconvulsive therapy (ECT). We created an anatomically-realistic finite element human head model incorporating tissue heterogeneity and white matter conductivity anisotropy using structural magnetic resonance imaging (MRI) and diffusion tensor MRI data. The electric field spatial distributions of three conventional ECT electrode placements (bilateral, bifrontal, and right unilateral) and an experimental electrode configuration, focal electrically administered seizure therapy (FEAST), were computed. A quantitative comparison of the electric field strength was subsequently performed in specific brain regions of interest thought to be associated with side effects of ECT (e.g., hippocampus and in-sula). The results show that neglecting white matter conductivity anisotropy yields a difference up to 19%, 25% and 34% in electric field strength in the whole brain, hippocampus, and insula, respectively. This study suggests that white matter conductivity anisotropy should be taken into account in ECT electric field models.",Excluded
3194,"Cerebral cyst formation following stereotactic ablative irradiation for non-nasopharyngeal head and neck malignancies: imaging findings and relevant dosimetric parameters. OBJECTIVE: To describe the clinical characteristics, imaging findings and relevant dosimetric parameters of cases presenting with cerebral cyst formation (CCF) after single or oligo-fractionated stereotactic radiotherapy (SRT) for non-nasopharyngeal head and neck malignancies (HNMs).METHODS: We identified four cases with the follow-up duration of 5.7-9.1 years from SRT. The irradiated sites included the middle ear in one case and the ethmoid sinus in three cases, two of the latter possessed brain invasion. The chronological changes in MR images and the dose-volume histogram of the adjacent brain tissue were evaluated.RESULTS: CCF with or without multiple septi presented with a latency of 29-86 months (median, 45.5 months), which was preceded by either non-specific parenchymal enhancement or typical radiation necrosis. In three cases, CCF adjacent to the frontal base resultantly caused mass effect, and two of these three cases required surgical intervention at 38 and 54 months, respectively, after SRT for alleviation of symptoms. The relation of the irradiated brain volumes to the biological equivalent dose based on the linear-quadratic (LQ) and LQ-cubic models was represented as a threshold.CONCLUSION: When contemplating SRT for HNM cases, caution should be exercised to the dose-volume relation-ship of the adjacent brain tissue, especially the frontal base, as well as other critical structures, and long-term vigilant follow-up is also mandatory.ADVANCES IN KNOWLEDGE: CCF can occur as an unusual consequence of late brain injury with variable but mostly long latency following SRT for non-nasopharyngeal HNMs adjacent to the brain, even superficial parts that were previously irradiated via conventional radiotherapy.",Excluded
3602,Effect of ultrahigh-frequency electric fields on cerebral circulation and thrombocyte aggregation in patients with sequelae of cerebral stroke. [Russian],Excluded
3425,"Lymphatic leakage (ll) after resection of neuroblastoma. Background/Objectives: Lymphangiogenesis and lymphangiogenic vessel remodeling is known to play an important role in cancer progression. Little is known about the impact of lymphangionesis in neuroblastoma. From a surgical point of view, lymphatic fistula is a potential complication after neuroblastoma surgery. Aim of this study was the evaluation of frequency and impact of lymphatic leakage in a center for neuroblastoma surgery. Design/Methods: Between 2003 and 2014, 210 patients (pts) were resected for neuroblastoma in our department for neuroblastoma. Out of these, 200 patients were eligible for this study. Patient charts were reviewed for INSS stage, surgical radicality, duration of abdominal or thoracic drainage and maximum amount of fluid drained per 24 h. Result(s): Out of 200 patients, 73 patients (37%) had a duration of drainage of 7 or more days. Maximum amount of drainage was 4 liters per day; longest duration of intraabdominal drainage was 91 days. In case of chylous fistula, all patients were treated with a conservative approach. Duration of drainage was significantly associated with surgical radicality (p=0.000). Furthermore, the duration of drainage was significantly associated with the maximum amount of fluid drained per 24 h (p=0.000). Lymphatic fistula was significantly associated with INSS stage (p=0.000). Overall Survival (OS) demonstrated a better OS for patients without LL (87% alive) than pts with LL (72% alive). OS was significantly associated with the maximum amount of fluid drained per 24 hrs (p=0.009), but not with duration of drainage. Conclusion(s): LL is a frequent complication after neuroblastoma surgery and in some cases with substantial loss of fluids and proteins. It can be treated in nearly all cases conservatively. One major problem is the delay of further chemotherapy and radiation which however does not seem to have a great impact on the prognosis.",Excluded
2796,Conformal Radiation for Benign Intracranial Tumors,Included
3598,"Modification of radiation myelopathy by the transplantation of neural stem cells in the rat. In a novel approach, neural stem cells were transplanted to ameliorate radiation-induced myelopathy in the spinal cords of rats. A 12-mm section of the cervical spinal cord (T2-C2) of 5-week-old female Sprague-Dawley rats was locally irradiated with a single dose of 22 Gy of (60)Co gamma rays. This dose is known to produce myelopathy in all animals within 6 months of irradiation. After irradiation, the animals were subdivided into three groups, and at 90 days after irradiation, neural stem cells or saline (for controls) were injected into the spinal cord, intramedullary, at two sites positioned 6 mm apart on either side of the center of the irradiated length of spinal cord. The injection volume was 2 microl. Group I received a suspension of MHP36 cells, Group II MHP15 cells, and Group III (controls) two injections of 2 microl saline. All rats received 10 mg/kg cyclosporin (10 mg/ml) daily i.p. to produce immunosuppression. All animals that received saline (Group III) developed paralysis within 167 days of irradiation. The paralysis-free survival rates of rats that received transplanted MHP36 and MHP15 cells (Groups I and II) were 36.4% and 32% at 183 days, respectively. It was concluded that transplantation of neural stem cells 90 days after irradiation significantly (P = 0.03) ameliorated the expression of radiation-induced myelopathy in the spinal cords of rats.",Included
2561,"Regulation of the DNA damage kinase ATM in the immune system. ATM is the protein kinase that is mutated in the hereditary autosomal recessive disease ataxia telangiectasia (A-T). A-T patients display immune deficiencies, cancer predisposition, neuronal degeneration and radiosensitivity. The molecular role of ATM is to respond to DNA double-strand breaks and alterations in chromatin structure by phosphorylating its substrates, thereby promoting repair of damage or arresting the cell cycle. ATM is activated by two known co-factors in a stimulus dependent manner. Following the induction of double-strand breaks by ionising radiation, NBS1 (mutated in Nijmegen breakage syndrome) is required for activation of ATM. ATM can also be activated in the absence of DNA damage by agents that induce changes in chromatin structure. We have recently described ATMIN, for ATM INteractor, to be required for ATM activation under these conditions. How ATM is regulated within the context of the immune system is unclear. We are using genetic mouse models to dissect the contribution of the ATM co-factors, ATMIN and NBS, to its function within the immune system. We will present data on how ATM is regulated within lymphocytes and hematopoietic stem cells in vivo, in order to maintain a functional immune system and suppress tumorigenesis.",Excluded
3527,"Digital subtraction angiography a door opener for neurosurgical residents who want to perform neurointerventional procedures. Digital subtraction angiography (DSA) has been a fluoroscopic golden investigative tool to know the vascular angiography of the brain and spinal cord. The technique in performing this procedure exposes residents in accessing the major vessels, branches of the arch of aorta, selective angiography and diagnosing different vascular anomalies of brain and spine. They are also exposed to the knowledge of different diagnostic catheters, its manipulation, use of dye and radiation exposure and safety. We would like to share our experience in training and disseminating the knowledge of digital subtraction angiography to the residents. Copyright Â© 2021, Kathmandu University. All rights reserved.",Excluded
2585,"Lipid peroxidation of liposomes with different ratios of phosphatidylcholine and cholesterol. [Chinese]. The purpose of this study was to investigate the effect of different ratios of phosphatidylcholine to cholesterol (PC/CHOL) in liposomes on lipid peroxidation. The liposomes were prepared by ultrasonication using egg yolk lecithin alone (PC, control) or with different contents of cholesterol in molar ratios of 1:0.125, 1:0.25, and 1:0.5. Conjugated dienes (CD), FOX (ferrous oxidation/xylenol orange), and TBARS (thiobarbituric acid reactive substances) were determined and used as indices of lipid peroxidation after incubation at 37degreeC in the presence of CuSO<inf>4</inf> over 24 h. Lipid peroxidation of the liposomes increased with increasing incubation time, irrespective of whether or not they contained cholesterol. In addition, results from the CD and FOX assays markedly increased after 2 h of incubation, while TBARS increased after 4 h of incubation. In the initial 8-h incubation, CD, FOX, and TBARS in PC/CHOL (1: 0.5) gradually decreased with increasing cholesterol contents of liposomes but were significantly higher after 24 h of incubation when compared to the control group. However, the cholesterol content of liposomes did not affect the fatty acid composition after 24 h of incubation. The results suggest that cholesterol in liposomes affects lipid peroxidation, and the oxidation status may be dependent upon incubation time.",Excluded
2736,"Neurochemical effects of photobiostimulation in the trigeminal ganglion after inferior alveolar nerve injury. Orofacial pain is associated with peripheral and central sensitization of trigeminal nociceptive neurons. Nerve injury results in release of chemical mediators that contribute to persistent pain conditions. The activation of the transient receptor potential vanilloid 1 (TRPV1), promotes release of calcitonin gene-related peptide (CGRP) and substance P (SP) from trigeminal nerve terminals. CGRP and SP contribute to the development of peripheral hyperalgesia. The expression of SP and CGRP by primary afferent neurons is rapidly increased in response to peripheral inflammation. CGRP receptor activation promotes activation of AMPA receptors, leading to increased firing of neurons which is reflected as central sensitization. In this study we investigated whether inferior alveolar nerve (IAN) injury influences AMPA receptors, CGRP, SP and TRPV1 expression in the trigeminal ganglion (TG). The relative expression of the protein of interest from naive rats was compared to those from injured rats and animals that received low level laser therapy (LLLT). IAN-injury did not change expression of GluA1, GluA2 and CGRP, but increased the expression of TRPV1 and SP. LLLT increases GluA1 and GluA2 expression and decreases TVPV1, SP and CGRP. These results, together with previous behavioral data, suggest that IAN-injury induced changes in the proteins analyzed, which could impact on nociceptive threshold. These data may help to understand the molecular mechanisms of pain sensitization in the TG.",Excluded
2946,"Impact of exercise with TheraBite device on trismus and health-related quality of life: A prospective study. Trismus is a common symptom in patients with head and neck cancer that affects many aspects of daily life negatively. The aim of this study was to investigate the impact of structured exercise with the jaw-mobilizing device TheraBite on trismus, trismus-related symptomatology, and health-related quality of life (HRQL) in patients with head and neck cancer. Fifteen patients with trismus (maximum interincisal opening [MIO] <=35 mm) after oncologic treatment for head and neck cancer, underwent a 10-week exercise program with the TheraBite device and were followed regularly. Time between oncologic treatment and start of TheraBite exercise ranged from 0.7 to 14.8 years (average 6.2 years). MIO, trismus-related symptoms, and HRQL was assessed before and after exercise and after 6 months. A significant improvement in MIO was observed post-exercise (3.5 mm, 15.3%, p = 0.0002) and after 6-month of follow-up (4.7 mm, 22.1%, p = 0.0029). A statistically significant correlation was found between increased MIO and fewer trismus-related symptoms. In conclusion, exercise with TheraBite improved MIO and trismus-related symptoms in patients with trismus secondary to head and neck cancer. Structured exercise with the jaw-mobilizing device seems to be beneficial for patients with trismus independent of time since oncologic treatment.",Excluded
3480,"Morphogenesis of asymmetry of rat brain nuclei under normal conditions and during exposure to microgravitation. Histological and morphometrical analysis of the brain and peripheral analyzers revealed proliferative migration abnormalities of brain development and neuron differentiation in mammals during a space flight, which can limit space exploration.",Included
2618,"Quetiapine attenuates cognitive impairment and decreases seizure susceptibility possibly through promoting myelin development in a rat model of malformations of cortical development. Developmental delay, cognitive impairment, and refractory epilepsy are the most frequent consequences found in patients suffering from malformations of cortical development (MCD). However, therapeutic options for these psychiatric and neurological comorbidities are currently limited. The development of white matter undergoes dramatic changes during postnatal brain maturation, thus myelination deficits resulting from MCD contribute to its comorbid diseases. Consequently, drugs specifically targeting white matter are a promising therapeutic option for the treatment of MCD. We have used an in utero irradiation rat model of MCD to investigate the effects of postnatal quetiapine treatment on brain myelination as well as neuropsychological and cognitive performances and seizure susceptibility. Fatally irradiated rats were treated with quetiapine (10mg/kg, i.p.) or saline once daily from postnatal day 0 (P0) to P30. We found that postnatal administration of quetiapine attenuated object recognition memory impairment and improved long-term spatial memory in the irradiated rats. Quetiapine treatment also reduced the susceptibility and severity of pentylenetetrazol-induced seizures. Importantly, quetiapine treatment resulted in an inhibition of irradiation-induced myelin breakdown in the cerebral cortex and corpus callosum. These findings suggest that quetiapine may have beneficial, postnatal effects in the irradiated rats, strongly suggesting that improving MCD-derived white matter pathology is a possible underlying mechanism. Collectively, these results indicate that brain myelination represents an encouraging pharmacological target to improve the prognosis of patients with MCD.",Excluded
3385,"Capillary optics for neutron capture therapy. The development of capillary neutron optics permits a new technology for neutron capture therapy involving the application of a focused thermal neutron beam at the medically optimal location within the patient. A subthermal neutron beam begins to converge as it travels through a neutron 'lens,' reaching a narrow focus within a tube that allows it to pass directly to the treatment region. This technique results in a substantially lower dose to untreated parts of the patient and a substantially weaker radiation field in the treatment room generally. Additional advantages include the relative ease of thermal neutron generation and the ability to shield the patient completely and effectively from fast neutrons or gamma rays originating at the neutron source. This work describes the application of capillary optics to neutron capture therapy, along with Monte Carlo calculations of the neutron flux profiles within a patient for an optimized system design. Specific dose profiles for the case of boron neutron capture therapy within the brain are also provided.",Excluded
2583,"A clonogenic survival assay of neural stem cells in rat spinal cord after exposure to ionizing radiation. Neural stem cells play an important role in neurogenesis of the adult central nervous system (CNS). Inhibition of neurogenesis has been suggested to be an underlying mechanism of radiation-induced CNS damage. Here we developed an in vivo/ in vitro clonogenic assay to characterize the survival of neural stem cells after exposure to ionizing radiation. Cells were isolated from the rat cervical spinal cord and plated as single cell suspensions in defined medium containing epidermal growth factor and basic fibroblast growth factor. The survival of the proliferating cells was determined by their ability to form neurosphere colonies. The number and size of neurospheres were analyzed quantitatively at day 10, 12, 14 and 16 after plating. Plating cells from 5, 10 and 15 mm of the cervical spinal cord resulted in a linear increase in the number of neurospheres from day 10-16. Compared to the nonirradiated spinal cord, there was a significant decrease in the number and size of neurosphere colonies cultured from a 10-mm length of the rat spinal cord after a single dose of 5 Gy. When dissociated neurospheres derived from a spinal cord that had been irradiated with 5 Gy were allowed to differentiate, the percentages of neurons, oligodendrocytes and astrocytes as determined by immunocytohistochemistry were not altered compared to those from the nonirradiated spinal cord. Secondary neurospheres could be obtained from cells dissociated from primary neurospheres that had been cultured from the irradiated spinal cord. In conclusion, exposure to ionizing radiation reduces the clonogenic survival of neural stem cells cultured from the rat spinal cord. However, neural stem cells retain their pluripotent and self-renewing properties after irradiation. A neurosphere-based assay may provide a quantitative measure of the clonogenic survival of neural stem cells in the adult CNS after irradiation.",Included
3290,"Caries clinical trial of a remineralising toothpaste in radiation patients. OBJECTIVES: The purpose of this study was to determine the efficacy and safety of a specially formulated remineralising toothpaste in controlling caries in a high-risk population: head and neck radiation patients.DESIGN: The study compared the performance of the remineralising toothpaste with a conventional fluoride dentifrice using double-blind randomisation.MATERIALS AND METHODS: Test products: The products compared contained equivalent quantities of fluoride (1100 p.p.m.). The dual-phase remineralising toothpaste, Enamelon, also delivered soluble calcium and phosphate ions, essential components of teeth, from separate phases. Both groups had all caries restored at baseline and used a fluoride rinse daily.SUBJECTS: Fifty-seven subjects who received radiation to the head and neck causing saliva hypofunction, entered the study, while 44 completed the 10-12 month visit.MEASUREMENTS: Examinations included coronal and root caries using the Pitts Diagnostic Criteria, salivary flow rate, plaque and gingival indices and microbiological counts over a 1-year period.RESULTS: The average net increment per year for root caries per subject was 0.04 (+/-.052) in subjects completing the study using the remineralising toothpaste and 1.65 (+/-0.51) for root caries in subjects completing the study using the conventional fluoride dentifrice. The difference was statistically significant (p = 0.03), suggesting lower net root surface increment/year for the remineralising toothpaste relative to the conventional toothpaste. No significant differences were noted on coronal surfaces.CONCLUSION: The results indicate that the remineralising toothpaste provides a significant benefit in preventing and remineralising root caries in high-risk patients.",Excluded
3105,"Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Substance P (SP) and calcitonin gene-related peptide (CGRP), released from capsaicin-sensitive sensory nerves induce local neurogenic inflammation, while somatostatin exerts systemic anti-inflammatory actions. The aim of the present study was to investigate the release of pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) and its effects on sensory neuropeptide release in vitro and acute neurogenic ear swelling in vivo. Capsaicin (10(-6) M) or electrical field stimulation (EFS; 40 V, 0.1 ms, 10 Hz, 120 s; 1200 impulses)-induced release of PACAP-38, SP, CGRP and somatostatin from isolated rat tracheae was measured with radioimmunoassay. Mustard oil-induced neurogenic inflammation in the mouse ear was determined with a micrometer and in the rat hind paw skin by the Evans Blue leakage technique. Capsaicin and EFS evoked 27% and more than twofold elevation of PACAP-38 release respectively, compared with the prestimulated basal values from isolated trachea preparation. Exogenously administered PACAP-38 (20-2000 nM) diminished both capsaicin- and EFS-evoked sensory neuropeptide release in a concentration-dependent manner. The maximal inhibitory effects of PACAP on capsaicin-induced substance P, CGRP and somatostatin release amounted to 75.4%, 73.3% and 90.0%, while EFS-evoked release of these peptides was 80.03%, 87.7% and 67.7%. In case of capsaicin stimulation the EC50 values for substance P, CGRP and somatostatin were 82.9 nM, 60.1 nM and 66.9 nM, respectively. When EFS was performed, these corresponding EC50 data were 92.1 nM, 67.8 nM and 20.9 nM. PACAP-38 (10, 100 and 1000 microg/kg i.p. in 200 microl volume) inhibited neurogenic ear swelling in the mouse. Furthermore, 100 microg/kg i.p. PACAP also significantly diminished mustard oil-evoked plasma protein extravasation in the rat skin. These results suggest that PACAP-38 is released from the stimulated peripheral terminals of capsaicin-sensitive afferents and it is able to inhibit the outflow of sensory neuropeptides. Based on this mechanism of action PACAP is also able to effectively diminish/abolish neurogenic inflammatory response in vivo after systemic administration.",Excluded
2911,"Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice. Copper tetracarboranyltetraphenylporphyrin (CuTCPH) is a minimally toxic carborane-containing porphyrin that has safely delivered high concentrations of boron for experimental boron neutron capture therapy (BNCT). Copper octabromotetracarboranylphenylporphyrin (CuTCPBr), synthesized by bromination of CuTCPH, is one of several new minimally toxic analogues of CuTCPH being studied in our laboratory, which could possess comparable or better tumour-targeting properties with enhanced tumour cytotoxicity. Its biodistribution, biokinetics and toxicity in mice with subcutaneous EMT-6 (mammary) or SCCVII (squamous cell) carcinomas were compared with those of CuTCPH. The administration of approximately 200 mg kg(-1) of either porphyrin in six intraperitoneal injections over 2 days had no apparent effect, but administration of approximately 400 mg kg(-1) slightly lowered body weights, elevated alanine and aspartate transaminase activities in blood plasma, and depressed blood platelet counts for several days. Enzymes and platelets returned to normal within 5 days after those injections and body weights returned to normal within 2 weeks. High average concentrations of boron from either porphyrin were achieved in the two tumour models from a total dose of approximately 200 mg kg(-1). The high tumour boron concentration decreased slowly while concentrations in blood decreased rapidly. Boron concentrations in brain and skin were consistently lower than in tumour by a factor of 10 or more. Although either CuTCPH or CuTCPBr can be labelled with (64)Cu for imaging by positron emission tomography (PET), CuTCPBr can also be labelled by (76)Br, another PET-imageable nuclide.",Excluded
2595,"Light-dependent regulation and postnatal development of the interferon-gamma receptor in the rat suprachiasmatic nuclei. The interferon-gamma receptor gene was detected in the rat hypothalamic suprachiasmatic nuclei (SCN), the main pacemaker for circadian rhythms, and the molecular identity of the transcript was confirmed by sequencing. The expression of the receptor protein showed a daily rhythm that was dependent on light. It reached its adult pattern in the SCN between postnatal day 11 and 20, i.e., at a time when capacity for photic entrainment of the pacemaker is established.",Excluded
3037,"5-[I-125/123]Iodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. The in vivo biodistribution profile of the novel nicotinic acetylcholine receptor (nAChR radioligand 5-[I-125/123]Iodo-3(2(S)-azetidinylmethoxy)pyridine, [I-125/123]-5-IA, in mouse brain was examined. This radiotracer displayed good brain penetration (3.1% of the injected dose (ID) in whole brain at 15 min post-radioligand injection). Radioligand distribution was consistent with the density of high affinity nAChRs with highest uptake observed in the nAChR-rich thalamus (14.9 %ID/g at 60 min), moderate uptake in cortex (8.5 %ID/g at 60 min), and lowest uptake in the cerebellum (2.4 %ID/g at 60 min). Pretreatment with several different nAChR agonists (A-85380, (-)-nicotine, cytisine) significantly inhibited [I-125]-5-IA binding in all brain regions studied (P < 0.01) demonstrating the high specificity of the radioligand for nAChRs. Blocking doses of the muscarinic antagonist scopolamine and the non-competitive nAChR channel blocker mecamylamine had no significant effect on radioactive uptake supporting the in vitro selectivity of [I-125]-5-IA for the nAChR component of the cholinergic system. [I-125]-5-IA binding sites were shown to be saturable with unlabeled 5-IA. With a relatively low acute toxicity (LD50 > 3 mg/kg via intravenous injection in mice) and high in vivo specificity and selectivity, 5-IA labeled with the imaging radionuclide I-123 may Drove useful for single photon emission computed tomography (SPECT) studies of nAChRs in human subjects.",Excluded
2424,"Radiation therapy for the palliation of multiple myeloma. Purpose: This study reviews the experience at the University of Arizona in an effort to define the minimum effective radiation dose for durable pain relief in the majority of patients with symptomatic multiple myeloma. Methods and Materials: The records of 101 patients with multiple myeloma irradiated for palliation at the University of Arizona between 1975 and 1990 were reviewed. Three hundred sixteen sites were treated. Ten sites were asymptomatic, including six hemibody fields with advanced disease unresponsive to chemotherapy and four local fields with impending pathological fractures. Three hundred six evaluable symptomatic sites remained. The most common symptom was bone pain. Other symptoms included neurological impairment and a palpable mass. Result(s): Total tumor dose ranged from 3.0 to 60 Gy, with a mean of 25 Gy. Symptom relief was obtained in 297 of 306 evaluable symptomatic sites (97%). Complete relief of symptoms was obtained in 26% and partial relief in 71%. Symptom relief was obtained in 92% of sites receiving a total dose less than 10 Gy (n = 13) and 98% of sites receiving 10 Gy or more (n = 293). No dose-response could be demonstrated. The likelihood of symptom relief was not influenced by the location of the lesion or the use of concurrent chemotherapy. Of the 297 responding sites, 6% (n = 19) relapsed after a median symptom-free interval of 16 months. Neither the probability of relapse nor the time to relapse was related to the radiation dose. Retreatment of relapsing sites provided effective palliation in all cases. Conclusion(s): Radiation therapy is effective in palliating local symptoms in multiple myeloma. A total dose of 10 Gy should provide durable symptom relief in the majority of patients.",Excluded
3234,"Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. Retinal ganglion cell axons within the globe are laden with mitochondria that are unprotected from light (400-760 nm) impinging onto the retina. Light can be absorbed by mitochondrial enzymes such as cytochrome and flavin oxidases causing the generation of reactive oxygen species, and we have suggested this may pose a risk to ganglion cell survival if their energy state is compromised, as may be so in glaucoma or in Leber's Hereditary Optic Neuropathy. Here, we demonstrate that light (400-760 nm) provokes apoptosis in cultured retinal ganglion-5 cells, and that this effect is enhanced in low serum, and attenuated by various antioxidants. Apoptosis is shown to be caspase independent, involving reactive oxygen species generation and the activation of poly(ADP-ribose) polymerase-1 and apoptosis-inducing factor. We further show that light-induced apoptosis requires the participation of the mitochondrial respiratory chain. This was demonstrated by culturing fibroblasts (BJhTERT cells) in ethidium bromide for 40 days to deplete their mitochondrial DNA and perturb their mitochondrial respiratory chain function (BJhTERT rh0 cells). Only BJhTERT cells, with intact mitochondrial respiratory chain function were affected by light insult. Finally, we show that exposure of anaesthetized pigmented rat eye to white, but not red light, causes changes in the expression of certain retinal mRNAs (neurofilament light, Thy-1 and melanopsin) and optic nerve proteins (neurofilament light and tubulin), suggesting that ganglion cell survival is affected. Our findings support the proposal that the interaction of light, particularly the blue component, with intra-axonal ganglion cell mitochondria may be deleterious under certain circumstances, and suggest that reducing the light energy impinging upon the retina might benefit patients with certain optic neuropathies.",Excluded
2682,"Influence of extremely low frequency magnetic fields on Ca2+ signaling and NMDA receptor functions in rat hippocampus. Extremely low frequency (ELF<300Hz) electromagnetic fields affect several neuronal activities including memory. Because ELF magnetic fields cause altered Ca(2+) homeostasis in neural tissues, we examined their influence on Ca(2+) signaling enzymes in hippocampus and related them with NMDA receptor functions. Hippocampal regions were obtained from brains of 21-day-old rats that were exposed for 90 days to 50Hz magnetic fields at 50 and 100 microT intensities. In comparison to controls, ELF exposure caused increased intracellular Ca(2+) levels concomitant with increased activities of Ca(2+)-dependent protein kinase C (PKC), cAMP-dependent protein kinase and calcineurin as well as decreased activity of Ca(2+)-calmodulin-dependent protein kinase in hippocampal regions. Simultaneous ligand-binding studies revealed decreased binding to N-methyl-D-aspartic acid (NMDA) receptors. The combined results suggest that perturbed neuronal functions caused by ELF exposure may involve altered Ca(2+) signaling events contributing to aberrant NMDA receptor activities.",Excluded
2515,"Two light-induced processes in the photoreceptor cells of Limulus ventral eye. The dark-adapted current-voltage (I-V) curve of a ventral photoreceptor cell of Limulus, measured by a voltage-clamp technique, has a high slope-resistance region more negative than resting voltage, a lower slope-resistance region between resting voltage and zero, and a negative slope-resistance region more positive than 0 v. With illumination, we find no unique voltage at which there is no light-induced current. At the termination of illumination, the I-V curve changes quickly, then recovers very slowly to a dark-adapted configuration. The voltage-clamp currents during and after illumination can be interpreted to arise from two separate processes. One process (fast) changes quickly with change in illumination, has a reversal potential at +20 mv, and has an I-V curve with positive slope resistance at all voltages. These properties are consistent with a light-induced change in membrane conductance to sodium ions. The other process (slow) changes slowly with changes in illumination, generates light-activated current at +20 mv, and has an I-V curve with a large region of negative slope resistance. The mechanism of this process cannot as yet be identified.",Excluded
3215,"Concentrations of <sup>137</sup>Cs radiocaesium in the organs and tissues of low-dose-exposed wild Japanese monkeys. OBJECTIVES: Following the massive earthquake that struck eastern Japan on March 11, 2011, a large amount of radioactive material was released into the environment from the damaged reactor of the Fukushima Daiichi Nuclear Power Plant (FDNPP). After the FDNPP accident, radiocaesium was first detected in muscle samples from wild Japanese monkeys exposed to radioactive materials, and haematologic effects, changes in head size, and delayed body weight gain were also reported, but little is known about the distribution of <sup>137</sup>Cs in the organs and tissues of wild Japanese monkeys.RESULTS: We detected the <sup>137</sup>Cs in various organ and tissue samples of 10 wild Japanese monkeys inhabiting the forested areas of Fukushima City that were captured between July and August 2012. Among muscle, brain, heart, kidney, liver, lung, and spleen, muscle exhibited the highest and the brain the lowest <sup>137</sup>Cs concentration. The concentration (mean +/- SD) of <sup>137</sup>Cs in muscle, brain, heart, kidney, liver, lung, and spleen was 77 +/- 66, 26 +/- 22, 41 +/- 35, 49 +/- 41, 41 +/- 38, 53 +/- 41, and 53 +/- 51 Bq/kg, respectively. These results can help us understand the biological effects of long-term internal radiation exposure in non-human primates.",Excluded
3312,Radiation toxicity to the visual system,Included
3402,"Lithium salts - Mechanisms of action. [Polish]. In spite of the fact that lithium is presently still useful in the treatment of bipolar disorder, cellular mechanisms of its action are not fully understood. Several principal targets of lithium salts action have been identified: cytoprotective and proapoptotic proteins, inositol, cAMP, GSK-3, glutamate, GABA, PKC. In this way lithium is able to regulate neuroplasticity and induce change in axon's morphology, It appears that lithium can be useful in Alzheimer therapy as well in other neurodegenerative disorders. Lithium may also relieve side effect of cranial irradiation (for example: neurocognitive deficit) and may have beneficial effect on depressive behavior induced by mild traumatic brain injury. Â© Copyright 2008 Via Medica.",Excluded
2538,"Effects of extremely low frequency electromagnetic fields on apoptosis and cell cycle of mouse brain and liver cells. [Chinese]. OBJECTIVE: To study the effects of extremely low frequency electromagnetic fields (ELF EMFs) on apoptosis and cell cycle of mouse brain and liver cells. METHOD(S): Mice were exposed to 50 Hz, 0.2 mT or 6.0 mT electromagnetic fields for 2 weeks. TUNEL and flow cytometric methods were used to analyze apoptosis and cell cycle of brain and liver cells. RESULT(S): After exposure to 0.2 mT and 6.0 mT ELF EMFs for 2 weeks, apoptosis rates of brain cells [(5.60 +/- 1.47)% and (4.73 +/- 0.48)% respectively] were higher than that of control [(2.90 +/- 0.75)%], and apoptosis rates of liver cells [(4.19 +/- 2.08)% and (3.38 +/- 0.65)% respectively] were higher than that of control [(1.84 +/- 0.76)%]. G0/G1 cell percentage of brain cells [(80.21 +/- 1.68)% and (79.54 +/- 0.56)% respectively] were higher than that of control [(76.85 +/- 0.83)%], and those of liver cells [(79.42 +/- 1.80)% and (80.47 +/- 1.79)% respectively] were higher than that of control [(73.36 +/- 3.10)%]. The above differences were all statistically significant as P < 0.05. At the same time S and G2 + M cell percentage of brain and liver cells were significantly decreased. CONCLUSION(S): Exposure to 50 Hz EMFs may alter cell cycle and induce apoptosis of mouse brain and liver cells.",Excluded
3399,"Treg/Tcon Immunotherapy and High Dose Marrow Irradiation Ensure Full Control of Leukemia Relapse in Haploidentical Transplantation. Allogeneic hematopoietic stem cell transplantation (HSCT) is the most powerful therapy for patients with high risk of relapse. In spite of that, no matter the donor source or conditioning regimen used, leukemia relapse is still the leading cause of HSCT failure. In HLA-haploidentical HSCT, we recently applied a clinical protocol consisting of total body irradiation (TBI)-based conditioning regimen and a peripheral blood CD34+ cell graft combined with the adoptive transfer of naturally occurring regulatory T cells (Tregs) and conventional T cells (Tcons). No post-transplant pharmacologic GvHD prophylaxis was given. Such protocol was associated with low GvHD and relapse rate (Martelli et al., Blood 2014). To further reduce leukemia relapse in Treg/Tcon-based haploidentical HSCT (Treg/Tcon haplo-HSCT) we used high dose hyper-fractionated TBI (HF-TBI) in the conditioning regimen. We also extended Treg/Tcon haplo-HSCT to patients that are unfit (because of previous comorbidities) and/or too old to withstand high intensity regimens. In these patients the extra-hematologic toxicity of irradiation was reduced with the use of targeted total marrow and lymph node irradiation (TMLI). 40 patients with high risk acute leukemia (36 AML, 4 ALL) received Treg/Tcon haplo-HSCT. All but 3 patients were transplanted in complete remission. 12 younger patients (median age: 28, range: 20-43) received HF-TBI, while 28 older or unfit patients (59, 40-70) received TMLI in the conditioning regimen. HF-TBI (14.4 Gy) was administered in 12 fractions, 3 times a day for 4 days. TMLI was administered by means of Helical Tomotherapy HI-ART (9 fractions, 2 times a day for 4.5 days). Irradiation was followed by chemotherapy with Thiotepa, Fludarabine, and Cyclophosphamide. 2 x 10<sup>6</sup>/kg freshly isolated CD4+CD25+FOXP3+ Tregs were transferred 4 days before the infusion of 1 x 10<sup>6</sup>/kg Tcons and a mega-dose of CD34+ hematopoietic stem cells. No post-transplant pharmacologic GvHD prophylaxis was given. 38/40 patients engrafted. 12 (31%) developed aGvHD grade 32 (10 are alive and off-therapy). 6 (16%) died because of transplant related complications (2 because of aGvHD, 2 infections, 1 veno-occlusive disease, 1 intracranial hemorrhage). Strikingly, despite the high risk diseases, no patient relapsed after a median follow up of 13 months (range 1-36, Fig. A). Further, only 1 patient developed cGvHD. Thus, cGvHD/Leukemia-free survival was 82% (Fig. B). Treg adoptive transfer allows for the safe infusion of an otherwise lethal dose of donor alloreactive Tcons in the absence of any other form of immune suppression. Our results demonstrate that the potent graft versus leukemia effect of Treg/Tcon adoptive transfer was boosted by high dose marrow irradiation. Thus, this study proves that the right combination of haploidentical Treg/Tcon immunotherapy plus a powerful conditioning regimen can fully eradicate leukemia. Copyright Â© 2018",Excluded
3144,"Regeneration of dopaminergic neurons after 6-hydroxydopamine-induced lesion in planarian brain. Planarians have robust regenerative ability dependent on X-ray-sensitive pluripotent stem cells, called neoblasts. Here, we report that planarians can regenerate dopaminergic neurons after selective degeneration of these neurons caused by treatment with a dopaminergic neurotoxin (6-hydroxydopamine; 6-OHDA). This suggests that planarians have a system to sense the degeneration of dopaminergic neurons and to recruit stem cells to produce dopaminergic neurons to recover brain morphology and function. We confirmed that X-ray-irradiated planarians do not regenerate brain dopaminergic neurons after 6-OHDA-induced lesioning, suggesting that newly generated dopaminergic neurons are indeed derived from pluripotent stem cells. However, we found that the majority of regenerated dopaminergic neurons were 5-bromo-2'-deoxyuridine-negative cells. Therefore, we carefully analyzed when proliferating stem cells became committed to become dopaminergic neurons during regeneration by a combination of 5-bromo-2'-deoxyuridine pulse-chase experiments, immunostaining/in situ hybridization, and 5-fluorouracil treatment. The results strongly suggested that G(2) -phase stem cells become committed to dopaminergic neurons in the mesenchymal space around the brain, after migration from the trunk region following S-phase. These new findings obtained from planarian regeneration provide hints about how to conduct cell-transplantation therapy for future regenerative medicine.",Excluded
3229,"The human CSB (ERCC6) gene corrects the transcription-coupled repair defect in the CHO cell mutant UV61. The human CSB gene, mutated in Cockayne's syndrome group B (partially defective in both repair and transcription) was previously cloned by virtue of its ability to correct the moderate UV sensitivity of the CHO mutant UV61. To determine whether the defect in UV61 is the hamster equivalent of Cockayne's syndrome, the RNA polymerase II transcription and DNA repair characteristics of a repair-proficient CHO cell line (AA8), UV61 and a CSB transfectant of UV61 were compared. In each cell line, formation and removal of UV-induced cyclobutane pyrimidine dimers (CPDs) were measured in the individual strands of the actively transcribed DHFR gene and in a transcriptionally inactive region downstream of DHFR. AA8 cells efficiently remove CPDs from the transcribed strand, but not from either the non-transcribed strand or the inactive region. There was no detectable repair of CPDs in any region of the genome in UV61. Transfection of the human CSB gene into UV61 restores the normal repair pattern (CPD removal in only the transcribed strand), demonstrating that the DNA repair defect in UV61 is homologous to that in Cockayne's syndrome (complementation group B) cells. However, we observe no significant deficiency in RNA polymerase II-mediated transcription in UV61, suggesting that the CSB protein has independent roles in DNA repair and RNA transcription pathways.",Excluded
2452,"Functional and structural recovery of injured spinal cord following delayed X-irradiation in rats. OBJECTIVE: To test the hypothesis that delayed X-irradiation can enhance the functional and structural recovery of the injured spinal cord in rats.METHODS: Seventy Sprague-Dawley rats were randomly divided into two groups, 35 rats in each. The control group sustained a one-minute clip compression (force of clip was 30 g) injury of the spinal cord at the T2 level, without X-irradiation. The experimental group received X-irradiation 14 days after injury. Neurological function was assessed by the modified Tarlov method, including hind limbs movement, inclined plane, and pain withdrawal. These tests were performed in a blinded fashion at 3, 7, 14, 21, 28, 35, and 42 days after injury. At 43 days after injury, histological examination of the injured spinal cord was performed following decapitation of the rats.RESULTS: Sixty-two rats met the experimental requirements (spinal cord injury was similar), 32 rats in experimental group and 30 rats in control group. Statistically significant difference was observed between the two groups in hind limbs movement and inclined plane (P < 0.01), but not in the pain withdrawal test. The edema and necrosis areas of injured spinal cords in experimental group were less than those in control group, and axons in experimental group were significantly more than those in control group (P < 0.01).CONCLUSION: Delayed X-irradiation following spinal cord injury may enhance functional recovery by improving and restoring structural integrity of the injured spinal cord in rats.",Excluded
2846,"[Anatomo-pathological contribution to the study of the relation between myasthenia and the thymus gland, with reference to the results of roentgenotherapy of the thymus region by to Bollini's technic]",Excluded
2460,"Spatial distribution of brain microhemorrhage resulting from traumatic brain injury (TBI). Introduction Microhemorrhages, commonly found on magnetic resonance imaging (MRI) of TBI, appear as punctuate hypointense foci on susceptibility weighted images (SWI). To better understand the spatial distribution of microhemorrhages, we map their locations to a normalized space and apply region of interest (ROI) analysis using brain atlases. Methods MRI was performed in a series of 46 sequential patients enrolled in a natural history study of TBI. Susceptibility weighted (TR = 64ms, TE = 25ms, FA = 20degree, 0.49 x 0.49 x 2.0 mm) and 3D T1-MPRAGE (TR = 25ms, TE = 3.03ms, FA = 7degree, 1 x 1 x 1 mm) images were acquired on a 3T Siemens Biograph mMR in all patients. SWI images were reviewed by a neuroradiologist on a Carestream PACS workstation, and microhemorrhages were labeled using the ""marker"" graphic tool. To characterize their spatial distribution in standard Montreal Neurological Institute (MNI) space, the T1-MPRAGE was affine registered to the MNI template. This transformation was applied to the co-registered SWI images and to the marker coordinates. The frequency of microhemorrhages in major brain structures was determined from ROIs using the digital Talairach brain atlas. Similarly, the frequency of microhemorrhage in labeled white matter (WM) tracts was performed by applying the Diffusion Oriented Tract Segmentation method to the image within MNI space. Results A total of 629 microhemorrhages were identified. An average of 13 +/- 34 (range = 1 +/- 179) microhemorrhages were present in the 24 positive patients out of all 46 cases. Microhemorrhages congregated around the periphery of the brain and were symmetrically distributed. Using Talairach ROI analysis, microhemorrhages were most prevalent in the frontal lobes 60% (377). The remaining lobar distribution was temporal: 10% (63), parietal 1.3% (8), occipital: 4.7% (30), limbic: 3.6% (23). Sublobar distribution was brainstem: 1.4% (9), cerebellum: 4.8% (31), deep cerebral WM: 6.8% (43), thalamus and basal ganglia: 1.3% (8). Microhemorrhages in WM tracts contributed 61% (384) in total. Restricting the analysis to WM tracts, microhemorrhages were primarily found in the corpus callosum 40.3% (253). Other WM tracts with notable proportions ( > 4%) include the anterior thalamic radiation: 4.3% (27), cortico-pontine tract: 4.4% (28), inferior frontooccipital fasciculus: 13.4% (84), inferior longitudinal fasciculus: 5.5% (35), middle cerebellar peduncle 9.1% (57), superior fronto-occipital fasciculus 8% (50), and uncinate fasciculus 4.4% (28). We note, however, that because white matter tracts are relatively small structures and the alignment was performed using only an affine transformation, these results should be considered as preliminary. Conclusions This study examines the spatial distribution of microhemorrhages in 24 TBI patients. Microhemorrhages were distributed mostly around the periphery of the brain, and were particularly common in the frontal lobes. Such a finding is likely due to many of these injuries resulting from motor vehicle accidents, possibly with head-on collisions. In the WM tract analysis, the corpus callosum was implicated as a WM pathway that may be vulnerable to damage. Future work will expand the analysis to additional subjects, as well as examine distribution differences between impact and blast injuries. The relationship between microhemorrhage location and neurobehavioral symptoms requires further study.",Excluded
3612,"Is there a future for therapeutic use of transcranial magnetic stimulation?. Repetitive transcranial magnetic stimulation (rTMS) has in recent years been used to explore therapeutic opportunities in a bewildering variety of conditions. Although there is good evidence that this technique can modify cortical activity, the rationale for its use in many of the conditions investigated so far is not clear. Here we discuss the effects of rTMS in healthy subjects and how it has been used in a number of neurological conditions. We argue that a better understanding of both the effects of rTMS and the pathological processes underlying the conditions for which it is used will reveal whether rTMS really does offer therapeutic potential and, if so, for which conditions. [References: 83]",Excluded
3029,"Postradiation ureteral obstruction: a reappraisal. Thirty-four patients who received radiation therapy for carcinoma of the cervix developed hydronephrosis. Twelve of 34 (35%) had no evidence of pelvic malignancy, and the obstruction was caused by periureteral fibrosis. The incidence of obstructive uropathy due to periureteral fibrosis not associated with recurrent tumor increased when the obstructing lesion was unilateral, the clinical staging of the cervical carcinoma prior to therapy was Stage IB or Stage II rather than Stage III or Stage IV, and the obstructing lesion appeared 2 or more years after the completion of radiation therapy. The appearance of hydronephrosis in association with ipsilateral leg edema, and sciatic pain these patients strongly suggest a recurrent tumor. The diagnosis of periureteral fibrosis should be considered in all patients who develop obstruction of the urinary tract after radiation therapy for carcinoma of the cervix. Laparotomy is indicated if all other methods of investigation fail to confirm the presence of a malignant lesion.",Excluded
2990,"Oral complications in the treatment of cancer patients. While treatment for cancer in terms of chemotherapy and radiation therapy have evolved significantly since their inception, both of these cancer treatment modalities, especially if used in combination (e.g., as with head and neck cancers), have a very real potential to result in painful and debilitating adverse effects that clearly decrease quality of life and, potentially, increase mortality due to cancer. Herein, we discuss the prevalence and etiology of three broad categories of oral complications found during the treatment of cancer patients: mucositis, dysgeusia, and infectious disease. Lastly, we present therapeutic options that may be helpful in ameliorating these uncomfortable and, sometimes, life-threatening oral complications.",Excluded
2435,"Marked rapid alterations in nocturnal pineal serotonin metabolism in mice and rats exposed to weak intermittent magnetic fields. Adult AMES mice and male Sprague Dawley rats were exposed to an artificial magnetic field, generated by Helmholtz coils. 3.5 hours after the onset of darkness the coils were activated for one hour resulting in an inversion of the horizontal component of the earth's magnetic field. The coils were activated and deactivated at 5 min intervals during the 1 hour exposure period. In both mice and rats, the levels of serotonin in the pineal were markedly increased by the exposure. In rats, an increase of pineal 5-hydroxyindole acetic acid and a decrease of the activity of the pineal enzyme serotonin-N-acetyltransferase also was observed. However, pineal and serum melatonin levels were not altered. The results indicate that the metabolism of serotonin in the pineal is quickly affected by the exposure of animals to a magnetic field.",Excluded
3600,Management of oral complications from radiation and chemotherapy,Excluded
3319,"Comparing radiation therapy and ipilimumab to ipilimumab alone in metastatic melanoma patients. Purpose/Objective: With evidence suggesting ipilimumab and intracranial stereotactic radiosurgery (SRS) improves survival compared to SRS alone, we compared toxicity, response rates (RRs), and outcomes of metastatic melanoma patients receiving radiation (RT) and ipilimumab to ipilimumab alone. Methods and Materials: We reviewed records of metastatic melanoma patients receiving ipilimumab 3mg/kg between 2010-2014. RRs, measured by immune RECIST criteria, and toxicity were compared by Fischer's exact text. Overall survival (OS) was estimated by the Kaplan Meier method. Result(s): 61 patients received ipilimumab, with 35 (57.4%) also receiving radiation within 4 months of ipilimumab. The radiation cohort was similar at baseline except for greater systemic burden of disease (82.9% vs. 42.3%, p = 0.005), higher dexamethasone use (14.3% vs. 0%, p = 0.048), and more brain involvement (74.3% vs. 0% p<0.001). 92.3% of brain metastases received SRS. Grade 3 toxicity was not statistically different between cohorts (5.9% vs. 20.0%, p = 0.113); one grade 4 was experienced (1.6%), while no grade 5 occurred. While the ipilimumab alone group demonstrated a trend toward higher 1-year OS (49.4% vs. 73.2%, p = 0.090), the cohort did not have any patients with brain metastases; therefore, comparing only patients with extra-cranial metastases, 1-year OS was similar (76.2% vs. 73.2%, p = 0.587). RR between both cohorts was similar (20.0% vs. 11.5%, p = 0.494). Pre-ipilimumab absolute lymphocyte count greater than 1000 was the only significant predictor for increased RR in multivariable analysis (Odds Ratio: 8.56, 95% CI: 1.82-40.42; p = 0.007). Comparing 2-5 fractions of radiation to ipilimumab alone demonstrated a trend towards higher response rate (42.9% vs. 11.5%, p = 0.074). Conclusion(s): Despite poorer prognostic characteristics in the RT with ipilimumab cohort, toxicity, RR and OS were similar between the arms. Prospective studies investigating the ideal radiation fractionation to improve ipilimumab response rates are warranted. ALC < 1000 should be considered an exclusion criteria for these trials.",Excluded
3008,"Re-Irradiation in Recurrent Gliomas: Treatment outcome and Prognostic factors. Purpose or Objective: Gliomas have diverse prognoses that differ primarily depending on histologic subtype, grade and molecular marker expression. Even after aggressive multimodal treatment, most gliomas eventually recur. Treatment options for recurrent gliomas include surgery, chemotherapy, and re-irradiation. We sought to review our institutional experience with re-irradiation in the management of recurrent gliomas. Material(s) and Method(s): We retrospectively reviewed 31 patients with recurrent or progressive gliomas who received re-irradiation between January 2012 and December 2016. Majority (20 patients) constituted High Grade Glioma. (Grade III and IV). Though the recurrence was more in Grade IV Glioma but these patients were not included in our analysis because of their poor performance status and Re-RT was not feasible in them. All the patients were assessed for Re-Surgery. Reirradiation was offered to recurrent glioma patients with good performance status and at least 6 months had passed after initial radiotherapy (RT). All the patients were treated after doing planning CT Scan (Non-Contrast) and MRI of Brain (3 D FSPGR sequence) with I.V contrast and images were fused for target delineation. Target volume was delineation was kept conservative and the mean volume was 80 cc (50 to 140 cc). Technique of Radiotherapy was IMRT/VMAT and fractionation used was conventional. 11 patients were treated with concurrent oral Tab TMZ and 1 patient was treated with Inj Bevacizumab, 2 weekly cycle. Result(s): Out of 31 patients, 11 patients were found to be fit for Re-Surgery but only 8 patients agreed to do so. All the patients received Re-Radiation. Median doses of reirradiation and initial RT were 45.0 Gy and 59.4 Gy, respectively. The median time interval between initial RT and re-irradiation was 18 months. The median PFS and OS after re-irradiation were 3 and 7 months respectively. 12-month OS rate was 40%. 3 patients developed radiation necrosis and needed prolonged steroid therapy. In univariate analysis, Karnofsky performance status (KPS) >=70 (p <0.001), re-irradiation dose >=45 Gy (p =0.040), and longer time interval between initial RT and re-irradiation (p =0.040) were associated with improved OS. In multivariate analysis, KPS (p =0.030) and length of time interval between initial RT and re-irradiation (p=0.048) were important predictors of OS. Use of TMZ did not show any benefit. Molecular markers were not available for most of the patients and hence correlation could not be done. Conclusion(s): Re-irradiation in conjunction with surgery could be a salvage treatment for very selected recurrent glioma patients with good performance status. Re-irradiation was associated with only modest palliative and survival benefits in this retrospective review. Difficulties separating toxicity due to retreatment versus tumor progression and limited patient survival following retreatment preclude definite conclusions. Radiation necrosis was infrequent. Inspite of multimodality treatment, the treatment outcome remains dismal. Copyright Â© 2019 Elsevier Ireland Ltd",Excluded
3174,"Adrenoreceptor development in rat cerebrum and the effects of ionizing radiation. Previous studies in the rat have shown that neonatal radiation alters certain aspects of CNS monoaminergic systems including altering cerebral norepinephrine levels [17]. To determine if cerebral adrenoreceptor development is also altered by neonatal ionizing radiation, a single dose of whole body gamma-radiation was administered to rats on postnatal day two. This treatment did not alter (3H)-dihydroalprenolol (beta adrenoreceptor) or (3H)-WB4101 (alpha1 adrenoreceptor) binding when cerebra from irradiated animals were compared to age-matched sham-irradiated controls on postnatal days 9, 15 and 35. In contrast, (3H)-yohimbine (alpha2-adrenoreceptor) binding was altered in gamma-irradiation, a change manifested on postnatal days 9, 15 and 35 by lower than normal receptor densities (pmoles/g wet weight of tissue) although no radiation-induced changes in KD were apparent.",Excluded
2933,"Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis. The aim of this study is to analyse the efficacy of linear accelerator stereotactic radiosurgery (SRS) on prognostic factors, local control rate and survival in patients with brain metastasis. Patients with either a single metastasis or up to 4 multiple brain metastases with a maximum tumour diameter of 40 mm for each tumour and a Karnofsky Performance Status (KPS) > or = 70 were eligible for SRS. SRS was applied to 150 lesions in 86 consecutive patients with a median age of 60 years (median 1 and mean 1.7 lesions per patient, mean KPS 86). Median overall survival was 6.2 months after SRS and 9.7 months from diagnosis of brain metastasis. Multivariate analysis revealed that a KPS of 90 or more (p = 0.009) and female sex (p = 0.003) were associated with a longer survival. Radiation dose < or = 15 Gy (p = 0.017) and KPS < 90 (p = 0.013) were independent predictors of a shorter time to local failure. Five patients showed evidence of radionecrosis with a median survival of 14.8 months. Addition of WBRT neither led to improvement of survival nor to improvement of local control. Improved local control following SRS for brain metastases was associated with KPS > or =90, a radiation dose > 15 Gy and a PTV < 13 cc. The potential of hypofractionated stereotactic radiotherapy (SRT) for brain metastases of larger volume warrants further study.",Excluded
3615,"A phase I study of etanidazole and radiotherapy in malignant glioma. Purpose: To determine the maximum tolerable total dose (MTD) of etanidazole (ETA) when administered with external beam radiotherapy (XRT) and as a continuous infusion during stereotactic brachytherapy for patients with malignant glioma (anaplastic astrocytoma or glioblastoma multiforme or mixed cell tumors). Methods and Materials: Seventy previously untreated patients were entered in a Phase I study. Prior to initiation of treatment, patients were stratified according to whether or not they were candidates for interstitial implantation. The implant patients (IMP, n = 17 pt) received accelerated fractionation XRT 20 Gy BID (6 h apart) to 40 Gy in 2 weeks with ETA 2 gm/m<sup>2</sup> x 6 doses, a 2 week break and then interstitial implant to 50 Gy (4-7 days) with a continuous infusion of ETA over 90-96 h. The two sequentially conducted nonimplant arms started with accelerated fractionation XRT 2 Gy BID (6 h apart) to 40 Gy in 2 weeks with ETA 2 gm/m<sup>2</sup> x 4-5 doses/week. NonIMP 1 arm (n = 38) received a 2-week break before standard fractionated boost XRT of 20 Gy/day for 2 weeks to a total dose of 60 Gy with ETA. NonIMP 2 arm (n = 14) did not have the 2-week break. All patients had plasma pharmacokinetic monitoring of ETA. Result(s): The dose-limiting toxicity (DLT) in the IMP group was the cramping/arthralgia syndrome (4) and the cumulative MTD was 26 gm/m<sup>2</sup>. For both nonIMP 1 and 2 the DLTs were peripheral neuropathy and the cramping-arthralgia syndrome. The MTD for nonIMP 1 was 34 gm/m<sup>2</sup> and nonIMP 2, 30 gm/m<sup>2</sup>. Conclusion(s): The clinical efficacy and radiation-related toxicity of these regimens are being evaluated. The doses of ETA that can be used with accelerated fractionation and with external beam irradiation plus brachytherapy have been established.",Excluded
3445,"Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments. <b>Rationale:</b> Delivery of therapeutic agents to the brain is limited by the presence of the blood-brain barrier (BBB). An emerging strategy to temporarily and locally increase the permeability of the BBB is the use of transcranial focused ultrasound (FUS) and systematically injected microbubbles (MBs). FUS+MB BBB treatments cause an acute inflammatory response, marked by a transient upregulation of pro-inflammatory genes; however, the cellular immune response remains unknown.",Excluded
3466,"Dosimetry of I-125 seeds implanted on the surface of a cavity. Dosimetry of a new implant technique to treat brain tumors is presented. High grade gliomas or astrocytomas are surgically removed, and radioactive I-125 seeds are implanted on the surface of the cavity. A computational model is presented to determine the number of seeds and the activity of the seeds for a given dose and cavity size.",Excluded
2748,"Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: A phase i dose-escalation study (ISIDE-BT-1). Background: We performed a dose-escalation trial to determine the maximum tolerated dose (MTD) of intensity-modulated radiotherapy (IMRT) with standard concurrent and sequential-dose temozolomide (TMZ) in patients with glioblastoma multiforme. Method(s): Histologically proven glioblastoma patients underwent IMRT dose escalation. IMRT was delivered over 5 weeks with the simultaneous integrated boost (SIB) technique to the two planning target volumes (PTVs) defined by adding 5-mm margin to the respective clinical target volumes (CTVs). CTV1 was the tumor bed plus the enhancing lesion with 10-mm margin; CTV2 was the area of perifocal edema with 20-mm margin. Only the PTV1 dose was escalated (planned dose escalation: 60, 62.5, 65, 67.5, 70 Gy) while the PTV2 dose remained the same (45 Gy). Result(s): Forty consecutive glioblastoma patients were treated. While no dose-limiting toxicity (DLT) was recorded during the dose escalation up to 67.5/2.7 Gy, two out of the first six consecutively enrolled patients on the highest dose level (70/2.8 Gy) experienced a DLT, and therefore a cohort expansion was required. 3/14 patients experienced a DLT on the highest planned dose level, and therefore the MTD was not exceeded. After a median follow-up time of 25 months no grade >2 late neurological toxicity was recorded. Conclusion(s): By using a SIB IMRT technique, a radiation dose of 70 Gy in 25 fractions (biological effective dose - BED - of 92.8 Gy) can be delivered with concurrent and sequential standard dose TMZ, without unacceptable acute toxicity in patients with glioblastoma. Â© 2012 Japan Society of Clinical Oncology.",Excluded
2851,"Tissue slice cultures from humans or rodents: a new tool to evaluate biological effects of heavy ions. The aim of this interdisciplinary project is to establish slice culture preparations from rodents and humans as a new model system for studying effects of X-rays and heavy ions within normal and tumor tissues. The advantage of such slice cultures relies on the conservation of an organotypic environment, the easy treatment and observation by live-imaging microscopy, and the independence from genetic immortalization strategies used to generate cell lines. Rat brains as well as human tumors were cut into 300-mum-thick sections and cultivated in an incubator in a humidified atmosphere at 37 degrees C. This is realized by a membrane-based culture system with a liquid-air interface. With this system, it is possible to keep rodent slices viable for several months. Human brain tumor slices remained vital for at least 21 days. Slices were irradiated with X-rays at the radiation facility of the University Hospital in Frankfurt/Main at doses up to 40 Gy. Heavy ion irradiations were performed at GSI (Darmstadt) with different ions, energies, and doses. The irradiated slices were analyzed by 3D-confocal microscopy following immunostaining for DNA damage, microglia, and proliferation markers. The phosphorylated histone gammaH2AX proved to be suitable for the detection of ion traversals in this system.",Included
2616,"LET dependence on killing effect and mutagenicity in the model filamentous fungus Neurospora crassa. PURPOSE: To assess the unique biological effects of different forms of ionizing radiation causing DNA double-strand breaks (DSBs), we compared the killing effect, mutagenesis frequency, and mutation type spectrum using the model filamentous fungus Neurospora.MATERIALS AND METHODS: Asexual spores of wild-type Neurospora and two DSB repair-deficient strains [one homologous recombination- and the other non-homologous end-joining (NHEJ) pathway-deficient] were irradiated with argon (Ar)-ion beams, ferrous (Fe)-ion beams, or X-rays. Relative biological effectiveness (RBE), forward mutation frequencies at the ad-3 loci, and mutation spectra at the ad-3B gene were determined.RESULTS: The canonical NHEJ (cNHEJ)-deficient strain showed resistance to higher X-ray doses, while other strains showed dose-dependent sensitivity. In contrast, the killing effects of Ar-ion and Fe-ion beam irradiation were dose-dependent in all strains tested. The rank order of RBE was Ar-ion > Fe-ion > C-ion. Deletion mutations were the most common, but deletion size incremented with the increasing value of linear energy transfer (LET).CONCLUSIONS: We found marked differences in killing effect of a cNHEJ-deficient mutant between X-ray and high-LET ion beam irradiations (Ar and Fe). The mutation spectra also differed between irradiation types. These differences may be due to the physical properties of each radiation and the repair mechanism of induced damage in Neurospora crassa. These results may guide the choice of irradiation beam to kill or mutagenize fungi for agricultural applications or further research.",Excluded
3100,"State of neuroendocrine systems and immunity in patients with burns. [Russian]. The study of hormonal shifts and immunity in 95 patients with burns has revealed hyperergic reaction of the neuroendocrine system in the early period after trauma, accompanied by a marked and prolonged inhibition of cellular and humoral immunity. The use of antistress agents (clofelin, pentamine) and intravenous laser blood irradiation leads to a more prompt arrest of hyperergic reaction of the neuroendocrine system and to the reduction of immunosuppressing effect of burn trauma, which decreases the number of pyoseptic complications from 26.4 to 16% and total lethality from 16 to 3.8%.",Excluded
2405,"Biophysical characterization of an integrin-targeted non-viral vector. BACKGROUND: The formulation of polycationic complexes containing plasmid DNA for optimal transfection in vitro and in vivo for DNA vaccination, gene therapy and other applications continues to be a major research goal. Here we present new data on the biophysical properties of an integrin-targeted plasmid DNA (LID) formulation.MATERIAL/METHODS: Two plasmids (D), pEGFP (4.7 kb) and pCI-luc (5.7 kb), were mixed with a synthetic a5b1 integrin-targeted peptide (I), [K]16 GACRRETAWACG, in the presence of a cationic liposome (L), Lipofectin, composed of DOTMA and DOPE to form LID complexes. The physical properties of the complexes were measured using a variety of techniques including dynamic light scattering and fluorescence methods. The in vitro gene delivery to neuroblastoma cells with LID complexes was also assessed.RESULTS: We demonstrate the effects of complex size and charge ratio on in vitro transfection of mouse (Neuro-2A) and human (IMR-32) neuroblastoma cells. We report a significant increase in the level of luciferase and green fluorescent protein expression when transfection is performed in buffers of physiological ionic strength and hypothesise that the enhancement in transfection is caused by an increase in the size of the complexes observed during mixing and maturation.CONCLUSIONS: Cell transfection is also shown to be dependent on complex size and charge ratio, with large complexes prepared at charge ratios above 4.0 demonstrating efficient transfection.",Excluded
2897,"Ophthalmologic aspects of treating optic neuropathy during the course of Graves-Basedow disease. [Polish]. The aim of the present study is to evaluate the efficacy of conservative treatment of optic neuropathy in the course of Graves' disease. Nineteen patients with neuropathy out of 520 patients with Graves' disease, including 15 women and 4 men were treated. Age of the patients ranged from 36 to 69 years, mean age was 51.3. In all patients thyroid function was normalized, 4 patients underwent strumectomy. Bi- and unilateral neuropathy was found in 13 and 6 cases respectively. The therapy consisted of high-dose steroids (Prednisone in 12 cases or Dexamethasone i.v. in 3 cases) or they were combined with gamma cobalt-60 irradiation of orbit tissues (2000 c Gy in 10 fractions) in 8 cases. In 2 cases radiotherapy alone was performed. Two cases were excluded from treatment because of optic atrophy during the first examination. In all patients full ophthalmological investigation, ultrasonography and computed tomography of the orbit before and after the treatment were performed. Follow-up ranged from 5 to 46 months, mean 21.4. Improvement of visual acuity and perimetry (p < 0.05) after the treatment was observed and changes of the fundus after the treatment were significantly (p = 0.000) improved. Exophthalmos significantly decreased (p < 0.05) but only in the right eye. In all patients the therapy reduced the ophthalmopathy index from mean 7.5 to 4.1 (p = 0.000). In conclusion: 1. Early diagnosis and appropriate, constant conservative treatment of optic neuropathy in Graves' disease prevent from blindness and surgical intervention. 2. Corticotherapy in combination with radiotherapy of the orbit is a beneficial method of the treatment of optic neuropathy in Graves' disease.",Excluded
2942,"The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications. The benefit of multimodality therapy is clearly established for adenocarcinomas of the distal esophagus and gastroesophageal junction, but its impact on toxicity is not well defined. We reviewed data from prospective randomized trials to better define the risks of multimodality therapy. The rates of surgical mortality and complications range from 0% to 10% and 23% to 49%, respectively. Multimodality therapy increases acute toxicity. The rate of severe acute hematologic toxicity varies considerably between trials (3%-78%) and appears to be primarily attributable to chemotherapy. Common severe acute nonhematologic toxicities include esophagitis (16%-63%), infection (2%-30%), pain (3%-24%), and gastrointestinal (6%-60%) and cardiac (3%-19%) events. The individual contribution of each modality to nonhematologic toxicities is unclear, but toxicity is increased when adding radiosensitizing chemotherapy to radiotherapy. There is an acute decrease in quality of life with multimodality therapy; however, quality of life usually returns to, or exceeds, baseline by 12 months after therapy. Late toxicities are less well defined, but commonly include esophageal, pulmonary, and cardiac toxicities.",Excluded
3281,"Real versus simulated mobile phone exposures in experimental studies. We examined whether exposures to mobile phone radiation in biological/clinical experiments should be performed with real-life Electromagnetic Fields (EMFs) emitted by commercially available mobile phone handsets, instead of simulated EMFs emitted by generators or test phones. Real mobile phone emissions are constantly and unpredictably varying and thus are very different from simulated emissions which employ fixed parameters and no variability. This variability is an important parameter that makes real emissions more bioactive. Living organisms seem to have decreased defense against environmental stressors of high variability. While experimental studies employing simulated EMF-emissions present a strong inconsistency among their results with less than 50% of them reporting effects, studies employing real mobile phone exposures demonstrate an almost 100% consistency in showing adverse effects. This consistency is in agreement with studies showing association with brain tumors, symptoms of unwellness, and declines in animal populations. Average dosimetry in studies with real emissions can be reliable with increased number of field measurements, and variation in experimental outcomes due to exposure variability becomes less significant with increased number of experimental replications. We conclude that, in order for experimental findings to reflect reality, it is crucially important that exposures be performed by commercially available mobile phone handsets. Copyright Â© 2015 Dimitris J. Panagopoulos et al.",Excluded
3317,"The effect of a single whole-body irradiation with a lethal dose on catecholamine levels in the pineal glands of rats. Male Wistar rats adapted to light-dark cycle (LD) 12:12 h were exposed in the darkness to a lethal single dose of 14.35 Gy gamma-rays on the whole body. Irradiation, sham-irradiation and decapitation 30, 60, 120 min after the exposure, were performed between 2000 h and 0100 h in the darkness. The changes in the concentrations of catecholamines (CA) were determined by the radioenzymatic method in the pineal gland of rats. Results were evaluated in comparison with those of the sham-irradiated (30, 60, 120 min) control groups of rats. From the results it follows that the concentration of dopamine (DA) and norepinephrine (NE) in the rat pineal gland significantly decreased 30 and 120 minutes after irradiation (p < 0.01). At min 60 of the postirradiation period it was possible to observe a tendency to recovery of the levels of DA and NE to control values. Epinephrine (EPI) exhibited a significant (p < 0.05) decrease at min 60 and 120 of postirradiation (by 61.8% and 62.8%, respectively).",Included
2982,"Ischemic optic neuropathies. Primary or secondary impairment of blood supply to the optic nerve results in a spectrum of ischemic optic neuropathies with multiple etiopathogenesis. Among these the clinical features of traumatic and radiation optic neuropathy are outlined. Diagnostic criteria, associated conditions, risk factors and functional prognosis of anterior ischemic optic neuropathy are reviewed and discussed in the light of the contribution of recent literature.",Excluded
3559,"Patterning the cone mosaic array in zebrafish retina requires specification of ultraviolet-sensitive cones. Cone photoreceptors in teleost fish are organized in precise, crystalline arrays in the epithelial plane of the retina. In zebrafish, four distinct morphological/spectral cone types occupy specific, invariant positions within a regular lattice. The cone lattice is aligned orthogonal and parallel to circumference of the retinal hemisphere: it emerges as cones generated in a germinal zone at the retinal periphery are incorporated as single-cell columns into the cone lattice. Genetic disruption of the transcription factor Tbx2b eliminates most of the cone subtype maximally sensitive to ultraviolet (UV) wavelengths and also perturbs the long-range organization of the cone lattice. In the tbx2b mutant, the other three cone types (red, green, and blue cones) are specified in the correct proportion, differentiate normally, and acquire normal, planar polarized adhesive interactions mediated by Crumbs 2a and Crumbs 2b. Quantitative image analysis of cell adjacency revealed that the cones in the tbx2b mutant primarily have two nearest neighbors and align in single-cell-wide column fragments that are separated by rod photoreceptors. Some UV cones differentiate at the dorsal retinal margin in the tbx2b mutant, although they are severely dysmorphic and are eventually eliminated. Incorporating loss of UV cones during formation of cone columns at the margin into our previously published mathematical model of zebrafish cone mosaic formation (which uses bidirectional interactions between planar cell polarity proteins and anisotropic mechanical stresses in the plane of the retinal epithelium to generate regular columns of cones parallel to the margin) reproduces many features of the pattern disruptions seen in the tbx2b mutant.",Excluded
2394,"Prospective assessment of gustatory function after radiotherapy for head and neck cancers. BACKGROUND: Taste disorders are major causes of morbidity in patients undergoing head and neck irradiation. We quantitatively assessed the gustatory function of patients with head and neck cancers who underwent radiotherapy using recently developed standardised tools for measuring taste.METHODS: Twenty patients undergoing head and neck irradiation responded to a specific questionnaire and were assessed by olfactory and gustatory function tests. To assess changes over time, testing was performed before, immediately after, and at 2- and 4-week intervals following the start of radiotherapy. Concurrently, patients were evaluated for xerostomia from radiotherapy.RESULTS: A decrease in the taste recognition threshold was observed in the second week after the beginning of radiotherapy. The taste detection threshold improved within the 14th-18th week. Most affected patients demonstrated that their gustatory function primarily decreased independent of the olfactory function. Disturbances in taste were exponentially worsened beyond an accumulated dose of 30 Gy and involved all tastants. According to a multivariate analysis, radiation-induced taste impairment was not influenced by the degree of xerostomia. However, there was an association between the dose of irradiation and the severity of taste disturbance.CONCLUSIONS: In this preliminary study, we found that the taste function was worse 2 weeks after the start of radiotherapy and returned to pretreatment levels within 4.5 months. Taste disturbances were exponentially worse beyond an accumulated dose of 20 Gy. Taste dysfunction after radiotherapy was not influenced by the degree of xerostomia, whereas only the dose of irradiation was associated with the severity of taste dysfunction.",Excluded
3481,The therapy of Hodgkin's disease--1978: a combined modality approach,Excluded
2829,"Non-invasive follow-up of patients with intracranial arteriovenous malformations after proton-beam radiation therapy. In order better to follow non-invasively the effect of proton beam therapy upon intracranial arteriovenous malformations, transcranial Doppler sonography (TCD) was used in 10 patients, in addition to conventional follow-up with angiography and computed tomography (CT); in six patients, pre- and postradiation TCD studies were obtained. The mean flow values obtained from the major arteries in the circle of Willis indicate an early flow reduction through the AVM of approximately 15% with further reduction between 2/3 and 1/2 of the initial values within 15 months of follow-up. CT showed a reduction of contrast enhancement in those patients in whom scans could be compared. In this limited experience, TCD was proven to yield additional information, in repeated non-invasive studies, on the haemodynamic influence of AVMs and the effect of proton beam therapy.",Excluded
3541,"Feasibility, Safety, and Periprocedural Complications of Pipeline Embolization for Intracranial Aneurysm Treatment Under Conscious Sedation: University at Buffalo Neurosurgery Experience. BACKGROUND: Endovascular Pipeline Embolization Device (PED) placement for intracranial aneurysms is performed under general anesthesia at most centers because of perceived improved image quality and patient safety.OBJECTIVE: To report the feasibility, safety, and outcomes associated with the use of the PED for intracranial aneurysms performed in awake patients after the administration of conscious sedation (CS) and a local anesthetic.METHODS: Between March 2012 and September 2014, 130 patients with 139 intracranial aneurysms (8 ruptured) were treated with the PED under CS at our institution. Procedure details and time (including duration, radiation exposure, and fluoroscopy) and procedure-related complications were retrospectively reviewed.RESULTS: A total of 155 PED deployment procedures were performed under CS. Treatment was successfully completed in all cases. Anesthesia was converted from CS to general anesthesia during 5 procedures. Mean interval from patient entry at the endovascular suite to procedure initiation was 18 minutes (range, 5 minutes-1 hour 10 minutes). Mean procedure length was 1 hour 25 minutes (range, 30 minutes-3 hours 51 minutes). Mean +/- SD values for fluoroscopy time and radiation exposure were 36.17 +/- 18.4 minutes and 1367 +/- 897 mGy, respectively. The mean amount of contrast material administered was 211.37 +/- 83.5 mL. Permanent neurological complications were seen in 4 patients (3%).CONCLUSION: In our experience, CS for PED placement for intracranial aneurysm treatment is feasible and safe. Procedure and fluoroscopy times and amount of radiation exposure are similar to or less than described in reports of PED placement under general anesthesia. CS allows direct neurological evaluation and earlier detection of and response to intraprocedural complications.",Excluded
3443,"[The absolute light sensitivity of the visual analyzer in sailors during a 10-month commercial voyage]. For the purpose of studying the influence of extreme conditions of a long-term voyage on the functional state of the visual analyser, light sensitivity was studied in 21 seamen. It is shown that adaptation mechanisms regulating light sensitivity have a phase tendency: phase is characterized by a rise of the level of light sensitivity within first 90-120 days of the voyage; phase II--by a gradual fall of the level of light sensitivity beginning from 120-140 days of the long-term voyage. The investigations performed allow to create an informative diagnostic test for a well-grounded therapy intended to widen adaptive possibilities of the system responsible for regulation of light sensitivity.",Excluded
3252,"Delayed central nervous system irradiation effects in rats--part 2: aggravation of experimental autoimmune encephalomyelitis. BACKGROUND: Central nervous system (CNS) irradiation has detrimental effects which become evident within hours to few days and after a long latency of months and years. However, the delayed effect of irradiation on neuroimmune diseases has not been thoroughly examined.OBJECTIVES: We evaluated the delayed effects of irradiation on the course of experimental autoimmune encephalomyelitis (EAE), which is used as a model for neuroimmune inflammation and multiple sclerosis.METHODS: Adult male rats were exposed to a dose of 15 Gy given to the thoracolumbar spinal cord. Six months later, EAE was induced by inoculation of rat spinal cord homogenate in complete Freund's adjuvant (CFA). The disease was evaluated by clinical, histopathological and immunological parameters.RESULTS: Irradiated rats developed clinical signs of EAE earlier than the control group and their disease was much more severe. Unlike the control group, all rats in the EAE-irradiated group died within 5 days after the onset of clinical signs. Sections taken from irradiated rats showed diffuse and large hemorrhagic infiltrates of lymphocytes and granulocytes. In contrast, control rats displayed fewer infiltrates, which were less prominent and not hemorrhagic.CONCLUSIONS: CNS irradiation has a delayed effect that caused a marked aggravation of the clinical and pathological signs of EAE. The severity of the disease may be a consequence of the effect of irradiation on the CNS vascular bed and impaired blood-brain barrier.",Included
3195,"UV-visible antagonism in extraocular photosensitive neurons of the anthomedusa, Spirocodon saltatrix (Tilesius). Attempts were made to identify extraocular photosensitive cells in the subtentacular region (the area between the ocelli and the nerve ring) and around the inner-nerve ring of the anthomedusan Spirocodon saltatrix. Irradiation with ultraviolet light (UV) led to inhibition of spontaneous impulses and after UV-off, an afterinhibition which lasted for a few minutes. This afterinhibition was rapidly overcome by exposure to visible light (VIS). UV-VIS antagonism of this type was identified in six different impulse systems monitored in extracellular recordings. Intracellular recordings from two of the six cell types showed that UV irradiation causes hyperpolarization which inhibits spontaneous activity. The other cell types showed no membrane potential changes during UV irradiation even though the cells' spontaneous outputs were inhibited. It was concluded that the photosensitivity lies in three kinds of nerves which are distributed widely through the subtentacular region and the nerve ring.",Excluded
2498,"Abciximab (ReoPro) Dosing Strategy for the Management of Acute Intraprocedural Thromboembolic Complications during Pipeline Flow Diversion Treatment of Intracranial Aneurysms. Background: Flow diversion with the Pipeline embolization device (PED) is an effective neuro-endovascular method and increasingly accepted for the treatment of cerebral aneurysms. Acute in situ thrombosis is a known complication of PED procedures. There is limited experience in the flow diversion literature on the use of abciximab (ReoPro) for the management of acute thrombus formation in PED cases. Method(s): Data were collected retrospectively on patients who received intra-arterial (IA) ReoPro with or without subsequent intravenous (IV) infusion during PED flow diversion treatment of intracranial aneurysms. Result(s): A total of 30 cases in patients with a mean age of 56.7 years (range 36-84) and a mean aneurysm size of 8.6 mm (range 2-25) were identified to have intraprocedural thromboembolic complications during PED treatment. IA ReoPro was administered in all cases, with 20 cases receiving increments of 5-mg boluses and 10 cases receiving a 0.125 mg/kg IA bolus (half cardiac dosing). Complete or partial recanalization was achieved in 100% of the cases. IV ReoPro infusion at 0.125 mug/kg/min for 12 h was administered postprocedurally in 22 cases with a residual thrombus. Postprocedurally, 18 patients were transitioned from clopidogrel (Plavix) to prasugrel (Effient). The majority of the cases (23/30; 77%) were discharged home. Periprocedural intracranial hemorrhage was noted in 2 cases (7%) and radiographic infarct was noted in 4 cases (13%), with an overall mortality of 0% at the time of initial discharge. Clinical follow-up was available for 28/30 patients. The average duration of follow-up was 11.7 months, at which time 23/28 (82%) of the patients had a modified Rankin Scale score of 0. Conclusion(s): IA ReoPro administration is an effective and safe rescue strategy for the management of acute intraprocedural thromboembolic complications during PED treatment. Using a dosing strategy of either 5-mg increments or a 0.125 mg/kg IA bolus (half cardiac dosing) can provide high rates of recanalization with low rates of hemorrhagic complications and long-term morbidity. Copyright Â© 2018 S. Karger AG, Basel.",Excluded
3690,"Functional interrelationships between dehydrogenases and transaminases in various regions of the rat brain as affected by small doses of gamma-radiation. [Russian]. Wistar rats were exposed to 10, 20 and 40 sGy of gamma-irradiation. Maximal activity of 2-oxoglutarate- and succinate dehydrogenases, as well as of aspartate-2-oxoglutarate and pyruvate-2-oxoglutarate in the brain tissue was measured within 30 days after the exposure. Dehydrogenase activity was measured in the brain cortex, limbic system and in the cerebellum; transaminase activity was determined in the brain cortex, diencephalic zone and in the hypophysis. It was found that small doses of irradiation resulted in an oscillating increase of dehydrogenase activity with a decrease of the amplitude by the 30th day of the experiment. As the dose of irradiation increases, the periods of normal activity change into phases of inhibition of dehydrogenase action, the period of oscillations diminishes. Transaminase activity, as a rule, changes in a phase in a reversible manner as compared with dehydrogenase activity. These observations are discussed from the point of view of structural relations between these two systems in the intramitochondrial supramolecular structures, the so-called metabolons.",Included
2952,"Regulation of prostaglandin E2 synthesis after brain irradiation. PURPOSE: A local tissue reaction, termed neuroinflammation, occurs after irradiation of brain tissue. Previous work suggested that cyclooxygenase (COX)-2 activity was important for changes in gene expression associated with neuroinflammation as well as increased prostaglandin E2 (PGE2) levels seen after radiation treatment.METHODS AND MATERIALS: To begin to determine the contributions of other enzymes involved in PGE2 production, we examined protein levels of COX-1 and COX-2 as well as 2 PGE synthases (membrane and cytosolic PGES) 4 h after 35 Gy single dose irradiation to the brains of C3HeN mice. We also evaluated the effects of specific COX inhibitors on PGE2 production and PGES expression.RESULTS: As expected, COX-2 expression increased after radiation exposure. Brain irradiation also increased tissue protein levels for both PGES isoforms. Specific COX-2 inhibition with NS398 lowered brain PGE2 levels by about 60%. Surprisingly, COX-1 inhibition with SC560 completely prevented the elevation of PGE2 seen after irradiation. Interestingly, NS398 reduced the membrane-associated PGES isoform, whereas SC560 treatment lowered cytosolic isoform levels below those seen in unirradiated controls.CONCLUSIONS: Taken together, these data indicate that both cyclooxygenases contribute to PGE2 production in irradiated brain and reveal dependence of PGES isoforms expression on specific cyclooxygenase activities.",Included
2512,"LINAC radiosurgery for glomus jugulare tumors: retrospective - cohort study of 23 patients. Background: Glomus jugulare tumors (GJTs) are uncommon and locally disruptive tumors that usually arise within the jugular foramen of the temporal bone. Surgery was the treatment of choice up until recently. In the last decades, however, radiosurgery has surfaced as a promising alternative treatment by providing excellent tumor control with low risk of cranial nerve injuries. Our aim was to examine the results of radiosurgery specifically, linear accelerator stereotactic radiosurgery (LINAC SRS) for GJT treatment. We hypothesized that radiosurgery will reduce the size of the tumor and improve neurological symptoms. Design and method: Between January 1, 1994 and December 31, 2013, 30 patients with GJTs were treated in Sheba Medical Center using LINAC SRS treatment. Comprehensive clinical follow-up was available for 23 patients. Sixteen patients were female and seven males with a median age of 64 years, with a range of 18-87 years. In 19 of the patients, LINAC SRS was the primary treatment, whereas in the remaining four cases, surgery or embolization preceded radiosurgery. The median treated dose to tumor margin was 14 Gy (range 12-27 Gy), and the median tumor volume before treatment was 5 ml (range 0.5-15 ml). Result(s): Following the LINAC SRS treatment, 14 of 23 patients (60%) showed improvement of previous neurological deficits, nine patients (40%) remained unchanged. At the end of a follow-up, tumor reduction was seen in 13 patients and a stable volume in eight (91% tumor control rate). Two cases of tumor progression were noted. Three patients (13%) had post- SRS complications during the follow-up, two of which achieved tumor control, while in one the tumor advanced. Conclusion(s): LINAC SRS is a practical treatment option for GJTs, with a high rate of tumor control and satisfactory neurological improvement. Copyright Â© 2020, Springer-Verlag GmbH Austria, part of Springer Nature.",Excluded
3208,"The role of palliative radiation in the management of brain, spinal cord, and bone metastases",Excluded
3256,"Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures. PURPOSE: We investigated the effects of fractionated radiation treatments on the life spans of athymic rats bearing intracerebral brain tumors.METHODS AND MATERIALS: U-251 MG or U-87 MG human glioblastoma cells were implanted into the brains of athymic rats, and the resulting tumors were irradiated once daily with various doses of ionizing radiation for 5 consecutive days or for 10 days with a 2-day break after Day 5.RESULTS: Five daily doses of 1 and 1.5 Gy, and 10 doses of 0.75 and 1 Gy, cured some U-251 MG tumors. However, five daily doses of 0.5 Gy increased the survival time of animals bearing U-251 MG tumors 5 days without curing any animals of their tumors. Ten doses of 0.3 Gy given over 2 weeks extended the lifespan of the host animals 9 days without curing any animals. For U-87 MG tumors, 5 daily doses of 3 Gy produced an increased lifespan of 8 days without curing any animals, and 10 doses of 1 Gy prolonged lifespan 5.5 days without curing any animals. The differences in extension of life span between the 5- and 10-fraction protocols were minor for either tumor type.CONCLUSION: The finding that the U-251 MG tumors are more sensitive than U-87 MG tumors, despite the fact that U-251 MG tumors contain many more hypoxic cells than U-87 MG tumors, suggests the intrinsic cellular radiosensitivities of these cell lines are more important than hypoxia in determining their in vivo radiosensitivities.",Excluded
3026,"Stereotactic body radiation therapy using tomotherapy for single or multiple vertebral metastases. Purpose/Objective(s): Conventional radiation therapy has been used to treat vertebral metastases (VM), but because of the dose constraint to the spinal cord, high enough doses to obtain long-term remission cannot necessarily be delivered. By using tomotherapy, the spinal cord dose can be lowered and higher doses can be delivered to VM. The purpose of this study was to evaluate efficacy and toxicity of stereotactic body radiation therapy (SBRT) for single or multiple VM using tomotherapy. Materials/Methods: Between October 2010 and January 2012, 27 patients (primary cancer: gastrointestinal 6, urethral 5, prostate 5, lung 5, breast 3, others 3) with 32 VM (location: cervical 3, thoracic 18, lumber 11) were treated with SBRT as initial radiation therapy. All patients treated on this protocol had WHO performance status 0-2 and could keep position on an immobilization device for > 20 minutes. Before SBRT, 2- mm-thick CT and MR images were obtained and the tumor and neighboring vertebral structures were contoured as the clinical target volume (CTV). The planning target volume was CTV plus 5 mm. Either 40 Gy in 8 fractions or 48 Gy in 16 fractions were prescribed depending on Katagiri's prognostic index. The radiation dose to the spinal cord and other risk organs were reduced to the tolerance levels using intensity modulation. One to 4 lesions in consecutive vertebrae were treated in one course of SBRT. Radiological (CT and/or MRI) and physical examinations were performed at 1-3 month intervals after SBRT. Birthel index (BI), numerical rating scale (NRS) and the National Cancer Institute Common Terminology Criteria ver 4.0 were used to evaluate activities of daily living (ADL), pain and toxicity. Result(s): Treatment times were within 15-20 minutes. A median followup period was 5 months (range, 1-14). Compared to pretreatment status, the majority of VM patients (29/32) had prompt pain relief within 4 weeks after SBRT. The NRS significantly dropped at 1 month after SBRT (4.0 +/- 0.8 [SE] vs. 1.0 +/- 0.2, p < 0.0001) and the effect continued over 2 months. Significant BI decrease was not observed at 2 months after SBRT (84 +/- 16 vs. 86 +/- 18, p = 0.7). BI decrease resulting from VM enlargement was observed in only 2 patients. They occurred during SBRT course and 9 months after SBRT, respectively. One Grade 3 dermatitis developed at 3 months after SBRT. One patient had Grade 2 ileus and 2 had Grade 1 neuralgia, although direct association with SBRT was not clear. No pneumonitis was observed in 18 patients with thoracic VM. No grade > 2 neurologic toxicity resulting from SBRT was observed. Conclusion(s): This is the first report on successful SBRT for bone metastases in up to 4 consecutive vertebrae using tomotherapy. Good ADL control and palliation of pain were achieved with acceptable toxicity by SBRT using tomotherapy.",Excluded
2650,"Review of severe osteoradionecrosis treated by surgery alone or surgery with postoperative hyperbaric oxygenation. We reviewed 41 patients with osteoradionecrosis of the mandible. Each patient was treated by radical resection followed by external beam irradiation. The diagnosis of infected osteoradionecrosis was confirmed clinically, radiologically, and histologically. After operation had failed, 20/41 were given hyperbaric oxygen (HBO) as in 'salvage' treatment. Daily sessions of HBO 2.5 ATA for 60 minutes (mean: 29 sessions) were given. The other 21 patients were treated by operation and antibiotics alone. HBO group (n = 20): The overall success rate for HBO after operation had failed was 13/20. Repeated debridement as first-line treatment followed by postoperative HBO was successful in 12/19. In seven of 19 patients, partial mandibulectomy and microvascular transplantation were required as second-line treatment, and this was successful in five. Primary partial mandibulectomy and microvascular transplantation followed by HBO was successful in 1 patient. Non-HBO group (n = 21): Repeated debridement was successful in 10/11 patients. Partial mandibulectomy was required as second-line treatment in the remaining one. In the other 10, partial mandibulectomy and microvascular transplantation were successful as first-line treatment in four. In the remaining six, further surgical intervention became necessary and were successful for 5-17 months (mean: 13). With a success rate of 13/20, we do not recommend HBO for the treatment of osteoradionecrosis.",Excluded
3213,"Horizontal angular VOR changes in orbital and parabolic flight: human neurovestibular studies on SLS-2. Further evidence was found for adaptive changes in the vestibular ""velocity storage"" (VS) component of the vestibuloocular reflex in four shuttle astronauts tested in parabolic flight and before, during, and after a 14-day mission. Nystagmus was recorded during and after 1 min of 120 degrees/s rotation. Gains and time constants were determined by computer analysis. Responses correlated with experience. Two subjects were making their first spaceflight. In parabolic flight, their time constants shortened to an average of 60% of 1 G values, presumably because unfamiliar otolith cues reduced VS. However, after 4-10 days in orbit, their time constants were similar or greater than those preflight, indicating VS recovery. The other two subjects had previously flown in space. Their time constants shortened in orbit to an average of 69% of 1 G values, indicating a persisting reduction of VS. This correlation with spaceflight experience has been seen in 9 of 11 subjects on 3 missions. Head pitch did not significantly ""dump"" nystagmus as it does on Earth.",Excluded
3502,"Intracellular analysis of reflex pathways underlying the stumbling corrective reaction during fictive locomotion in the cat. In cat and humans, contact between an obstacle and the dorsum of the foot evokes the stumbling corrective reaction (reflex) that lifts the foot to avoid falling. This reflex can also be evoked by short trains of stimuli to the cutaneous superficial peroneal (SP) nerve in decerebrate cats during the flexion phase of fictive locomotion. Here we examine intracellular events in hindlimb motoneurons accompanying stumbling correction. SP stimulation delivered during the flexion phase excites knee flexor motoneurons at short latency [minimum excitatory postsynaptic potential (EPSP) latency 1.8 ms; mean 2.7 ms]. Although a similar short latency excitation occurs in ankle extensors (mean latency, 2.8 ms), recruitment is delayed until successive shocks in the stimulus train overcome the locomotor-related hyperpolarization of ankle extensors. In ankle flexor motoneurons, SP stimulation evokes an inhibition (mean latency, 2.7 ms) that briefly reduces or stops their firing during the flexion phase. There is a phase-dependent modulation of SP-evoked EPSP amplitude as well as latency during locomotion. However, the more obvious change in SP reflex pathways with the onset of fictive locomotion is the reduced inhibition of ankle extensor motoneurons and the increased inhibition of ankle flexors. These results show that the characteristic pattern of hindlimb motoneuron activation during SP nerve-evoked stumbling correction results from 1) di- and trisynaptic excitation of knee flexor and ankle extensor motoneurons; 2) increased inhibitory postsynaptic potentials in ankle flexors and a suppression of inhibition in extensors, 3) sculpting of the short-latency SP postsynaptic effects by motoneuron membrane potential, and 4) longer latency excitatory effects that are likely evoked by lumbar interneurons involved in the generation of fictive locomotion.",Excluded
3518,Surgery after high dose radiotherapy,Excluded
3288,Electrical stimulation of vestibular nuclei: effects on spontaneous activity of lateral geniculate nucleus neurones,Excluded
2858,"Electrical brain imaging reveals spatio-temporal dynamics of timbre perception in humans. Timbre is a major attribute of sound perception and a key feature for the identification of sound quality. Here, we present event-related brain potentials (ERPs) obtained from sixteen healthy individuals while they discriminated complex instrumental tones (piano, trumpet, and violin) or simple sine wave tones that lack the principal features of timbre. Data analysis yielded enhanced N1 and P2 responses to instrumental tones relative to sine wave tones. Furthermore, we applied an electrical brain imaging approach using low-resolution electromagnetic tomography (LORETA) to estimate the neural sources of N1/P2 responses. Separate significance tests of instrumental vs. sine wave tones for N1 and P2 revealed distinct regions as principally governing timbre perception. In an initial stage (N1), timbre perception recruits left and right (peri-)auditory fields with an activity maximum over the right posterior Sylvian fissure (SF) and the posterior cingulate (PCC) territory. In the subsequent stage (P2), we uncovered enhanced activity in the vicinity of the entire cingulate gyrus. The involvement of extra-auditory areas in timbre perception may imply the presence of a highly associative processing level which might be generally related to musical sensations and integrates widespread medial areas of the human cortex. In summary, our results demonstrate spatio-temporally distinct stages in timbre perception which not only involve bilateral parts of the peri-auditory cortex but also medially situated regions of the human brain associated with emotional and auditory imagery functions. Â© 2006 Elsevier Inc. All rights reserved.",Excluded
2934,"Maternal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) alters indolamine levels and turnover in adult male and female rat brain regions. Perinatal exposure to delta 9-THC has been shown to produce effects on brain development. In this study we evaluated the changes induced by maternal exposure to delta 9-THC (5 mg/kg per day) from gestational day 5 to postnatal day 24 in eight discrete brain areas on the central serotoninergic system in both adult male and female rats. These result show that maternal exposure to delta 9-THC from gestational day 5 to postnatal day 24 affects development of the various central indoleaminergic system of the offsprings brain. Perinatal exposure to delta 9-THC decreased the levels of 5-HT in hypothalamus and rostral neostriatum in exposed males, and also decreased the levels of 5-HT in ventral hippocampus, septum, and midbrain raphe nuclei in both exposed males and females. Perinatal exposure to delta 9-THC increased the levels of 5-HIAA in dorsal hippocampus, hypothalamus, septum, midbrain raphe nuclei, and rostral neostriatum in exposed males and females. We have also found differences between nonexposed males and females in several brain regions. Our results confirm a regional and sexual specificity in endogenous levels of indoleamine after perinatal delta 9-THC treatment, being the midbrain raphe nuclei the most affected area.",Excluded
2572,"Androstenes mediated oncophagy of glial and myeloid tumor cells by different mechanisms. Cellular death by necrosis, apoptosis and autophagy can be considered as one of host resistance processes. We reported that beta androstene hormones, Dehydroepiandrosterone, Androstenediol and Androstenetriol, up regulate host resistance against lethal infections by bacteria, viruses and restore host myelopoiesis after whole body radiation exposures. In contrast, the a androstenediol (17alphaAED) epimer, mediates host resistance by oncophagy of myeloid, epithelial and brain tumor cells by either apoptotic or autophagy mechanisms. In myeloid tumor cell, 17alphaAED induces apoptosis as shown by TUNEL assay and electron microscopy. 17alphaAED inhibits DNA synthesis in myelocytic leukemia cells whereas 17alphaAED does not. Similarly, l7alphaAED inhibited the proliferation of estrogen receptor positive or negative human mammary carcinomas, but its activity is independent of either estrogen or androgen receptors. 17alphaAED also inhibits proliferation and induces cell death of multiple, unrelated glioma with an IC50 of 8 to 25 ?M. Treatment with 17alphaAED induced autophagosomes and acidic vesicular organelles formation in human malignant glioma. The position of the hydroxyl group on C-17 dictates the anti-tumor activity of the androstenes and must be in the a-configuration, demonstrating a strict structure-activity relationship. Exposure of U937 lymphoma cells to 17alphaAED induces apoptosis without the activation of the autophagic process as determined by the elevated levels of caspase 3 cleavage and PARP processing. In contrast beclin-1 and conversion of LC3-I to LC3-II were evident in T98G glioblastoma cells treated with 17alphaAED. In human glioblastoma 17alphaAED autophagy is induced by PERK/eIF2 signaling mediated ER stress. These findings reveal that the same agent 17alphaAED induces oncophagy in different tumor cells: autophagy in human glioblastoma and apoptosis in human myelocytic leukemia. The target cell determines the oncophagic pathway used.",Excluded
2440,"Interindividual heterogeneity of molecular weight of human brain neutral sphingomyelinase determined by radiation inactivation method. The molecular weight (Mr) of the membrane-bound neutral sphingomyelinase from human brain was determined using the radiation inactivation procedure. Previous studies on three human brains suggested a Mr of 165 +/- 25 kDa (J. Neurochem. 1985, 45:630-632). We now report that in another human brain the neutral sphingomyelinase had a Mr of 740 +/- 100 kDa; this higher Mr was not accompanied by differences in enzymatic properties nor heat-stability.",Excluded
3455,"Effect of exposure to the edge signal on oxidative stress in brain cell models. In this study we investigated the effect of the Enhanced Data rate for GSM Evolution (EDGE) signal on cells of three human brain cell lines, SH-SY5Y, U87 and CHME5, used as models of neurons, astrocytes and microglia, respectively, as well as on primary cortical neuron cultures. SXC-1800 waveguides (IT'IS-Foundation, Zurich, Switzerland) were modified for in vitro exposure to the EDGE signal radiofrequency (RF) radiation at 1800 MHz. Four exposure conditions were tested: 2 and 10 W/kg for 1 and 24 h. The production of reactive oxygen species (ROS) was measured by flow cytometry using the dichlorofluorescein diacetate (DCFH-DA) probe at the end of the 24-h exposure or 24 h after the 1-h exposure. Rotenone treatment was used as a positive control. All cells tested responded to rotenone treatment by increasing ROS production. These findings indicate that exposure to the EDGE signal does not induce oxidative stress under these test conditions, including 10 W/kg. Our results are in agreement with earlier findings that RF radiation alone does not increase ROS production.",Excluded
2818,"Sex-dependent differences in the activity and modulation of N-methyl-d-aspartic acid receptors in rat dorsal root ganglia neurons. Women have greater temporal summation of experimental pain stimuli and also have a higher propensity for developing chronic visceral pain conditions. Sex hormone-mediated regulation of N-methyl-d-aspartic acid receptors (NMDARs) in nociceptive pathways is a plausible mechanism that may underlie these phenomena. The aim of this study was to compare the effect of 17-beta-estradiol (E2) in modulation of NMDAR activity in adult male and female rat dorsal root ganglia (DRG) neurons. DRG neurons were collected from adult male or female rats and grown in short-term culture in steroid-free media. NMDAR currents were recorded on small to medium size neurons by whole cell patch clamp using rapid perfusion with saturating concentrations of N-methyl-d-aspartic acid and glycine in the absence of extracellular Mg(2+). We found that the average density of NMDAR currents was 2.8-fold larger in DRG neurons from female rats compared with male rats (P<0.0001). Addition of 100 nM E2 increased NMDAR currents 55+/-15% in female neurons, but only 19+/-7% in male neurons. Potentiation was maximal after 20-40 min and dose dependent with an apparent 50% excitatory concentration of 17-23 nM. This effect was mimicked by E2 conjugated to BSA and attenuated by pretreatment with the protein tyrosine kinase inhibitor lavendustin A (1 microM) or the estrogen receptor (ER) antagonist, ICI 182,780 (1 microM), strongly suggesting activation of a cell surface ER acting through a non-genomic mechanism involving protein tyrosine kinases to increase NMDAR currents. These results identify sex-based differences in both the basal expression and the regulation of the NMDARs in DRG neurons.",Excluded
3045,"The white 'matter' in obsessive compulsive disorder: Effect of pharmacological treatment and symptom dimensions models. Background: Obsessive-Compulsive Disorder (OCD) is highly heterogeneous in its manifestations, both across patients and within the same patient over time. The disorder is probably best described by a multidimensional model involving several symptom dimensions, whose precise number and phenotypes are debated. This heterogeneity partly explains, beyond methodological discrepancies, the inconsistency of results in current brain imaging research in the disorder, particularly in diffusion tensor imaging studies. Purpose(s): We aimed at investigating white matter (WM) alterations associated with OCD, controlling for the impact of variables known to affect WM structure, and specifically for the effect of current and lifetime pharmacological treatment. Then, we tested two different symptom dimensions models [1,2] within OCD patients, analysing theirWMcorrelates, for both prevailing current symptom dimension and symptom dimension at onset. Method(s): We compared 58 adult pure-OCD patients and 58 age- and gender-matched healthy controls (HC), with Tract-Based Spatial Statistics on diffusion tensor images, using TFCE correction (p = 0.05). With respect to symptom dimensions, separate analyses were carried on the sole OCD sample. The diffusion measures Fractional Anisotropy (FA), Axial Diffusivity (AD), Radial Diffusivity (RD) and Mean Diffusivity (MD) were used as parameters of WM organisation. Result(s): The observed differences between OCD patients and HC were totally carried by the effect of previous and current medications. No differences were in fact observed between drugna ive patients and HC. Current medication was associated with a widespread decrease of FA and increase of RD throughout the whole brain. Lifetime treatment was associated with a decrease in FA in the tracts surrounding the thalami, site of major neurotransmitter alteration in OCD. In the analysis of symptom dimensions, only a finer-grained five-factors model [2] allowed for the identification of specific neural correlates. Patients having current Symmetry/Perfectionism dimension show a reduction in RD and MD in the body of corpus callosum and in left higher-order visual association tracts, including: left uncinate fasciculus, left inferior longitudinal fasciculus and/or inferior fronto-occipital fasciculus, and left superior longitudinal fasciculus. Furthermore, patients having Doubt/Checking dimension at onset show a widespread reduction of AD, encompassing corpus callosum, and bilaterally the thalamic radiations, internal capsule, cingulum, corona radiata and inferior longitudinal fasciculus. Finally, patients having Rituals/Superstition dimension at onset show an increase in FA in the cortico-striato-thalamic circuits: genu of corpus callosum, bilateral posterior limb of the internal capsule, bilateral anterior thalamic radiations and left external capsule. Conclusion(s): Present results confirm the effect of medications on WM in OCD [3], showing a large effect of current treatment on myelination and a site-specific, disorder-specific, effect of medications on brain systems. Furthermore, our findings provide support to a multidimensional model of OCD, and indicate that the distinction of clinically homogeneous dimensions is essential for the identification of reliable neural correlates. Finally, we evidence, to our knowledge for the first time, that onset symptom dimensions are associated with enduring alterations of WM structure. Onset symptom dimensions may reflect underlying endophenotypes, and our results suggest their relevance for future investigations on OCD neuroanatomy and aetiopathology.",Excluded
3546,"Cranial CT with adaptive statistical iterative reconstruction: Improved image quality with concomitant radiation dose reduction. BACKGROUND AND PURPOSE: To safeguard patient health, there is great interest in CT radiation-dose reduction. The purpose of this study was to evaluate the impact of an iterative-reconstruction algorithm, ASIR, on image-quality measures in reduced-dose head CT scans for adult patients. MATERIALS AND METHODS: Using a 64-section scanner, we analyzed 100 reduced-dose adult head CT scans at 6 predefined levels of ASIR blended with FBP reconstruction. These scans were compared with 50 CT scans previously obtained at a higher routine dose without ASIR reconstruction. SNR and CNR were computed from Hounsfield unit measurements of normal GM and WM of brain parenchyma. A blinded qualitative analysis was performed in 10 lower-dose CT datasets compared with higher-dose ones without ASIR. Phantom data analysis was also performed. RESULT(S): Lower-dose scans without ASIR had significantly lower mean GM and WM SNR (P = .003) and similar GM-WM CNR values compared with higher routine-dose scans. However, at ASIR levels of 20%-40%, there was no statistically significant difference in SNR, and at ASIR levels of >=60%, the SNR values of the reduced-dose scans were significantly higher (P < .01). CNR values were also significantly higher at ASIR levels of >=40% (P < .01). Blinded qualitative review demonstrated significant improvements in perceived image noise, artifacts, and GM-WM differentiation at ASIR levels >=60% (P < .01). CONCLUSION(S): These results demonstrate that the use of ASIR in adult head CT scans reduces image noise and increases low-contrast resolution, while allowing lower radiation doses without affecting spatial resolution.",Excluded
2532,"Delayed occurrence of ectopic ACTH syndrome (EAS) 5 years after the diagnosis of a neuroendocrine carcinoma. Background: Ectopic ACTH syndrome (EAS) in patients with neuroendocrine carcinoma (NEC) is characterized by increased mortality, however early detection and treatment of EAS may improve survival. In rare cases, EAS can arise >3 months after NEC diagnosis (metachronously). Elevations in plasma levels of the ACTH precursor proopiomelanocortin (POMC) and/or agouti-related peptide (AgRP) have been associated with EAS. Clinical Case: A 61-year-old woman with a 5-year history of a poorly-differentiated lung neuroendocrine carcinoma with widely-disseminated metastases, treated with chemotherapy and radiation, was admitted for new-onset hypokalemia, 2 weeks after the initiation of hydrochlorothiazide (HCTZ) for lower extremity edema. Despite discontinuation of HCTZ, hypokalemia persisted and 120-200 meq of potassium chloride daily were required to maintain normal potassium levels. Proximal muscle weakness and hyperglycemia were noted. Morning cortisol and ACTH levels were 48 mcg/dL (nl 4.8-19.5mcg/dL) and 141pg/mL (nl 6-58 pg/mL) respectively, compared to a morning cortisol and ACTH of 9.3mcg/dL and 19pg/mL 5 years prior, at the time of NEC diagnosis. Serum cortisol was 61mcg/dL after an overnight 1mg dexamethasone suppression test and urinary free cortisol was 7544mcg/24h (nl<45mcg/24h), confirming the diagnosis of Cushing's syndrome. Plasma POMC and AgRP were measured and were 80 fmol/mL (nl <45 fmol/mL) and 884 pg/mL (nl<280 pg/mL), respectively, supporting a diagnosis of EAS. Potassium levels normalized following spironolactone treatment. Metyrapone therapy was initiated, but hypercortisolism persisted and the patient succumbed to multifocal pneumonia 4 weeks after presentation. Postmortem examination showed an absence of ACTH immunoreactivity in metastatic tumor tissue obtained at the time of diagnosis of NEC, as well as in the tissues biopsied 3 years later (subcarinal lymph node, liver). However, sites of tumor metastases (subcutaneous shoulder mass, ovary) sampled 4 or more years after NEC diagnosis showed focal staining for ACTH, consistent with EAS arising years after the development of NEC. Conclusion(s): This case highlights the rare occurrence of ectopic metachronous ACTH secretion occurring in a NEC. The observed elevations in plasma POMC likely reflect aberrant tumoral processing of POMC to ACTH. While glucocorticoids may modulate the synthesis and release of AgRP, the magnitude of the elevation in plasma AgRP in this case supports the possibility of a concomitant tumoral AgRP source. The elevations in plasma POMC and AgRP in EAS associated with NEC in this case underscore the potential utility of these neuropeptides as tumor markers that could improve clinical monitoring for EAS and facilitate more timely interventions to optimize survival.",Excluded
3227,"Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry. The alpha-emitter astatine-211 (T<inf>1/2</inf> = 7.2 h) has great potential for use in targeted radionuclide therapy. Its potent alpha-radiation makes <sup>211</sup>At unsuitable for dose planning. Its x-rays can be used for gammacamera monitoring of the radioactivity distribution during therapy but not for accurate estimation of absorbed dose in critical organs. This study was intended to establish whether the absorbed dose delivered by astatinated antibody could be accurately determined by analogue labeling with radiohalogens, better suited for quantitative measurements in vivo. PET facilitates quantitative pharmacokinetics; possible halogen labels are, e.g., <sup>76</sup>Br (T<inf>1/2</inf> = 16.2 h) and <sup>124</sup>I (T<inf>1/2</inf> = 4.18 d). Antibody A33 was labeled with <sup>76</sup>Br, <sup>125</sup>I and <sup>211</sup>At using N-succinimidyl-p-halobenzoates. The conjugates were co-injected into Sprague-Dawley rats. Radioactivity concentrations in different organs and tissues were measured at three time points. Pharmacokinetic data were used to calculate absorbed doses. <sup>125</sup>I and <sup>76</sup>Br reflected the biokinetics of astatine reasonably well. The absorbed doses in bladder, kidney, pancreas, liver, bone and brain were determined with 10% accuracy. The absorbed doses in stomach, spleen and thyroid were underestimated by a factor 2-3. Positron-emitting analogues can be used to predict the astatine-derived dose in critical organs. Correction factors should be used for stomach, spleen and thyroid.",Excluded
2790,"Control of DNA repair linked to neuroblastoma differentiation. Mouse neuroblastoma cells, which can be induced to undergo reversible differentiation in culture, have been used as a model to investigate the effects of ultra-violet (U.V.) radiation on terminally-differentiated nerve cells. Differentiated neuroblastoma cells were found to be extremely sensitive to U.V.-radiation when compared with proliferating cells from the same clone. However, normal resistance was regained if the differentiated cells were allowed to proceed to the next G1 phase of the cell-cycle before irradiation. Neuroblastoma cells in the differentiated mode are capable of carrying out soem excision repair of DNA damage, but they appear to lack a repair mechanism present in proliferating cells.",Excluded
2810,A 26-year-old female with a millimetric prepontine lesion,Excluded
3608,"Computerized tomography. [French]. Computerized tomography is a valuable tool in carrying out treaments using ionizing irradiation. It determines the contour of the patient with exactitude. Within this contour it situates, respectively, the tumor which is to be irradiated and the healthy adjacent organs which are to be preserved. The study of the distribution of the doses delivered is improved, all the more so as it takes into account the variations in density of tissues it passes through which modifies the absorption of rayons. Computerized tomography linked to computerized dosimetric study permits the establishment of more precise plans of irradiation perfectly suited to each patient.",Excluded
3613,"Effects of Preoperative Simulation on Minimally Invasive Hybrid Lumbar Interbody Fusion. OBJECTIVE: The main focus of this study was to evaluate how preoperative simulation affects the surgical work flow, radiation exposure, and outcome of minimally invasive hybrid lumbar interbody fusion (MIS-HLIF).METHODS: A total of 132 patients who underwent single-level MIS-HLIF were enrolled in a cohort study design. Dose area product was analyzed in addition to surgical data. Once preoperative simulation was established, 66 cases (SIM cohort) were compared with 66 patients who had previously undergone MIS-HLIF without preoperative simulation (NO-SIM cohort).RESULTS: Dose area product was reduced considerably in the SIM cohort (320 cGy.cm<sup>2</sup> NO-SIM cohort: 470 cGy.cm<sup>2</sup>; P < 0.01). Surgical time was shorter for the SIM cohort (155 minutes; NO-SIM cohort, 182 minutes; P < 0.05). SIM cohort had a better outcome in Numeric Rating Scale back at 6 months follow-up compared with the NO-SIM cohort (P < 0.05).CONCLUSIONS: Preoperative simulation reduced radiation exposure and resulted in less back pain at the 6 months follow-up time point. Preoperative simulation provided guidance in determining the correct cage height. Outcome controls enabled the surgeon to improve the procedure and the software algorithm.",Excluded
3392,"Large cell neuro-endocrine carcinoma presenting as pancoast's syndrome. Pancoast's syndrome was first described in 1932 by Henry Pancoast as signs and symptoms of shoulder and arm pain, Horner's Syndrome, bone destruction and atrophy of hand muscles. While apical bronchial carcinoma commonly presents as Pancoast's syndrome, infection, benign tumors, and metastases should be considered. Thus, histopathological diagnosis is mandatory. Tumors of neural origin are rarely located at the thoracic inlet. We present a rare pathological tumor of Large Cell Neuroendocrine Carcinoma (LCNEC) presenting as typical Pancoast's Syndrome. A 70-year-old man with lifelong smoking history presented with progressive pain in his left shoulder and armpit for 6 months. His other complaints were blurry vision in the left eye, hoarse voice, weight loss and decreased appetite. Examination was significant for decreased breath sounds, left sided shoulder tenderness, ptosis, small pupil with enopthalmos, and atrophy of the hypothenar muscles and decreased sensation on the ulnar distribution of the hand and forearm with decreased motor strength and handgrip. Imaging studies revealed left apical lung mass and a mediastinal mass abutting the aortic arch with lymph node involvement. MRI of brain and spine showed involvement of subarachnoid space with left and right paravertebral masses. A biopsy of the mass revealed tumor cells positive for CK7, TTF-1, synaptophysin and chromogranin. It was negative for Napsin A, CD56, markers of squamous differentiation p63 and p40. This immunoprofile is compatible with Large Cell Neuroendocrine Carcinoma. The patient was started on radiation therapy and was scheduled for chemotherapy as an outpatient. Neuroendocrine tumors are rare and can occur anywhere in the body. Currently, LCNEC is classified a variant of large cell carcinomas; however, it is different from typical lung large-cell carcinoma in that these tumors display biological behaviors resembling those of small cell lung carcinoma and features of high-grade neuroendocrine tumors. LCNEC represent only 3% of all pulmonary malignancies. The current treatment approach, which has remained unchanged for the past 30 years, involves combination of platinum based chemotherapy and radiation, however outcome remains poor. No targeted therapy exists for these tumors because therapeutic biomarkers are incompletely known. Thus, advances in the treatment of LCNEC are needed to improve survival in patients with this class of tumors. The discovery of new, rational targeted therapies as well as preclinical models that will encompass this important subtype of lung cancer is necessary. To our knowledge this is the first reported case of Pancoast's syndrome caused by a LCNEC. (Figure Presented).",Excluded
3329,"Retinal damage experimentally induced by microwave radiation at 55 mW/cm2. The action of 550 W/m2 (mean) 3100 MHz pulsed radiation on the rabbit retina in vivo was investigated by fundus photography, blood-retinal barrier tracers, light and electron microscopy, either after a single 1--1.5 h exposure or after a series of repeated 1 h exposures for up to 53 h during about 100 days. The electron microscopic investigation of the repeatedly exposed retinas revealed degenerative changes in the retinal neurons. The neurons appeared depleted of their cytoplasmic constituents and often contained phago-lysosomal structures with myelin bodies. There were many degenerating synaptic boutons. The glial cells displayed reactive changes. These ultrastructural changes could not be demonstrated by the other methods used. A single microwave exposure, followed by an induced 70--100% blood-pressure increase, did not enhance blood-retina barrier permeability to tracers. There was no evidence of blood brain barrier leakage. These studies show that the rabbit eye can be affected by microwave radiation at intensities lower than previously reported.",Excluded
3470,"The effect of a 50 Hz magnetic field on cognitive function in humans. OBJECTIVES: To examine whether the power frequency magnetic field of 0.6mT applied to humans has an effect on cognitive function as has been suggested by animal studies. These fields are less than the suggested intervention level in the UK of 1.6mT and are similar to those found close to some domestic appliances.METHOD AND MATERIALS: A randomized three-way cross-over design using a battery of computerized cognitive function tests were used in the presence or absence of a 50Hz or static magnetic field. Sixteen healthy volunteers undertook two training and three test sessions with a 50Hz or static 0.6 mT magnetic field from a set of coils centred on the head.RESULTS: In response to the 50 Hz field, disruptions of accuracy were seen from an attentional task (the ability to correctly recognize words shown 20min previously and the ability to maintain a string of digits in working memory). There was no similar response to comparable levels of static magnetic field.CONCLUSIONS: These tests indicated at least temporary deterioration in attention, and working and secondary memory performance while a 50 Hz field is applied. There were no adverse effects on speed from any of the tasks. It was not possible in this study to be sure if these effects were persistent.",Excluded
3265,"Time resolved dosimetry of human brain exposed to low frequency pulsed magnetic fields. An accurate dosimetry is a key issue to understanding brain stimulation and related interaction mechanisms with neuronal tissues at the basis of the increasing amount of literature revealing the effects on human brain induced by low-level, low frequency pulsed magnetic fields (PMFs). Most literature on brain dosimetry estimates the maximum E field value reached inside the tissue without considering its time pattern or tissue dispersivity. Nevertheless a time-resolved dosimetry, accounting for dispersive tissues behavior, becomes necessary considering that the threshold for an effect onset may vary depending on the pulse waveform and that tissues may filter the applied stimulatory fields altering the predicted stimulatory waveform's size and shape. In this paper a time-resolved dosimetry has been applied on a realistic brain model exposed to the signal presented in Capone et al (2009 J. Neural Transm. 116 257-65), accounting for the broadband dispersivity of brain tissues up to several kHz, to accurately reconstruct electric field and current density waveforms inside different brain tissues. The results obtained by exposing the Duke's brain model to this PMF signal show that the E peak in the brain is considerably underestimated if a simple monochromatic dosimetry is carried out at the pulse repetition frequency of 75 Hz.",Excluded
2863,"Palliative radiation for spinal metastases: Does the presence of soft tissue disease affect the choice of treatment dose and fractionation?. Purpose/Objective(s): Spinal bone metastases associated with soft tissue disease (ST) are frequently considered at higher risk of developing further complications such as neuropathic pain and cord compression. The objectives of our study were to describe the prevalence of ST in patients presenting for spine radiation therapy (XRT), and whether presence of soft tissue disease is associated with a difference in treatment approach compared with those whose do not (nST). Materials/Methods: We retrospectively reviewed records of all consecutive patients receiving spine XRT within our palliative radiation program during 2012. Patient demographics, symptoms intensity, performance status and life expectancy were captured at the time of consultation. Diagnostic imaging including CT +/- MRI as well as planning CT relevant to the course of treatment were reviewed to document whether ST, cord compression (CC) or compression fracture (CF) was present at the levels being irradiated. Whether a field based or volume based approach was employed by the radiation oncologist to define the treatment plan was recorded. Binary logistic regression was used for inferences, using the generalized estimating equation approach to adjust the standard error to account for the correlation of observations within a patient. Result(s): One hundred fifty patients receiving 177 treatments were reviewed. This included 19 patients receiving simultaneous treatment to 2 separate sites and 4 patients receiving treatment to 3 sites. The mean age was 64 years. 71% (106/150) of patients in both groups were estimated to have a life expectancy of over 6 months. Fifty-five percent of treatments given were in the lumbosacral area. Nocomplicating radiological features (i.e., noST, CC, CF) was present in 89/177 (50%) of cases. ST was present in 50/177 cases [28% [95% CI 25-32%)]. Of these,32%(16/50) also had aCCand 32%(16/50) had aCF. There were no significant difference between the two groups in terms of age, sex distribution and source of primary. The proportion of patients with severe pain (>5 on a scale of 0-10) was 46% ST and 60% nST (p = 0.82). Volume based planning was employed for 58% ST and 48% nST. Fractionated treatments (mostly 20 Gy/ 5 fractions) were employed in 84% ST and 66% nST of cases. After adjustment for CC and CF, there was a trend to suggest physicians were more likely to prescribe fractionated treatments in cases with ST (p =0.16). Conclusion(s): Fifty percent of treatment courses delivered to spine were associated with some complicating radiological features including ST, SC or CF. ST was present in 28% cases. We were unable to identify any clinical features that would predict for the presence of ST disease. There is a trend that physicians were more likely to prescribe fractionated radiation therapy when ST was present.",Excluded
3108,"Effect of whole body hyperthermia and BCNU on the development of radiation myelitis in the rat. A radiant heat device was used to study the interaction of 41.8degreeC whole body hyperthermia (WBH), radiation (40 Gy) and the lipophilic anti-neoplastic agent BCNU in the development of myelitis in the rat spinal cord. The addition of WBH and BCNU neither precipitated myelitis acutely nor shortened the latency before the onset of neurological signs in irradiated animals.",Included
3452,"Indirect measurement of mitochondrial proton leak and its application. In mitochondria, ATP synthesis is coupled to oxygen consumption by the proton electrochemical gradient established across the mitochondrial inner membrane in a process termed oxidative phosphorylation. It has long been known from stoichiometric studies that ATP synthesis is not perfectly coupled to oxygen consumption. The major inefficiency in the system is leakage of protons across the mitochondrial inner membrane driven by the proton electrochemical gradient. The kinetics of the proton leak can be determined indirectly, by measuring the oxygen consumption of mitochondria under non-phosphorylating conditions (plus oligomycin) as a function of the proton electrochemical gradient. This experimental system provides a convenient means to investigate inner membrane permeability to protons and the effect of factors that may effect that permeability. In this paper we review some results from our laboratory of indirect measurement of mitochondrial proton leak and how it has been applied to investigate the effect of aging, obesity and thyroid status on proton leak. The results show that (i) proton leak in isolated liver mitochondria is not significantly different in a comparison of young and old rats, in contrast (ii) there is an apparent increase in proton leak in in situ mitochondria in hepatocytes from old rats when compared to those from young rats, (iii) proton leak in neuronal mitochondria in situ in synaptosomes is not significantly different in young and old rats, (iv) proton leak is greater in isolated liver mitochondria from ob/ob mice compared to lean controls, (v) acute leptin (OB protein) administration restores the increased leak rate in isolated liver mitochondria from ob/ob mice to that of lean controls, (vi) administration of thyroid hormone (T3) increases proton leak in rat muscle mitochondria, and (vii) proton leak in muscle mitochondria is insensitive to the presence of GDP. It is proposed that the experimental system described here for measuring proton leak, is an ideal functional assay for determining whether the novel uncoupling proteins increase inner membrane permeability to protons.",Excluded
2795,Cobalt 60 bean therapy: post-radiation effects in breast cancer patients,Included
3162,[A new technic of transnasal hypophysis removal with Y90],Included
2438,"CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP<sup>5</sup>. Although radiation therapy can be effective against cancer, potential damage to normal tissues limits the amount that can be safely administered. In central nervous system (CNS), radiation damage to normal tissues is presented, in part, as suppressed hippocampal neurogenesis and impaired cognitive functions. Mn porphyrin (MnP)-based redox active drugs have demonstrated differential effects on cancer and normal tissues in experimental animals that lead to protection of normal tissues and radio- and chemo-sensitization of cancers. To test the efficacy of MnPs in CNS radioprotection, we first examined the tissue levels of three different MnPs - MnTE-2-PyP<sup>5+</sup>(MnE), MnTnHex-2-PyP<sup>5+</sup>(MnHex), and MnTnBuOE-2-PyP<sup>5+</sup>(MnBuOE). Nanomolar concentrations of MnHex and MnBuOE were detected in various brain regions after daily subcutaneous administration, and MnBuOE was well tolerated at a daily dose of 3mg/kg. Administration of MnBuOE for one week before cranial irradiation and continued for one week afterwards supported production and long-term survival of newborn neurons in the hippocampal dentate gyrus. MnP-driven S-glutathionylation in cortex and hippocampus showed differential responses to MnP administration and radiation in these two brain regions. A better understanding of how preserved hippocampal neurogenesis correlates with cognitive functions following cranial irradiation will be helpful in designing better MnP-based radioprotection strategies.",Excluded
2828,"Structural analysis of the alpha N-terminal region of erythroid and nonerythroid spectrins by small-angle X-ray scattering. We used SpalphaI-1-156 peptide, a well-characterized model peptide of the alphaN-terminal region of erythrocyte spectrin, and SpalphaII-1-149, an alphaII brain spectrin model peptide similar in sequence to SpalphaI-1-156, to study their association affinities with a betaI-spectrin peptide, SpbetaI-1898-2083, by isothermal titration calorimetry. We also determined their conformational flexibilities in solution by small-angle X-ray scattering (SAXS) methods. These two peptides exhibit sequence homology and could be expected to exhibit similar association affinities with beta-spectrin. However, our studies show that the affinity of SpalphaII-1-149 with SpbetaI-1898-2083 is much higher than that of SpalphaI-1-156. Our SAXS findings also indicate a significantly more extended conformation for SpalphaII-1-149 than for SpalphaI-1-156. The radius of gyration values obtained by two different analyses of SAXS data and by molecular modeling all show a value of about 25 A for SpalphaI-1-156 and of about 30 A for SpalphaII-1-149, despite the fact that SpalphaI-1-156 has seven amino acid residues more than SpalphaII-1-149. For SpalphaI-1-156, the SAXS results are consistent with a flexible junction between helix C' and the triple helical bundle that allows multiple orientations between these two structural elements, in good agreement with our published NMR analysis. The SAXS findings for SpalphaII-1-149 support the hypothesis that this junction region is rigid (and probably helical) for alphaII brain spectrin. The nature of the junction region, from one extreme as a random coil (conformationally mobile) segment in alphaI to another extreme as a rigid segment in alphaII, determines the orientation of helix C' relative to the first structural domain. We suggest that this particular junction region in alpha-spectrin plays a major role in modulating its association affinity with beta-spectrins, and thus regulates spectrin tetramer levels. We also note that these are the first conformational studies of brain spectrin.",Excluded
3461,"A new technique of ""double-A"" bilateral flaps based on perforators for the treatment of sacral defects. BACKGROUND: Myocutaneous and fasciocutaneous flaps can provide stable coverage of sacral defects. For neurologically intact patients, sensate innervated gluteal artery perforator flaps are the ideal solution. For patients with spinal cord injury, soft-tissue coverage can be performed with a variety of noninnervated flaps. METHOD(S): Between 1997 and 2004, the authors operated on 30 patients, 21 men and nine women, using bilateral gluteal distal fasciocutaneous and proximal musculocutaneous vertical vector rotation-advancement flaps, based on perforators with V-Y closures. The ages of the patients ranged from 32 to 74 years. Twenty-five patients had spinal cord injuries and all had sacral pressure sores extending to the bone. Three patients had low-grade malignant tumors (sacral chordomas); one had a sacral radiation-induced necrosis and two senile patients with large sacral defects had chronic renal failure and multiple sclerosis. No comorbidities were found in the sample. RESULT(S): All the lesions were closed successfully. After follow-up of 1 to 8 years, 27 patients never required repeated surgery after wound complications. Three patients had infection and partial dehiscence of the flaps that healed after reoperation with V-Y readvancement; three died as a result of their primary diseases. CONCLUSION(S): This flap design has been used only in selected cases because, after its elevation, use of other gluteal-based flaps for future sacral reconstructions may not be possible. Five neurologically intact patients were found to have good sensitive protection of the flaps and adequate cushion contour after surgery because the authors conserved the gluteal arteries, perforators, and their corresponding sensory nerves. Â©2007American Society of Plastic Surgeons.",Excluded
3577,"810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice. We explored whether 810nm near-infrared light (NIr) offered neuroprotection and/or improvement in locomotor activity in an acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse model of Parkinson's disease. Mice received MPTP and 810nm NIr treatments, or not, and were tested for locomotive activity in an open-field test. Thereafter, brains were aldehyde-fixed and processed for tyrosine hydroxylase immunohistochemistry. Our results showed that MPTP-treated mice that were irradiated with 810nm NIr had both greater locomotor activity (~40%) and number of dopaminergic cells (~20%) than those that were not. In summary, 810nm (as with 670nm) NIr offered neuroprotection and improved locomotor activity in MPTP-treated mice.",Excluded
3520,"Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events. With continuing improvements in spatial resolution of positron emission tomography (PET) scanners, small patient movements during PET imaging become a significant source of resolution degradation. This work develops and investigates a comprehensive formalism for accurate motion-compensated reconstruction which at the same time is very feasible in the context of high-resolution PET. In particular, this paper proposes an effective method to incorporate presence of scattered and random coincidences in the context of motion (which is similarly applicable to various other motion correction schemes). The overall reconstruction framework takes into consideration missing projection data which are not detected due to motion, and additionally, incorporates information from all detected events, including those which fall outside the field-of-view following motion correction. The proposed approach has been extensively validated using phantom experiments as well as realistic simulations of a new mathematical brain phantom developed in this work, and the results for a dynamic patient study are also presented.",Excluded
3158,Cell phones & brain cancer. No clear connection,Excluded
2776,"Incidental retinal phototoxicity associated with ingestion of photosensitizing drugs. BACKGROUND: to report on the possible correlation between incident retinal phototoxicity and the use of photosensitizing drugs.METHODS: four patients were examined because of scotomas and visual loss after an incidental exposure to a strong light source. One patient (two eyes) was exposed to standard camera flash; one patient (one eye) had a brief exposure to welding light; one patient (two eyes) underwent uncomplicated phacoemulsifications with intraocular lens implantation. The fourth patient had a severe retinal phototoxicity following a secondary intraocular lens implantation. All four patients underwent a thorough assessment including history of systemic drug use. These patients had ophthalmologic evaluation including: best corrected visual acuity (ETDRS charts), fundus examination, fluorescein and indocyanine green angiographies and were followed for 1 year.RESULTS: on presentation, the mean visual acuity was 7.5/20 (range: 20/400-20/20). Fundus examination disclosed yellow-gray sub-retinal lesions in all affected eyes. Early phase fluorescein angiography showed one or multiple hypofluorescent spots surrounded by a halo of hyperfluorescent window defect. In the late phase, some of these spots leaked the fluorescein dye. Indocyanine green angiography demonstrated hypofluorescent spots throughout with ill-defined borders of hyperfluorescence observed during the late stages. The common finding in these four patients was the fact that they were all taking one or more photosensitizing drugs (hydrochlorothiazide, furosemide, allopurinol, and benzodiazepines). Three of the patients had a full visual recovery a few months after the phototoxicity. The fourth patient remained with a visual acuity of 20/60 12 months after the light exposure. Despite the visual recovery, non-homogeneous retinal pigment epithelial disturbances persisted in all affected eyes.CONCLUSION: phototoxicity following incidental light exposure may occur in patients taking drugs of photosensitizing potential. Therefore, the thorough history of systemic drug ingestion should be obtained if patients have exposure to strong light sources.",Excluded
3464,Vitamin E induces morphological differentiation and increases the effect of ionizing radiation on neuroblastoma cells in culture,Included
2638,"Spatial learning and long-term potentiation of mutant mice lacking D-amino-acid oxidase. We evaluated the role of D-amino-acid oxidase on spatial learning and long-term potentiation (LTP) in the hippocampus, since this enzyme metabolizes D-amino-acids, some of which enhance the N-methyl-D-aspartate receptor functions. The Morris water maze learning and the LTP in the CA1 area of the hippocampal slice were observed in wild-type mice and mutant mice lacking D-amino-acid oxidase. The mutant mice showed significantly shorter platform search times in the water maze and significantly larger hippocampal LTPs than the wild-type mice. These results suggest that the abundant D-amino-acids in the mutant mouse brain facilitate hippocampal LTP and spatial learning.",Excluded
3102,"Uncertainty in assessment of radiation-induced diffusion index changes in individual patients. The purpose of this study is to evaluate repeatability coefficients of diffusion tensor indices to assess whether longitudinal changes in diffusion indices were true changes beyond the uncertainty for individual patients undergoing radiation therapy (RT). Twenty-two patients who had low-grade or benign tumors and were treated by partial brain radiation therapy (PBRT) participated in an IRB-approved MRI protocol. The diffusion tensor images in the patients were acquired pre-RT, week 3 during RT, at the end of RT, and 1, 6, and 18 months after RT. As a measure of uncertainty, repeatability coefficients (RC) of diffusion indices in the segmented cingulum, corpus callosum, and fornix were estimated by using test-retest diffusion tensor datasets from the National Biomedical Imaging Archive (NBIA) database. The upper and lower limits of the 95% confidence interval of the estimated RC from the test and retest data were used to evaluate whether the longitudinal percentage changes in diffusion indices in the segmented structures in the individual patients were beyond the uncertainty and thus could be considered as true radiation-induced changes. Diffusion indices in different white matter structures showed different uncertainty ranges. The estimated RC for fractional anisotropy (FA) ranged from 5.3% to 9.6%, for mean diffusivity (MD) from 2.2% to 6.8%, for axial diffusivity (AD) from 2.4% to 5.5%, and for radial diffusivity (RD) from 2.9% to 9.7%. Overall, 23% of the patients treated by RT had FA changes, 44% had MD changes, 50% had AD changes, and 50% had RD changes beyond the uncertainty ranges. In the fornix, 85.7% and 100% of the patients showed changes beyond the uncertainty range at 6 and 18 months after RT, demonstrating that radiation has a pronounced late effect on the fornix compared to other segmented structures. It is critical to determine reliability of a change observed in an individual patient for clinical decision making. Assessments of the repeatability and confidence interval of diffusion tensor measurements in white matter structures allow us to determine the true longitudinal change in individual patients.",Excluded
3301,"Computed tomography super-resolution using deep convolutional neural network. The objective of this study is to develop a convolutional neural network (CNN) for computed tomography (CT) image super-resolution. The network learns an end-to-end mapping between low (thick-slice thickness) and high (thin-slice thickness) resolution images using the modified U-Net. To verify the proposed method, we train and test the CNN using axially averaged data of existing thin-slice CT images as input and their middle slice as the label. Fifty-two CT studies are used as the CNN training set, and 13 CT studies are used as the test set. We perform five-fold cross-validation to confirm the performance consistency. Because all input and output images are used in two-dimensional slice format, the total number of slices for training the CNN is 7670. We assess the performance of the proposed method with respect to the resolution and contrast, as well as the noise properties. The CNN generates output images that are virtually equivalent to the ground truth. The most remarkable image-recovery improvement by the CNN is deblurring of boundaries of bone structures and air cavities. The CNN output yields an approximately 10% higher peak signal-to-noise ratio and lower normalized root mean square error than the input (thicker slices). The CNN output noise level is lower than the ground truth and equivalent to the iterative image reconstruction result. The proposed deep learning method is useful for both super-resolution and de-noising.",Excluded
2412,"Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis. The role of radiosurgery has become further accentuated in the era of targeted agents (TA). Thus, the neurologic outcome of radiosurgery in brain metastasis (BM) of non-small cell lung cancer (NSCLC) was reviewed. We analyzed 135 patients with BM of NSCLC who were administered Cyberknife radiosurgery (CKRS) as either initial or salvage therapy. We evaluated local failure (LF), intracranial failure (IF), and neurological death (ND) due to BM. Primary outcome was neurological death-free survival (NDFS). Median follow-up was 16.2 months. Median CKRS dose of 22 Gy was administered to median 2 targets per patient. Among 99 deaths, 14 (14%) were ND. Upfront treatment for BM included CKRS alone in 85 patients (63%), CKRS + TA in 26 patients (19%), and WBRT in 24 patients (18%). No patients or tumor related factors were associated with ND. However, the type of upfront treatment for BM was significantly associated with ND [HR 0.07 (95% CI 0.01-0.57) for CKRS + TA, HR 0.56 (95% CI 0.19-1.68) for CKRS alone] compared with the WBRT group (P = 0.01). The 2-year NDFS rates for the CKRS + TA, CRKS alone, and WBRT groups were 94%, 87%, and 78%, respectively (P = 0.03). Upfront CKRS showed significantly higher 2-year LF-free survival rate (P < 0.01). IF rate was insignificantly lower in the WBRT group compared with CKRS group (P = 0.38). Upfront CKRS + TA was associated with the best neurological outcome with high NDFS. Active brain control by early delivery of radiosurgery could achieve better neurological outcome in NSCLC with BM.",Excluded
3300,"Deep cerebral invasion by basal cell carcinoma of the scalp. We report recurrent basal cell carcinoma of the scalp with deep cerebral invasion in an 82-year-old man. Plain films and CT showed extensive, full thickness, skull destruction at the vertex. Gadolinium-enhanced MRI revealed neoplastic invasion of the meninges and left cerebral hemisphere, down to the lateral ventricle. We postulate that tumour extended into the brain along perivascular spaces of transcerebral vessels. This hypothesis is supported by the cleft-like contrast enhancement on MRI.",Excluded
2397,"Machine Friendly Machine Learning: Interpretation of Computed Tomography Without Image Reconstruction. Recent advancements in deep learning for automated image processing and classification have accelerated many new applications for medical image analysis. However, most deep learning algorithms have been developed using reconstructed, human-interpretable medical images. While image reconstruction from raw sensor data is required for the creation of medical images, the reconstruction process only uses a partial representation of all the data acquired. Here, we report the development of a system to directly process raw computed tomography (CT) data in sinogram-space, bypassing the intermediary step of image reconstruction. Two classification tasks were evaluated for their feasibility of sinogram-space machine learning: body region identification and intracranial hemorrhage (ICH) detection. Our proposed SinoNet, a convolutional neural network optimized for interpreting sinograms, performed favorably compared to conventional reconstructed image-space-based systems for both tasks, regardless of scanning geometries in terms of projections or detectors. Further, SinoNet performed significantly better when using sparsely sampled sinograms than conventional networks operating in image-space. As a result, sinogram-space algorithms could be used in field settings for triage (presence of ICH), especially where low radiation dose is desired. These findings also demonstrate another strength of deep learning where it can analyze and interpret sinograms that are virtually impossible for human experts.",Excluded
2558,"The damage of the neural retina and of the retinal pigment epithelium of eyes of rats exposed to highly intensive visible light under alloxanic diabetes. [Russian]. The experiments on white mongrel rats showed that the light with the intensity of 6000 1x lasting for 6 hours resulted the destruction of the retinal pigment epithelium, of the internal and the external neurosensory cellular processes with subsequent nuclei piknosis and radial glia replacement. On the 7th day after exposure to light focal effusion of the retina corresponding layers. Under the irradiation in diabetes the amount of cells with karyopyknosis increases in 1.6 times in comparision with the findings in case free of diabetes. Was found, that the alloxanic diabetes in its early stage increases the light impairment of the neurosensory cells of the retina.",Excluded
2895,"Effects of electrode-to-fiber distance on temporal neural response with electrical stimulation. This paper presents an analysis of the effects of the electrode-to-fiber distance on the temporal response properties of an auditory nerve fiber stimulated by electric current pulses. This analysis was based upon results from a computational model of a mammalian auditory nerve fiber axon having 50 nodes of Ranvier, each consisting of 130 stochastic sodium channels and 50 stochastic potassium channels, making it possible to represent the temporal fluctuations of action potential initiation and conduction. A monopolar stimulus electrode was located above a central (26th) node at electrode-to-fiber distances of 1, 4, and 7 mm, while the recording electrode was located at the 36th node. Action potentials (spikes) were generated by the biophysical model using the Crank-Nicholson method to solve a diffusive partial differential equation. By observing the occurrence times of spikes in response to 2000 cathodic monophasic stimulus pulses, temporal jitter (i.e., the standard deviation of spike times) was calculated and the poststimulus time (PST) histogram was generated as well. Furthermore, by computing the PST histogram for each initiation node as functions of space (node number) and time (PST), it was shown that spike initiation was distributed not only spatially but also temporally for stimulus levels producing firing efficiencies (FEs) near 0.5. However, at levels producing FEs near 0.99, while temporal variations approached zero, the spatial distribution of initiating nodes was comparable to that observed for the FE near 0.5. As temporal fluctuations are important for speech coding in cochlear implants, we conclude that spatial characteristics of the electrode-auditory nerve fiber interface may play a significant role in influencing these stochastic temporal processes.",Excluded
3550,"Anti-apoptotic and antioxidant effects of low dose gamma irradiation against diabetes-induced brain injury in rats. The current study aimed to investigate the effect of different low doses of gamma irradiation on hyperglycemia-induced brain injury. The aim was further extended to investigate the sub-chronic effect of low dose radiation on the neuronal damage induced by diabetes. To induce diabetes, male albino rats were injected with dexamethasone (10 mg/kg/day, for 9 successive days, subcutaneously). Different diabetic groups were irradiated with 0.1, 0.25 and 0.5 Gy. The effect of low dose gamma irradiation on the hyperglycemia-induced brain damage based was analyzed at two levels: oxidative stress and apoptosis. The brain contents of glutathione, malondialdhyde and total nitrate/nitrite were measured to assess the oxidative stress. In order to evaluate the extent of the apoptotic changes in brain, tissue caspase-3 expression was detected using immunohistochemistry and the degree of DNA fragmentation was estimated. Moreover, brain tissues were examined using light microscopy to evaluate the histological changes in different groups and serum lactate dehydrogenase activity was determined as an indicator for the brain tissue damage. Results indicated that exposure to 0.5 Gy ameliorated the hyperglycemia and subsequently inhibited oxidative stress and apoptosis. Radiation exposure at this dose level also increased the survival rate of diabetic animals.",Excluded
3197,"Proliferation and cell death of human glioblastoma cells after carbon-ion beam exposure: Morphologic and morphometric analyses. Histological analyses of glioblastoma cells after carbon-ion exposure are still limited and ultrastructural characteristics have not been investigated in detail. Here we report the results of morphological and morphometric analyses of a human glioblastoma cell line, CGNH-89, after ionizing radiation to characterize the effect of a carbon-beam on glioblastoma cells. Using CGNH-89 cells exposed to 0-10 Gy of X-ray (140 kVp) or carbon-ions (18.3 MeV/nucleon, LET = 108 keV/mum), we performed conventional histology and immunocytochemistry with MIB-1 antibody, transmission electron microscopy, and computer-assisted, nuclear size measurements. CGNH-89 cells with a G to A transition in codon 280 in exon 8 of the TP53 gene had nuclei with pleomorphism, marked nuclear atypia and brisk mitotic activity. After carbon-ion and X-ray exposure, living cells showed decreased cell number, nuclear condensation, increased atypical mitotic figures, and a tendency of cytoplasmic enlargement at the level of light microscopy. The deviation of the nuclear area size increased during 48 h after irradiation, while the small cell fraction increased in 336 h. In glioblastoma cells of the control, 5 Gy carbon-beam, and 10 Gy carbon-beam, and MIB-1 labeling index decreased in 24 h (12%, 11%, 7%, respectively) but increased in 48 h (10%, 20%, 21%, respectively). Ultrastructurally, cellular enlargement seemed to depend on vacuolation, swelling of mitochondria, and increase of cellular organelles, such as the cytoskeleton and secondary lysosome. We could not observe apoptotic bodies in the CGNH-89 cells under any conditions. We conclude that carbon-ion irradiation induced cell death and senescence in a glioblastoma cell line with mutant TP53. Our results indicated that the increase of large cells with enlarged and bizarre nuclei, swollen mitochondria, and secondary lysosome occurred in glioblastoma cells after carbon-beam exposure. Â© 2008 Japanese Society of Neuropathology.",Excluded
3363,"Simulation of pulsed ELF magnetic fields generated by GSM mobile phone handsets for human electromagnetic bioeffects research. Human provocation studies that investigate the effects of Global System for Mobiles (GSM) communication systems on the brain have focused on Radio Frequency (RF) exposure. We wish to further extend such study by investigating the effect of both RF and Extremely Low Frequency (ELF) field exposure, the latter generated by the GSM handset's battery switching. The use of a commercial handset as an exposure source for such investigations is problematic for a number of reasons and therefore a simulated exposure source, capable of producing both RE and ELF components of exposure, is desirable. As a first step in developing such a source, we have quantified and characterized the ELF field from several commercial handsets (the RF characteristics being already well understood). Through experimental measurement we deduce that these fields can be sufficiently simulated by a 9mm radius loop residing 10mm beneath the front surface of the handset device and carrying enough current to generate peak fields of 25 muT at the surface of the handset. Copyright Â© 2008 ACPSEM.",Excluded
2814,"Evaluating DNA damage in rodent brain after acute 60 Hz magnetic-field exposure. In recent years, numerous studies have reported a weak association between 60 Hz magnetic-field exposure and the incidence of certain cancers. To date, no mechanism to explain these findings has been identified. The objective of the current study was to investigate whether acute magnetic-field exposure could elicit DNA damage within brain cells from both whole brain and cerebellar homogenates from adult rats, adult mice and immature mice. Rodents were exposed to a 60 Hz magnetic field (0, 0.1, 1 or 2 mT) for 2 h. Then, at 0, 2 and 4 h after exposure, animals were killed humanely, their brains were rapidly removed and homogenized, and cells were cast into agarose gels for processing by the alkaline comet assay. Four parameters (tail ratio, tail moment, comet length and tail length) were used to assess DNA damage for each comet. For each species, a significant increase in DNA damage was detected by each of the four parameters in the positive control (2 Gy X rays) relative to the concurrent nonirradiated negative and sham controls. However, none of the four parameters detected a significant increase in DNA damage in brain cell homogenates from any magnetic-field exposure (0- 2 mT) at any time after exposure. The dose-response and time-course data from the multiple animal groups tested in this study provide no evidence of magnetic-field-induced DNA damage.",Excluded
2912,"Changes of aggressive behavior and brain serotonin turnover after very low-dose X-irradiation of mice. Social isolation has been widely described to induce compulsive aggressive behavior and produce a large decrease of brain serotonin turnover in male mice. The aggressiveness by isolation in mice has been often used as a means for a better understanding of disturbed behavior in human beings. We found that male ICR white Swiss mice exhibiting isolation-induced aggression became gradually calm and showed remarkably quiet behavior 7 to 10 days after whole body irradiation of very low-dose X-rays (5-15 cGy). Higher doses (25-35 cGy), however, could not induce such effects. We also obtained the data on brain biochemistry giving a further support for the above low-dose effects on the mouse behavior. Brain serotonin turnover which has been known to be related to aggressive behavior in 5 or 15 cGy irradiated mice was faster than in aggressive control animals.",Included
2721,"CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. The c-Jun N-terminal kinase signaling cascade appears to play a role in some cases of cell death, including neuronal apoptosis. CEP-1347 (KT7515), an indolocarbazole of the K252a family, blocks this stress signaling cascade and promotes survival. Here, we used CEP-1347 to probe whether neuronal death pathways activated by distinct insults also possess elements in common. Cultured rat sympathetic neurons and neuronally differentiated PC12 cells were induced to die by withdrawal of nerve growth factor, exposure to ultraviolet irradiation, or subjection to oxidative stress. In each case, death was prevented by 100-200 nM CEP-1347. Moreover, in each of these death paradigms, c-Jun N-terminal kinase 1 activity in neuronally differentiated PC12 cells was elevated by two- or threefold, and this increase was totally blocked by CEP-1347 at concentrations that promoted survival. In contrast, 200 nM CEP-1347 did not block death due to serum withdrawal from undifferentiated PC12 cells or to activation of Fas in Jurkat T cell cultures, even though in each case c-Jun N-terminal kinase 1 activation occurred and was inhibited by CEP-1347. These observations suggest that some but not all death pathways triggered by different insults can include a common mechanistic component, a likely candidate for which is activation of the c-Jun N-terminal kinase signaling cascade.",Excluded
2804,Radiotherapy for extensive stage small-cell lung cancer,Excluded
3233,"Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database. BACKGROUND: Although the standard of care for glioblastoma remains maximal safe resection followed by chemoradiation, conflicting reports have emerged regarding the importance of the time interval between these 2 treatments.OBJECTIVE: To assess whether differences in the duration between surgery and initiation of chemoradiation for glioblastoma had an impact on overall survival (OS) in a large hospital-based database.METHODS: The National Cancer Database was queried to identify patients diagnosed with glioblastoma between 2010 and 2012 treated with surgery followed by chemoradiation. Patients who received biopsy only were excluded. The time from surgery to initiation of radiation therapy was divided into 4 equal quartiles of <=24, 25 to 30, 31 to 37, and >37 d. Patient characteristics were compared between groups using Pearson Chi Square and Fisher's Exact test. OS was analyzed via the Kaplan-Meier method and compared via the log-rank test. Univariable and multivariable Cox regression were performed to assess for impact of covariables on OS.RESULTS: A total of 11 652 patients were included in the analysis. Median duration from surgery to radiation was 30 d. On multivariable regression, black race, larger tumor, gross-total resection, methyguanine-methyl transferase (MGMT+), and treatment at an academic facility were associated with a duration >30 d. On multivariable analysis, there were no significant differences when comparing start within 24 d to 25 to 30 d (hazard ratio [HR] 0.96, 95% confidence interval [CI] 0.90-1.01, P = .13) or > 37 d (HR 0.97, 95% CI 0.91-1.03, P = .26), although a small OS improvement was seen if initiated within 31 to 37 d (HR 0.93, 95% CI 0.88-0.99, P = .02).CONCLUSION: There was no clear association between duration from surgery to initiation of chemoradiation on OS.",Excluded
3609,[Is it possible to determine from x-ray findings the time of origin of deafness],Excluded
3614,Opening the third eye,Excluded
3581,Central and peripheral neural pathways necessary for pineal function in the adult female rat,Excluded
2927,"Relapse in patients with high-risk neuroblastoma after treatment with 3F8+GM-CSF+CIS-retinoic acid in first complete/very good partial remission: Patterns, management and long-term outcome. Background/Objectives: Anti-GD2 immunotherapy is now standard of care for high-risk neuroblastoma (HR-NB). However, prognosis after first relapse post-immunotherapy is deemed dismal; patients are often enrolled on early phase studies without curative intent. Design/Methods: HR-NB patients relapsing post-3F8+GMCSF+cis-retinoic acid (CRA) in first complete (CR) or very good partial remission (VGPR) (NCT00072358) underwent the following reinduction strategies: (1) Isolated CNS relapse (CNS-R): multimodality therapy including intra-Ommaya radioimmunotherapy (MM-RIT) (J Neurooncol 97:409). (2) Disseminated (D-R) or focal soft-tissue relapse (FS-R): High-dose chemotherapy using active agents as previously described (Cancer 119: 665; Bone Marrow Transplant 48:642; Pediatr Blood Cancer 56: 403; Eur J Cancer 47: 84; Cancer 116: 3054) +/-surgery (+/-IORT)+/-radiation. (3) Focal bone relapse (FB-R): low-dose chemotherapy (J Clin Oncol 24:5271) +/- radiation. Patients achieving second CR/VGPR were retreated with 3F8+GM+CRA (Oncoimmunol In Press 2015) +/-anti-GD2/GD3 humoral vaccine (ClinCanRes 20:1375). Progression-free (PFS) and overall survival (OS) analyses were performed (Kaplan-Maier method) and prognostic variables compared (log-rank test). Result(s): Of 145 consecutive patients treated with 3F8+GM+CRA in first CR/VGPR, 64 (44%) relapsed (median follow-up 60 months from starting 3F8): 17 CNS-R, 24 D-R, 12 FS-R, 11 FB-R. 39 (61%) achieved second CR. 19 (29%) continued in remission >5 years after relapse. Respective five-year PFS and OS rates (%) for groups CNS-R receiving MM-RIT, D-R, FS-R and FB-R were 77+/-12 and 68+/-13, 6+/-7 and 6+/-7, 25+/-13 and 30+/-7, 54+/-15 and 62+/-15. Adverse prognostic factors for survival post-relapse included failure to achieve second CR, D-R as opposed to other relapse patterns, and early (<6mo from starting 3F8 ) relapse (p<0.05 for each), but not MYCN amplification (p=0.4). Conclusion(s): Long-term PFS and OS are possible in HR-NB patients post-relapse if CR/VGPR can be achieved, especially when relapse is focal. Agents with proven anti-NB activity should be considered initially at first relapse rather than purely experimental approaches.",Excluded
2955,"Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers. A neuropathological hallmark of Alzheimer's disease (AD) is the presence of large numbers of senile plaques in the brain. These deposits are rich in fibrils that are composed of 40- and 42-residue amyloid-beta (Abeta) peptides. Several lines of evidence indicate that soluble Abeta aggregates as well as fibrils are important in the etiology of AD. Low levels of endogenous soluble Abeta aggregates make them difficult to characterize, but several species in extracts of AD brains have been detected by gel electrophoresis in sodium dodecyl sulfate (SDS) and immunoblotting. Individual Abeta oligomers ranging in size from dimers through dodecamers of 4 kDa monomeric Abeta have been resolved in other laboratories as discrete species by size exclusion chromatography (SEC). In an effort to reconstitute soluble Abeta aggregates in vitro that resemble the endogenous soluble Abeta aggregates, we previously found that monomeric Abeta(1-42) rapidly forms soluble oligomers in the presence of dilute SDS micelles. Here we extend this work in two directions. First, we contrast the size and secondary structure of these oligomers with those of synthetic Abeta(1-42) fibrils. SEC and multiangle light scattering were used to obtain a molecular mass of 150 kDa for the isolated oligomers. The oligomers partially dissociated to monomers through nonamers when incubated with SDS, but in contrast to endogenous oligomers, we saw no evidence of these discrete species prior to SDS treatment. One hypothesis to explain this difference is that endogenous oligomers are stabilized by covalent cross-linking induced by unknown cellular agents. To explore this hypothesis, optimal mass spectrometry (MS) analysis procedures need to be developed for Abeta cross-linked in vitro. In our second series of studies, we began this process by treating monomeric and aggregated Abeta(1-42) with three cross-linking agents: transglutaminase, glutaraldehyde, and Cu(II) with peroxide. We compared the efficiency of covalent cross-linking with these agents, the effect of cross-linking on peptide secondary structure, the stability of the cross-linked structures to thermal unfolding, and the sites of peptide cross-linking obtained from proteolysis and MS.",Excluded
2960,"Headache and sinus mass as presenting features of an aggressive nonfunctional pituitary adenoma. Non-functioning pituitary adenomas (NFPA) generally are treated surgically and with radiation (XRT) depending on their location and surrounding structures. Residual pituitary adenomas (PA) after treatment may exhibit growth with slow extension into surrounding structures which can take years to occur. Ectopic PA are rare and are mostly located in the sphenoid sinus. Predicting aggressive or malignant behavior in PA remains challenging. A 55-yo AA man with a PMH of a NFPA resected in 2001 and treated with gamma knife radiation to residual tissue, had anterior hypopituitarism, and presented to the ED with left sided headaches worsening over 4 days. Sinus CT scan revealed a new mass extending from the left maxillary sinus into the sella turcica. He had been followed by Endocrinology and Neurosurgery for his thus far stable residual tumor in the left sphenoid sinus as well as hormone requirements. His most recent MRI 2 y before his ED presentation showed the size of the residual tumor at that time being smaller than on prior MRIs. In the ED, neurosurgery colleagues evaluated him and recommended a biopsy of the sinus mass which was performed by Otolaryngology along with a left maxillary sinusotomy, anterior ethmoidectomy, and sphenoidotomy with tissue removal. The bx revealed a recurrence of the NFPA with tumor cells on pathology staining positive for Ki-67 (> 3%) and for p53, suggesting it was more aggressive. The patient's sx improved and he continued hormone replacement therapy with close f/u. This case illustrates the need for longterm follow-up of patients with NFPA, especially after treatment with any form of radiation (1). It further underscores the lack of biomarkers that could reliably assist in predicting which tumors are more likely to recur or become more aggressive including invasion (2). CT and MRI features of sphenoid sinus ectopic PA are well described (3,4). Misdiagnosis (such as olfactory neuroblastoma, neuroendocrine carcinoma, sinonasal undifferentiated carcinoma, paraganglioma, melanoma) of patients with a sinus mass and/or a history of PA should be avoided (5). Surgical removal of residual tumors remains the mainstay of therapy, if feasible. Nonsurgical therapy options are less standardized (1). PA that stain positive for Ki-67 or P53 are more likely to be aggressive than those that do not. Aggressive PA and pituitary carcinomas often require more novel treatments when traditional surgery and XRT fail (6,7).",Excluded
2856,"Small cell cancer of the anal canal - Case report of a rare tumor. Background: We report on a rare case of small cell cancer located at the anal canal. Case report: A 41-year old woman presented with locally advanced small cell anal cancer and simultaneous hepatic and pulmonal deposits. Due to metastatic disease, chemotherapy with etoposide and cisplatin was performed with mixed response after four cycles of chemotherapy. After application of two additional chemotherapy cycles, locally progressive disease occurred causing symptomatic bowel obstruction. Pelvic irradiation was started and several days later, additional irradiation of cerebral metastases was initiated due to rapid progression of distant disease. Despite adequate local treatment the patient's condition further deteriorated and irradiation was stopped. The patient died 10 months after initial diagnosis due to rapid tumor progression. Conclusion(s): In patients with metastatic small cell anal cancer chemotherapy remains the mainstay of therapy. Radiotherapy exerts additional activity and remains a prime choice to gain local control and ameliorate symptoms. Careful histopathological examination, together with immunohistochemistry, is needed to determine the therapeutic strategy to be followed.",Excluded
3371,"Cutaneous pain and detection thresholds to short CO2 laser pulses in humans: evidence on afferent mechanisms and the influence of varying stimulus conditions. Pain and detection thresholds to short CO2 laser pulses were studied in healthy human subjects. Pain thresholds were significantly higher than detection thresholds in both hairy and glabrous skin; in the glabrous skin both thresholds were higher in the hairy skin. The range from detection threshold to pain threshold was larger in the glabrous skin. The minimal energy per surface area needed to produce any sensation (detection) or pain sensation decreased with increasing stimulus surface, and this spatial summation effect was to equal magnitude in the hairy and the glabrous skin. With decreasing stimulus pulse duration (from 45 to 15 msec) the detection and pain thresholds were elevated: this effect was stronger on pain thresholds. With increasing adapting skin temperature, less energy was needed to produce any sensation (detection) or pain sensation. The effect of adapting skin temperature was equal on pain and detection thresholds. The conduction velocity of fibers mediating laser evoked first sensations was in the thin fiber range (less than 10 msec), according to a reaction time study. The results suggest that short CO2 laser pulses produce both non-pain and pain sensations, but that both these sensations are based on the activation of the same primary afferent fiber population of slowly conducting nociceptive fibers. Central summation of primary afferent impulses is needed to elicit a liminal non-painful sensation, and an increased number of impulses in the same fibers produces pain.",Excluded
3294,"Outcomes of Obese and Morbidly Obese Patients Undergoing Percutaneous Coronary Intervention. Background: The risks of percutaneous coronary intervention (PCI) in obese and particularly morbidly obese patients remain uncertain. Method(s): 1082 consecutive patients were categorised as non-obese (NO, body mass index (BMI) <30 kg/m<sup>2</sup>, n = 688), obese (O, BMI 30-40 kg/m<sup>2</sup>, n = 354) or morbidly obese (MO, BMI >=40 kg/m<sup>2</sup>, n = 40). Demographic and procedural information was collated. Monte Carlo simulations modelled radiation dosimetric data. Result(s): Obese and morbidly obese patients were younger (p = 0.016), more frequently female (p = 0.036), more frequently diabetic (p < 0.0001), with better renal function (p < 0.0001), and prior PCI (p = 0.01). There was no difference in major adverse cardiovascular or cerebrovascular events (MACCE) (NO = 1.2%, O = 0.8%, MO = 2.5%, p = NS), acute kidney injury, bleeding, length of stay, 30-day readmission or 30-day mortality. Obese and morbidly obese patients received increased contrast (NO = 180 [150-230]mL, O = 190 [160-250]mL, MO = 200 [165-225]mL, p = 0.016), dose area product (NO = 75.56 [50.61-113.69]Gycm<sup>2</sup>, O = 116.4 [76.11-157.82]Gycm<sup>2</sup>, MO = 125.62 [92.22-158.81]Gycm<sup>2</sup>, p < 0.0001), entrance air kerma (NO = 1439.42 [977.0-2075.5]mGy, O = 2111.63 [1492.0-3011.0]mGy, MO = 2376.0 [1700.0-3234.42]mGy, p < 0.0001), and peak skin dose (NO = 1439.42 [977.0-2075.5], O = 2111.63 [1492.0-3011.0], MO = 2376.0 [1700.0-3234.42], p < 0.0001). Effective radiation dose increased in obese patients (NO = 20.9 +/- 14.9mSv, O = 27.4 +/- 17.1mSv, MO = 24.1 +/- 12.6mSv, p < 0.0001 for NO vs O, p = 0.449 for NO vs MO). Conclusion(s): Percutaneous coronary intervention can be performed in obese and morbidly obese patients without elevated risk for most clinical outcomes. However, radiation increases above levels that could cause both transient and late effects. Strategies should be pursued to minimise radiation dose. Copyright Â© 2017",Excluded
3472,"Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy. BACKGROUND: Treatment for advanced lung adenocarcinoma (AC) has become increasingly personalized based on molecular results. However, for patients with AC brain metastases (BMs), intracranial outcomes based on molecular subtype and the frequency of molecular aberrations are less well defined. This study sought to report targeted next-generation sequencing results and investigate molecularly based outcomes for patients with AC-BMs treated with radiotherapy.METHODS: The records of 132 patients with AC-BMs treated at Emory University from September 2008 to August 2016 with successful next-generation sequencing were reviewed. Rates of local disease recurrence, distant brain failure (DBF), and salvage whole-brain radiotherapy (WBRT) were estimated using cumulative incidence with competing risk analysis. Univariate and multivariate analyses were performed.RESULTS: The most common aberrations included tumor protein 53 (TP53) (60%), KRAS (29%), epidermal growth factor receptor (EGFR) (20.5%), phosphatase and tensin homolog (PTEN) loss (15.5%), and MET amplification (13%). The majority of patients (62%) were treated with stereotactic radiosurgery alone. In these patients, KRAS mutation, anaplastic lymphoma kinase (ALK) rearrangement, and having >= 6 BMs were associated with an increased risk of salvage WBRT (P < .05). KRAS mutation remained significant for an increased risk of salvage WBRT when compared with EGFR/ALK/KRAS-negative patients (hazard ratio, 5.17; P < .05), despite a similar risk of DBF. PTEN loss was associated with increased risk of DBF (P < .05), whereas EGFR and ALK aberrations were associated with a decreased risk of local disease recurrence (P < .05).CONCLUSIONS: The results of the current study quantified the frequency of genetic aberrations in patients with AC-BMs and demonstrated their association with intracranial outcomes. In particular, a cohort of patients with KRAS mutations and >=6 BMs were identified to be at high risk of requiring salvage WBRT after undergoing upfront stereotactic radiosurgery.",Excluded
3198,Modulated cerebellar evoked potentials after exposure of the cerebellum to Cobalt-60,Included
2641,"Motexafin gadolinium: a novel redox active drug for cancer therapy. Motexafin gadolinium (MGd, Xcytrin) is an aromatic macrocycle that has a strong affinity for electrons, i.e., it is easily reduced. In the presence of oxygen, MGd accepts electrons from various cellular reducing metabolites and forms superoxide and other reactive oxygen species (ROS) by redox cycling. The reaction with NADPH is dramatically accelerated by various oxido-reductases including thioredoxin reductase. In vitro studies with various cancer cell lines have shown an increase in ROS and intracellular free zinc in cells treated with MGd. MGd increases cytotoxicity of ionizing radiation and various chemotherapy agents and may be directly cytotoxic to tumor cells under certain conditions. MGd selectively localizes in tumors, perhaps due to their metabolic perturbations. MGd treatment in murine models enhances tumor response to radiation and chemotherapy agents. In controlled, randomized clinical trials, combining MGd treatment with ionizing radiation improves time to neurologic progression in lung cancer patients with brain metastases. The molecular target for MGd appears to be thioredoxin reductase which, when inhibited, results in cellular redox stress, cytotoxicity and an increase in tumor responsiveness to a variety of treatments. [References: 66]",Excluded
2653,"The efficacy of stereotactic radiotherapy for metastases from renal cell carcinoma. Our purpose was to evaluate the efficacy of stereotactic radiotherapy (SRT) for intracranial and extracranial metastases in patients with renal cell carcinoma. The retrospective analysis of 85 patients (151 tumors) treated with SRT was performed. SRT was the sole treatment in 35% of tumors, the other 65% had received additional treatment such as surgery, palliative radiotherapy, immunotherapy or chemotherapy. In 60% and 40% of patients SRT was delivered to brain and extracranial lesions, respectively. The assessment of the efficacy of SRT was based on a radiological imaging (Computed Tomography or Magnetic Resonance Imaging) and estimation of Local Control (LC) as well as Overall Survival (OS). Single fraction was used for 104 tumors and fractionated treatment for 47 tumors. The crude LC for evaluable lesions was 81%, stratified by tumor location: brain LC=94%, extracranial tumors LC=70% (p=0.049). The median OS was 9.4 months; 1-year and 2-year OS were 40% and 29%, respectively. The additional treatment did not lead to a better local response (p=0,543), but resulted in a benefit in OS (7 vs 13 months, p=0,01). A positive relationship between the biologically effective dose (BED) and local response was noted, but the BED was influenced by a tumor volume (R=-0,38; p<0,00001). The presence of multi-organ metastases reduced the OS rate (8.7 vs 19.1 months; p=0,01). The interval between the diagnosis of the metastasis and its treatment with SRT was inversely related to OS (P=0.0001). SRT results in a good local response, which is more beneficial for brain than extracranial lesions. The local efficacy of the SRT depends on the radiation dose. Multidisciplinary treatment and earlier application of SRT improves the prognosis of patients. Copyright Â© 2016, Cancer Research Institute Slovak Acad. of Sciences. All rights reserved.",Excluded
3121,"Endovascular recanalization of the common carotid artery in a patient with radio induced chronic occlusion. Recanalization of chronic occlusion of the common carotid artery (CCA) in patients with a history of neck irradiation is challenging, both for vascular surgeons and interventional neuroradiologists. We describe a case of successful stenting of radio induced chronic occlusion of the right CCA in a 41-year-old patient with neurological deterioration and minor stroke due to cerebral hypoperfusion caused by concomitant bilateral arterial occlusions. Direct surgery and surgical bypass were considered contraindicated. The endovascular approach was successful and required multiple precautions during the procedure. We describe particular solutions, not used in day to day practice, that allowed us to carry out the endovascular treatment in this unusual situation.",Excluded
3389,"Age dependence of the radiosensitivity of glial progenitors for In vivo fission-neutron and X irradiation. O-2A progenitor cells are the stem cells of the myelin-forming oligodendrocytes in the central nervous system. In the epithermal reactor beams used for boron neutron capture therapy (BNCT) for treatment of brain tumors, fission neutrons are a contaminating component. To estimate the radiosensitivity of the O-2A progenitors for fission neutrons, an in vivo-in vitro clonogenic assay was used. Radiosensitivity of progenitors obtained from the spinal cord of 1- or 5-day-old rats or the optic nerve of 2- or 12-week-old rats for 1 MeV fission neutrons was compared to that for 300 kVp X rays. Dose-survival curves were fitted according to the linear-quadratic model. The resulting beta component was very small to negligible. Progenitor cells obtained from rats of different ages show differences in radiosensitivity, characterized by different alpha values. RBE values for fission neutrons were 3.5 for 1-day-old spinal cord, 3.2 for 5-day-old spinal cord, 3.0 for 2-week-old optic nerve, and 4.3 for 12-week-old optic nerve. These high RBE values indicate the importance of minimizing the fast-neutron component in the epithermal neutron beams used for BNCT.",Included
3465,"Linear quadratic model and biologically equivalent dose for single fraction treatments. The linear quadratic model has been used to calculate the biologically equivalent dose for single fraction treatments. Our calculations suggest that for late reacting tissue, such as the brain, a single fraction of 1440 cGy is equivalent to a conventional treatment of 5000 cGy in 25 fractions.",Excluded
3426,"Collagen expression in gbm correlates with the mesenchymal subtype and patient survival. Purpose/Objective(s): Despite advances in surgery, radiation, and chemotherapy, glioblastoma multiforme (GBM) has a poor very prognosis. Gene expression analysis is used to group GBMs into four subtypes: classical, proneural, mesenchymal, and neural, and potentially provide information about patient prognosis and therapeutic response. New biomarkers are emerging and used with the above subtyping to derive more information about patient prognosis and guide clinical treatment. The tumor microenvironment is involved with GBM progression and collagen is a large component of the tumor microenvironment. We have shown that fibrillar collagen is a survival marker for GBM, and performed this study to assess the interaction of collagen expression and organization with the four molecular GBM subtypes. Materials/Methods: The Cancer Genome Atlas (TCGA) was used to analyze fibrillar collagen gene expression in GBM patients in the classical, proneural, and mesenchymal subtypes. GSC sphere cultures were established from patient GBM samples by marker-neutral culture in stem cell media. Orthopedic xenografts were initiated in NOD-SCID mice by implanting 2x10<sup>5</sup> GSCs into the right striatum. Subsequent tumor formation (10-14 weeks) was verified by MRI and animals were sacrificed when moribund. Histology and immunohistochemistry (IHC) was performed on paraffin-embedded sections. GBM subtype was determined based on IHC. Classical GBM subtype is defined by high expressions of EGFR; the proneural GBM subtype is defined by high expression of PDGFRA, P53, or OLIG2; the mesenchymal GBM subtype is defined by high expression of two or more of vimentin, PTEN, YKL40, and/or CD44. IHC was also performed on a GBM tissue microarray (TMA) with clinical data for 111 patients in order to determine patient subtype. Picrosirius red staining was performed on brain sections and the TMA to detect collagen. Custom software was used to extract collagen fiber data and to quantify collagen fiber angle, length, straightness, and width from the picrosirius images. Result(s): TCGA analysis found that fibrillar collagen genes were most associated with the mesenchymal subtype. More organized collagen was found in the mesenchymal GBM xenografts with less organized collagen being found in the proneural and classical subtypes. Mice with mesenchymal xenografts and more organized collagen had a longer survival. Patients with more organized collagen were found in the mesenchymal group as well and also demonstrated increased survival. Conclusion(s): More organized collagen is associated with the mesenchymal GBM subtype and may be a biomarker for GBM patients. Patients with mesenchymal GBM are more resistant to radiation therapy. Thus, collagen might be a useful marker to determine radiotherapeutic strategies for patients in the future.",Excluded
3496,"The homeobox transcription factor Even-skipped regulates acquisition of electrical properties in Drosophila neurons. BACKGROUND: While developmental processes such as axon pathfinding and synapse formation have been characterized in detail, comparatively less is known of the intrinsic developmental mechanisms that regulate transcription of ion channel genes in embryonic neurons. Early decisions, including motoneuron axon targeting, are orchestrated by a cohort of transcription factors that act together in a combinatorial manner. These transcription factors include Even-skipped (Eve), islet and Lim3. The perdurance of these factors in late embryonic neurons is, however, indicative that they might also regulate additional aspects of neuron development, including the acquisition of electrical properties.RESULTS: To test the hypothesis that a combinatorial code transcription factor is also able to influence the acquisition of electrical properties in embryonic neurons we utilized the molecular genetics of Drosophila to manipulate the expression of Eve in identified motoneurons. We show that increasing expression of this transcription factor, in two Eve-positive motoneurons (aCC and RP2), is indeed sufficient to affect the electrical properties of these neurons in early first instar larvae. Specifically, we observed a decrease in both the fast K+ conductance (IKfast) and amplitude of quantal cholinergic synaptic input. We used charybdotoxin to pharmacologically separate the individual components of IKfast to show that increased Eve specifically down regulates the Slowpoke (a BK Ca2+-gated potassium channel), but not Shal, component of this current. Identification of target genes for Eve, using DNA adenine methyltransferase identification, revealed strong binding sites in slowpoke and nAcRalpha-96Aa (a nicotinic acetylcholine receptor subunit). Verification using real-time PCR shows that pan-neuronal expression of eve is sufficient to repress transcripts for both slo and nAcRalpha-96Aa.CONCLUSION: Taken together, our findings demonstrate, for the first time, that Eve is sufficient to regulate both voltage- and ligand-gated currents in motoneurons, extending its known repertoire of action beyond its already characterized role in axon guidance. Our data are also consistent with a common developmental program that utilizes a defined set of transcription factors to determine both morphological and functional neuronal properties.",Excluded
3202,"ATP consumption by mammalian rod photoreceptors in darkness and in light. Why do vertebrates use rods and cones that hyperpolarize, when in insect eyes a single depolarizing photoreceptor can function at all light levels? We answer this question at least in part with a comprehensive assessment of ATP consumption for mammalian rods from voltages and currents and recently published physiological and biochemical data. In darkness, rods consume 10(8) ATP s(-1), about the same as Drosophila photoreceptors. Ion fluxes associated with phototransduction and synaptic transmission dominate; as in CNS, the contribution of enzymes of the second-messenger cascade is surprisingly small. Suppression of rod responses in daylight closes light-gated channels and reduces total energy consumption by >75%, but in Drosophila light opens channels and increases consumption 5-fold. Rods therefore provide an energy-efficient mechanism not present in rhabdomeric photoreceptors. Rods are metabolically less ""costly"" than cones, because cones do not saturate in bright light and use more ATP s(-1) for transducin activation and rhodopsin phosphorylation. This helps to explain why the vertebrate retina is duplex, and why some diurnal animals like primates have a small number of cones, concentrated in a region of high acuity.",Excluded
2780,"Rhenium-188(Sn)HEDP for treatment of osseous metastases. UNLABELLED: Rhenium-188 (tin) hydroxyethylidine diphosphonate [188Re(Sn)HEDP] is a new radiopharmaceutical that localizes in skeletal metastases and emits beta particles that may be therapeutically beneficial.METHODS: It was evaluated by in vitro and in vivo testing in the laboratory, in animals and in humans using 188Re from a variety of sources. It may be produced by a desk-top method developed previously for 186Re(Sn)HEDP using 188Re produced through neutron irradiation of either enriched 187Re or naturally occurring rhenium targets or the use of a 188W/188Re generator.RESULTS: So long as the mass of rhenium in the 188Re-perrhenate to be processed into 188Re(Sn)HEDP is at least 100 microg, satisfactory radiochemical yields and purity may be obtained by all methods. The 188Re(Sn)HEDP has biodistribution and radiation dosimetry characteristics that are similar to those noted previously for 186Re(Sn)HEDP and appears to result in similar benefits and toxicities in patients with skeletal metastases. External radiation exposure monitoring indicates that, only 4 hr after a therapeutic administration of 1110 MBq (30 mCi) of 188Re(Sn)HEDP, average exposure rates at 1 meter from the patient would be only 0.5 mR/hr.CONCLUSION: Same-day, on-demand, outpatient therapy of disseminated skeletal metastases appears to be feasible with 188Re(Sn)HEDP.",Excluded
2809,"Dose reduction to radiosensitive tissues in CT. Do commercially available shields meet the users' needs?. AIM: To assess the effectiveness and economy of routinely using commercially available in-plane bismuth shielding during CT scanning of the chest and brain.METHODS AND MATERIALS: Forty patients were scanned with thermoluminescent dosemeters (TLDs) in situ to measure the radiation dose to the thyroid and eye during CT scanning of the brain and chest. Half of the patients had the ""AttenuRad"" shield in place during scanning.RESULTS: Use of the shielding reduced the mean dose to the eye from 6.0 +/- 0.3 mGy to 4.9 mGy +/- 0.2 mGy and the thyroid dose from 16.4 mGy +/- 1.2 mGy to 7.1 mGy +/- 0.5 mGy.CONCLUSION: Use of the thyroid shield is recommended for all CT scanning of the chest. The eye shield does not produce as marked a reduction in radiation dose to the lens of the eye, when an angled gantry is used, since the eyes are not in the primary beam. Use of the eyeshield is justifiable where irradiation of the orbit is unavoidable, although whether artifacts would be a problem if the shield was used in this way was not assessed.",Excluded
3168,"High-frequency afferent stimulation induces long-term potentiation of field potentials in the ventral tegmental area. Excitatory synapses on dopamine neurons in the VTA can undergo both long-term potentiation and depression. Additionally, drug-induced plasticity has been found at VTA synapses, and is proposed to play a role in reward-related learning and addiction by modifying dopamine cell firing. LTP at these synapses is difficult to generate experimentally in that it requires an undisturbed intracellular milieu and is often small in magnitude. Here, we demonstrate the induction of LTP as a property of evoked field potentials within the VTA. Excitatory field potentials were recorded extracellularly from VTA neurons in acute horizontal midbrain slices. Using extracellular and intracellular recording techniques, we found that evoked field potentials originate within the VTA itself and are largely composed of AMPA receptor-mediated EPSPs and action potentials triggered by activation of glutamatergic synapses on both dopamine and GABA neurons. High-frequency afferent stimulation (HFS) induced LTP of the field potential. The induction of this LTP was blocked by application of the NMDAR antagonist, d-APV, prior to HFS. As reported previously, glutamatergic synapses on GABA neurons did not express LTP while those on dopamine neurons did. We conclude that the potentiation of glutamatergic synapses on dopamine neurons is a major contributor to NMDA receptor-dependent LTP of the field potential. Field potential recordings may provide a convenient approach to explore the basic electrophysiological properties of VTA neurons and the development of addiction-related processes in this brain region.",Excluded
2566,"DNA damage response of clinical carbon ion versus photon radiation in human glioblastoma cells. BACKGROUND AND PURPOSE: Carbon ion radiotherapy is a promising therapeutic option for glioblastoma patients due to its high physical dose conformity and greater biological effectiveness than photons. However, the biological effects of carbon ion radiation are still incompletely understood. Here, we systematically compared the biological effects of clinically used carbon ion radiation to photon radiation with emphasis on DNA repair.MATERIALS AND METHODS: Two human glioblastoma cell lines (U87 and LN229) were irradiated with carbon ions or photons and DNA damage response was systematically analyzed, including clonogenic survival, induction and repair of DNA double-strand breaks (DSBs), cell cycle arrest and apoptosis or autophagy. gammaH2AX foci were analyzed by flow cytometry, conventional light microscopy and 3D superresolution microscopy.RESULTS: DSBs were repaired delayed and with slower kinetics after carbon ions versus photons. Carbon ions caused stronger and longer-lasting cell cycle delays, predominantly in G2 phase, and a higher rate of apoptosis. Compared to photons, the effectiveness of carbon ions was less cell cycle-dependent. Homologous recombination (HR) appeared to be more important for DSB repair after carbon ions versus photons in phosphatase and tensin homolog (PTEN)-deficient U87 cells, as opposed to PTEN-proficient LN229 cells.CONCLUSION: Carbon ions induced more severe DSB damage than photons, which was repaired less efficiently in both cell lines. Thus, carbon ion radiotherapy may help to overcome resistance mechanisms of glioblastoma associated with DNA repair for example in combination with repair pathway-specific drugs in the context of personalized radiotherapy.",Excluded
2757,[Change in the hypophysis after radiogold implantation],Included
2781,Role of hippocampal avoidance during therapeutic whole-brain radiotherapy. [German],Excluded
2730,"Cranial nerve preservation and outcomes after stereotactic radiosurgery for jugular foramen schwannomas. OBJECTIVE: Jugular foramen region schwannomas are rare intracranial tumors that usually present with multiple lower cranial nerve deficits. For some patients, complete surgical resection is possible but may be associated with significant morbidity. Stereotactic radiosurgery is a minimally invasive alternative or adjunct to microsurgery for such tumors. We reviewed our clinical and imaging outcomes after patients underwent gamma knife radiosurgery for management of jugular foramen schwannomas.METHODS: Thirty-four patients with 35 tumors (one patient had bilateral tumors) underwent radiosurgery between May 1990 and December 2005. Twenty-two patients had previous microsurgical resection and all patients experienced various cranial neuropathies. A median of six isocenters were used. Median marginal and maximum doses were 14 and 28 Gy, respectively.RESULTS: None of the patients were lost to evaluation and the mean duration of follow-up was 83 months. Tumors regressed in 17 patients, remained stable in 16, and progressed in two. Five- and 10-year actuarial control rates were 97 and 94%, respectively. Preexisting cranial neuropathies improved in 20% and remained stable in 77% after radiosurgery. One patient worsened. The function of all previous intact nerves was preserved after radiosurgery.CONCLUSION: Stereotactic radiosurgery proved to be a safe and effective management for newly diagnosed or residual jugular foramen schwannomas. Long-term tumor control rates and stability or improvement in cranial nerve function was confirmed.",Excluded
3348,"The Impact of body-only proton radiation on immune-CNS communication. Hematopoietic stem cell transplant (HSCT) is an established treatment for many hematological disorders including lymphomas and leukemias. Although the prognosis after HSCT has historically been poor, associated with high mortality rates, advances in treatment have led to increases in long-term survival and, consequently, an increased risk for neuropsychological dysfunction. Roughly 40% of all allogeneic HSCTs performed in 2006-2010 involved total body irradiation (TBI) conditioning. Previously, we reported that many TBI-induced changes in splenic phagocytic populations were mitigated by chlorisondamine (CHL), a non-selective nicotinic blocker that crosses the blood-brain barrier. In this study, we characterized the effects of body-only proton irradiation (excluding brain) and CHL on the response to a bacterial challenge in 8- to 10-week-old female C57BL/6 mice. Mice were given CHL (1 mg/kg, i.p.) and irradiated (0 or 3 Gy) 60-90 min later. Ten days post-irradiation, mice were inoculated with 5e7 CFU of Escherichia coli (i.p.) and euthanized 90-120 min later. We characterized blood and splenic leukocyte population distributions (flow cytometry and hematology), cytokine levels (multiplexed cytokine analysis) and oxidative burst capacity. Radiation decreased virtually all splenic leukocyte counts while increasing oxidative burst capacity. In the blood, radiation decreased lymphocytes but increased innate subsets. Sympathetic blockade did not counter most of these radiation effects. This suggests that the disruptive effect of TBI on brain-immune communication is dependent on direct exposure to the brain.",Included
3140,"Seizure control after radiosurgery for cerebral arteriovenous malformations: A 25-year experience. OBJECTIVE Seizures are the second-most common presenting symptom in patients with lobar arteriovenous malformations (AVMs). However, few studies have assessed the long-term effect of stereotactic radiosurgery (SRS) on seizure control. The authors of this study assess the outcome of SRS for these patients to identify prognostic factors associated with seizure control. METHODS Patients with AVM who presented with a history of seizure and underwent SRS at the authors' institution between 1987 and 2012 were retrospectively assessed. The total cohort included 155 patients with a mean follow-up of 86 months (range 6-295 months). Primary outcomes assessed were seizure frequency, antiepileptic drug regimen, and seizure freedom for 6 months prior to last follow-up. RESULTS Seizure-free status was achieved in 108 patients (70%), with an additional 23 patients (15%) reporting improved seizure frequency as compared to their pre-SRS status. The median time to seizure-free status was estimated to be 12 months (95% CI 0-27 months) as evaluated via Kaplan-Meier survival analysis. The mean seizure frequency prior to SRS was 14.2 (95% CI 5.4-23.1) episodes per year. Although not all patients tried, the proportion of patients successfully weaned off all antiepileptic drugs was 18% (28/155 patients). On multivariate logistic regression, focal impaired awareness seizure type (also known as complex partial seizures) and superficial venous drainage were significantly associated with a decreased odds ratio for seizure-free status at last follow-up (OR 0.37 [95% CI 0.15-0.92] for focal impaired awareness seizures; OR 0.36 [95% CI 0.16-0.81] for superficial venous drainage). The effects of superficial venous drainage on seizure outcome were nonsignificant when excluding patients with < 2 years of follow-up. AVM obliteration did not correlate with long-term seizure freedom (p = 0.202, chi-square test). CONCLUSIONS This study suggests that SRS improves long-term seizure control and increases the likelihood of being medication free, independently of AVM obliteration. Patients with focal impaired awareness seizures were less likely to obtain long-term seizure relief. Copyright Â© AANS 2019",Excluded
2977,"Dorsal column stimulation for persistent vegetative state. Dorsal column stimulation (DCS) is described as a therapy for persistent deterioration of consciousness. The mechanism of its effect has not yet been elucidated. Various other methods, such as deep brain stimulation of the CM-p f complex, vagus nerve stimulation, and musical functional therapy, are being investigated as potential treatments of this problem. We present our series of DCS for persistent vegetative state and review the potential mechanisms of action and the relevant literature.",Excluded
3380,"[Effect of the psychostimulants caffeine and methylphenidate on the efficiency of physical activity in rats exposed to ionizing radiation]. The authors carried out studies on 267 male rats and examined the effect of ionizing irradation (single irradation with 737 roentgens) on the duration of swimming and on the alteration of this effect by psychic stimulators caffeine and methylphenidate, administered in overthreshold doses (30 and 50 mg/kg of body weight for caffeine and 5 and 10 mg/kg of body weight for methylphenidate). On the 7th day after irradiation there was statistically significant shortening of the duration of swimming in the control animals. The mentioned doses (statistically significant for the larger dose) were used in nonirradiated animals and the two psychic stimulators also shortened the duration of swimming in comparison with the control nonirradiated animals. This effect could be explained by hyperexcitatory action of these doses of caffeine and methylphenidate. As a result of this, desoptimization of the cerebral activity occurred and as a consequence of which was the diminution of the efficiency of the physical activity. Together with this they observed that both psychic stimulators partially counteracted the shortening of the duration of swimming of rats, caused by ionizing irradiation itself. This effect, especially for caffeine, could be explained by the induced of the ionizing irradiation increase in the sensitivity of cerebral phosphodiesterase of rats to its inhibitor caffeine as a result of which under these conditions the effect of caffeine on the level of cerebral cyclic AMP was reinforced. The cyclic AMP is presumed to have some protective effect against ionizing irradiation.",Included
3542,"Assessment of MRI-based attenuation correction for MRI-only radiotherapy treatment planning of the brain. Magnetic resonance imaging-only radiotherapy treatment planning (MRI-only RTP) and positron emission tomography (PET)-MRI imaging require generation of synthetic computed tomography (sCT) images from MRI images. In this study, initial dosimetric evaluation was performed for a previously developed MRI-based attenuation correction (MRAC) method for use in MRI-only RTP of the brain. MRAC-based sCT images were retrospectively generated from Dixon MR images of 20 patients who had previously received external beam radiation therapy (EBRT). Bone segmentation performance and Dice similarity coefficient of the sCT conversion method were evaluated for bone volumes on CT images. Dose calculation accuracy was assessed by recalculating the CT-based EBRT plans using the sCT images as the base attenuation data. Dose comparison was done for the sCTand CT-based EBRT plans in planning target volume (PTV) and organs at risk (OAR). Parametric dose comparison showed mean relative differences of <0.4% for PTV and <1.0% for OARs. Mean gamma index pass rates of 95.7% with the 2%/2 mm agreement criterion and 96.5% with the 1%/1 mm agreement criterion were determined for glioma and metastasis patients, respectively. Based on the results, MRI-only RTP using sCT images generated from MRAC images can be a feasible alternative for radiotherapy of the brain. Copyright Â© 2020 by the authors.",Excluded
3605,"Epstein virus Barr-positive diffuse large B-Cell lymphoma associated with hemophagocytic lymphohistiocytosis. Hemophagocytic lymphohistiocytosis (HLH) is a rare and often fatal disease if not diagnosed and treated promptly. HLH can be due to genetic factors or infections, malignancies and collagen-associated vascular diseases. Malignancy-associated HLH is not only more common in the setting of T/NK-cell lymphomas, but may also rarely be seen in the setting of B-cell lymphoma. Here, we describe a unique case of a patient who initially was diagnosed with HLH secondary to Epstein Barr virus (EBV) infection and subsequently developed EBV-positive diffuse large B-cell lymphoma affecting the brain. This case highlights the spectrum of findings associated with EBV infections and the challenges in diagnosing underlying diseases associated with HLH. Copyright Â© 2020 American Association of Neuropathologists, Inc. All rights reserved.",Excluded
2684,"Bremsstrahlung dose of 165Dy in radiosynovectomy. There has been an increased interest in 165Dy radiossynovectomy, which emits relatively high-energy (> 1 MeV) beta rays. The production of in vivo bremsstrachlung radiation hazards warrants evaluation. The bremsstrahlung component of the decay scheme of 165Dy has been traditionally ignored in internal dosimetry calculations. We have estimated the bremsstrahlung dose of 165Dy distributed in muscle and bone to body by various internal organs (adrenals, brain, breasts, gallbladder wall, LLI wall, small intestine, stomach, ULI wall, heart wall, kidneys, liver, lungs, muscle, ovaries, pancreas, red marrow, bone surfaces, skin, spleen, testes, thymus, thyroid, urine bladder wall, uterus, fetus, placenta, and total body) during radiosynovictomy. In the present study, muscle and bone are considered to be source organs. These estimated values show that the bremsstrahlung radiation absorbed dose contribution from an organ to itself is very small compared to that originating from the beta source. However, contribution to other organs is not always negligible, especially when large amounts of 165Dy may be involved, such as in therapy applications. Hence the component of the total dose due to bremsstrahlung dose should be considered in radiosynovictomy or other therapy applications.",Excluded
2658,"Lobular histology shows tendency of higher risk of involved margins after first breast-conserving surgery. Background: Tumor positive surgical margin after breast-conserving treatment is used as a quality indicator in breast cancer healthcare. The aim of the study was to analyze the positive margin cases in our Breast Unit, risk factors for inadequate margin and the impact of positive margin on outcomes after breast-conserving therapy. Material(s) and Method(s): 107 women with invasive breast cancer (T1-2, N0-2, M0) diagnosed between 2005-2010, who underwent breastconserving surgery(BCS) as first surgery, were retrospectively selected from the Pauls Stradins Clinical University Hospital Breast Unit Registry. A positive resection margin was defined as a microscopic invasive or in situ tumor at the cutting edge in permanent pathologic reports. Result(s): The mean tumor size was 1.65 cm in the positive margin group and 1.68 cm in the other group(p > 0.893). 13 of 107 (12.1%) had positive margins at initial resection. Of these patients 4(30.7%)had involved caudal margin, 2 (15.3%) cranial margin, 2 (15.3%) medial margin, 2(15.3%) deep margin and 1 (7.6%) lateral margin, there were insufficient data available about the type of margin in 2 cases. 8 (61.5%) had an invasive carcinoma at the margins and in other cases carcinoma in situ was detected. 4 (30.7%) underwent additional surgery-mastectomy, to achieve negative margins. Postoperative radiation was performed for 12 (92.3%) patients. 7 (53.8%) received adjuvant chemotherapy. Patients with inadequate margins had ER positive tumors in 76.5% vs. 47.3% in other group, PR positive tumors in 46.8% vs. 52.3% in other, HER 2/neu negative tumors in 76.9% vs. 56.2% in other. Patients with a positive margins at the initial resection showed higher lobular histology rate (15.3% vs. 6.4%), incidence of multiple ipsilateral tumors (23.1% vs. 15.4%), presens of intraductal component (76.9% vs. 65.1%), but these differences between two groups were no statistically significant. 73.1% of all patients were tested for the two common founder mutaions in BRCA1(4153delA and 5382insC). There was 1 BRCA1(5382insC) mutation-positive patient in the other group and no mutation-positive patients in the positive margin group. Mean follow-up time was 19.9(11-37) months, and there were no local recurrences during the follow-up period in the tumor positive margin group. Conclusion(s): The overall percentage of positive margins in the Pauls Stradins Clinical University Hospital Breast Unit is within the predefined targets. Lobular histology, multiple ipsilateral tumors and presens of intraductal component have shown a tendency of higher risk for inadequate margins of excision..",Excluded
2839,"[Changes of EEG coherence in different stages of the formation of the psychoorganic syndrome]. The group of liquidators of Chernobyl Nuclear Power Plant accident (n=170) with nonpsychotic mental disorders of exogenic-organic origin was studied. Patients were stratified into five groups on the basis of dominating symptoms in different stages of disorders: group 1 included patients with the prevalence of asthenic symptoms (n=104); group 2 - with the prevalence of autonomous disorders (n=37); group 3 - with the marked neurotic-like symptom complex (n=10); group 4 - with depressive symptoms (n=10); group 5 - with disturbances of cognitive function. The control group included 150 healthy people. Recording and mapping of coherence (COH) of the brain electrical activity was conducted using the apparatus-software complex for topographic mapping of brain electrical activity NEURO-CM (Russia) with the bandwidth from 0 to 40 Hz and the time constant of 0.3 sec. The EEG record was carried out monopolar from symmetrical cortical zones (10-20% scheme). Changes of COH were characterized by staging in patients compared to the controls. In the initial stage of disease, the integrative links were decreased in the temporal cortical zones of the left hemisphere. The reduction of functional activity in temporal-central cortical zones was found that might be the consequence of mesodiencephalic dysfunction. In the later stages, temporal zones of the right hemisphere were mostly affected. The parallel reinforcement of functional activity of occipital zones, in particular, the increase of 'long links' with frontal areas, was noted in the overall formation of the psychoorganic syndrome. This phenomenon may be considered as a compensatory mechanism when the phylogenetically older cortical zones, which are more resistant to pathological changes, become leaders in the realization of integrative brain activity during the development of a pathological state.",Included
2446,"Transformation of benign metastasizing leiomyoma to leiomyosarcoma. INTRODUCTION: Benign metastasizing leiomyoma (BML) is a rare entity in which solitary leiomyoma-like nodules are present in a distant location. The origin is presumed to be the uterus, occurring predominantly in women of reproductive age. It is extremely atypical for BML to undergo malignant transformation. Here we present a rare case of BML transforming to leiomyosarcoma. CASE PRESENTATION: This is a 53 year old female with a history of benign metastasizing leiomyoma (BML) who was admitted for dyspnea. She underwent a hysterectomy in 1996. That same year she suffered a spontaneous pneumothorax secondary to a ruptured lung cyst. In 2005 she underwent a left thoracotomy with resection of a new cystic lesion. Pathology was consistent with BML (positive for estrogen receptor, progesterone receptor, CD10, desmin, smooth muscle actin, caldesmon but negative for HMB-45 stain) and she was started on anastrazole. She underwent a redo thoracotomy in 2011 with resection of a pleural-based giant tumor; the pathology again confirmed BML. In January 2017 she was admitted for progressive shortness of breath, right shoulder pain and headache. A magnetic resonance image (MRI) brain showed a right superior frontal mass. Contrast tomography (CT) chest showed worsening of nodular densities without significant cystic changes (image1). A MRI of her right shoulder demonstrated a large mass at the lateral third of the clavicle. Subsequent positron emission tomography (PET) revealed extensive hyper-metabolic activity consistent with metastasis. The right frontal and right clavicular masses were biopsied and pathology was consistent with leiomyosarcoma (image 2). Unfortunately, she was not a candidate for chemotherapy or radiation and ultimately expired. DISCUSSION: BML is a rare disease entity with only 150 reported cases to date.1 The lungs are the most common site of metastatic spread. Radiographically BML appears as well-circumscribed, multiple solid nodules. Uncommonly, as seen in our patient, it can present as cavitation or cysts, increasing the risk for pneumothorax. Typically, the tumors maintain the benign nature of uterine leiomyomas as evidenced by their lack of avidity on PET and low mitotic activity.2 This is the third reported case of malignant transformation. Few guidelines exist for managing BML although current treatment includes surgical resection or hormone modulating therapies. CONCLUSION(S): Transformation of BML to leiomyosarcoma is uncommon.",Excluded
2751,"In vivo protein secretion by lung. Evidence for active secretion and interspecies differences. The present study is an attempt to determine (a) if the lung actively secretes protein into the surface-active fraction of lung lavage returns; (b) if there are interspecies differences in this secretory activity; and (c) if the amount of nonradioactive protein in the lavage surface-active fraction shows interspecies variation. I found that pilocarpine stimulates the release of radioactive protein into the lavage surface-active fraction of rabbits and that this pilocarpine effect is completely blocked by atropine. Inhibition of lung oxygen consumption by iodoacetate is associaged with a dose-dependent inhibition of the pilocarpine-induced secretion. Microtubules may be involved in this secretory process because colchicine inhibits the pilocarpine effect. Of the radioactive protein in the total surface-active fraction (tissue plus lavage returns), a greater percent appears in the lavage surface-active fraction at 2 and 4 h, after a pulsed injection [U-14C] leucine, in the mouse than in the rat, which in turn has a greater amount than the rabbit. There is also a difference in the amount of nonradioactive protein per square meter of alveolar surface area in the lavage surface-active fraction of different species: mouse greater than rabbit greater than cat greater than dog. The amount of nonradioactive protein per square meter of alveolar surface area in the lavage surface-active fraction is directly proportional to the species respiratory rate; the log of the nonradioactive protein in the lavage surface-active fraction is inversely proportional to the log of the species alveolar diameter. I conclude that the lung actively secretes protein into the lavage surface-active fraction, that this secretion is under neurohumoral regulation, and that respiratory rate and alveolar size may influence this secretory activity and the amount of protein in this surface-active fraction.",Excluded
2770,"Chemoradiotherapy for brain tumors: Current status and perspectives. Brain tumors growing in the parenchyma of the brain infiltrate diffusely, and the role of surgery is restricted to maximal tumor-bulk removal. Residual tumor cells beyond the surgical margin are not killed by conventional radiation therapy with 60 'Gy. Many clinical trials delivering chemotherapy during radiation therapy and after radiation therapy have been performed, but the results remain poor. Here the author reviews the current treatments of gliomas, malignant lymphomas, medulloblastomas, and germ cell tumors, and their results.",Excluded
2522,"Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging. MRI and magnetic resonance spectroscopy (MRS) along with computed tomography and PET are the most common imaging modalities used in the clinics to detect structural abnormalities and pathological conditions in the brain. MRI generates superb image resolution/contrast without radiation exposure that is associated with computed tomography and PET; MRS and spectroscopic imaging technologies allow us to measure changes in brain biochemistry. Increasingly, neurobiologists and MRI scientists are collaborating to solve neuroscience problems across sub-cellular through anatomical levels. To achieve successful cross-disciplinary collaborations, neurobiologists must have sufficient knowledge of magnetic resonance principles and applications in order to effectively communicate with their MRI colleagues. This review provides an overview of magnetic resonance techniques and how they can be used to gain insight into the active brain at the anatomical, functional and molecular levels with the goal of encouraging neurobiologists to include MRI/MRS as a research tool in their endeavors.",Excluded
3563,The use of MR perfusion in assessing the efficacy of treatment for malignant brain tumors. [Russian],Excluded
3222,Radiation therapy of metastatic brain tumors (author's transl). [Japanese],Included
2840,"Comparison of whole-body <sup>18</sup>F FDG PET/MR imaging and whole-body <sup>18</sup>F FDG PET/CT in terms of lesion detection and radiation dose in patients with breast cancer. Purpose: To compare fluorine 18 (18F) fluorodeoxyglucose (FDG) combined positron emission tomography (PET) and magnetic resonance (MR) imaging with 18F FDG combined PET and computed tomography (CT) in terms of organ-specific metastatic lesion detection and radiation dose in patients with breast cancer. Material(s) and Method(s): From July 2012 to October 2013, this institutional review board-approved HIPAA-compliant prospective study included 51 patients with breast cancer (50 women; mean age, 56 years; range, 32-76 years; one man; aged 70 years) who completed PET/MR imaging with diffusion-weighted and contrast material-enhanced sequences after unenhanced PET/CT. Written informed consent for study participation was obtained. Two independent readers for each modality recorded site and number of lesions. Imaging and clinical follow-up, with consensus in two cases, served as the reference standard. Result(s): There were 242 distant metastatic lesions in 30 patients, 18 breast cancers in 17 patients, and 19 positive axillary nodes in eight patients. On a per-patient basis, PET/MR imaging with diffusion-weighted and contrast-enhanced sequences depicted distant (30 of 30 [100%] for readers 1 and 2) and axillary (eight of eight [100%] for reader 1, seven of eight [88%] for reader 2) metastatic disease at rates similar to those of unenhanced PET/CT (distant metastatic disease: 28 of 29 [96%] for readers 3 and 4, P = .50; axillary metastatic disease: seven of eight [88%] for readers 3 and 4, P. .99) and outperformed PET/CT in the detection of breast cancer (17 of 17 [100%] for readers 1 and 2 vs 11 of 17 [65%] for reader 3 and 10 of 17 [59%] for reader 4; P<.001). PET/MR imaging showed increased sensitivity for liver (40 of 40 [100%] for reader 1 and 32 of 40 [80%] for reader 2 vs 30 of 40 [75%] for reader 3 and 28 of 40 [70%] for reader 4; P<.001) and bone (105 of 107 [98%] for reader 1 and 102 of 107 [95%] for reader 2 vs 106 of 107 [99%] for reader 3 and 93 of 107 [87%] for reader 4; P = .012) metastases and revealed brain metastases in five of 51 (10%) patients. PET/CT trended toward increased sensitivity for lung metastases (20 of 23 [87%] for reader 1 and 17 of 23 [74%] for reader 2 vs 23 of 23 [100%] for reader 3 and 22 of 23 [96%] for reader 4; P = .065). Dose reduction averaged 50% (P<.001). Conclusion(s): In patients with breast cancer, PET/MR imaging may yield better sensitivity for liver and possibly bone metastases but not for pulmonary metastases, as compared with that attained with PET/CT, at about half the radiation dose. Copyright Â© RSNA, 2016.",Excluded
2775,"Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy. OBJECT: Patients with adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas may require a bilateral adrenalectomy to treat their Cushing's disease. Approximately one third of these patients, however, will experience progressive enlargement of the residual pituitary adenoma, develop hyperpigmentation, and have an elevated level of serum ACTH. These patients with Nelson's syndrome can be treated with Gamma Knife surgery (GKS).METHODS: The prospectively collected University of Virginia Gamma Knife database of patients with pituitary adenomas was reviewed to identify all individuals with Nelson's syndrome who were treated with GKS. Twenty-three patients with a minimum of 6 months of follow up were identified in the database. These patients were assessed for tumor control (that is, lack of tumor growth over time) with neuroimaging studies (median follow-up duration 22 months) and for biochemical normalization of their ACTH levels (median follow-up duration 50 months). Neuroimaging follow-up studies were available for 22 patients, and endocrine follow up was available for 15 patients in whom elevation of ACTH levels was documented prior to GKS. In the 22 patients in whom neuroimaging follow-up studies were available, 12 had a decrease in tumor size, eight had no tumor growth, and two had an increase in tumor volume. Ten of 15 patients with elevated ACTH levels prior to GKS showed a decrease in their ACTH levels at last follow up; three of these 10 patients achieved normal ACTH levels (< 50 pg/ml) and the other five patients with initially elevated values had an increase in ACTH levels. Ten patients were thoroughly evaluated for post-GKS pituitary function; four were found to have new pituitary hormone deficiency and six did not have hypopituitarism after GKS. One patient suffered a permanent third cranial nerve palsy and four patients are now deceased.CONCLUSIONS: Gamma Knife surgery may control the residual pituitary adenoma and decrease ACTH levels in patients with Nelson's syndrome. Delayed hypopituitarism or cranial nerve palsies can occur after GKS. Patients with Nelson's syndrome require continued multidisciplinary follow-up care. Given the difficulties associated with management of Nelson's syndrome, even the modest results of GKS may be helpful for a number of patients.",Excluded
3431,"Effects of cediranib (VEGF signaling inhibitor) on edema in newly diagnosed glioblastoma patients during initial chemoradiation. Background: A significant benefit of antiangiogenic therapy is control of brain edema. We evaluated the impact of adding cediranib to standard chemoradiation (CRT) on peritumoral edema in patients with newly diagnosed glioblastoma(GBM) during the initial 6 weeks of CRT. Method(s): Two cohorts of patients were enrolled in two clinical trials. The control group (N=13) received radiation for 6 weeks plus temozolomide. The cediranib (CED) group received standard CRT plus daily cediranib (N=34). MRIs were performed at baseline and weekly during CRT. Volumes of interest (VOIs) were drawn outlining the enhancing tumor on T1-weighted post contrast images and the abnormal FLAIR hyperintensity. ADC (apparent diffusion coefficient) maps were calculated from diffusion-weighted images and histograms of the distribution of ADC values created for each visit using the baseline FLAIR VOI to characterize the peritumoraledema. Patients were on stable or decreasing doses of steroids. Result(s): In the CED group, T1 and FLAIR VOI decreased during CRT vs controls where T1 VOI did not change and FLAIR VOI increased. By the end of CRT, the mode of the ADC histogram in the CED group shifted to the left while the mode of the controls shifted to the right. The skewness, a measure of asymmetry of the distribution, increased in the CED group and decreased in controls. Conclusion(s): In patients with newly diagnosed GBM treated with CRT and cediranib, tumor volume decreased on T1 and FLAIR images whereas the FLAIR volume significantly increased in the control group suggesting increased edema. The shift of mode to the right and decreasing skewness in controls (indicating an increase in the proportion of very high ADC values) suggests that adding cediranibprevented the development of edema and contributed to the resolution of existing edema. Preventing the edema by adding anti-VEGF treatment may improve the tolerability of CRT for GBM patients. (Table presented) .",Excluded
2872,"Yttrium-90 Radioembolization for Liver Metastasis From Neuroendocrine Cancer: A Single-Institution Retrospective Review. Purpose: Many publications can be found on the use of yttrium-90 (Y-90) transarterial radioembolization (TARE) for the treatment of primary liver cancer or liver metastasis from colorectal adenocarcinoma. It is important to study the results that could be achieved when TARE is being used to treat liver metastasis of other origin. This retrospective analysis concentrates on our institutional experience with TARE for the treatment of liver metastasis from neuroendocrine cancer. Material(s) and Method(s): Our institutional review board (IRB)-approved Y-90 databank was reviewed to identify patients with neuroendocrine cancer who received Y-90 TARE for liver metastasis from February 2011 to September 2013. Information on patient demographics, performance status, disease-related characteristics (liver panel, complete blood count [CBC], chromogranin A, and gross tumor volume [GTV] measured in cc on the most recent study pre-TARE), treatment-related parameters (Y-90 dose delivered), and treatment outcome (treatment toxicity, overall survival [OS]) were captured for this analysis. Result(s): Between February 2011 and September 2013, a total of 16 patients with metastatic neuroendocrine (liver-predominant disease) received Y-90 TARE in our institution. Eight of these patients received treatment to both liver lobes, for a total of 24 procedures. All patients had an Eastern Cooperative Oncology Group (ECOG) performance status between 0 and 2 prior to treatment. In addition, all patients had a bilirubin level below 2.0 and an albumin level above 3.0 prior to treatment. The median GTV per lobe was 299 cc (range: 27-670 cc). With a median follow-up of 16.5 months (range: 2-26 mo), the 1-year OS was 75%. There was no relationship between OS and GTV volume. Two patients with severe endocrine disorders that required repeated hospitalization (one patient with severe hypoglycemia and a second patient with hypertensive crisis) responded well to TARE, with marked improvement in their medical condition and no need for further admission postprocedure. In terms of treatment toxicity, one patient was diagnosed with a radiation-induced liver disease and died 13 months post-treatment. One patient developed a pancytopenia that was potentially related to treatment. Conclusion(s): The use of Y-90 TARE for patients with liver metastasis from neuroendocrine carcinoma is a treatment option that should be assessed in a prospective multicentric study. In this series, Y-90 TARE was associated with a high 1-year survival rate. However, patients need to be monitored closely postprocedure, since serious treatment-related toxicity could develop.",Excluded
2673,"Stereotactic radiotherapy for small and very small tumours (<=1 to <=3 cc): Evaluation of the influence of volumetric-modulated arc therapy in comparison to dynamic conformal arc therapy and 3D conformal radiotherapy as a function of flattened and unflattened beam models. Purpose: The objective of this article is to evaluate the dosimetric efficacy of volumetric modulated arc therapy (VMAT) in comparison to dynamic conformal arc therapy (DCAT) and 3D conformal radiotherapy (3DCRT) for very small volume (<=1 cc) and small volume (<=3 cc) tumours for flattened (FF) and unflattened (FFF) 6 MV beams. Material(s) and Method(s): A total of 21 patients who were treated with single-fraction stereotactic radiosurgery, using either VMAT, DCAT or 3DCRT, were included in this study. The volume categorisation was seven patients each in <1, 1-2 and 2-3 cc volume. The treatment was planned with 6 MV FF and FFF beams using three different techniques: VMAT/Rapid Arc (RA) (RA_FF and RA_FFF), dynamic conformal arc therapy (DCA_FF and DCA_FFF) and 3DCRT (Static_FF and Static_FFF). Plans were evaluated for target coverage (V100%), conformity index, homogeneity index, dose gradient for 50% dose fall-off, total MU and MU/dose ratio [intensity-modulated radiotherapy (IMRT) factor], normal brain receiving >12 Gy dose, dose to the organ at risk (OAR), beam ON time and dose received by 12 cc of the brain. Result(s): The average target coverage for all plans, all tumour volumes (TVs) and delivery techniques is 96.4 +/- 4.5 (range 95.7 +/- 6.1-97.5 +/- 2.9%). The conformity index averaged over all volume ranges <1, 2, 3 cc> varies between 0.55 +/- 0.08 and 0.68 +/- 0.04 with minimum and maximum being exhibited by DCA_FFF for 1 cc and Static_FFF/RA_FFF for 3 cc tumours, respectively. Mean IMRT factor averaged over all volume ranges for RA_FF, DCA_FF and Static_FF are 3.5 +/- 0.8, 2.0 +/- 0.2 and 2.0 +/- 0.2, respectively; 50% dose fall-off gradient varies in the range of 0.33-0.42, 0.35-0.40 and 0.38-0.45 for 1, 2 and 3 cc tumours, respectively. Conclusion(s): This study establishes the equivalence between the FF and FFF beam models and different delivery techniques for stereotactic radiosurgery in small TVs in the range of <=1 to <=3 cc. Dose conformity, heterogeneity, dose fall-off characteristics and OAR doses show no or very little variation. FFF could offer only limited time advantage due to excess dose rate over an FF beam. Copyright Â©",Excluded
2941,"Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. The objectives were to (1) prospectively evaluate fatigue utilizing validated instruments in patients with localized prostate cancer, and (2) examine the relationships between fatigue, depression, quality of life, and sleep disturbance. The instruments used included: Piper Fatigue Scale, Beck Depression Inventory, Epworth Sleepiness Scale, and Functional Assessment of Cancer Therapy for Prostate Scale. Data on cancer stage, prostate specific antigen levels, hematocrit, patient's body weight and radiation dosage were recorded. Patients were evaluated preradiotherapy, middle of radiotherapy, completion of radiotherapy, and at 4-5 weeks follow-up. Thirty-six veterans with localized prostate cancer were studied. Mean age was 66.9 years (range 55-79). Duration of treatment was 7-8 weeks. Univariate procedure and Wilcoxon Signed Rank-test were used to examine changes in pretreatment scores for each of the three subsequent study periods. To adjust for multiple comparisons Bonferroni test was used. Spearman Correlations were calculated among parameters. No significant changes were noted in mean scores of hematocrit and body weight during the study period. On the Piper Fatigue Scale, adjusted for multiple comparisons, the median scores were significantly higher at completion of radiotherapy as compared with preradiotherapy values. Three patients (8%) were experienced fatigue according to Piper Fatigue Scale before treatment as compared to nine patients (25%) at completion of radiotherapy. On Prostate Cancer Specific and Physical Well Being subscales of the Functional Assessment for Prostate Cancer Therapy, the scores were significantly lower at middle and completion of radiotherapy than at pretreatment. At preradiotherapy, middle of radiotherapy, completion of radiotherapy and follow-up evaluation, patients scoring higher on the Piper Fatigue Scale were more likely to report a poorer quality of Physical Well Being on Functional Assessment of Cancer Therapy for Prostates. No significant changes were noted in the Beck Depression Inventory and Epworth Sleepiness Scale scores during treatment. Eight patients scored 10 or more on the Beck Depression Inventory before starting radiotherapy, suggesting depressive symptomatology. Of these, only seven patients scored 10 or more at completion of treatment. The incidence of fatigue is lower in our study than in previously published data. A relationship exists between fatigue scores and physical well being subscale scores. Higher scores on the Piper Fatigue Scale at the completion of radiotherapy, as well as no changes on depression and sleepiness scales, suggest that fatigue may not be the result of depression or sleep disturbance. Based upon our previous work, we propose that the physical expression of fatigue may be secondary to a decline in neuromuscular efficiency and enhanced muscle fatigue.",Excluded
2716,"Further evidence to support disconjugate eye torsion as a predictor of space motion sickness. Disconjugate eye torsion in hypo- and hypergravity of parabolic flight was examined in four former astronauts and four previously tested ex-astronauts to replicate an earlier study and to further test the asymmetry hypothesis of otolith function. Results in the new subjects supported the asymmetry hypothesis and confirmed previous findings that those with low scores of torsional disconjugacy on the KC-135 did not suffer space motion sickness in their prior Shuttle missions while those with high scores did. Tilting subjects with high disconjugacy scores slightly to one side and the other failed to find a position that decreased disconjugacy in hypergravity, leading to the conclusion that a simple planar asymmetry about the y-axis was probably not the cause of the observed torsional differences in the two eyes. Disconjugacy increased at 0 G with increasing parabolas, much more so in subjects who had suffered SMS. Because of this, 10 to 20 parabolas were deemed to be a more certain discriminator than a fewer number.",Excluded
2968,"Small cell bladder cancer: should we consider prophylactic cranial irradiation?. PURPOSE: To describe the clinical characteristics, treatment patterns, and outcomes in patients with small cell bladder cancer at our institution, including those who received prophylactic cranial irradiation (PCI) for the prevention of intracranial recurrence.MATERIALS AND METHODS: Patients with small cell bladder cancer treated at a single institution between January 1990 and August 2015 were identified and analyzed retrospectively for demographics, tumor stage, treatment, and overall survival.RESULTS: Of 44 patients diagnosed with small cell bladder cancer, 11 (25%) had metastatic disease at the time of presentation. Treatment included systemic chemotherapy (70%), radical surgery (59%), and local radiation (39%). Six patients (14%) received PCI. Median overall survival was 10 months (IQR 4 - 41). Patients with extensive disease had worse overall survival than those with organ confined disease (8 months vs. 36 months, respectively, p = 0.04). Among those who received PCI, 33% achieved 5 - year survival.CONCLUSION: Outcomes for patients with small cell bladder cancer remain poor. Further research is indicated to determine if PCI increases overall survival in small call bladder cancer patients, especially those with extensive disease who respond to chemotherapy.",Included
3444,[Neuromuscular excitability and isonizing radiations],Included
3339,"Intracranial Injection of an Optogenetics Viral Vector Followed by Optical Cannula Implantation for Neural Stimulation in Rat Brain Cortex. Optogenetics is rapidly gaining acceptance as a preferred method to study specific neuronal cell types using light. Optogenetic neuromodulation requires the introduction of a cell-specific viral vector encoding for a light activating ion channel or ion pump and the utilization of a system to deliver light stimulation to brain. Here, we describe a two-part methodology starting with a procedure to inject an optogenetic AAV virus into rat cortex followed by a second procedure to surgically implant an optical cannula for light delivery to the deeper cortical layers.",Excluded
3525,Neuroprotective role of protein tyrosine phosphatase-1B in rod photoreceptor neurons,Excluded
3583,"The role of PET in target localization for radiotherapy treatment planning. Positron emission tomography (PET) is currently accepted as an important tool in oncology, mostly for diagnosis, staging and restaging purposes. It provides a new type of information in radiotherapy, functional rather than anatomical. PET imaging can also be used for target volume definition in radiotherapy treatment planning. The need for very precise target volume delineation has arisen with the increasing use of sophisticated three-dimensional conformal radiotherapy techniques and intensity modulated radiation therapy. It is expected that better delineation of the target volume may lead to a significant reduction in the irradiated volume, thus lowering the risk of treatment complications (smaller safety margins). Better tumour visualisation also allows a higher dose of radiation to be applied to the tumour, which may lead to better tumour control. The aim of this article is to review the possible use of PET imaging in the radiotherapy of various cancers. We focus mainly on non-small cell lung cancer, lymphoma and oesophageal cancer, but also include current opinion on the use of PET-based planning in other tumours including brain, uterine cervix, rectum and prostate. [References: 56]",Excluded
3340,"Emerging locoregional therapy. Selective internal radiation therapy (SIRT): SIRT, or radioembolization, delivers yttrium-90 (Y-90) microspheres via a catheter in the hepatic artery to treat intra-hepatic disease. SIRT takes advantage of the fact that the blood supply for much of the normal liver parenchyma arrives through the portal circulation, while tumors are preferentially fed by the arterial system. Glass- or resin-based microspheres tagged with Y-90 are delivered typically in a ""lobar"" fashion and preferentially distribute into the tumoral and peritumoral vasculature, thereby delivering a high radiation dose (>100 Gy). Because Y-90 is a beta emitter, the effect is relatively selective and mostly affects only the metastatic sites while sparing normal liver parenchyma. The two currently available Y-90 products include SIR-spheres and TheraSphere. SIR-spheres deliver a higher dose per treatment and are more embolic. In contrast, the TheraSphere product delivers a higher specific radioactivity dose per microsphere allowing for smaller dose per treatment and are not as embolic. Both products have been shown to be welltolerated. SIRT can be an effective therapy for patients with advanced hepatocellular carcinoma, as well as metastatic colorectal or neuroendocrine liver disease.",Excluded
3098,"Monte Carlo optimisation of a BNCT facility for treating brain gliomas at the TAPIRO reactor. An epithermal boron neutron capture therapy facility for treating brain gliomas is currently under construction at the 5 kW fast-flux reactor TAPIRO located at ENEA, Casaccia, near Rome. In this work, the sensitivity of the results to the boron concentrations in healthy tissue and tumour is investigated and the change in beam quality on modifying the moderator thickness (within design limits) is studied. The Monte Carlo codes MCNP and MCNPX were used together with the DSA in-house variance reduction patch. Both usual free beam parameters and the in-phantom treatment planning figures-of-merit have been calculated in a realistic anthropomorphic phantom ('ADAM'). Â© The Author 2005. Published by Oxford University Press. All rights reserved.",Excluded
2854,"[Cushing's syndrome, pituitary radiotherapy and late unilateral optic atrophy]",Included
2811,"Angiogenic response of rat hippocampal vasculature to focused ultrasound-mediated increases in blood-brain barrier permeability. Focused ultrasound (FUS) and circulating microbubbles can induce a targeted and transient increase in blood-brain barrier permeability. While preclinical research has demonstrated the utility of FUS for efficacious drug deliver to the brain, there remain gaps in our knowledge regarding the long-term response of brain vasculature to this intervention. Previous work has demonstrated transcriptional changes in hippocampal microvessels following sonication that are indicative of the initiation of angiogenic processes. Moreover, blood vessel growth has been reported in skeletal muscle following application of FUS and microbubbles. The current study demonstrates that blood vessel density in the rat hippocampus is modestly elevated at 7 and 14 d post-FUS compared to the contralateral hemisphere (7 d: 10.9 +/- 6.0%, p = 0.02; 14 d: 12.1 +/- 3.2%, p < 0.01), but returns to baseline by 21 d (5.9 +/- 2.6%, p = 0.12). Concurrently, relative newborn endothelial cell density and frequency of small blood vessel segments were both elevated in the sonicated hippocampus. While further work is required to determine the mechanisms driving these changes, the findings presented here may have relevance to the optimal frequency of repeated treatments.",Excluded
2831,"Role of thin-sliced reformatted ct imaging for acute ischemic stroke patients, do we need CT angiography before deciding for acute neurointervention?. Objective: To investigate if thin-sliced reformatted non-contrast CT scans could be reliably used to detect and measure size of the thrombus in patients with LVOs. Background(s): Thin-sliced reformatted non-contrast CT head are not considered sensitive enough for thrombus detection. CTA is done to confirm large vessel occlusion. CTA adds extra radiation and contrast. Design/Methods: Retrospective analysis of patients who underwent acute endovascular intervention for LVOs at a community based, university affiliated comprehensive stroke center during two year period (Jan 2015-Dec 2016) was done. The raw data of non-enhanced CT scans and CTAs were collected. All raw data were reconstructed with thin slices of 0.625 mm using standard GE software. Vessel diameter and clot length were measured on both CT and CTA. (5- mm maximum intensity projections of the thin slices on CT and axial/coronal projections on CTA). Each patient's CT and CTA were paired for length and diameter in millimeters. Paired two sample hypothesis test was run on SPSS. Result(s): 926 patients presented with acute ischemic stroke during the specified time period. Of those 99 were LVOs that received endovascular treatment of which, 37 had both CT and CTA done and had intracranial lesions. Mean clot length was 13.99 (SD 5.34) on thin slices CT and 14.18 (SD 5.64) on CTA. Vessel diameter was 2.83 (SD 0.54) on thin sliced CT and 2.55 (SD 0.51) on CTA. There was no significant difference in estimated clot length done on CT as compared with CTA. (P=0.601) There was significant difference in estimated vessel diameter on CT as compared with CTA. Conclusion(s): Thin-sliced reconstructions of standard cranial nonenhanced CT raw data can be reliably used to detect and measure the thrombus size in LVOs. It does slightly overestimate the vessel diameter but still making intervention planning possible. Larger multicenter trials are needed to validate our data.",Excluded
2657,"Fourier models and the loci of adaptation. First measures of sensitivity and the need for a model to interpret them are addressed. Then modeling in the Fourier domain is promoted by a demonstration of how much an approach explains spatial sensitization and its dependence on luminance. Then the retinal illuminance and receptor absorptions produced by various stimuli are derived to foster interpretation of the neural mechanisms underlying various psychophysical phenomena. Finally, the sequence and the anatomical loci of the processes controlling visual sensitivity are addressed. It is concluded that multiplicative adaptation often has effects identical to response compression followed by subtractive adaptation and that, perhaps as a consequence, there is no evidence of retinal gain changes in human cone vision until light levels are well above those available in natural scenes and in most contemporary psychophysical experiments; that contrast gain control fine tunes sensitivity to patterns at all luminances; and that response compression, modulated by subtractive adaptation, predominates in the control of sensitivity in human cone vision.",Excluded
3183,[Frequency of roentgen and chemically induced chromosome translocations in the differentiable portions of Oenothera skeins during miosis],Excluded
2904,"The neuro-immuno-cutaneous system and ultraviolet radiation. Numerous cells are closely associated with cutaneous nerve fibers, which through the action of neuropeptides are able to modulate cellular function. Anatomical and physiological links between immune cells and nerves and other cells in skin are so close that we propose the concept of a neuro-immuno-cutaneous system (NICS). Under the impact of ultraviolet radiation (UVR) virtually all properties of the NICS are modified. UVR induces melanin synthesis and immunosuppression, events in which neuropeptides, especially melanocyte stimulating hormone (MSH) and the calcitonin gene-related peptide CGRP, play a role. [References: 48]",Excluded
3128,"Treatment of brain metastases from renal cell cancer. OBJECTIVE: To evaluate disease pattern, patient characteristics, and survival in patients treated for brain metastases from renal cell carcinoma.METHODS: Retrospective analysis of all patients with brain metastases from renal cell carcinoma treated between 1983 and 2009 in northern Norway.RESULTS: The time interval between first cancer diagnosis and brain metastases was dependent on initial TNM stage (median 42 months in stage II vs. 10 months in both stage III and stage IV). Only few patients did not harbor extracranial metastases. Systemic therapy after diagnosis of brain metastases has been used in only three patients. Surgical resection and/or radiosurgery have been administered in 34% of patients, but whole-brain radiotherapy (WBRT) alone remained the cornerstone. Median survival was 4.1 months (3.7 months in the WBRT alone group, 10.1 months in the surgery and/or radiosurgery group). Two factors were significantly associated with better survival: solitary brain metastasis and age <=64 years. The prognostic impact of the recursive partitioning analysis classes was not confirmed, while the new graded prognostic assessment index performed better.CONCLUSIONS: Surgical resection and/or radiosurgery contribute to prolonged survival. As most patients harbor extracranial metastases that threaten their lives, systemic treatment theoretically might play a role in the management of these patients, but more data need to be collected to confirm the clinical impact of immunotherapy, angiogenesis inhibition, and other signal transduction inhibitor approaches.",Excluded
3476,What's hot that the other lot got,Excluded
3486,Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss,Excluded
2518,"Cumulative genetic damage in hematopoietic stem cells in a patient with a 40-year exposure to alpha particles emitted by thorium dioxide. Thorotrast, a colloidal suspension of the long-lived radionuclide, thorium-232, was widely used as a radiographic contrast medium for several decades. Due to the poor excretion of the sol, however, Thorotrast would deposit in the liver, bone marrow and other tissue, and patients would receive alpha-particle irradiation for life. To gauge the cumulative genetic damage to hematopoietic stem cells due to chronic exposure to alpha particles, we conducted a multi-end-point evaluation in a 72-year-old man who had been administered a 32-ml bolus of Thorotrast during cerebral angiography performed over 40 years ago in 1950. Peripheral T lymphocytes were cultured to quantify the frequencies and cellular distributions of asymmetrical and symmetrical types of chromosome aberrations in first-division metaphases and micronuclei in cytokinesis-arrested interphase II cells. Aberrations were scored using classical chromosome group analysis methods and chromosome painting techniques. Assays of glycophorin-A (GPA) mutations in red blood cells were also performed to obtain a relative measurement of damage sustained by the erythroid stem cell population. Results revealed that approximately 30% of the lymphocytes in this patient contained one or more chromosome aberrations, the majority of which were of the ""stable"" type. About one-third of the lymphocytes with chromosome damage carried multiple aberrations, suggesting that significant numbers of stem cells survive exposures to alpha-particle radiation that induce complex genomic alterations. Increased frequencies of GPA mutations were observed, demonstrating that genomic damage is also induced in erythroid progenitors. The numbers of micronuclei in lymphocytes were only moderately increased compared to expected values for persons of comparable age, and thus this end point was not useful for quantifying exposure level. Despite the relatively severe burden of somatic cell damage induced by 40 years of internal alpha-particle irradiation, the patient remains surprisingly free of any serious illness.",Excluded
2947,"Image-guided stereotactic radiotherapy in 4 dogs with intracranial neoplasia. The purpose of this study was to describe the use, and side effects, of a novel stereotactic radiotherapy protocol using TomoTherapy( R) in 4 dogs with confirmed or suspected primary extra-axial intracranial neoplasia. Three fractions of 8 Gy were prescribed. Acute side effects were noted in 1 dog; no late effects were noted.",Excluded
3377,"Direct Parametric Reconstruction for Improved Characterization of Neurotransmitter Release using Dynamic PET. Objectives: Kinetic analyses of dynamic PET data with reversibly binding receptor-ligand radiotracers can be used to detect endogenous neurotransmitter (NT) releases elicited by cognitive tasks or drug stimulation. Conventionally, NT release is characterized by fitting time-activity curves (TACs) with an appropriate kinetic model such as LSRRM (Alpert et al 2003), an extension of the simplified reference region model that incorporates time-varying binding due to tracer displacement by NT. A limitation of this 'indirect' approach, however, is the poor signal-to-noise ratio (SNR) of the estimated parametric images. In the current work, we developed a method for estimation of LSRRM parametric maps with significantly higher SNR by direct parameter estimation from raw dynamic PET projection data. We conducted simulation and human C-raclopride studies to evaluate the performance of this method against the standard indirect method. Method(s): A numerical phantom comprised of 22 different brain regions including 7 striatal sub-divisions was created using the MNI atlas. Kinetic parameters values were assigned to each brain region based on measurements performed on 16 subjects studied with C-raclopride. Dopamine (DA) release was simulated in the striatum (executive area). LSRRM was used to generate the corresponding 4-D (i.e., 3-D + time) activity images which were then forward-projected to produce noise-free dynamic sinograms. Attenuation, detector sensitivity, point spread function and radioactive decay were modeled during sinogram data generation. After scaling to standard counts levels, Poisson noise was added to the sinograms to achieve noise levels comparable to our human studies. For empirical evaluation, a 45-min human study was conducted on the Siemens mMR camera using C-raclopride (13.5mCi). A reward task was started ~27 min after radiotracer injection to induce striatal DA release. For both simulation and human studies, parametric images of binding potential with non-displaceable reference (BP<inf>ND</inf>) and magnitude of DA release (gamma) were computed using the indirect method and the proposed direct method. For the indirect approach, parameters were estimated by pixel-wise application of LSRRM using the cerebellum as a reference tissue input and weighted least-squares fitting of TACs obtained following fully-3D dynamic OSEM reconstruction. No post-reconstruction smoothing was included. For the direct method, parameters were directly estimated from the dynamic sinograms by preconditioned conjugate gradient based optimization of a four-dimensional Poisson log-likelihood objective function incorporating LSRRM kinetics and accounting for the effects of attenuation, sensitivity, scatter and randoms. Result(s): In simulation studies, the indirect method estimated striatal BP<inf>ND</inf> and gamma with 7.8% and 79.2% bias, respectively. For the direct reconstruction, bias was reduced to 6.9% and 5.5% for striatal BP<inf>ND</inf> and gamma estimates, respectively. Coefficients of variation ('CV', i.e. pixel-wise variability) of striatal BP<inf>ND</inf> and gamma estimates were 65.3% and 72.0% for the indirect method as compared to 17.4% and 17.9% for the direct method. Likewise, in the human study, the direct method yielded BP<inf>ND</inf> and gamma images with improved SNR. CV of BP<inf>ND</inf> and gamma estimates in the putamen were 71.4% and 91.4% for the indirect method and 32.9% and 37.6% for the direct method. Conclusion(s): Direct reconstruction can reduce bias and increase the SNR of parametric images. The method has the potential to improve the characterization of localized neurotransmitter release, potentially allowing detection of weaker effects, reducing the needed sample size, or reducing radioactivity dose to facilitate repeated experiments or minimize radiation exposure.",Excluded
3111,"Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. OBJECTIVE: RADPLAT (concurrent selective supradose intraarterial cisplatin and external-beam irradiation) delivers extraordinarily high cisplatin concentration to head and neck structures. This study was designed to quantify and compare RADPLAT and systemic chemoradiation treatment effects on swallowing and speech.METHODS: Videofluorographic swallowing studies and articulation testing of 14 head and neck cancer patients treated with RADPLAT were compared with 16 treated with systemic chemoradiation 1 month after treatment.RESULTS: RADPLAT and systemic chemoradiation patients did not differ significantly on most swallow outcome measures, and there was significantly less aspiration on 1 and 3 mL liquid for RADPLAT individuals. Speech function was comparable except for RADPLAT's significantly worse /s, z/ productions.CONCLUSIONS: Increased concentration of cisplatin to the head and neck did not result in generally reduced swallowing or articulatory function.",Excluded
2734,"Significant reduction of beta-amyloid in the CNS following external radiation: Implications for treatment in alzheimer's disease. Purpose/Objective(s): Alzheimer's disease (AD), the most frequent form of dementia in the elderly population, is characterized by the progressive accumulation of extracellular beta-amyloid (Ab) plaques and neurofibrillary Tau protein tangles. These events are especially prevalent in the hippocampus region which is responsible for long term memory. In this animal study, we investigated if cranial X-irradiation could reduce the formation of Ab plaques as a potential novel clinical treatment for Alzheimer's disease, the rationale being that external beam radiotherapy has been used previously as an effective clinical treatment for systemic amyloidosis. Materials/Methods: A transgenic mouse model was used that expresses a chimeric mouse/human amyloid precursor protein (Mo/HuAPP695swe) and a mutant human presenilin 1 (PS1-dE9) both directed to CNS neurons. Both mutations are associated with early-onset AD. Radiation treatments were either a single dose (5 Gy, 10 Gy or 15 Gy) or daily fractionation (1 Gy, 2 Gy) to a dose of 10 Gy to a single side of the head. Brains were harvested at various times post-irradiation (2-8 wks) and coronal sections were evaluated for H&E and antibody specific immunohistochemistry to detect beta-amyloid plaques and assess radiation response, staining for IL1, TGF-beta, TNF-alpha, microglia cells (CD11b) and activated microglia cells (CD68). Result(s): Radiation treatments were well-tolerated. H&E stained tissue sections indicated no evidence of a significant decrease in cell density (Nissl staining) and no compelling evidence of significant cellular necrosis. No signs of devitalization, malacia or spongiosus or classic acute or chronic inflammatory features were evident. The number and size of beta-amyloid plaques were compared between the irradiated and shielded halves of the brain. The average number of plaques in the unirradiated brain increased with age, the values for 32, 34 and 38 week old animals were 43.9 (SD +/- 17.6; n = 9), 61.7 (SD +/- 19.8, n = 9) and 109 (SD +/- 26.9, n = 9) respectively. Radiation treatment was associated with a statistically significant reduction of plaques throughout the brain (paired t-test p = 0.002).This effect was more significant in the hippocampus region (p = 0.0004). At 4 weeks post-treatment 5, 10 and 15 Gy caused a 71 +/- 3%, 87 +/- 24%, 92 +/- 34% reduction in plaque incidence in the hippocampus. The greatest reductions were noted at longer times post-treatment. TGF-beta staining was restricted to the irradiated side of the brain, little or no site-specific staining of IL1 or TNF-alpha was seen. A trend was evident of activated microglia in the irradiated brain. Conclusion(s): We report the first experience that external beam irradiation can produce a significant reduction in beta-amyloid plaques associated with AD.",Excluded
2431,"Lack of depolarization-induced suppression of inhibition (DSI) in layer 2/3 interneurons that receive cannabinoid-sensitive inhibitory inputs. In layer 2/3 of neocortex, brief trains of action potentials in pyramidal neurons (PNs) induce the mobilization of endogenous cannabinoids (eCBs), resulting in a depression of GABA release from the terminals of inhibitory interneurons (INs). This depolarization-induced suppression of inhibition (DSI) is mediated by activation of the type 1 cannabinoid receptor (CB1) on presynaptic terminals of a subset of INs. However, it is not clear whether CB1 receptors are also expressed at synapses between INs, and whether INs can release eCBs in response to depolarization. In the present studies, brain slices containing somatosensory cortex were prepared from 14- to 21-day-old CD-1 mice. Whole cell recordings were obtained from layer 2/3 PNs and from INs classified as regular spiking nonpyramidal, irregular spiking, or fast spiking. For all three classes of INs, the cannabinoid agonist WIN55,212-2 suppressed inhibitory synaptic activity, similar to the effect seen in PNs. In addition, trains of action potentials in PNs resulted in significant DSI. In INs, however, DSI was not seen in any cell type, even with prolonged high-frequency spike trains that produced calcium increases comparable to that seen with DSI induction in PNs. In addition, blocking eCB reuptake with AM404, which enhanced DSI in PNs, failed to unmask any DSI in INs. Thus the lack of DSI in INs does not appear to be due to an insufficient increase in intracellular calcium or enhanced reuptake. These results suggest that layer 2/3 INs receive CB1-expressing inhibitory inputs, but that eCBs are not released by these INs.",Excluded
2647,"Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. PURPOSE: To analyze the factors that affect survival in patients with brain metastases (BM) from breast cancer who were treated with whole brain radiotherapy (WBRT).METHODS AND MATERIALS: We identified 116 women with breast cancer who were treated with WBRT alone between February 1984 and September 2000. All patients had treatment and follow-up data available in their medical charts, which we extracted for this retrospective study. We evaluated a number of potential predictors of survival after WBRT: age, primary tumor stage, control of primary tumor, presence of other systemic metastases, site of systemic metastases, Karnofsky performance status, Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis class, total dose of WBRT, and number of BM. Eighteen patients received a total dose >3000 cGy and 7 received a partial brain boost.RESULTS: For the entire cohort, the median survival from the start of WBRT was 4.2 months. The 1-year survival rate was 17%, and the 2-year survival rate was 2%. Using univariate analysis, only Karnofsky performance status (p = 0. 0084), recursive partitioning analysis class (p = 0. 0147), and total WBRT dose (p = 0.0001) were predictive of longer survival. In multivariate analysis, Karnofsky performance status was the only significant predictor.CONCLUSION: Overall survival in breast cancer patients with BM treated with WBRT is poor. We recommend breast cancer patients with BM be enrolled in prospective trials to improve results.",Excluded
2635,"Pain management of lumbosacral plexopathy with the new anticonvulsant gabapentin. [German]. Clinical manifestation of radiation-induced lumbosacral plexopathy (LSP) remain a rare event. Paintreatment is mainly supportive. Recovery with LSP is less satisfactory and occurs over months to years, but may be incomplete. A 59-year old man was referred for intermittent, neuralgic pain localized to the right gluteal region and leg. He also developed slight neurologic symptoms such as numbness, paraesthesias and a slight weakness of the right leg. The symptoms had begun 6 months after radiation therapy after prostatectomy for prostate carcinoma. There were no antecendent back or hip injuries. There was a right Lasegue sign. On the visual analog scale pain ranks between 0 (rest) and 8-10 (attack) were recorded. Needle electromyography showed denervation in gluteus medius and maximus, biceps femoris, quadriceps femoris, tibialis ant and peroneus longus. Normal laboratory studies included urin analysis, complete blood count, erythrocyte sedimention rate, serumglucose, electrolytes, rheumatoid factor, and protein electrophoresis. Pelvic computed tomography (CT) was normal. Lumbosacral MRI was not performed. Liver- and renal enzymes were elevated. On admission the patient was treated with diclofenac (2 x 50 mg/d) and carbarnazepine (3 x 200 mg). Gabapentin was chosen because it is well tolerated and it appears to have a favorable efficacy-to-toxicity ratio. He was then started on gabapentin, 100 mg given orally three times daily. 60 minutes after the first dose of gabapentin, the patient had a significant pain relief that lasted 6 h. The gabapentin dose was increased to 300 mg three times daily. After 6 months he continued to report good pain relief with minimal sedating side effects on a regimen of 3 x 300 mg/d gabapentin. To our knowledge this is the first case report of LSP which was successfully treated with the novel anti-epileptic drug gabapentin.",Excluded
3003,"Extracellular spike microrecordings from the subthalamic area in Parkinson's disease. Intraoperative neuronal microrecordings can help in localizing the subthalamic nucleus (STN) during stereotactic neurosurgery for deep-brain stimulation (DBS) in Parkinson's disease. To obtain quantitative information on neuronal spike descriptors, we systematically analysed neuronal spikes in the STN and substantia nigra pars reticulata (SNr) in 31 sides of the brain in awake patients undergoing stereotactic neurosurgery for DBS electrode implantation. In these two structures we evaluated spike amplitude, area, duration, rise time and mean total firing rate. The recording spike density was higher in the STN than in the SNr (94% vs. 28%). Microelectrode recordings showed a larger spike area and amplitude in the SNr than in the STN ([mean+/-SD] amplitude: 46.7+/-31.1 vs. 36.3+/-29.6 microV; area: 25.6+/-24.2 vs. 36.7+/-21.4 microVmsec), a higher total firing rate at rest in the SNr than in the STN (78.6+/-53.5 vs. 61.9+/-40.8 Hz), and a longer duration and rise time in the SNr than in the STN (duration: 2.0+/-1 vs. 1.3+/-0.6 ms; rise time: 0.95+/-0.6 vs. 0.67+/-0.3 ms). Our analysis also revealed sex-related differences in the studied spike descriptors, paralleling recent findings from deep electroencephalography recordings. In the STN, males had larger spike area and amplitude (amplitude: 41.97+/-32.57 vs. 26.2+/-19.7 microV; area: 31.8+/-26.4 vs. 13.0+/-10.6 microVmsec), whereas females had higher mean total firing rate (66.7+/-53.4 vs. 82.8+/-50.8 Hz). Our results have implications for clinical practice and the development of algorithms for the neurophysiological identification of the STN during stereotactic neurosurgery for Parkinson's disease, based on the on-line automated computation of multiple spike-variables.",Excluded
2523,"X-ray therapy promotes structural regeneration after spinal cord injury in a rat model. OBJECTIVE: This study aims to investigate the therapeutic effects and mechanisms of x-ray treatment on rats following spinal cord injury (SCI).METHODS: Forty-six female Sprague-Dawley rats were subjected to spinal cord injury using the modified Allen weight-drop method. The animals were randomly divided into six groups. Two of the animal groups were irradiated with 10 Gy at the lesion site; another two groups were irradiated with 20 Gy; and the last two groups without irradiation were regarded as the sham group. One of the each of two animal groups was euthanized at different time points at 4 and 12 weeks, respectively, after irradiation. Spinal cord calluses were assessed using kinology and electrophysiology and histology methods.RESULTS: In all of the groups, the neurofilament (NF) counts at 14 weeks were found to be higher than that at 6 weeks after SCI. Both 10-Gy irradiated and 20-Gy irradiated groups were higher than those of the sham group at each time point (P < 0.05). The myelin basic protein (MBP) count decreased at 14 weeks after SCI in the irradiated groups (P < 0.05) but increased at 14 weeks in the sham group (P < 0.05). Furthermore, the MBP count of the irradiated groups was lower than that of the sham group at 14 weeks (P < 0.05). The glial fibrillary acidic protein (GFAP) and Nogo-A counts at 14 weeks were higher than those at 6 weeks in all the groups (P < 0.05), and there was no statistical significance with kinology and electrophysiology tests in all groups.CONCLUSIONS: A self-repair mechanism exists after spinal cord injury, which lasts at least 14 weeks. X-ray therapy promotes the regeneration of the spinal cord system after injury.",Excluded
3118,"DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)-A randomized phase III doubleblind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation. Background: Radiation therapy (RT), plus androgen deprivation therapy (ADT) with a luteinizing hormone releasing hormone analogue (LHRHA), is standard of care for men with very high-risk localized prostate cancer (PC), or with very high- risk features and persistent PSA after radical prostatectomy (RP). Despite this, incurable distant metastases develop within 5 years in 15% of men with very high-risk features. Darolutamide is a structurally distinct oral androgen receptor antagonist with low blood-brain-barrier penetration, a demonstrated favorable safety profile and low potential for drug-drug interactions. Our aim is to determine the efficacy of adding darolutamide to ADT and RT in the setting of either primary definitive therapy, or adjuvant therapy for very high-risk PC. Method(s): This study is a randomized (1:1) phase III placebo-controlled, double-blind trial for men planned for RT who have very high-risk localized PC; or very high-risk features with PSA persistence or rise within one year following RP. The trial will be stratified by: RP; use of adjuvant docetaxel; pelvic nodal involvement. 1100 participants will be randomized to darolutamide 600 mg or placebo twice daily for 96 weeks. Participants will receive LHRHA for 96 weeks, plus RT starting week 8-24 from randomisation. Participants are allowed nonsteroidal antiandrogen (up to 90 days) in addition to LHRHA up until randomisation. Early treatment with up to 6 cycles of docetaxel completed at least 4 weeks prior to RT is permitted. The primary endpoint is metastasis-free survival (ICECaP-validated), with secondary endpoints overall survival, PC-specific survival, PSA-progression free survival, time to subsequent hormonal therapy, time to castrationresistance, frequency and severity of adverse events, health related quality of life, fear of recurrence. Tertiary endpoints include incremental cost-effectiveness, and identification of prognostic and/or predictive biomarkers of treatment response, safety and resistance to study treatment.",Excluded
2819,"Audiometric outcomes for acoustic neuroma patients after single versus multiple fraction stereotactic irradiation. OBJECTIVE: To compare tumor control and changes in audiometric parameters of acoustic neuroma patients treated with either linac-based stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT) at Allegheny General Hospital.STUDY DESIGN: Twenty-three patients with acoustic neuroma were treated between February 2003 and April 2009 with either SRS (n = 13) or SRT (n = 10). The median age for all patients was 69 years and the median size of lesions was 1.2 cm (range 0.5-2.2 cm). The prescribed dose was a single dose of 1250 cGy for all SRS patients compared to 2500 cGy in 5 daily fractions for SRT patients. All patients had pre- and post-procedure audiometry including hearing acuity assessed using pure tone average (PTA), speech discrimination score (SDS), and speech reception threshold (SR). The results of treatment type and tumor variables resulting in hearing degradation were evaluated and compared.RESULTS: At a median follow-up of 13 months (range 3-36 months), only 1 of 13 patients treated with SRS and 2 of 10 patients treated with SRT develped progression of disease. However; all patients developed deterioration in PTA, SDS, or SR on the treated side. There were no statistically significant audiometric differences between patients treated with SRT or SRS and tumor response was similar regardless of irradiation technique.CONCLUSION: Both SRS and SRT provide excellent local control rates for the treatment of acoustic neuroma. While SRS demonstrated a trend toward worsening of SDS and the treatment of lesions >1.2 cm demonstrated a trend toward worsening of PTA, neither reached statistical significance. Our data suggest that single dose irradiation using the SRS technique should be considered primarily for patient convenience. All patients treated with radiotherapy for acoustic neuromas should undergo formal hearing testing before and after treatment.",Excluded
3120,"Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. On intracerebral infection with the BeAn strain of Theiler's murine encephalomyelitis virus (TMEV), certain mouse strains develop a chronic demyelinating disease similar both clinically and pathologically to human multiple sclerosis. Other strains remain resistant. We previously established that differential susceptibility to this demyelinating disease exists among BALB/c substrains, with BALB/cAnNCr mice being susceptible while BALB/cByJ mice are resistant. BALB/cByJ mice are rendered susceptible to TMEV-induced demyelination on exposure to low dose gamma-irradiation before TMEV infection. BALB/cAnNCr and irradiated, infected BALB/cByJ animals are protected against TMEV-induced demyelination by the transfer of a splenic population from TMEV-infected BALB/cByJ donors. Resistance to demyelination appears to be mediated by a CD8+ radiosensitive population, which is induced on infection with TMEV and which must act early to establish resistance to TMEV-induced demyelination.",Excluded
2939,[X-ray diagnosis of the volvulus of the right colon],Excluded
2742,"Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot Study. OBJECTIVES: Epilepsy heavily affects the quality of life (QoL) of patients with brain tumor because in addition to taking treatments for the oncological illness, patients are required to live with the long-term taking of antiepileptic drugs (AEDs). The AEDs' adverse effects are common in these patients and can negatively influence their perceptions of their QoL. We conducted an observational pilot study in patients with brain tumor-related epilepsy to verify efficacy, tolerability, and impact on QoL and global neurocognitive performances of zonisamide (ZNS) in add-on.MATERIALS AND METHODS: We recruited 13 patients (5 females, 8 males; mean age, 49.6 years) presenting uncontrolled seizures. At first visit and at final follow-up at 6 months, patients underwent neurological examination, evaluation of adverse events, and cognitive and QoL tests. A seizure diary was given.RESULTS: Eight patients underwent chemotherapy, 3 underwent radiotherapy, and 5 had disease progression. Mean dosage of ZNS at final follow-up was 300 mg/d.Of 9 patients who reached the sixth month follow-up, the mean weekly seizure number before ZNS had been 3.2 +/- 5.0, and at final follow-up, the mean weekly seizure number was 0.18 +/- 0.41 (P = 0.05). Compared with baseline, we observed stability in all cognitive domains, except for verbal fluency that significantly worsened. Results on QoL tests showed that QoL remained unchanged over time, which could indicate that ZNS did not influence the patients' perceived QoL.CONCLUSIONS: Zonisamide as add-on in our patients seems to be well tolerated and efficacious in controlling seizures. Despite having limitations represented by the fact that our study is observational, with a small study population and a short follow-up period, our results confirm that when choosing an AED, in addition to efficacy, the drug's effect on patients' QoL also needs to be considered, especially for patients facing many psychosocial challenges, such as those with brain tumor-related epilepsy.",Excluded
2640,"Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM). UNLABELLED: Iodine-123-(S)-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl) methyl] benzamide ([123I]-(S)-IBZM) is a radiolabeled benzamide usually employed to study neuropsychiatric disorders, such as schizophrenia and Parkinson's disease. The ectodermic origin of melanocytes and the presence of melanin in the substantia nigra are the theoretic basis of the experimental use of this class of tracers for melanoma imaging.METHODS: Eleven patients with proven metastatic melanoma entered the study. Whole-body and planar scintigrams were performed 2, 4 and 24 hr after intravenous injection of a mean tracer activity of 205 MBq. The dosimetric evaluation was performed by the Medical Internal Radiation Dose Committee method.RESULTS: The [123I]-(S)-IBZM scans allowed the detection of all six cutaneous lesions, five of six superficial pathologic lymph nodes, four of five pulmonary and one of two hepatic metastases. The maximum tumor-to-background ratio was 2.6 in planar images. The hepatobiliary excretion of the tracer may limit detection of intra-abdominal lesions. Dosimetry is similar to data for nononcologic patients.CONCLUSION: Although it is unclear if the mechanism of radiopharmaceutical uptake in melanoma is due to binding to membrane receptors or due to interactions with intracellular structures, radiolabeled benzamide is a promising tracer to detect melanoma.",Excluded
2567,"MiR-149-3p inhibits the glioma stem cellphenotype and re-sensitizes therapy-resistant GBM cells. Intra-tumor heterogeneity presents one of the biggest challenges in the development of solid cancer therapeutics. Cells within the same tumor display distinct phenotypes that affect their growth rate, survival, migration, therapy-response, and tumor-propagating capacity. We now understand cancer stem cells (CSCs) play critical roles in driving intra-tumor cellular heterogeneity by establishing dynamic cellular transitions within tumors. GBM are highly aggressive tumors that display a poorly differentiated cell phenotype characterized by high expression of genes enriched in embryonic stem cells (ESCs). Lineage-tracing experiments show that stem-like cells are responsible for GBM re-growth after therapy and this process is in part mediated by known drivers of stemness (e.g. Sox2). There is a strong correlation between the expression of stem cell drivers and markers and tumor recurrence in multiple cancers, including GBM. We and others have established that reprogramming transcription factors Oct4 and Sox2 are important drivers of the stem-cell, tumor and therapy-resistant phenotype in GBM. We present data showing that GBM cells expressing transgenic Oct4 and Sox2 are more resistant to ionizing radiation (IR) treatment and exposing GBM neurospheres to temozolomide (TMZ) and IR gives rise to a cell sub-set with higher gene expression levels of Oct4 and Sox2 compared to untreated cells. The clinical and potential therapeutic relevance of this phenotype is supported by multi-dimensional transcriptome analyses that identifies a group of genes induced by Oct4 and Sox2 enriched in recurrent GBM. The promiscuous quality of miRNAs is an underexploited characteristic that could allow the targeting of multiple parallel oncogenic pathways using a single agent, enhancing therapeutic efficacy and reducing chances of tumor recurrence. To explore this untapped potential, we predicted miRNAs likely to target the transcripts induced by Oct4/Sox2 in recurrent GBM and identified miR-149-3p as a high-priority candidate. Importantly, transient expression of miR-149-3p simultaneously repressed these transcripts in GSCs as measured by qRT-PCR, concurrent with a decrease in the capacity of both parental and GSCs expressing transgenic Oct4/Sox2 to self-renew as spheres, a biomarker of cell stemness and tumor-propagating potential. Additionally, transient expression of miR-149-3p also re-sensitized therapy-resistant GBM neurospheres to TMZ treatment. These results show this resistant phenotype is reversible and support our hypothesis that GSC-driving mechanisms induce a subset of genes that give rise to therapy-resistant GBM cells and suggests that miR-149-3p can be developed as a therapeutic for recurrent GBM.",Excluded
3028,"Radiation-induced cerebral aneurysm successfully treated with endovascular coil embolization. In a 30-year-old male, multiple cerebral aneurysms developed 19 years after receiving 60 Gy of irradiation for craniophariginoma. Angiogram revealed right IC-PC and upper basilar trunk aneurysms in addition to atherosclerotic change. The right IC-PC aneurysm was wrapped and the basilar trunk aneurysm located between the origins of SCA and AICA was treated by endovascular coil embolization. The packing of the aneurysm was complete, but stenosis of the basilar artery appeared. The patient was discharged uneventfully and follow-up angiogram 6 months later demonstrated that the aneurysm had disappeared and the patency of the basilary artery had been preserved. Radiation-induced intracranial vasculopathy is a well-recognized phenomenon, but aneurysm formation is less common than arterial occlusive lesion. However, the mortality rate after bleeding is so high that immediate diagnosis and treatment by direct surgery or coil embolization are necessary.",Excluded
2634,"Solution X-ray scattering evidence for agonist- and antagonist-induced modulation of cleft closure in a glutamate receptor ligand-binding domain. Agonist-induced conformational changes in the ligand-binding domains (LBD) of glutamate receptor ion channels provide the driving force for molecular rearrangements that mediate channel opening and subsequent desensitization. The resulting regulated transmembrane ion fluxes form the basis for most excitatory neuronal signaling in the brain. Crystallographic analysis of the GluR2 LBD core has revealed a ligand-binding cleft located between two lobes. Channel antagonists stabilize an open cleft, whereas agonists stabilize a closed cleft. The crystal structure of the apo form is similar to the antagonist-bound, open state. To understand the conformational behavior of the LBD in the absence of crystal lattice constraints, and thus better to appreciate the thermodynamic constraints on ligand binding, we have undertaken a solution x-ray scattering study using two different constructs encoding either the core or an extended LBD. In agreement with the GluR2 crystal structures, the LBD is more compact in the presence of agonist than it is in the presence of antagonist. However, the time-averaged conformation of the ligand-free core in solution is intermediate between the open, antagonist-bound state and the closed, agonist-bound state, suggesting a conformational equilibrium. Addition of peptide moieties that connect the core domain to the other functional domains in each channel subunit appears to constrain the conformational equilibrium in favor of the open state.",Excluded
3191,"Structural and enzymatic aspects of rhodopsin phosphorylation. Photoactivated rhodopsin (Rho*) is phosphorylated near the C terminus at multiple sites, predominantly at Ser334, Ser338, and Ser343. We systematically examined the sites of phosphorylation upon flash activation of Rho in rod outer segment (ROS) homogenates. Addition of an inhibitory antibody against rhodopsin kinase (RK) lowered phosphorylation at Ser334, Ser338, and Ser343, without changing the ratio between phosphorylation sites. In contrast, no effect of protein kinase C was detected after stimulation (by a phorbol ester), inhibition (with H7), or reconstitution of protein kinase C with purified ROS membranes. The stoichiometry and the ratio between different phosphorylation sites in purified Rho were also reproduced using RK, purified to apparent homogeneity from ROS or from an insect cell expression system. Thus, we conclude that light-dependent phosphorylation of Rho is mediated primarily by RK. Depalmitoylation of Rho at Cys322 and Cys323 altered the conformation of the C terminus of Rho, as observed by phosphorylation by casein kinase I, but did not affect phosphorylation by RK. The sites of phosphorylation were influenced, however, by the presence of four conserved amino acids at the C terminus of Rho. The accumulation of phosphorylated Ser334 observed in vivo could result from slower dephosphorylation of this site as compared with dephosphorylation of Ser338 and Ser343. These data provide a molecular mechanism for the site-specific phosphorylation of Rho observed in vivo.",Excluded
2835,"Action of gamma-aminobutyric acid (GABA) in the isolated photosensory pineal organ. The effect of GABA (gamma-aminobutyric acid), its agonists (muscimol, baclofen) and antagonist (bicuculline) on pineal ganglion cells of the luminosity type were studied in the isolated, superfused pineal organ of the rainbow trout, Oncorhynchus mykiss. Extracellular recordings revealed that GABA added through the superfusion medium caused a clear alteration of the activity of projecting neurons, which transmit luminosity responses to the brain. Spontaneous discharges of ganglion cells were predominantly suppressed by GABA (33 neurons out of 48), but 10 neurons were clearly excited. Similar effects were observed after addition of muscimol, but not of baclofen. Bicuculline reversed the GABA and muscimol induced inhibition or excitation. In 4 neurons of the luminosity type, GABA caused bidirectional, inhibitory and excitatory responses depending on the state of light- or dark-adaptation. These observations suggest a role of a GABAergic mechanism in the generation and transmission of luminosity responses in the trout pineal organ. It appears that GABA participates in the modulation of light sensitivity during light- and dark-adaptation processes and that this action is mediated by GABAA receptors.",Excluded
2483,"Improvement of dexterity by single session low-frequency repetitive transcranial magnetic stimulation over the contralesional motor cortex in acute stroke: a double-blind placebo-controlled crossover trial. PURPOSE: Increasing evidence suggests that the contralesional motor cortex (M1) inhibits the ipsilesional M1 in stroke patients. This inhibition could impair motor function of the affected hand. We investigated if inhibitory 1~Hz repetitive transcranial magnetic stimulation (rTMS) over the contralesional M1 improved motor performance of the affected hand in acute stroke.METHODS: A double-blind study of real versus placebo rTMS was conducted. Twelve patients early after subcortical stroke (mean: 7 days) received 1200 stimuli of real and placebo rTMS in a crossover design. The sequence of stimulations was counterbalanced across subjects. Stimulus intensity was subthreshold (90% of motor threshold at rest). Motor function was tested by grip strength recordings and Nine Hole Peg Test (NHPT) executions before and after each rTMS session.RESULTS: Compared to sham stimulation, real rTMS improved NHPT results but not grip strength in the affected hand. No change of performance was observed for the unaffected hand. NHPT baseline repetitions in a subgroup of patients indicated stable motor performance prior to the rTMS sessions.CONCLUSIONS: The study suggests that therapeutic rTMS applications over the contralesional hemisphere are feasible in acute stroke patients and can transiently improve dexterity of the affected hand. RTMS may become an additional tool for early neurorehabilitation.",Excluded
3176,Top-down control of dyskinesias in PD using brain stimulation,Excluded
2470,"Light-Dependent OCT Structure Changes in Photoreceptor Degenerative rd 10 Mouse Retina. Purpose: Using optical coherence tomography (OCT) to analyze the effects of light/dark adaptation in a mouse model of inherited photoreceptor degeneration (rd10), and to study dynamics of subretinal fluid during the progress of retinal degeneration.Methods: rd10 and wild-type (WT) C57BL/6J mice were reared in cyclic light or darkness and imaged with Bioptigen UHR-OCT or Spectralis HRA+OCT after adaptation to either light or darkness.Results: OCT images from rd10 mice were analyzed at three progressive stages of degeneration. After light-adaptation, stage I (postnatal age [P]26-29) eyes demonstrated no apparent subretinal fluid. At stage II (P32-38), subretinal fluid was present and restricted to parapapillary area, while at stage III (P44-45) extensive subretinal fluid was present across many retinal areas. Following overnight dark-adaptation, WT eyes showed a large reduction in outer retinal thickness (4.6 +/- 1.4 mum, n = 16), whereas this change was significantly smaller in stage I rd10 eyes (1.5 +/- 0.5 mum, n = 14). In stage II rd10 eyes, dark-adaptation significantly reduced the extent of subretinal fluid, with the amount of reduction correlating with the amount of fluid pre-existing in the light-adapted state. However, dark-adaptation did not significantly alter the amount of subretinal fluid observed in stage III rd10 mice. In addition, dark-rearing of rd10 mice from P6 to P30 slowed retinal degeneration.Conclusions: Visual experience in the form of light/dark adaptation exerts a significant effect on outer retinal structure in the context of photoreceptor degeneration. This effect may arise from light-dependent alterations in fluid transport across the RPE monolayer, and promote photoreceptor survival as induced by dark-rearing.",Excluded
2620,"Extremely Low-Frequency Electromagnetic Fields Promote In Vitro Neuronal Differentiation and Neurite Outgrowth of Embryonic Neural Stem Cells via Up-Regulating TRPC1. Exposure to extremely low-frequency electromagnetic fields (ELF-EMFs) can enhance hippocampal neurogenesis in adult mice. However, little is focused on the effects of ELF-EMFs on embryonic neurogenesis. Here, we studied the potential effects of ELF-EMFs on embryonic neural stem cells (eNSCs). We exposed eNSCs to ELF-EMF (50 Hz, 1 mT) for 1, 2, and 3 days with 4 hours per day. We found that eNSC proliferation and maintenance were significantly enhanced after ELF-EMF exposure in proliferation medium. ELF-EMF exposure increased the ratio of differentiated neurons and promoted the neurite outgrowth of eNSC-derived neurons without influencing astrocyes differentiation and the cell apoptosis. In addition, the expression of the proneural genes, NeuroD and Ngn1, which are crucial for neuronal differentiation and neurite outgrowth, was increased after ELF-EMF exposure. Moreover, the expression of transient receptor potential canonical 1 (TRPC1) was significantly up-regulated accompanied by increased the peak amplitude of intracellular calcium level induced by ELF-EMF. Furthermore, silencing TRPC1 expression eliminated the up-regulation of the proneural genes and the promotion of neuronal differentiation and neurite outgrowth induced by ELF-EMF. These results suggest that ELF-EMF exposure promotes the neuronal differentiation and neurite outgrowth of eNSCs via up-regulation the expression of TRPC1 and proneural genes (NeuroD and Ngn1). These findings also provide new insights in understanding the effects of ELF-EMF exposure on embryonic brain development.",Excluded
2749,Trigeminal nerve radiosurgical treatment in intractable chronic cluster headache: Unexpected high toxicity - Commentary,Excluded
3413,"An expanded set of photoreceptors in the Eastern Pale Clouded Yellow butterfly, Colias erate. We studied the spectral and polarisation sensitivities of photoreceptors of the butterfly Colias erate by using intracellular electrophysiological recordings and stimulation with light pulses. We developed a method of response waveform comparison (RWC) for evaluating the effective intensity of the light pulses. We identified one UV, four violet-blue, two green and two red photoreceptor classes. We estimated the peak wavelengths of four rhodopsins to be at about 360, 420, 460 and 560 nm. The four violet-blue classes are presumably based on combinations of two rhodopsins and a violet-absorbing screening pigment. The green classes have reduced sensitivity in the ultraviolet range. The two red classes have primary peaks at about 650 and 665 nm, respectively, and secondary peaks at about 480 nm. The shift of the main peak, so far the largest amongst insects, is presumably achieved by tuning the effective thickness of the red perirhabdomal screening pigment. Polarisation sensitivity of green and red photoreceptors is higher at the secondary than at the main peak. We found a 20-fold variation of sensitivity within the cells of one green class, implying possible photoreceptor subfunctionalisation. We propose an allocation scheme of the receptor classes into the three ventral ommatidial types.",Excluded
3204,"Interstitial lung disease induced by docetaxel and ramucirumab chemotherapy after nivolumab treatment. Three men (aged 64, 65, and 67 years) with advanced lung cancer who had been treated with nivolumab developed interstitial lung disease (ILD) during chemotherapy with docetaxel and ramucirumab. The treatment was clinically effective; however, the patients experienced immune-related adverse effects due to nivolumab therapy: two patients developed ILD and the third developed psoriasis. Because the patients showed progression, docetaxel and ramucirumab chemotherapy was administered. Although two patients showed a clinical response, all patients developed grade 3 ILD during therapy. Furthermore, the patients developed respiratory failure and needed corticosteroid therapy. Although their condition improved owing to the therapy, the patients could not receive additional cancer treatment and died of cancer. On the basis of the results obtained, we speculated that although the regimen of docetaxel and ramucirumab after nivolumab therapy might be effective against non-small cell lung cancer, it might increase the risk for ILD in some patients. Copyright Â© 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology",Excluded
2931,"Isocitrate dehydrogenase 1 mutant glioblastomas demonstrate a decreased rate of pseudoprogression: A multi-institutional experience. Background: Pseudoprogression (psPD) represents false radiologic evidence of tumor progression and is observed in some glioblastoma (GBM) patients after postoperative chemoradiation (CRT) with temozolomide (TMZ). The ambiguity of the psPD diagnosis confounds identification of true progression and may lead to unnecessary interventions. The association between psPD and isocitrate dehydrogenase 1 (IDH1) mutational (mut) status is understudied, and its incidence may alter clinical decision making. Method(s): We retrospectively evaluated 120 patients with IDH1-mut (n = 60) and IDH1-wild-type (IDH-WT; [n = 60]) GBMs who received postoperative CRT with TMZ at 4 academic institutions. Response Assessment in Neuro-Oncology criteria were used to identify psPD rates in routine brain MRIs performed up to 90 days after CRT completion. Result(s): Within 90 days of completing CRT, 9 GBM patients (1 [1.7%] IDH1-mut and 8 [13.3%] IDH1-WTs) demonstrated true progression, whereas 17 patients (3 [5%] IDH1-muts and 14 [23.3%] IDH1-WTs) demonstrated psPD (P =. 004). IDH1-mut GBMs had a lower probability of psPD (hazard ratio: 0.173, 95% CI, 0.047-0.638, P =. 008). Among the patients with radiologic signs suggestive of progression (n = 26), psPD was found to be the cause in 3 of 4 (75.0%) of the IDH1-mut GBMs and 14 of 22 (63.6%) of the IDH1-WT GBMs (P =. 496). Median overall survival for IDH1-mut and IDH1-WT GBM patients was 40.3 and 23.0 months, respectively (P <. 001). Conclusion(s): IDH1-mut GBM patients demonstrate lower absolute rates of psPD expression. Irrespective of GBM subtype, psPD expression was more likely than true progression within 90 days of completing CRT. Continuing adjuvant treatment for IDH1-mut GBMs is suggested if radiologic progression is suspected during this time interval. Copyright Â© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.",Excluded
3155,[Paraplegia due to late damage of the spinal cord following radiotherapy],Included
3448,"Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system. Mice were exposed to 1 month of spaceflight on Russian biosatellite BION-M1 to determine its effect on the expression of key genes in the brain dopamine (DA) and serotonin (5-HT) systems. Spaceflight decreased the expression of crucial genes involved in DA synthesis and degradation, as well as the D1 receptor. However, spaceflight failed to alter the expression of tryptophan hydroxylase-2, 5-HT transporter, 5-HT1A, and 5-HT3 receptor genes, though it reduced 5-HT2A receptor gene expression in the hypothalamus. We revealed risk DA and 5-HT neurogenes for long-term spaceflight for the first time, as well as microgravity-responsive genes (tyrosine hydroxylase, catechol-O-methyltransferase, and D1 receptor in the nigrostriatal system; D1 and 5-HT2A receptors in the hypothalamus; and monoamine oxidase A (MAO A) in the frontal cortex). Decreased genetic control of the DA system may contribute to the spaceflight-induced locomotor impairment and dyskinesia described for both humans and rats.",Included
3356,"Gamma radiation (5-10 Gy) impairs neuronal function in the guinea pig hippocampus. Guinea pigs were exposed to 5 and 10 Gy gamma radiation. Hippocampal brain slices were isolated 30 min, 1 day, 3 days and 5 days after irradiation or sham irradiation and the electrophysiological characteristics of the neural tissue were evaluated. Both radiation doses elicited significant changes that were dependent on dose, dose rate and time. Synaptic efficacy decreased soon after exposure to 5 Gy at dose rates of both 1 and 20 Gy/min. Recovery occurred by 5 days. Ten grays at 20 Gy/min potentiated the postsynaptic potential 1 day after irradiation. By 3 days, synaptic efficacy was decreased and did not recover. The ability of the synaptic potentials to generate spikes was potentiated within 30 min after exposure to 5 Gy at 1 Gy/min and persisted through 3 days, with recovery at 5 days. At the 20 Gy/min dose rate, a similar potentiation did not result with 10 Gy and occurred only at 3 days after irradiation with 5 Gy. Rather, within 30 min and after 5 days, spike generation was significantly depressed by these exposures. Both synaptic efficacy and spike generation contribute to the net input-output relationship of the neuronal population. This relationship was profoundly decreased within 30 min with recovery at 1 day and subsequent decline with the higher dose rate in a dose-dependent manner. These persistent changes in neuronal function are likely to be a consequence of the actions of ionizing radiation on the physiological processes that influence the neuronal environment.",Included
3368,European Guidelines on cardiovascular disease prevention in clinical practice (version 2012),Excluded
3420,"Lung cancer: ASCO 2014 update. At the American Society of Clinical Oncology (ASCO) meeting 2014, the most striking abstracts on lung cancer treatment addressed-as expected-aspects of targeted therapy. The most probable practice changing data came from the presentation of the PROFILE 1014 trial dealing with anaplastic lymphoma kinase-positive non-small-cell lung carcinoma patients treated with crizotinib or chemotherapy in the first-line setting, which confirmed a comparable degree of benefit from crizotinib treatment as reported in second-line treatment. After 10 years of epidermal growth factor receptor (EGFR)-directed therapy, there were for the first time reports on phase I data on new agents showing efficacy in tyrosine-kinase inhibitor pre-treated patients with secondary resistance (i.e. T790M mutation). Monoclonal antibodies directed against EGFR and vascular endothelial growth factor receptor given in addition to conventional chemotherapy (SQUIRE and REVEL, respectively) resulted in significant but less impressive results. Notable improvements in overall survival in these two studies were not restricted to patients with adenocarcinoma but proved beneficial in patients with squamous cell carcinoma as well. Unfortunately, as in the aftermath of many past ASCO meetings, there will be no significant changes concerning systemic treatment of small cell lung cancer in the near future. Copyright Â© 2014, Springer-Verlag Wien.",Excluded
2950,"Skin dose to patients from interventional radiology and cardiology procedures with potentially long fluoroscopy times. The increasing frequency and complexity of interventional procedures means that there is an increasing potential for the patient to suffer radiation-induced skin injuries. Dose measurements were initiated in a number of radiology, neuroradiology and cardiology departments in the Northern Ireland region which carry out interventlonal procedures with potentially long fluoroscopy times. The intention was to measure patient skin dose and thus estimate the likelihood of deterministic effects occurring from such examinations. For each patient, several thermoluminescence (TL) dosemeters were placed on the areas of skin the radiologist or cardiologist considered were most likely to receive the greatest irradiation. Results are presented which indicate that several types of procedure have the potential to produce deterministic effects to patients' skin. It was concluded that skin dose should be routinely measured for each patient undergoing an interventional radiology procedure which has potentially a long fluoroscopy time.",Excluded
3011,"Nuclear matrix associated DNA is preferentially repaired in normal human fibroblasts, exposed to a low dose of ultraviolet light but not in Cockayne's syndrome fibroblasts. In this study we addressed the questions as to whether repair is confined to the nuclear matrix compartment, analogous to replication and transcription and how repair events are distributed in DNA loops associated with the nuclear matrix. Pulse labelling of ultraviolet (254 nm) irradiated confluent human fibroblasts revealed that repair was preferentially located in nuclear matrix associated DNA in cells exposed to 5 J/m2. However, in cells exposed to 30 J/m2 repair approached a random distribution. The non-random distribution of repair label at 5 J/m2 was most pronounced directly after irradiation and gradually changed to a more random distribution within two hours after treatment. The results of pulse-chase experiments exclude the possibility of transient binding of repair sites to the matrix and favour the model of preferential repair of DNA sequences permanently associated with the nuclear matrix. Pronounced differences in distribution pattern of repair events in DNA loops were found among normal and UV-sensitive cell lines exposed to 5 J/m2. Repair in nuclear matrix associated DNA was 1.7 fold more efficient than in loop DNA in normal and xeroderma pigmentosum group D cells and over 3 fold in xeroderma pigmentosum group C cells. In Cockayne's syndrome fibroblasts repair in nuclear matrix DNA was found to be 2 fold less efficient than in loop DNA. This heterogeneity in distribution of repair correlates well with preferential removal of pyrimidine dimers from transcriptionally active DNA in normal and xeroderma pigmentosum group C cells and its absence in Cockayne's syndrome cells as recently reported by Mayne et al., 1988. The results suggest that Cockayne's syndrome cells have a defect in excision of UV-damage from transcriptionally active genes located proximal to the nuclear matrix. Xeroderma pigmentosum group C cells may possess a defect in DNA repair associated with chromatin regions outside transcriptionally active DNA.",Excluded
3239,Retinal damage after prolonged exposure to visible light. A light and electron microscopic study,Excluded
3501,"Standard radiotherapy for patients with nasopharyngeal carcinoma results in progressive tract-specific brain white matter alterations: A one-year follow-up via diffusion tensor imaging. BACKGROUND AND PURPOSE: Radiation therapy (RT)-induced neurocognitive disability may be mediated by brain tissue damage. The aim of the present study was to investigate the effects of standard RT on normal brain tissue via in vivo neuroimaging in patients with nasopharyngeal carcinoma (NPC).MATERIALS AND METHODS: A total of 146 newly diagnosed NPC patients who were treated with standard RT were longitudinally followed up at multiple time points during the first year post-RT, with 19 comparable healthy controls followed up in parallel serving as normal age-related benchmarks. Magnetic resonance diffusion tensor imaging was used to evaluate longitudinal brain white matter tract changes in NPC patients. The relationships between RT-related white matter changes, hippocampal atrophy, and cognitive impairment were also assessed.RESULTS: Bilateral cingulate angular bundle (CAB) fibers had progressive diffusion reduction [radial diffusivity (RD) and mean diffusivity] over time (P < 0.05, corrected for multiple comparisons) in NPC patients during the first year after RT. RT-associated progressive RD reduction in the left CAB correlated with longitudinal atrophy of the ipsilateral hippocampus (P = 0.033). Additionally, RT-associated progressive RD reduction in the left CAB correlated with progressive cognitive impairment in NPC patients post-RT (P = 0.048).CONCLUSION: We present evidence of progressive RT-associated changes in the bilateral CAB in NPC patients, which may underlie RT-related cognitive impairment. These findings illustrate that the use of white matter tract alterations as potential biomarkers to detect RT-related brain injury in NPC patients may be useful for better understanding the pathogenesis of RT-induced cognitive decline.",Included
3313,"A review of the necessary planning target volume margins for patients receiving radiation to the brain, with the current immobilization devices in use at the hopital regional de sudbury regional hospital regional cancer program. The purpose of this study is to examine the effectiveness of the current margins of the planning target volumes in brain patients being treated at the Sudbury Regional Cancer Program. The gross tumour volume (GTV) is defined in the International Commission for Radiation Units & Measurements (ICRU) report 83 (2010) as the gross demonstrable extent and location of the tumour. The clinical target volume (CTV) is defined as the volume of a tissue that contains the GTV and any microscopic tumour spread. The planning target volume (PTV) is defined by the ICRU 83 report (2010) as the margin accounting for both the internal and external uncertainties. With the use of image-guided radiation therapy such as cone beam computed tomography (CBCT), imaging and positioning has become much more accurate. A CBCT uses a 3D reconstructed volume of the patient's current position before treatment to verify and correct the setup. This is done by comparing it to the planning patient position as seen with the planning CT image and making any adjustments while the patient is on the bed (Pouliot, Bani-Hashemi, Chen, Svatos, Ghelmansarai, Mitschke, 2005). Daily imaging before treatment has allowed for positioning of the patient accurately to match the image taken for planning purposes. This allows the patient to be set up within millimetres of the position they were in for planning. Currently at the Sudbury Regional Cancer Program, daily imaging for patients receiving radiation to the brain is not standard practice, however, some patients are imaged daily by request from the physician. By using the shift data from patients who have received daily imaging, the setup uncertainty for every fraction can be determined and used to determine an appropriate PTV margin for the majority of patients, who are not imaged daily. If the PTV can be reduced for brain patients being treated, less of the normal brain tissue would be irradiated and could have the potential to reduce acute and late neurotoxicity of treatment (McDonald et al., 2011). A retrospective review of patients who have previously received radiation to the brain with daily CBCT imaging will be done to examine the shifts done before treatment to match the CBCT to the planning CT image. The patient population will include patients who received brain radiation and a daily CBCT before treatment since July 2010. The images taken daily before treatment will be retrospectively studied using the Sudbury Regional Cancer Program's electronic charting system (Mosaic). The shift data examined of patients who received daily imaging can be applied to a calculation proposed by van Herk (2004) to determine the PTV margin accounting for setup error. The shift data describes the measurements by which the patient was shifted after daily imaging to match the original planning image. This equation uses the shift data to determine the PTV margin for those patients who do not receive daily imaging. All patient data will be anonymous and will be kept on a locked password protected computer.",Excluded
2865,"[A case of chronic progressive radiation myelopathy--a diagnostic significance of gadolinium-DTPA enhancement MRI]. A 65-year-old man had a biopsy diagnosis of right cervical squamous cell carcinoma. Post operative irradiation (4000 rads) was given to the bilateral cervical areas. Twenty five months after completion of irradiation, the patient developed muscle weakness in the right upper and lower extremities, and sensory disturbance below the C2 level in the left side, which was considered as Brown-Sequard syndrome. MRI of T1 weighted images (T1W1) showed mild swelling of the spinal cord from C1 to C6, while T2 weighted images (T2W1) revealed high intensity area at the same level. Gadolinium (Gd)-DTPA injection revealed ring enhancement in the right side of the spinal cord from C1 to C2 on sagittal and axial images. The neurological symptoms improved after the administration of corticosteroid. Two weeks after the therapy, a follow-up study revealed disappearance of cervical cord swelling on T1W1 and high intensity area was remarkably diminished on T2W1. Gd-DTPA enhancement, however, showed unremarkable change. Gd-DTPA enhancement was suggested to be a sensitive and valuable diagnostic method of CPRM.",Excluded
3175,"Iodinated contrast agent time course in human brain metastasis: A study for synchrotron stereotactic radiotherapy clinical trials. Purpose/Objective(s): Synchrotron stereotactic radiotherapy (SSRT) is an innovative treatment combining the selective accumulation of heavy elements in tumors with stereotactic irradiations using monochromatic medium energy x-rays from a synchrotron source. Phase I/II clinical trials on brain metastasis are underway using venous infusion of iodinated contrast agents. The radiation dose enhancement depends on the amount of iodine in the tumor and its time course. Quantitative, post-infusion iodine bio-distribution and associated brain perfusion parameters were studied in human brain metastasis as key parameters for treatment feasibility and quality. The reproducibility of iodine concentrations between the recruitment day and the treatment day was assessed in order to predict dose errors. Materials/Methods: Twelve patients received an intravenous bolus of iodinated contrast agent (40 mL, 4 mL/s), followed by a steady-state infusion (160 mL, 0.5 mL/s) in order to ensure stable intratumoral amounts of iodine during the treatment. Absolute iodine concentrations and quantitative perfusion maps were derived from 40 multi-slice dynamic conventional CT images of the brain (recruitment day) or from quantitative synchrotron radiation CT (treatment day). For three of these patients, iodine concentrations reached in the tumor were compared between the recruitment day and the treatment day (~ 10 days interval). Result(s): The post-infusion mean intratumoral iodine concentration (over thirty minutes) reached 1.94 +/- 0.12 mg/mL. Reasonable correlations were obtained between these concentrations and the permeability surface area product and the cerebral blood volume. Iodine concentrations were reproducible leading to dose errors in the radiotherapy standards. Conclusion(s): To our knowledge, this is the first quantitative study of contrast agent biodistribution versus time in brain metastasis. The study demonstrates that suitable and stable amounts of iodine can be reached in brain metastasis for SSRT treatment. Moreover, the associated perfusion measurements provide useful information for the patient recruitment and management processes.",Excluded
2646,Rat mammary cell survival following irradiation with 14.3-MeV neurons,Included
2488,"Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice. PURPOSE: Although gene expression profiling provides critical information, knowledge remains limited regarding the differential effects of molecular subtype on clinical course. This study evaluated the impact of molecular status on long-term patterns of failure in patients with non-metastatic breast cancer.METHODS: We analyzed data from 1181 individuals with invasive breast cancer undergoing surgery plus PORT from 2003 to 2011. Molecular subtypes were defined as luminal A (LA), luminal B (LB)-HER2(-), LB-HER2(+), HER2, and triple-negative (TN) based on the 2013 St. Gallen Consensus criteria. Competing risks analysis and baseline hazard rate function plots were used to explore subtype-specific recurrence patterns.RESULTS: The 10-year overall survival rates of LA, LB-HER2(-), LB-HER2(+), HER2, and TN groups were 96, 93, 94, 84, and 85%, respectively (P < 0.001). Distant metastatic events differed significantly according to molecular subtype (P < 0.001). In competing risks regression analysis, initial development of distant metastasis was the highest with TN tumors, followed by HER2, LB-HER2(-), and LB-HER2(+) subtypes (P = 0.005). Regarding preferential sites of distant metastasis, the risk of initial brain metastasis was significantly higher with HER2 tumors, followed by TN tumors (P = 0.001). A low-level but sustained metastatic risk increment was observed in luminal tumors, whereas TN and HER2 subtypes showed a short-term risk surge within 5 years.CONCLUSION: From the significant impact of molecular profile on distant metastasis, subtype-specific individualization of systemic treatment and close surveillance are suggested. The preferential and long-term risk of brain metastasis in the HER2 subtype underlines the importance of alternative anti-HER2 therapies.",Excluded
2774,"Radiotherapy management of brain metastases using conventional linear accelerator. BACKGROUND AND AIMS: As treatments for primary cancers continue to improve life expectancy, unfortunately, brain metastases also appear to be constantly increasing and life expectancy for patients with brain metastases is low. Longer survival and improved quality of life may be achieved using localised radiological and surgical approaches in addition to low dose corticosteroids. Stereotactic brain radiotherapy is one rapidly evolving localized radiation treatment. This article describes our experience with stereotactic radiotherapy using a linear accelerator.METHODS: We reviewed patients treated with stereotactic radiotherapy, from the time of its introduction into daily practice in our Department of Oncology in 2014. We collected the data on patient treatment and predicted survival based on prognostic indices and actual patient outcome.RESULTS: A total of 10 patients were treated by stereotactic radiotherapy, in one case in combination with whole brain radiotherapy and hippocampal sparing. There was no significant treatment related toxicity during the treatment or follow-up and due to the small number of fractions, the overall tolerance of the treatment was excellent. The patient intrafractional movement in all cases was under 1 mm suggesting that 1 mm margin around the CTV to create the PTV is sufficient and also that patient immobilization using the thermoplastic mask compared with invasive techniques, is feasible. We also found that prognostic indices such as the Graded Prognostic Assessment provide accurate predictions of patient survival.CONCLUSIONS: Based on our current evidence, patients with brain metastases fit enough, should be considered for stereotactic radiotherapy treatment.",Excluded
2447,"Unmyelinated visceral afferents exhibit frequency dependent action potential broadening while myelinated visceral afferents do not. Sensory information arising from visceral organ systems is encoded into action potential trains that propagate along afferent fibers to target nuclei in the central nervous system. These information streams range from tight patterns of action potentials that are well synchronized with the sensory transduction event to irregular, patternless discharge with no clear correlation to the sensory input. In general terms these afferent pathways can be divided into unmyelinated and myelinated fiber types. Our laboratory has a long standing interest in the functional differences between these two types of afferents in terms of the preprocessing of sensory information into action potential trains (synchrony, frequency, duration, etc.), the reflexogenic consequences of this sensory input to the central nervous system and the ionic channels that give rise to the electrophysiological properties of these unique cell types. The aim of this study was to determine whether there were any functional differences in the somatic action potential characteristics of unmyelinated and myelinated vagal afferents in response to different rates of sensory nerve stimulation. Our results showed that activity and frequency-dependent widening of the somatic action potential was quite prominent in unmyelinated but not myelinated vagal afferents. Spike broadening often leads to increased influx of Ca(2+) ions that has been associated with a diverse range of modulatory mechanisms both at the cell body and central synaptic terminations (e.g. increased neurotransmitter release.) We conclude that our observations are indicative of fundamentally different mechanisms for neural integration of sensory information arising from unmyelinated and myelinated vagal afferents.",Excluded
2449,"Accelerated recovery of consciousness after general anesthesia is associated with increased functional brain connectivity in the high-gamma bandwidth. Recent data from our laboratory demonstrate that high-frequency gamma connectivity across the cortex is present during consciousness and depressed during unconsciousness. However, these data were derived fromstatic and well-defined states of arousal rather than during transitions that would suggest functional relevance. We also recently found that subanesthetic ketamine administered during isoflurane anesthesia accelerates recovery upon discontinuation of the primary anesthetic and increases gamma power during emergence. In the current study we re-analyzed electroencephalogram (EEG) data to test the hypothesis that functional cortical connectivity between anterior and posterior cortical regions would be increased during accelerated recovery induced by ketamine when compared to saline-treated controls. Rodents were instrumented with intracranial EEG electrodes and general anesthesia was induced with isoflurane anesthesia. After 37.5 min of continuous isoflurane anesthesia, a subanesthetic dose of ketamine (25 mg/kg intraperitoneal) was administered, with evidence of a 44% reduction in emergence time. In this study, we analyzed gamma and theta coherence (measure of undirected functional connectivity) and normalized symbolic transfer entropy (measure of directed functional connectivity) between frontal and parietal cortices during various levels of consciousness, with a focus on emergence from isoflurane anesthesia. During accelerated emergence in the ketamine-treated group, there was increased frontal-parietal coherence {p = 0.005, 0.05-0.23 [95% confidence interval (CI)]} and normalized symbolic transfer entropy [frontal to parietal: p < 0.001, 0.010-0.026 (95% CI); parietal to frontal: p < 0.001, 0.009-0.025 (95% CI)] in high-frequency gamma bandwidth as compared with the saline-treated group. Surrogates of cortical information exchange in high-frequency gamma are increased in association with accelerated recovery from anesthesia. This finding adds evidence suggesting a functional significance of high-gamma information transfer in consciousness. Copyright Â© 2017 Li, Hambrecht-Wiedbusch and Mashour.",Excluded
3404,"Action of laser radiation on Na,K-ATPase activity of brain synaptosomes in rats. [Russian]",Excluded
2979,"Responses of perivascular macrophages to circulating lipopolysaccharides in the subfornical organ with special reference to endotoxin tolerance. BACKGROUND: Circulating endotoxins including lipopolysaccharides (LPS) cause brain responses such as fever and decrease of food and water intake, while pre-injection of endotoxins attenuates these responses. This phenomenon is called endotoxin tolerance, but the mechanisms underlying it remain unclear. The subfornical organ (SFO) rapidly produces proinflammatory cytokines including interleukin-1beta (IL-1beta) in response to peripherally injected LPS, and repeated LPS injection attenuates IL-1beta production in the SFO, indicating that the SFO is involved in endotoxin tolerance. The purpose of this study is to investigate features of the IL-1beta source cells in the SFO of LPS-non-tolerant and LPS-tolerant mice.METHODS: We first established the endotoxin-tolerant mouse model by injecting LPS into adult male mice (C57BL/6J). Immunohistochemistry was performed to characterize IL-1beta-expressing cells, which were perivascular macrophages in the SFO. We depleted perivascular macrophages using clodronate liposomes to confirm the contribution of IL-1beta production. To assess the effect of LPS pre-injection on perivascular macrophages, we transferred bone marrow-derived cells obtained from male mice (C57BL/6-Tg (CAG-EGFP)) to male recipient mice (C57BL/6N). Finally, we examined the effect of a second LPS injection on IL-1beta expression in the SFO perivascular macrophages.RESULTS: We report that perivascular macrophages but not parenchymal microglia rapidly produced the proinflammatory cytokine IL-1beta in response to LPS. We found that peripherally injected LPS localized in the SFO perivascular space. Depletion of macrophages by injection of clodronate liposomes attenuated LPS-induced IL-1beta expression in the SFO. When tolerance developed to LPS-induced sickness behavior in mice, the SFO perivascular macrophages ceased producing IL-1beta, although bone marrow-derived perivascular macrophages increased in number in the SFO and peripherally injected LPS reached the SFO perivascular space.CONCLUSIONS: The current data indicate that perivascular macrophages enable the SFO to produce IL-1beta in response to circulating LPS and that its hyporesponsiveness may be the cause of endotoxin tolerance.",Excluded
3207,"Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone. CONTEXT: Visceral adipose tissue (VAT) is established as a risk factor for type 2 diabetes and cardiovascular disease, but the radiation exposure and cost of computed tomography (CT) measurements limits its daily clinical use.OBJECTIVE: The main objective of this study was to compare the degree of agreement between VAT measurements by a new dual-energy X-ray absorptiometry (DXA) application and one of the standard methods, CT, in a population of patients with Prader-Willi syndrome (PWS) before and after GH treatment. Furthermore, we tested whether VAT estimations by these two methods are equivalent in assessing the metabolic risk in this population.DESIGN AND PATIENTS: Data from the Norwegian population of a multicenter study in adults with genetically proven PWS were used. Subjects with complete anthropometry, biochemical, and imagistic measurements at all study visits (baseline and after 12 and 24 months of GH treatment) (n = 14, six men) were included. VAT was quantified both using CT scans (GE Lightspeed 16 Pro) of the abdomen at L2-L3 level and a total body DXA scan (GE Healthcare Lunar Prodigy).RESULTS: VAT DXA was strongly associated with VAT CT at baseline (r = 0.97) and after 12 (r = 0.90) and 24 months (r = 0.89) of GH treatment (all P < .001). We found moderate to strong positive correlations between VAT by both methods, and blood pressure, weight, body mass index, waist circumference, glucose metabolism, and other fat depots (arms, legs, android, trunk, total body) but no association with age, gender, blood lipids, and IGF-I. Adiponectin was negatively associated with the amount of VAT. At baseline, the highest correlation with homeostasis model assessment of insulin resistance (HOMA-IR) was found for VAT DXA (r = 0.76, P = .001) and VAT CT (r = 0.75, P = .002), respectively.CONCLUSION: VAT can be accurately estimated by DXA, in patients with PWS, and might contribute to the assessment of the metabolic risk.",Excluded
3342,"Gamma surgery for Hemangiopericytomas. A retrospective analysis of a consecutive series of 12 patients with 15 intracranial hemangiopericytomas treated at the University of Virginia using Gamma surgery is presented. Clinical and radiographic follow up of 3 to 56 months is available for 10 patients with 12 tumors. There was one tumor present at the time of initial Gamma surgery in each patient. Two new tumors occurred in patients previously treated. Nine of the tumors decreased in volume and three remained stable. Four of the nine tumors that shrank later progressed at an average of 22 months after treatment. Of the tumors that decreased in volume and have not progressed, the response has been for an average of 11 months. The follow-up for two tumors that remained unchanged was 10 and 34 months (average 22 months). A third tumor was unchanged at 42 months but the patient died of new disease adjacent to the treated area in the anterior skull base. There were no complications and the quality of life following the procedure was maintained or improved in every case. Gamma surgery is effective in palliating the patients by decreasing tumor volume and delaying recurrence.",Excluded
3353,The treatment of osteoradionecrosis of the mandible: the case for hyperbaric oxygen and bone graft reconstruction,Excluded
2513,"Magnetic resonance guided focused ultrasound for unilateral thalamotomy in medication refractory essential tremor. Introduction: Essential Tremor (ET) is the most common movement disorder and is associated with significant functional impairment and disability. Ablative and stimulation-based surgical treatments have been developed to treat the significant number of patients who remain symptomatic despite optimal medical management. Although often providing effective tremor control, current surgical options have risks associated with intracranial procedures, as well as issues of durability and predictability of treatment response. Here, we explore the application of MR-guided focused ultrasound (MRgFUS) as an alternative, non-invasive means of generating thalamic lesions in patients with treatment-resistant ET. Method(s): Four patients underwent awake MRgFUS thalamotomy for refractory essential tremor (mean age 70.8; mean duration of illness 17.8 years). Diagnosis of refractory ET was confirmed by a movement disorder neurologist, and patients underwent baseline medical and imaging investigations prior to treatment. Tremor assessments and serial structural imaging were performed at 1, 7, 30 and 90 days following the procedure. Result(s): All four patients experienced immediate and sustained improvements in their dominant (treated) hand tremor (Figure 1). At 1- and 3-months following treatment, dominant hand tremor scores were reduced by a mean of 89% and 78%, respectively, on part A of the Clinical Rating Scale for Tremor. Functional impairment decreased significantly at 3-months, with patients reporting improvements in writing, drinking and eating. There were no serious adverse events, with only one patient reporting persistent lip and finger paraesthesias at 3-months. Conclusion(s): MRgFUS appears to be a safe and effective means of non-invasively generating thalamic lesions for the relief of refractory ET. This technology is a promising alternative to radiation- and surgical-based approaches to lesional functional neurosurgery, but requires larger trials with more patients to verify its efficacy. (Figure presented).",Excluded
3588,"A novel specific application of pyruvate protects the mouse retina against white light damage: differential stabilization of HIF-1alpha and HIF-2alpha. PURPOSE: To mimic hypoxia preconditioning by a novel specific pyruvate treatment and to study its retinal protection against white light damage.METHODS: Six-to-eight-week-old BALB/c mice were exposed to strong white light calculated to produce photoreceptor degeneration. Some were given injections of pyruvate in a preordained protocol because evidence exists that proves pyruvate can affect the concentration of hypoxia inducible factor (HIF). Western blotting and real-time PCR were used to determine the concentration of proteins and mRNAs in retinas. Morphology was analyzed with toluidine blue staining and was plotted using a spidergraph. A free nucleosome cell death assay was used to examine apoptosis. Retina explant cultures were used to investigate the background mechanism.RESULTS: Pyruvate administration stabilized hypoxia inducible factor (HIF)-1alpha but not HIF-2alpha. Expression of the downstream genes hemoxygenase-1 and erythropoietin mirrored the changes of the two HIFs, respectively. Importantly, pyruvate given not only before but also after exposure to light protected photoreceptors against apoptosis. In the retinal explant system, addition or depletion of pyruvate caused only changes of HIF-1alpha and prolyl hydroxylase (PHD)-2, while HIF-2alpha and PHD1 were not affected. However, under hypoxic conditions, HIF-2alpha was stabilized by pyruvate but not HIF-1alpha.CONCLUSIONS: Pyruvate evoked a hypoxia-like response under normoxic conditions and was retina-protective against strong white light. This response included stabilization of HIF-1alpha but not HIF-2alpha. This differential stabilization might be related to the distinct preference of their degrading enzyme of PHD2 and PHD1 in response to pyruvate treatment.",Excluded
2521,"Transforming growth factor-beta promotes glioblastoma multiforme to establish radiation resistance by mesenchymal differentiation. Glioblastoma multiforme (GBM) is the most malignant primary brain tumor. Current standard therapy is surgery combined with radio-therapy and/or chemo-therapy. Due to the existence of resistance, GBM is one of the most difficult-to-treat tumor. It has been shown radio-therapy may induce mesenchymal differentiation (MD). Transforming Growth Factor-beta (TGF-beta) is a modifier of radiation response, and plays an important role in cell transformation. Therefore, we hypothesized that TGF-beta pathway might be involved in the development of radiation resistance via regulating MD. Thus, we explored whether TGF-beta regulates MD in radiation resistance in GBM. We first examined the effect of radiation doses on cell viability by Trypan blue assay, and evaluated cell viability and morphology. The cells showed morphology change were defined as transformed cells. We used the radiation dose of 50% cell viability to establish consecutive-irradiation-induced resistance. The radiation dose of the cell viability greater than 50% was established high-dose-irradiation-induced resistance positive control. When viability of cells recovered from consecutive-irradiation exposures which were higher than positive control, the cells were defined as consecutive-irradiation-induced resistance. To develop radiation resistance, 3.5Gy exposure for 6 times were required for 1306MG, and 2Gy exposure for 4 times were needed for U87MG. The numbers of transformed cells increased in radiation resistant cells population. Moreover, immunocytochemistry staining showed expression of certain MD markers on transformed cells were different from on non-transformed cells. Immunoblotting results showed increased mesenchymal marker N-cadherin and decreased epithelial marker beta-catenin in radiation resistance. Finally, we used TGF-beta and TGF-beta receptor inhibitor LY364947 to determine if TGF-beta/Smad pathway regulates radiation-induced resistance. The immunoblotting results revealed that inhibition of TGF-beta pathway reversed MD in consecutive-irradiation-induced resistant cell lines via increasing the expression of beta-catenin and reducing the expression of N-cadherin and Fibronectin. We concluded that TGF-beta promotes GBM to establish radiation resistance by MD.",Excluded
3147,"Interfractional setup error and intrafractional bladder motion during radiation therapy for bladder tumors. Purpose/Objective(s): To estimate planning margins based on interfractional setup error and intrafractional bladder motion during radiation therapy for bladder tumors by using the real-time tumor-tracking radiation therapy (RTRT) system with fiducial gold markers for the positioning. Materials/Methods: We analyzed 151 sessions in 19 patients with bladder tumors who had received radiation therapy with a localized boost using the RTRT system and fiducial markers for positioning from 1999 to 2011. Up to six gold markers were transurethrally implanted into the bladder wall around the tumor bed after the transurethral tumor reduction and 40-Gy pelvic irradiation. After the manual setup using skin marks, the coordinates of the center of gravity of fiducial markers were measured at the start of treatment and during irradiation. The table position was adjusted to the planned position if the discrepancy was larger than 2.0 mm along the cranial-caudal (CC), left-right (LR), or anterior-posterior (AP) direction. Using the position at the start of radiation dose delivery as the reference position, we analyzed the interfractional setup error and intrafractional error due to bladder motion. Result(s): The overall number of sessions in which table adjustments were required was 108 (71.5%) for pretreatment offsets and 38 (25.2%) for offsets after the initiation of radiation therapy. The number of table adjustments in a session ranged from 0 to 4, and more than two adjustments were required in 7 sessions involving 5 patients. To guarantee that 90% of patients in the population receive a minimum cumulative clinical target volume (CTV) dose of at least 95% of the prescribed dose, the setup margin (SM) was 14.5 mm, 9.6 mm, and 10.6 mm along the CC, LR, and AP directions, respectively. The internal margin (IM) calculated from offsets at the end of irradiation was 2.6 mm, 2.1 mm, and 2.1 mm, and number of sessions in which the length of required table adjustment was greater than the calculated IM after the initial setup was 12 (7.9%), 14 (9.3%), and 17 (11.3%), and the average time interval (range, standard deviation) between the initiation of radiation therapy and the table adjustment greater than the calculated IM was 4.2 (0.2-15.0, 5.2) minutes, 5.6 (0.2-14.7, 5.0) minutes, 4.4 (0.2-14.7, 3.9) minutes along these directions, respectively. Conclusion(s): In contrast to a large SM based on skin marks, the positioning procedure of the RTRT system with fiducial markers is useful to reduce the planning target volume substantially. Considering that the incidence of table adjustment greater than the calculated IM was about 10% and that the interval time was highly variable, the table adjustment based on the on-line imaging has an advantage in detecting unexpected internal organ movement.",Excluded
2861,"Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors. The inclusion of neurocognitive end points in clinical trials of patients with CNS tumors is increasing. Neurocognitive end points are used to understand what cognitive problems exist before treatment to establish a baseline by which the effect of treatment is judged, and to determine whether different treatment regimens improve neurocognitive function due to better tumor control, slow expected neurocognitive deterioration due to the tumor, or have more or less short- and long-term neurotoxicity. However, the use of neurocognitive end points in clinical trials for patients with CNS tumors is in its infancy, so that long-term outcomes are difficult to predict and the ability to determine the effects of different agents and treatment approaches is scant. Including this aspect of patient evaluation in addition to survival and time to tumor progression will yield better risk-versus-benefit assessments as well as provide a basis for improving interventions. Â© 2006 by American Society of Clinical Oncology.",Excluded
3703,X-ray-induced teratogenesis in the mouse and its possible significance to man,Included
3442,"Gene expression in rat vestibular and reticular structures during and after space flight. Space flight produces profound changes of neuronal activity in the mammalian vestibular and reticular systems, affecting postural and motor functions. These changes are compensated over time by plastic alterations in the brain. Immediate early genes (IEGs) are useful indicators of both activity changes and neuronal plasticity. We studied the expression of two IEG protein products [Fos and Fos-related antigens (FRAs)] with different cell persistence times (hours and days, respectively) to identify brainstem vestibular and reticular structures involved in adaptation to microgravity and readaptation to 1 G (gravity) during the NASA Neurolab Mission (STS-90). IEG protein expression in flight animals was compared to that of ground controls using Fisher 344 rats killed 1 and 12 days after launch and 1 and 14 days after landing. An increase in the number of Fos-protein-positive cells in vestibular (especially medial and spinal) regions was observed 1 day after launch and 1 day after landing. Fos-positive cell numbers were no different from controls 12 days after launch or 14 days after landing. No G-related changes in IEG expression were observed in the lateral vestibular nucleus. The pattern of FRA protein expression was generally similar to that of Fos, except at 1 day after landing, when FRA-expressing cells were observed throughout the whole spinal vestibular nucleus, but only in the caudal part of the medial vestibular nucleus. Fos expression was found throughout the entire medial vestibular nucleus at this time. While both Fos and FRA expression patterns may reflect the increased G force experienced during take-off and landing, the Fos pattern may additionally reflect recent rebound episodes of rapid eye movement (REM) sleep following forced wakefulness, especially after landing. Pontine activity sources producing rhythmic discharges of vestibulo-oculomotor neurons during REM sleep could substitute for labyrinthine signals after exposure to microgravity, contributing to activity-related plastic changes leading to G readaptation. Reticular structures exhibited a contrasting pattern of changes in the numbers of Fos- and FRA-positive cells suggestive of a major influence from proprioceptive inputs, and plastic re-weighting of inputs after landing. Asymmetric induction of Fos and FRAs observed in some vestibular nuclei 1 day after landing suggests that activity asymmetries between bilateral otolith organs, their primary labyrinthine afferents, and vestibular nuclei may become unmasked during flight.",Included
3428,"Integration of the heart rhythmogenesis levels: heart rhythm generator in the brain. We propose that along with the intracardiac pacemaker, a generator of cardiac rhythm exists in the central nervous system--in the efferent structures of the cardiovascular center of the medullar oblongata. Signals in the medulla oblongata arise as a result of the hierarchic interaction of the brain structures. Neural signals originating there in the form of bursts of impulses conduct to the heart along the vagus nerves and after interaction with cardiac pacemaker structures, cause generation of the cardiac pulse in exact accordance with the frequency of ""neural bursts"". The intrinsic cardiac rhythm generator (the sinus node) is a life-sustaining factor that maintains the heart pumping function when the central nervous system is in a stage of deep inhibition, (e.g., under anesthesia or during unconsciousness). The brain generator is the factor that provides heart adaptive reactions in behaving organism. The integration of the two levels of rhythmogenesis in the brain and heart provides reliability and functional perfection of the cardiac rhythm generation system in the whole organism.",Excluded
2712,"Acute and subacute myelopathy. Myelopathy is a term referring to any pathologic process affecting the spinal cord, and encompasses a broad spectrum of etiologies. The first step is to categorize myelopathy, according to the time to reach maximum deficit. Myelopathies are commonly classified as acute, subacute or chronic, for which the etiologies are totally different. Myelopathy is considered acute when the symptoms progress to their nadir in maximum 21 days after onset. Due to heterogeneity in pathogenesis, and the overlap in the clinical and imaging presentation among etiologies, acute myelopathy is considered as a diagnostic dilemma. A simple and efficient algorithm for timely identification of the underlying cause is thus useful. In this review, we provide a simplified approach for the differential diagnosis among all causes of acute myelopathies, and describe the principal clinical and imaging features of the main etiologies in adults, including recently characterized antibody-mediated myelitis, and its mimics. Copyright Â© 2020 Elsevier Masson SAS",Excluded
3415,An electron microscopic study of acute radiation injury of the rat brain,Included
3523,"Differential actions of corticotropin releasing factor on basolateral and central amygdaloid neurones, in vitro. Intracellular current- and voltage-clamp recordings were obtained from basolateral (BLA) and central (ACe) neurones of the rat amygdala in vitro. The effect of superfusion of rat corticotropin releasing factor (rCRF) was examined on the ACe and BLA, nuclei with a high density of CRF-immunoreactive cell bodies and CRF receptors, respectively. rCRF (12.5-250 nM) had no effect on either resting membrane potential or input resistance in BLA neurones. In contrast, at low nanomolar concentrations rCRF (10-50 nM) caused hyperpolarisation and decreased membrane input resistance in the majority of ACe neurones. The equilibrium potential for this effect was -84 mV in the presence of tetrodotoxin (0.5 microM), suggesting that this response may be mediated by a postsynaptic increase in K+ conductance. Furthermore, rCRF consistently reduced the amplitude of, and the current mediating, the slow after hyperpolarisation following evoked action potential firing in both nuclei. This effect was concentration-dependent with an EC50 of 40 nM in BLA neurones and was insensitive to tetrodotoxin and noradrenergic antagonists. In addition, the putative CRF antagonist alpha-helical CRF9-41 (5 microM) blocked the effect of rCRF and showed partial agonist action on slow after hyperpolarisations. In BLA neurones, rCRF (50 nM) prolonged the Ca(2+)-spike evoked in the presence of tetrodotoxin and tetraethylammonium (2 mM), suggesting that the blockade of the slow after hyperpolarisation occurs subsequent to Ca2+ entry. These results suggest that rCRF has a differential effect on the membrane properties of BLA and ACe neurones possibly by activation of a heterogeneous population of CRF receptors.",Excluded
3046,"Effects of external beam radiation in the rat tibial nerve after crush, transection and repair, or nerve isograft paradigms. INTRODUCTION: In head and neck surgery, radiation therapy is often administered to an injured nerve. Previous studies have examined the effects of either preoperative or postoperative radiation on nerve regeneration in rodents. In these studies, histomorphometric analysis was performed up to 8 month postoperatively. Given the exceptional neuroregenerative capacity of rodents, significant differences in nerve regeneration may go undetected if nerves are evaluated at such distant postoperative time points. This study is designed with a more appropriate model and investigates the effects of radiation after three common nerve injury paradigms.METHODS: Sixty-four Lewis rates were randomized to 8 groups corresponding to uninjured, tibial nerve crush, transection and repair, or reconstruction with isografts. Half of the animals in each of these paradigms (n = 8 per group) were treated with 10 Gy of external beam radiation to the site of nerve injury at 7 days postoperatively. On postoperative day 28, functional recovery and histomorphometric assessment was performed.RESULTS: For a given paradigm of nerve injury, no significant differences in nerve fiber number, neural density, neural debris, or fiber width were noted between the control and radiated groups, and radiation did not affect functional recovery.CONCLUSION: Radiation had no discernible effect on nerve regeneration or functional recovery in the rodent nerve injury models studied. All assessments were made at time points suitable for detecting differences in nerve regeneration between groups. These findings suggest that administration of radiation to fields containing injured peripheral nerve is unlikely to adversely affect functional outcomes.",Included
2652,"Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database. OBJECTIVE: To test the hypothesis whether the effects of GH replacement therapy in adults could be affected by prior pituitary irradiation, the baseline characteristics and response to GH were evaluated in adults with severe GH deficiency (GHD), who had received or not irradiation for the treatment of pituitary adenoma or craniopharyngioma.DESIGN: Data from 447 patients, who had received radiotherapy (427 in addition to surgery), and 630 patients, who were operated on but not irradiated for their tumour, were retrieved from Pfizer International Metabolic Database (KIMS) and compared at baseline and 1 and 2 years following the onset of GH replacement.RESULTS: Irradiated and non-irradiated patients exhibited the expected phenotype of GHD at baseline. However, irradiated patients had a greater impairment in the quality of life (QoL), a higher fat mass, lower high-density lipoprotein cholesterol levels and a lower bone mineral content (BMC) than non-irradiated patients. Treatment with GH induced similar changes in both groups. After 1 year of GH replacement, there was an increase in serum IGF-I and fat-free mass, a reduction in fat mass and an improvement in QoL, all changes being equivalent in irradiated and non-irradiated patients. The lipid profile also improved with the irradiated patients showing a better response. These beneficial effects were maintained and the BMC also increased in both groups by the second year of treatment.CONCLUSIONS: This analysis shows that prior irradiation for pituitary adenoma or craniopharyngioma does not compromise the beneficial effects of GH replacement therapy.",Included
3129,"Malignant blue nevus with metastases to lymph nodes and brain. [German]. We report a patient who developed malignant transformation of a cellular blue nevus. At the age of 19 years the congenital, pigmented tumor on the left buttock was histopathologically diagnosed as cellular blue nevus. Thirty years later the tumor dramatically increased in size, involving the entire left buttock within several months. Multiple biopsies revealed the presence of a cellular blue nevus within the papillary dermis and an invasive, pleomorphic pigmented sarcoma in the depth of the tissue spreading into subcutis and skeletal muscle. Both benign and malignant cells were S100<sup>+</sup>, vimentin<sup>+</sup> and HMB-45<sup>+</sup>, but only the malignant tumor cells stained positive for the proliferating cell nuclear antigen. General examination disclosed multiple metastases in the paraaortal lymph nodes and the retroperitoneum as well as a single brain metastasis. Despite palliative therapy with ionizing radiation and chemotherapy, the patient developed generalized metastases and died within weeks. This case clearly confirms that cellular blue nevi have the potential for malignant transformation and that the malignant variant may behave aggressively just as a malignant melanoma.",Excluded
2932,"Toward improved target conformity for two spot scanning proton therapy delivery systems using dynamic collimation. Purpose: To quantify improvement in target conformity in brain and head and neck tumor treatments resulting from the use of a dynamic collimation system (DCS) with two spot scanning proton therapy delivery systems (universal nozzle, UN, and dedicated nozzle, DN) with median spot sizes of 5.2 and 3.2 mm over a range of energies from 100 to 230 MeV. Method(s): Uncollimated and collimated plans were calculated with both UN and DN beam models implemented within our in-house treatment planning system for five brain and ten head and neck datasets in patients previously treated with spot scanning proton therapy. The prescription dose and beam angles from the clinical plans were used for both the UN and DN plans. The average reduction of the mean dose to the 10-mm ring surrounding the target between the uncollimated and collimated plans was calculated for the UN and the DN. Target conformity was analyzed using the mean dose to 1-mm thickness rings surrounding the target at increasing distances ranging from 1 to 10 mm. Result(s): The average reductions of the 10-mm ring mean dose for the UN and DN plans were 13.7% (95% CI: 11.6%-15.7%; p < 0.0001) and 11.5% (95% CI: 9.5%-13.5%; p < 0.0001) across all brain cases and 7.1% (95% CI: 4.4%-9.8%; p < 0.001) and 6.3% (95% CI: 3.7%-9.0%; p < 0.001), respectively, across all head and neck cases. The collimated UN plans were either more conformal (all brain cases and 60% of the head and neck cases) than or equivalent (40% of the head and neck cases) to the uncollimated DN plans. The collimated DN plans offered the highest conformity. Conclusion(s): The DCS added either to the UN or DN improved the target conformity. The DCS may be of particular interest for sites with UN systems looking for a more economical solution than upgrading the nozzle to improve the target conformity of their spot scanning proton therapy system. Copyright Â© 2016 Am. Assoc. Phys. Med.",Excluded
2944,Synchronous occurrence of paraganglioma of the glomus jugulare and olfactory groove meningioma,Excluded
2676,"Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. Evaluation of potential health effects from high energy charged particle radiation exposure during long duration space travel is important for the future of manned missions. Cognitive health of an organism is considered to be maintained by the capacity of hippocampal precursors to proliferate and differentiate. Environmental stressors including irradiation have been shown to inhibit neurogenesis and are associated with the onset of cognitive impairments. The present study reports on the protective effects of N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK), a melatonin metabolite, against high energy charged particle radiation-induced oxidative damage to the brain. We observed that radiation exposure (2.0 Gy of 500 MeV/nucleon (56)Fe beams, a ground-based model of space radiation) impaired the spatial memory of mice at later intervals without affecting the motor activities. AFMK pretreatment significantly ameliorated these neurobehavioral ailments. Radiation-induced changes in the population of immature and proliferating neurons in the dentate gyrus were localized using anti-doublecortin (Dcx) and anti-Ki-67 expression. AFMK pretreatment significantly inhibited the loss of Dcx and Ki-67 positive cells. Moreover, AFMK pretreatment ameliorated the radiation-induced augmentation of protein carbonyls and 4-hydroxyalkenal + malondialdehyde (MDA + HAE) in the brain and maintained the total antioxidant capacity of plasma and nonprotein sulfhydryl contents in brain.",Included
3357,"YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. PURPOSE: YKL-40 is a secreted protein that has been reported to be overexpressed in epithelial cancers and gliomas, although its function is unknown. Previous data in a smaller sample set suggested that YKL-40 was a marker associated with a poorer clinical outcome and a genetically defined subgroup of glioblastoma. Here we test these findings in a larger series of patients with glioblastoma, and in particular, determine if tumor YKL-40 expression is associated with radiation response.EXPERIMENTAL DESIGN: Patients (n=147) with subtotal resections were studied for imaging-assessed changes in tumor size in serial studies following radiation therapy. An additional set (n=140) of glioblastoma patients who underwent a gross-total resection was tested to validate the survival association and extend them to patients with minimal residual disease.RESULTS: In the subtotal resection group, higher YKL-40 expression was significantly associated with poorer radiation response, shorter time to progression and shorter overall survival. The association of higher YKL-40 expression with poorer survival was validated in the gross-total resection group. In multivariate analysis with both groups combined (n = 287), YKL-40 was an independent predictor of survival after adjusting for patient age, performance status, and extent of resection. YKL-40 expression was also compared with genetically defined subsets of glioblastoma by assessing epidermal growth factor receptor amplification and loss at chromosome 10q, two of the common recurring aberrations in these tumors, using fluorescent in situ hybridization. YKL-40 was significantly associated with 10q loss.CONCLUSIONS: The findings implicate YKL-40 as an important marker of therapeutic response and genetic subtype in glioblastomas and suggest that it may play an oncogenic role in these tumors.",Included
3344,"Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. OBJECTIVE: This study was carried out to examine the neuropsychological status of patients treated for pituitary tumour by transfrontal surgery, transphenoidal surgery or medical treatment only, with or without radiotherapy.DESIGN AND MEASUREMENTS: Three groups of 23 patients who had been treated for pituitary tumour were compared with 23 healthy controls on a range of neuropsychological measures. The surgical patients were also subdivided into two groups and compared. The neuropsychological measures were standardized psychological tests designed to assess aspects of attention, memory and executive function.PATIENTS: The patients were those who had been treated with transfrontal surgery (n = 23), transsphenoidal surgery (n = 23) and medication only (n = 23). The groups did not differ with respect to age, education or premorbid ability level as assessed by the National Adult Reading Test. All participants were free of known sources of cognitive impairment other than pituitary tumour.RESULTS: Comparison of the four groups revealed that nearly half of the transfrontal, one-third of the transsphenoidal and one-quarter of the non-surgical group had three or more neuropsychological tests scores below the 10th percentile compared to less than 5% of the controls. Impairments in memory and executive function were found in both surgical groups. The non-surgical patients appeared to have problems only on tasks requiring high levels of cognitive processing. Differences were found between the two surgical groups with respect to the severity of the cognitive impairment, the transfrontal patients having more severe impairment than the transsphenoidal. No significant negative effects on cognitive functioning were associated with radiotherapy; however, transfrontal surgery patients who had not been treated with radiotherapy were found to be more impaired than other patients. This was thought to be related to radical surgery.CONCLUSIONS: Many patients with treated pituitary tumour suffer significant cognitive impairment. The severity and nature of impairment differs between treatment groups, although the cause of this could not be addressed by this study. Recommendations are made for future research and clinical practice.",Excluded
3366,"Chirp-evoked potentials in the awake and anesthetized rat. A procedure to assess changes in cortical oscillatory activity. Steady-state potentials are oscillatory responses generated by rhythmic stimulation of a sensory pathway. The frequency of the response, which follows the frequency of stimulation and potentially indicates the preferential working frequency of the auditory neural network, is maximal at a stimulus rate of 40 Hz for auditory stimuli in humans, but may be different in other species. Our aim was to explore the responses to different frequencies in the rat. The stimulus was a tone modulated in amplitude by a sinusoid with linearly-increasing frequency from 1 to 250 Hz (""chirp""). Time-frequency transforms were used for response analysis in 12 animals, awake and under ketamine/xylazine anesthesia. We studied whether the responses were due to increases in amplitude or to phase-locking phenomena, using single-sweep time-frequency transforms and inter-trial phase analysis. A progressive decrease in the amplitude of the response was observed from the maximal values (around 15 Hz) up to the limit of the test (250 Hz). The high-frequency component was mainly due to phase-locking phenomena with a smaller amplitude contribution. Under anesthesia, the amplitude and phase-locking of lower frequencies (under 100 Hz) decreased, while the phase-locking over 200 Hz increased. In conclusion, amplitude-modulation following responses differ between humans and rats in response range and frequency of maximal amplitude. Anesthesia with ketamine/xylazine modifies differentially the amplitude and the phase-locking of the responses. These findings should be taken into account when assessing the changes in cortical oscillatory activity related to different drugs, in healthy rodents and in animal models of neurodegenerative diseases.",Excluded
3181,"Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors. PURPOSE: The enhanced relative biological effectiveness (RBE) at the end of the proton range might increase the risk of radiation-induced toxicities. This is of special concern for intracranial treatments where several critical organs at risk (OARs) surround the tumor. In the light of this, a retrospective analysis of dose-averaged linear energy transfer (LET<sub>d</sub> ) and RBE-weighted dose (D<sub>RBE</sub> ) distributions was conducted for three clinical cases with suspected treatment-related toxicities following intracranial proton therapy. Alternative treatment strategies aiming to reduce toxicity risks are also presented.METHODS: The clinical single-field optimized (SFO) plans were recalculated for 81 error scenarios with a Monte Carlo dose engine. The fractionation D<sub>RBE</sub> was 1.8 Gy (RBE) in 28 or 30 fractions assuming a constant RBE of 1.1. Two LET<sub>d</sub> - and alpha/beta-dependent variable RBE models were used for evaluation, including a sensitivity analysis of the alpha/beta parameter. Resulting distributions of D<sub>RBE</sub> and LET<sub>d</sub> were analyzed together with normal tissue complication probabilities (NTCPs). Subsequently, four multi-field optimized (MFO) plans, with an additional beam and/or objectives penalizing protons stopping in OARs, were created to investigate the potential reduction of LET<sub>d</sub> , D<sub>RBE</sub> , and NTCP.RESULTS: The two variable RBE models agreed well and predicted average RBE values around 1.3 in the toxicity volumes, resulting in an increased near-maximum D<sub>RBE</sub> of 7-11 Gy (RBE) compared to RBE = 1.1 in the nominal scenario. The corresponding NTCP estimates increased from 0.8%, 0.0%, and 3.7% (RBE = 1.1) to 15.5%, 1.8%, and 45.7% (Wedenberg RBE model) for the three patients, respectively. The MFO plans generally allowed for LET<sub>d</sub> , D<sub>RBE</sub> , and NTCP reductions in OARs, without compromising the target dose. Compared to the clinical SFO plans, the maximum reduction in the near-maximum LET<sub>d</sub> was 56%, 63%, and 72% in the OAR exhibiting the toxicity for the three patients, respectively.CONCLUSIONS: Although a direct causality between RBE and toxicity cannot be established here, high LET<sub>d</sub> and D<sub>RBE</sub> correlated spatially with the observed toxicities, whereas setup and range uncertainties had a minor impact. Individual factors, which might affect the patient-specific radiosensitivity, were however not included in these calculations. The MFO plans using both an additional beam and proton track-end objectives allowed the largest reductions in LET<sub>d</sub> , D<sub>RBE</sub> , and NTCP, and might be future tools for similar cases.",Excluded
2805,"The association between white matter abnormalities and processing speed deficits in bipolar disorder. Background: Abnormality of white matter (WM) integrity, as measured by fractional anisotrophy (FA) with diffusion tensor imaging (DTI), has been observed in bipolar disorder (BD). However, few studies have examined the relationship of FA with cognitive performance in BD. We used DTI to examine regional differences in FA between BD and healthy comparison (HC) participants and the relationship with processing speed and switching abilities within regions of aberrant WM integrity. Method(s): 20 medicated euthymic BD (age=44.6+/-2.1yrs) and 20 HC (age=45.3+/-1.8yrs) participants completed neuropsychological tests of processing speed and switching (D-KEFS Trailmaking) and a 51-direction DTI scan. FA was calculated and tract-based spatial statistics were used to identify common WM tracts. Group differences were examined with independent-samples T-tests. Within significantly different regions, the association of FA with cognitive performance was examined in each group separately. Result(s): BD patients had lower FA within seven WM regions, including clusters in bilateral superior longitudinal fasciculus, left inferior longitudinal fasciculus, and left anterior thalamic radiation, and exhibited mildly slower processing speed. Among BD patients, lower FA values within left inferior and superior longitudinal fasciculus was associated with slower processing speed. There were no significant associations among HC subjects or for switching performance in either group. Conclusion(s): Consistent with the literature, BD patients demonstrated abnormal WM integrity, primarily in the longitudinal fasciculus, and this deficit was most pronounced among BD patients with the slowest processing speed. These findings suggest that BD processing speed deficits may be due to abnormal WM integrity in the longitudinal fasciculus.",Excluded
2632,"Stimulation through electrodes implanted near the subthalamic nucleus activates projections to motor areas of cerebral cortex in patients with Parkinson's disease. High-frequency electrical stimulation through electrodes implanted in the subthalamic nucleus (STN) has been shown to reduce significantly the cardinal symptoms of Parkinson's disease (PD). Despite the success of this treatment, the mechanisms of action of stimulation are poorly understood. To elucidate further the mechanisms of action of deep brain stimulation and its effects on cortical activity, we recorded electroencephalographic potentials from 61 scalp-surface electrodes during low-frequency (5-10 Hz) bipolar stimulation in 11 patients with advanced PD (14 implanted electrodes were tested). In all electrodes tested, stimulation through at least one of the four contacts produced a medium-latency waveform with an average onset of 14 +/- 3 ms and peak at 23 +/- 4 ms. This potential typically increased in magnitude across contacts from ventral to dorsal. Within-subject comparisons of median nerve somatosensory evoked potentials demonstrated that the generator of the medium-latency potential was within the primary sensorimotor cortex or lateral premotor cortex ipsilateral to stimulation. The timing and topography of this potential were consistent with indirect activation of the cortex by excitation of pallido-thalamic axons that traverse the dorsal aspect of the STN. The potential evoked by stimulation through the contact used for optimal clinical effect was highly variable across electrodes and frequently different from the medium-latency potential described above, suggesting that the neuronal elements mediating the medium-latency potential were different from those that mediate the clinical effects.",Excluded
2439,"Radiotherapy of maxillary cancer using 9 equi-spaced beam coplanar beam arrangement and 9 non-coplanar beam arrangement with beam angle optimization - A dosimetric comparison. Background: IMRT is a novel radiotherapy that can deliver high conformal homogeneous dose to the target volume while sparing surrounding tissues and structures. Conventional routine IMRT usually uses equi-spaced beam arrangement of 5 to 9. However, in recent development, manipulating the beam arrangement of IMRT is offered in beam angle optimization (BAO), in which it automatically chooses optimized beam angles in either coplanar or non-coplanar beam arrangements. In Pugachev et al. (2001) study it has been suggested that improvement of the dose distribution was seen in complicated head and neck cancer cases with BAO. Nevertheless, opposite opinion has been raised by Stein et al. (1997) which stated that the marginal gain by manipulating beam angle diminished when there are more than 7 beams. Notwithstanding the controversy in study results, it was observed that careful selection of beam orientation contributed to a better dose distribution in the final treatment plan in clinical experience. This study is to investigate the dosimetric effect of manipulating beam angles with BAO in maxillary cancer cases compared with 9 equi-spaced beam co-planar arrangement. Method(s): The subjects in this study were recruited from the Princess Margaret Hospital, Kowloon, Hong Kong within the period of 1st Jan 2006 to 31st Dec 2010. Planning computed tomography (CT) images of the samples were retrospectively restored. Five samples were recruited using random sampling. It was an experimental study to test the effect of using equispaced beams, BAO and VMAT in IMRT. The parameters for comparison are tumour dose conformity, homogeneity; and the OARs maximum, mean dose. 2 plans were produced for each recruited patients. One using 9 equispaced beam arrangement and the other using 9 non-coplanar field using BAO. Result(s): For the five recruited patients, both 9 equi-spaced beam arrangement and BAO resulted in clinically satisfactory dose distribution and were of similar quality. It was found that IMRT plans with BAO resulted in better OARs sparing, including the parotid, cochlear, eyes, optic nerves, the optic chiasm and brain stem. In terms of target coverage, 4 out of 5 plans produced better in BAO when compared with 9 equi-spaced beam arrangement. Conclusion(s): The effect of the selection of beam angle orientations was significant within the samples. The choice of beam orientations is a factor affecting the dosimetric outcome even when the beam number is equal to 9.",Excluded
2670,"Which prognostic index is most appropriate in the setting of delayed stereotactic radiosurgery for brain metastases?. Objectives: To determine if five commonly used prognostic indices (PIs) - recursive partitioning analysis (RPA), Score Index for Radiosurgery (SIR), Basic Score for Brain Metastases (BSBM), graded prognostic assessment (GPA), and the diagnosis-specific GPA - are valid following delay between diagnosis and treatment of brain metastases. Method(s): In a single-institutional cohort, records of patients who underwent stereotactic radiosurgery (SRS) more than 30 days from diagnosis of brain metastases were collected, and five PI scores were calculated for each patient. For each PI, three score-based groupings were made to examine survival differences by means of adjusted log-rank analysis and area under the curve (AUC). Result(s): Of 121 patients with sufficient PI information, 72 underwent SRS more than 30 days after diagnosis. Median age and Karnofsky performance status were 60 years and 80, respectively. Forty-three (60%) patients had lung primaries. Prior to SRS, 38 (52.8%) and 12 (16.7%) patients underwent whole brain radiation therapy (WBRT) and surgery, respectively. Two (2.8%) patients underwent both WBRT and surgery prior to SRS. A median of two lesions were treated per SRS course. Median survival of the cohort was 9.0 months. Using adjusted log-rank analysis for pairwise comparison, BSBM and GPA showed significance between two out of the three prognostic groups, while the other scores showed either one or no significant differences on comparison. AUC demonstrated good applicability for BSBM, RPA, and GPA, although SIR was statistically less prognostic than the other PIs. Conclusion(s): The PIs analyzed in this study were applicable in the setting of delayed SRS. Although these data are hypothesis generating, they serve to encourage further analyses to validate a PI that is most optimal for these patients. Copyright Â© 2016 Malouff, Bennion, Verma, Martinez, Balkman, Bhirud, Smith and Lin.",Excluded
2579,"Evaluation of acute radiation optic neuropathy by B-scan ultrasonography. We studied the accuracy of B-scan ultrasonography to diagnose radiation-induced optic neuropathy in 15 patients with uveal melanoma. Optic neuropathy was diagnosed by an observer masked as to clinical and photographic data. We analyzed planimetry area measurements of the retrobulbar nerve before and after irradiation. The retrobulbar area of the optic nerve shadow on B-scan was quantitated with a sonic digitizer. Increased optic nerve shadow area was confirmed in 13 of 15 patients who had radiation optic neuropathy (P less than .004). The correct diagnosis was confirmed when the results of ultrasound were compared to fundus photography and fluorescein angiography. In 13 patients there was acute radiation optic neuropathy. Two patients did not show an enlarged retrobulbar optic nerve, and the clinical appearance suggested early progression to optic atrophy. Ultrasonography documents the enlargement of the optic nerve caused by acute radiation changes.",Excluded
3065,Effect of X-Irradiation and Certain Other Treatments on Blood Brain Barrier Permeability,Included
2655,"Treatment Considerations in the Radiologically Isolated Syndrome. Purpose of review: This review provides the reader with updated information needed to make an accurate diagnosis of radiologically isolated syndrome (RIS), discusses controversies and considerations related to therapeutic intervention in RIS, and summarizes ongoing clinical intervention trials. Recent findings: Individuals with RIS lack clinical neurological symptoms but are at risk for the subsequent development of a first clinical neurological event consistent with a diagnosis of multiple sclerosis. There are two ongoing clinical intervention trials to determine whether disease-modifying treatments for multiple sclerosis can delay or prevent a first clinical event in individuals with RIS. Summary: If clinical trials demonstrate a beneficial effect of disease-modifying therapy, such interventions should be considered in individuals with RIS. Copyright Â© 2020, Springer Science+Business Media, LLC, part of Springer Nature.",Excluded
2773,"Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution. BACKGROUND: Palliative irradiation of osteolytic lesions is a considerable component in the treatment for patients with multiple myeloma. In this study, we analyzed the efficacy of irradiation in these patients.PATIENTS AND METHODS: We retrospectively analyzed 153 patients with multiple myeloma who were admitted to our department between 1989 and 2013. According to the staging system of Durie & Salmon 116 patients were classified as stage III. 107/153 patients were treated with radiotherapy of at least one and up to 6 bony lesions at different times. In order to evaluate the effect of local radiotherapy on pain relief and bone recalcification a uni- and multivariate analysis was performed using a binary logistic regression model to correct for multiple measurements. Complete information on dose, fractionation and volume of radiotherapy was available from 81 patients treated in 136 target volumes for pain relief, and from 69 patients treated in 108 target volumes for recalcification. Total radiation doses varied between 8 Gy to 50 Gy (median dose 25 Gy in 2.5 Gy fractions, 5 times a week).RESULTS: Radiotherapy resulted in complete local pain relief in 31% and partial local pain relief in 54% of the patients. In the univariate analysis, higher total radiation doses (p = 0.023) and higher age (p = 0.014) at the time of radiotherapy were significantly associated with a higher likelihood of pain relief, whereas no significant association was detected for concurrent systemic treatment, type and stage of myeloma and location of bone lesions. The same variables were independent predictors for pain relief in the multivariate analysis. Recalcification was observed in 48% of irradiated bone lesions. In the uni- and multivariate analysis higher radiation doses were significantly associated (p = 0.048) with an increased likelihood of recalcification. Side effects of radiotherapy were generally mild.CONCLUSIONS: Higher total biological radiation doses were associated with better pain relief and recalcification in this retrospective evaluation of multiple myeloma patients. In addition, in the elderly the therapeutic measures appear to develop a better analgesic effect.",Included
3223,"The involvement of ATF4 and S-opsin in retinal photoreceptor cell damage induced by blue LED light. PURPOSE: Blue light is a high-energy emitting light with a short wavelength in the visible light spectrum. Blue light induces photoreceptor apoptosis and causes age-related macular degeneration or retinitis pigmentosa. In the present study, we investigated the roles of endoplasmic reticulum (ER) stress induced by blue light-emitting diode (LED) light exposure in murine photoreceptor cells.METHODS: The murine photoreceptor cell line was incubated and exposed to blue LED light (464 nm blue LED light, 450 lx, 3 to 24 h). The expression of the factors involved in the unfolded protein response pathway was examined using quantitative real-time reverse transcription (RT)-PCR and immunoblot analysis. The aggregation of short-wavelength opsin (S-opsin) in the murine photoreceptor cells was observed with immunostaining. The effect of S-opsin knockdown on ATF4 expression in the murine photoreceptor cell line was also investigated.RESULTS: Exposure to blue LED light increased the bip, atf4, and grp94 mRNA levels, induced the expression of ATF4 protein, and increased the levels of ubiquitinated proteins. Exposure to blue LED light in combination with ER stress inducers (tunicamycin and dithiothreitol) induced the aggregation of S-opsin. S-opsin mRNA knockdown prevented the induction of ATF4 expression in response to exposure to blue LED light.CONCLUSIONS: These findings indicate that the aggregation of S-opsin induced by exposure to blue LED light causes ER stress, and ATF4 activation in particular.",Excluded
3597,"Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?. High-grade glioma is the most common primary brain tumor, with glioblastoma multiforme (GBM) accounting for 52% of all brain tumors. The current standard of care (SOC) of GBM involves surgery followed by adjuvant fractionated radiotherapy and chemotherapy. However, little progress has been made in extending overall survival, progression-free survival, and quality of life. Attempts to characterize and customize treatment of GBM have led to mitigating the deleterious effects of radiotherapy using hypofractionated radiotherapy, as well as various immunotherapies as a promising strategy for the incurable disease. A combination of radiotherapy and immunotherapy may prove to be even more effective than either alone, and preclinical evidence suggests that hypofractionated radiotherapy can actually prime the immune system to make immunotherapy more effective. This review addresses the complications of the current radiotherapy regimen, various methods of immunotherapy, and preclinical and clinical data from combined radioimmunotherapy trials.",Excluded
3052,"Immunomodulatory effect of new quinolone derivative against cisplatin/gamma radiation-induced renal and brain toxicity in mice. Treatment of cancer often requires exposure to radiation, which has several limitations involving non-specific toxicity toward normal cells, reducing the efficacy of treatment. Recent studies synthesize new quinolone derivatives to satisfy other purposes such as treatment of inflammatory and malignant diseases. The main purpose of the present study is to evaluate the effect of a new quinolone derivative; 2-(1-Ethyl-4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)-2-oxoacetic acid (EHQA) and its possible mechanism against gamma radiation (IRR) and cisplatin (Cis) induced nephrotoxicity and neurotoxicity in mice. The structure of the newly synthesized quinolone derivative was elucidated by microanalytical and spectral data, which were found consistent with the assigned structures. Exposure to Cis and IRR significantly induced renal damage manifested by a significant increase in levels of urea and creatinine. Moreover, the exposure to both Cis and IRR significantly decreased the levels of anti-apoptotic protein; Bcl-2 in both renal and brain tissue homogenate accompanied by activation of an inflammatory marker; IL-17. Immunophenoting results showed an activation of T- lymphocytes marker; CD3 and B-lymphocytes marker; CD19. Interperitonial administration of EHQA significantly ameliorated the above-mentioned parameters. Overall, the present results indicated that EHQA is a promising anti-inflammatory and anti-apoptotic agent. From the obtained results it can be concluded that EHQA could be a candidate as immunomodulatory agents. Further studies are required to establish its molecular mechanism.",Excluded
3349,"Inhibiting the inhibition: a neuronal network for sound localization in reverberant environments. The precedence effect describes the phenomenon whereby echoes are spatially fused to the location of an initial sound by selectively suppressing the directional information of lagging sounds (echo suppression). Echo suppression is a prerequisite for faithful sound localization in natural environments but can break down depending on the behavioral context. To date, the neural mechanisms that suppress echo directional information without suppressing the perception of echoes themselves are not understood. We performed in vivo recordings in Mongolian gerbils of neurons of the dorsal nucleus of the lateral lemniscus (DNLL), a GABAergic brainstem nucleus that targets the auditory midbrain, and show that these DNLL neurons exhibit inhibition that persists tens of milliseconds beyond the stimulus offset, so-called persistent inhibition (PI). Using in vitro recordings, we demonstrate that PI stems from GABAergic projections from the opposite DNLL. Furthermore, these recordings show that PI is attributable to intrinsic features of this GABAergic innervation. Implementation of these physiological findings into a neuronal model of the auditory brainstem demonstrates that, on a circuit level, PI creates an enhancement of responsiveness to lagging sounds in auditory midbrain cells. Moreover, the model revealed that such response enhancement is a sufficient cue for an ideal observer to identify echoes and to exhibit echo suppression, which agrees closely with the percepts of human subjects.",Excluded
2456,"Therapeutic effect of pregabalin on radiotherapy-induced trismus in nasopharyngeal carcinoma patients. AIMS: To evaluate the effect of pregabalin on radiotherapy-induced trismus in patients with nasopharyngeal carcinoma, a hospital-based, clinical retrospective cohort study was conducted.MATERIALS AND METHODS: Data were collected on patients diagnosed with radiotherapy-induced trismus from March 2014 and March 2016 in the department of neurology in our hospital. Patients in the treatment group were administrated pregabalin for 8 weeks combined with rehabilitation, while the control group only received rehabilitation. The clinical therapeutic effects were observed and evaluated by mandibular motion, severity of trismus measured by late effects of normal tissues/subjective and objective medical analysis (LENT/SOMA) scales, and quality of life (QOL) assessed using the World Health Organization QOL instrument (WHOQOL-BREF) at baseline, week 4 and week 8 during treatment in these two groups, respectively.RESULTS: In the treatment group, the number of patients with improvement on maximal vertical dimension (MVD) was significantly more than controls at week 4 and week 8 (P=0.013, P=0.004, respectively). Moreover, at week 4 and week 8, the severity of trismus was both significantly improved on LENT/SOMA grade in treatment group (P=0.047, P=0.032, respectively). And at week 8, the physical health and the whole life domain of the WHOQOL-BREF score were significantly increased (P=0.037, P=0.034, respectively). In the treatment group, 11 patients (36.7%) presented dizziness, and 7 patients (23.3%) presented somnolence.CONCLUSIONS: Administration of pregabalin, in adjunct to rehabilitation, might provide a better outcome in patients with radiotherapy-induced trismus.",Excluded
2867,"Early neural grafts transiently reduce the behavioral effects of radiation-induced fascia dentata granule cell hypoplasia. X-irradiation of the neonatal rat hippocampus produces a selective hypoplasia of fascia dentata granule cells, locomotor hyperactivity, perseverative movements and deficits in passive avoidance. We previously reported that transplantation of fetal hippocampal tissue into the adult (age = 182 +/- 4 days) brain produced a partial recovery of these behavioral deficits. Since graft/host interconnections are more prominent when transplants are conducted soon after radiation-induced hippocampal damage, in this study we transplanted hippocampal or cerebral cortex neurons when host rats were 33 +/- 5 days of age (i.e. only 16 days after radiogenic brain damage). Behavioral evaluations were conducted 80 and 182 days after transplantation or surgical control procedures. In the first test series only, selective components of locomotion (e.g. stereotypy and total distance traveled) and perseverative turning (e.g. mean bout length and turning speed topography) were normalized by the hippocampal grafts. Radiation-induced changes in passive avoidance were less prominent in these studies than in past experiments. Still, transplantation of hippocampal tissue improved performance on this learning task as well. Cerebral cortex grafts did not produce reliable improvements in most behavioral measures. These data suggest that hippocampal grafts placed soon after X-ray induced fascia dentata hypoplasia reduce a broad range of behavioral deficits. However, these benefits are transient and, for the most part, depend on the use of transplant tissues homologous with those damaged.",Excluded
3517,"Coronary intervention and arteria lusoria-Not simple as it may seem. We reviewed the letter from Dr. Walter W. Woody and would like to thank him for showing his interest in our article and providing his opinion and point of view. However, we respectfully disagree with few points that have been raised. Switching to a femoral approach was considered to be a safer alternative for percutaneous intervention due to the presence of arteria lusoria. Risks and possible complications would include increased contrast use, increased radiation exposure, aortic dissection and even cerebral stroke, all of which have been reported extensively in literature. One single procedural methodology cannot be applied to a particular clinical scenario, whether simple or challenging. We have multiple different catheters and multiple different interventional approaches at our disposal to help and guide us through a case, in the best interest of the patient.",Excluded
2687,"A comparison of radiation exposure between diagnostic CTA and DSA examinations of cerebral and cervicocerebral vessels. BACKGROUND AND PURPOSE: While the number of CTA examinations is continually increasing compared with DSA examinations, there is little comparative dose information about the different imaging techniques. We compared patient radiation exposure resulting from diagnostic CTA and DSA examinations for both cerebral and cervicocerebral vessels. MATERIALS AND METHODS: An anthropomorphic phantom was irradiated by using typical diagnostic CTA and DSA setups and imaging parameters. For both imaging techniques, the imaging area of cerebral vessels included intracranial vessels only, while the imaging area of cervicocerebral vessels included both cervical and intracranial vessels from the aortic arch to the vertex. The effective dose was determined by using RPLDs. The DSA examination was simulated by using a biplane angiography system, and the CTA examination, by using a 64-row multidetector CT scanner. RESULT(S): For the imaging of cerebral vessels, the effective dose according to ICRP 103 was 0.67 mSv for CTA and 2.71 mSv for DSA. For the imaging of cervicocerebral vessels, the effective dose was 4.85 mSv for CTA and 3.60 mSv for DSA. The maximum absorbed dose (milligray) for skin, brain, salivary glands, and eyes was 166.2, 73.5, 35.6, and 21.8 mGy for DSA and 19.0, 16.9, 20.4, and 14.8 mGy for CTA, respectively. The conversion factors from DAP and DLP to effective dose were calculated. CONCLUSION(S): The effective dose for CTA assessment of cerebral vessels was approximately one-fifth the dose compared with DSA. In the imaging of cervicocerebral vessels, the effective dose for CTA was approximately one-third higher compared with DSA.",Excluded
3030,[Effect of thyroid gland function following 60Co-gamma ray irradiation on rabbit pituitary gland],Included
2578,"Effects of hypokinesia and hypodynamia upon protein turnover in hindlimb muscles of the rat. Hypokinesia/hypodynamia was induced in the hindlimb muscles of the rat using a suspension technique. This caused differing degrees of atrophy in different muscles, however, this atrophy was reduced in muscles held in a lengthened position. The greatest degree of wasting was observed in the unstretched soleus, a slow postural muscle, where both Type 1 and Type 2a fibers atrophied to the same degree. However, wasting of the gastrocnemius muscle was associated with a reduction in the size of the Type 2b fibers. In both slow postural and fast phasic hindlimb muscles, atrophy was brought about by a reduction in the rate of protein synthesis in conjunction with an elevation in the rate of protein degradation. When inactive muscles were passively stretched, both protein synthesis and degradation were dramatically elevated. Even periods of stretch of as little as 0.5 h.d-1 were found to significantly decrease atrophy in inactive muscles.",Excluded
3403,"[Action of laser radiation on Na,K-ATPase activity of brain synaptosomes in rats]",Excluded
2766,"Serotonergic modulation of psychological stress-induced alteration in synaptic plasticity in the rat hippocampal CA1 field. In order to elucidate possible involvement of the serotonergic neuronal system in the stress-induced alteration in synaptic plasticity, the effects of contextual fear conditioning (CFC) on long-term potentiation (LTP) in the hippocampal CA1 field were examined in 5-HT-depleted rats by pretreatment with 5,7-dihydroxytryptamine (5,7-DHT, 200 microg/rat, i.c.v.). LTP induction was suppressed by footshock (FS) stimulation in 5-HT-lesioned rats and vehicle-treated controls. When rats were exposed to CFC, which was received 24 h after FS stimulation, LTP was also blocked in both-treated groups. CFC-induced impairment of LTP, however, significantly attenuated in 5-HT-lesioned rats when compared with that in controls. Fear-related freezing behavior after FS stimulation occurred similarly in both treated groups, whereas the behavior observed during exposure to CFC significantly reduced in 5-HT-lesioned rats. These results suggest that the serotonergic mechanism is involved in the psychological stress-induced alteration in synaptic plasticity, which appears to be associated with fear-related behavior.",Excluded
3141,"Stereotactic Radiosurgery in the Multimodality Management of Residual or Recurrent Glioblastoma Multiforme. Management options for residual or recurrent glioblastoma multiforme (GBM) are limited despite advances in surgical, chemotherapeutic, and radiotherapeutic techniques. Stereotactic radiosurgery (SRS) is often beneficial in such cases providing improved survival of patients, but still remains underutilized as part of the multimodality management of malignant gliomas. During the last 20 years, 297 patients with histologically proven residual or recurrent GBM underwent Gamma Knife surgery in the University of Pittsburgh. Retrospective analysis of outcomes revealed median survival after initial diagnosis of 18 months, and 1- and 2-year survival rates of 72.5 and 29.5%, respectively. Median survival from the time of SRS was 9 months. The use of modified RPA (recursive partitioning analysis) classification demonstrated superior survival in our series in comparison with historical data. Important prognostic variables include tumor volume <14 cm3, marginal radiation dose of >=15 Gy, and younger age of the patients (<60 years). Adverse radiation effects (ARE) were noted in 23% of cases and were mainly controlled with corticosteroids. Combining SRS with bevacizumab resulted in further improvement of the overall and progression-free survival and decreased incidence of ARE. Nevertheless, for future application of SRS in patients with GBM, evaluation of its efficacy in a well-designed prospective controlled clinical trials seems mandatory.",Excluded
2752,"Effect of Ginkgo biloba (EGb 761) on staurosporine-induced neuronal death and caspase activity in cortical cultured neurons. Previous studies suggest the protective potentiality of Ginkgo biloba (EGb 761) against apoptotic cell death induced by hydroxyl radicals, staurosporine, serum deprivation and beta-amyloid (betaA) peptide. We have extended these observations to cultured cortical neurons and studied the effect of EGb 761 on neuronal survival (evaluated as MTT reduction), the presence of condensed nuclei (monitored as Hoechst staining), the time-course of caspase-1, caspase-3 and caspase-9 activation (measured by cleavage of specific fluorescent substrates) and superoxide anion production (evaluated by hydroethidine staining) after the exposure to staurosporine. Results show that 200 mug/ml of EGb 761 increased cell survival and reduced the number of condensed nuclei after the exposure to 200 nM staurosporine. Vitamin E and the spin trapper alpha-phenyl-N-tert-butylnitrone (PBN) also significantly increased cell survival. In contrast, the broad-spectrum caspase inhibitors ZVAD and ZBIOT showed no protection. Similarly, selective inhibitors of caspase-1 (YVAD-CHO), caspase-2 (VDVAD-CHO), caspase-3 (DEVD-CHO) and caspase-8 (IETD-CHO) did not protect against cell damage induced by staurosporine. The protective effect of EGb 761 was not enhanced when coincubated with vitamin E or DEVD-CHO. Caspase-3 activity was maximally induced 5-8 h after staurosporine exposure. Both EGb 761 and vitamin E showed a tendency to decrease caspase-3 activity. In contrast, activation of caspase-1 and caspase-9 was not observed at any of the times studied after STS exposure. Exposure to staurosporine resulted in increased superoxide production that was maximal at 5 h. EGb 761 significantly inhibited superoxide production at short times after staurosporine exposure. Vitamin E and PBN also significantly reduced superoxide production. Results suggest that EGb 761 neuroprotective effect might be mediated by its well-known antioxidant activity, which might also influence caspase-3 activation. Inhibition of capase-3 induced by EGb 761 and vitamin E does not seem to contribute to their observed protective action. Â© 2004 Elsevier B.V. All rights reserved.",Excluded
3219,"Prognostic Value of Preradiotherapy <sup>18</sup>F-FDG PET/CT Volumetrics in Limited-Stage Small-Cell Lung Cancer. Background Whether <sup>18</sup>F-fludeoxyglucose positron emission tomography (PET)/computed tomography (CT) metrics predict outcome in limited-stage (LS) small-cell lung cancer (SCLC) has not been well established; most previous reports have only analyzed maximal standardized uptake values (SUV<inf>max</inf>). We investigated multiple pretreatment PET metrics, including SUV<inf>max</inf>, mean SUV (SUV<inf>mean</inf>), total lesion glycolysis, and metabolic tumor volume (MTV) in LS-SCLC patients undergoing chemoradiotherapy (CRT) and correlated them with survival and disease control outcomes. Patients and Methods All patients received platinum-based chemotherapy and a median radiation dose of 45 Gy. Kaplan-Meier and competing-risks analyses were performed to assess the prognostic value of PET metrics with respect to overall survival (OS), distant failure (DF), disease-free survival (DFS), and locoregional failure (LRF). Univariate and multivariate analyses were performed to account for the effect of other clinical factors on outcomes. Results A total of 120 patients with LS-SCLC had analyzable pre-CRT PET/CTs. The median follow up was 34 months. Median OS was 26.9 months. OS was 53.2% at 2 years and 33.1% at 5 years. SUV<inf>max</inf>, SUV<inf>mean</inf>, MTV, and total lesion glycolysis of the primary tumor were not significantly associated with OS, LRF, and DFS on univariate analysis. MTV was significantly associated with DF (P =.024) on univariate but not multivariate analysis. Conclusion This is the largest reported series to date evaluating the prognostic value of baseline PET metrics in LS-SCLC. Neither SUV<inf>max</inf> nor other analyzed PET metrics demonstrated significant correlation with OS or LRF. MTV was correlated with DF and DFS, but this association was no longer significant after adjustment for other clinical factors. This analysis suggests that pretreatment PET scans, even with the use of advanced metrics, do not have independent prognostic value for outcomes in LS-SCLC patients after CRT. Copyright Â© 2015 Elsevier Inc.",Excluded
3475,"Selective decrease in serotonin synthesis rate in rat brainstem raphe nuclei following chronic administration of low doses of amitriptyline: an effect compatible with an anti-migraine effect. The effects of chronic, low-dose amitriptyline on serotonin (5-HT) synthesis rate were measured in rat brain using autoradiography and the trapping of alpha-[14C]-methyl-L-tryptophan (alpha-[14C]-MTrp). Rats received amitriptyline (2 mg/kg per day) or saline via intraperitoneal osmotic minipumps for 21 days. Amitriptyline had no effect on any physiological parameters measured, or on free or total plasma tryptophan levels. However, amitriptyline exerted selective decreases of 15% and 17% (P < 0.001) in serotonin synthesis rates in the dorsal and median raphe nuclei, respectively. There was no reduction in any of the projection areas studied, including the cerebral cortex, hippocampus, thalamus, hypothalamus or striatum. The data suggest that chronic low doses of amitriptyline can lead to sustained 5-HT re-uptake inhibition selectively in the raphe nuclei, an effect compatible with tonic activation of 5-HT(1A) autoreceptors and inhibition of 5-HT synthesis. The failure of chronic amitriptyline treatment to affect 5-HT synthesis rate in the projection areas may ensure an adequate regulation of pain pathways implicated in migraine headache, an effect possibly related to amitriptyline anti-migraine efficacy.",Excluded
2760,Experimental study of the response to exposure to permanent magnetic field (ultrastructural changes in the central nervous system neurons and various neuroimmune phenomena). [Russian],Excluded
3611,"Thalamic energy dysregulation drives microstructural changes of thalamocortical projections in multiple sclerosis. Background and aims: Neuronal energy dysfunction in multiple sclerosis (MS) has been proposed as a key driver of axonal degeneration. Diffusion-weighted 1H magnetic resonance spectroscopy (DW-MRS) can measure the diffusivity of creatine-phosphocreatine (Cr/PhCr), whose reduction in the MS thalamus has been proposed to reflect limited energy reserves. We tested in-vivo whether thalamic energy dysregulation is associated with microstructural degeneration of its projection tracts in MS. Method(s): Seventeen patients and thirteen healthy controls (HCs) underwent 3T MRI scan including DW-MRS and DW sequences. From DW-MRS, Cr apparent diffusion coefficient (ADC(tCr)) was extracted in the bilateral thalami. Thalamic projections to somatosensory, dorsolateral prefrontal cortexes and optic radiations (case tracts) and the arcuate (non-thalamic control tract) were manually drawn in TrackVis (Fig.1). Fractional anisotropy (FA) and mean diffusivity (MD), reflecting microstructural damage, were extracted for each tract. Associations between ADC(tCr) and microstructural parameters were tested using linear mixed-effect models. (Figure presented) Results: In MS, lower thalamic ADC(tCr) was associated with lower mean FA and higher mean MD of pooled thalamo-cortical tracts after adjusting for disease duration, gender and tract-specific lesion load (p=0.033 and p=0.047). No correlation was found in HCs. Unadjusted tract-by-tract analysis confirmed the correlation between thalamic ADC(tCr) and MD in patients. The arcuate tract, not connected to the thalamus, showed no correlation (Fig.2). (Figure presented) Conclusion(s): Thalamic ADC(tCr) was associated with specific microstructural damage of thalamo-cortical tracts in MS, suggesting that energy dysfunction in this crucial hub - through an impaired Cr/PhCr transport/utilization - may disrupt thalamo-cortical networks by inducing the selective anterograde degeneration of connected fibers.",Excluded
3248,"Exposure to 2.45 GHz Radiation Triggers Changes in HSP-70, Glucocorticoid Receptors and GFAP Biomarkers in Rat Brain. Brain tissue may be especially sensitive to electromagnetic phenomena provoking signs of neural stress in cerebral activity. Fifty-four adult female Sprague-Dawley rats underwent ELISA and immunohistochemistry testing of four relevant anatomical areas of the cerebrum to measure biomarkers indicating induction of heat shock protein 70 (HSP-70), glucocorticoid receptors (GCR) or glial fibrillary acidic protein (GFAP) after single or repeated exposure to 2.45 GHz radiation in the experimental set-up. Neither radiation regime caused tissue heating, so thermal effects can be ruled out. A progressive decrease in GCR and HSP-70 was observed after acute or repeated irradiation in the somatosensory cortex, hypothalamus and hippocampus. In the limbic cortex; however, values for both biomarkers were significantly higher after repeated exposure to irradiation when compared to control animals. GFAP values in brain tissue after irradiation were not significantly different or were even lower than those of nonirradiated animals in all brain regions studied. Our results suggest that repeated exposure to 2.45 GHz elicited GCR/HSP-70 dysregulation in the brain, triggering a state of stress that could decrease tissue anti-inflammatory action without favoring glial proliferation and make the nervous system more vulnerable.",Excluded
2945,"Patient dosimetry for <sup>131</sup>I-MIBG therapy for neuroendocrine tumours based on <sup>123</sup>I-MIBG scans. Pre-therapeutic metaiodobenzylguanidine (MIBG) scans can be performed using labelling with either iodine-123 or iodine-131. <sup>123</sup>I-MIBG scans provide better image quality and count statistics, while <sup>131</sup>I-MIBG allows registration of tracer kinetics over a longer period. The aim of this study was to determine how much information about the <sup>131</sup>I-MIBG therapy total body dose according to the MIRD formalism can be gathered from <sup>123</sup>I-MIBG pre-therapy scans. Thirty-eight <sup>131</sup>I-MIBG therapies administered to a total of 15 patients suffering from neuroblastoma (n=6), carcinoid tumours (n=5), phaeochromocytoma (n=3) and medullary thyroid carcinoma (n=1) were included. The mean administered activity was 5.3 GBq (SD 2.4 GBq). Three biplanar <sup>123</sup>I-MIBG total body scans were taken only once before a series of therapies while three biplanar <sup>131</sup>I-MIBG scans were taken after each therapy. Attenuation correction was performed taking into account the difference in attenuation between <sup>123</sup>I and <sup>131</sup>I. Using the MIRD formalism, the total body dose to the patient was calculated on the basis of: (1) a single exponential fit drawn through the data from the <sup>123</sup>I-MIBG pre-therapy scans, (2) a bi-exponential fit through the combined data of <sup>123</sup>I-MIBG pre-therapy and <sup>131</sup>I-MIBG post-therapy scans. The mean total body dose calculated in our study was significantly higher for patients suffering from neuroblastoma (mean+/-SD 0.37+/-0.21 mGy/MBq) than for patients suffering from phaeochromocytoma (0.08+/-0.02 mGy/MBq), carcinoid tumours (0.07+/-0.01 mGy/MBq) and medullary thyroid carcinoma (0.09 mGy/MBq). The correlation coefficient between the dose calculated on the basis of the <sup>123</sup>I-MIBG pre-therapy scans and the subsequent <sup>131</sup>I-MIBG therapy was 0.93 when a correction factor of 1.26 was taken into account. When considering all following therapies, the correlation was 0.85 and the correction factor, 1.20. Our results show that it is feasible to use data from pre-therapy <sup>123</sup>I-MIBG scans to calculate the total body dose of the subsequent <sup>131</sup>I-MIBG therapy. Â© Springer-Verlag 2002.",Excluded
3274,"[Induratio penis plastica]. BACKGROUND: To evaluate the benefit of radiotherapy with fast electrons in induratio penis plastica (IPP).PATIENTS AND METHODS: Within 7 years we treated 58 patients with manifested clinically induratio penis plastica. We applied single dose of 3 Gy 2-3 times weekly and a maximum dose of 24-30 Gy. Follow-up was 2 years and included documentation of subjective discomforts (induration, deviation and painful erection).RESULTS: Induration (27.6%) and deviation (24.1%) of the erected penis are little improved, but in two-third of patients (65%) with painful erection defined relief could be obtained. It could also be shown that patients with short history of symptoms had best chances for a successful treatment. Side effects were not seen.CONCLUSION: In our experience radiotherapy is not suitable for all stages of IPP. Only patients in the early stages of IPP-especially the ones who suffer from painful erection-should be considered suitable for treatment with ionising radiation.",Excluded
2628,"Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. BACKGROUND: We performed this study to determine the outcomes (pathologic response, survival, local-regional control, and toxicity) in patients treated with neoadjuvant chemoradiotherapy and planned operation for stage IIIA non-small cell lung carcinoma.METHODS: Patients treated from 1993 to 2000 with neoadjuvant chemoradiotherapy and a predetermined plan for subsequent surgical resection for stage III non-small cell lung carcinoma were analyzed. All patients underwent pretreatment evaluation at the university's Multidisciplinary Lung Cancer Center. Most patients (87%) had complete mediastinoscopy staging, and all were believed to be poor candidates for up-front operation because of bulky extent of disease. The radiotherapy program used conventional, 2-dimensionally planned treatment to 45 to 54 Gy in 1.8- to 2-Gy fraction size. Concurrent chemotherapy consisted of etoposide/cisplatin or carboplatin/paclitaxel. Study end points included resectability, pathologic response, local-regional control, survival, and toxicity. An exploratory comparison between pathologic response and long-term survival was performed. An exploratory comparison between older chemotherapy (etoposide/cisplatin) and third-generation chemotherapy (carboplatin/paclitaxel) was also performed.RESULTS: Of 53 patients, 45 (85%) were deemed surgical candidates after induction therapy. Twenty-two (42% of the initial cohort) patients had a major pathologic response to stage 0, I, or II disease. The 5-year actuarial survival was 31%. Major pathologic response was associated with improved survival (48% vs 24%; P =.027). The overall rate of early death potentially related to therapy in this series was 9%; this mostly occurred in patients who underwent right pneumonectomy. There was no difference in efficacy or mortality between etoposide/cisplatin and radiotherapy versus carboplatin/paclitaxel and radiotherapy, although the latter regimen was associated with less grade 3 or higher acute toxicity necessitating interruption or hospitalization during neoadjuvant treatment (P =.02). In-field local control was achieved in 83% of all patients (90% of the patients who underwent resection). Brain metastases as the first site of treatment failure occurred in 23% of all patients.CONCLUSIONS: Neoadjuvant concurrent chemoradiation delivers high resectability, major pathologic response rate, and excellent local-regional control, with encouraging long-term survival considering the patient population studied. Major pathologic response correlates with long-term survival. Neoadjuvant carboplatin/paclitaxel and radiotherapy is an appropriate framework on which to add new therapies.",Excluded
3406,"Small Cell Lung Cancer: Therapies and Targets. Small cell lung cancer (SCLC) remains a fatal disease due to limited therapeutic options. Systemic chemotherapy is the bedrock of treatment for both the limited and extensive stages of the disease. However, the established management paradigm of platinum-based chemotherapy has reached an efficacy plateau. A modest survival improvement, approximately 5%, was witnessed with the addition of cranial or thoracic radiation to systemic chemotherapy. Other strategies to improve outcome of platinum-based chemotherapy in the last two decades have met with minimal success. The substitution of irinotecan for etoposide in the frontline treatment of SCLC achieved significant efficacy benefit in Japanese patients, but similar benefit could not be reproduced in other patient populations. Salvage treatment for recurrent or progressive SCLC is particularly challenging, where topotecan remains the only agent with regulatory approval to date. Ongoing evaluation of biologic agents targeting angiogenesis, sonic hedgehog pathway, DNA repair pathway, and immune checkpoint modulators hold some promise for improved outcome in SCLC. It is hoped that the coming decade will witness the application of new molecular biology and genomic research techniques to improve our understanding of SCLC biology and identification of molecular subsets that can be targeted appropriately using established and emerging biological agents similar to the accomplishments of the last decade with non-small cell lung cancer (NSCLC). Â© 2014 Elsevier Inc.",Excluded
3324,"Cross-talk between the O(6)-Methylguanine-DNA methyltransferase (MGMT) and p53 in glioblastoma multiforme. Background. Glioblastoma multiforme (GBM) is a fatal malignant primary brain tumor in adults with a median survival time of approximately 14.6 months, despite treatment with surgery, concurrent radiation therapy (RT) and the alkylating agent temozolomide (TMZ). O(6)-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair protein involved in resistance to TMZ in GBM. Our group showed that MGMT is a critical regulator of GBM angiogenesis, invasion and response to antiangiogenic treatment (sunitinib). While sunitinib treatment significantly decreased invasion in MGMT-positive cell lines, it led to a significant increase of invasion in MGMT-negative cell lines. Our group launched the first phase II clinical trial of concurrent sunitinib with RT and TMZ for selected patients with MGMT-positive tumors. The p53 tumor suppressor protein is involved in proliferation, angiogenesis and response to RT. Previous studies showed the effect of p53 in regulating MGMT levels. The role of MGMT and p53 in response to RT and sunitinib is unknown. We hypothesize that MGMT may affect levels of p53 and response to RT and sunitinib treatment. Results. We used isogenic human GBM cell lines isogenic for MGMT and assessed p53 levels by Western blotting and immunofluorescence. We showed for the first time that stable transfection of GBM cell line negative for MGMT (U87MG) and harboring wild type TP53 with a vector encoding for MGMT (U87MGMT) led to significant increase of p53 expression and its nuclear localization. Strikingly, increased p53 in U87MGMT cells did not lead to increased p21 protein, one of the main targets of p53. As shown by western blotting analysis, ionizing radiation (6 and 10 Gy) did not increase p21 levels compared to sham control. Interestingly, it was previously shown that irradiation does not lead to p21 activation in GBM cells with basal overexpression of p21 mRNA and can even lead to its repression as a mechanism of resistance to RT. We suggest that MGMT could be an upstream regulator of this resistance. Conclusion. Our study revealed a novel mechanism for regulation of p53 through MGMT, which may affect response to RT in GBM. We will further establish the relationship between MGMT/p53 status and response to combined RT and sunitinib in GBM cell lines and samples from patients enrolled in our clinical trial. This will lead to more efficient strategies of treatment for patients with tumors unresponsive to combined RT and sunitinib. Grant acknowledgments. This work has been funded by the Cedar Cancer Foundation, Research Institute of McGill University Health Center and the McGill-CIHR Drug Development Training Program (DDTP).",Excluded
2613,"Schizophrenia-like behavioral changes after partial hippocampal kindling. The effect of hippocampal kindling on behavioral changes following 10 and 21 hippocampal afterdischarges (ADs) or electrographic seizures was examined in behaving rats. As compared to control, non-stimulated rats, 21 but not 10 hippocampal ADs resulted in a decrease in social contact, an increase in social isolation, and an increase in climbing and chasing behavior tested in an open field 3 days after cessation of kindling. Porsolt forced swimming test was not different among the control, 10- or 21-AD groups of rats. A deficit in sensorimotor gating, measured by prepulse inhibition of an acoustic startle, was observed in kindled as compared to control rats at 2 weeks after 21 ADs, but not after 10 ADs. Similarly, methamphetamine (1 mg/kg i.p.) induced higher locomotor activity in kindled rats, as compared to controls, after 21 ADs but not after 10 ADs. Spontaneous locomotor activity in a novel cage, without drug administration, was not different between kindled and control rats. These findings suggest that behavioral alterations after repeated hippocampal electrographic seizures may be mediated by increased dopaminergic functions, which may also mediate the psychiatric symptoms in human epileptic patients.",Excluded
3297,"Effectiveness of fentanyl pectin nasal citrate in controlling episodes of breakthrough cancer pain triggered by routine radiotherapy procedures. PURPOSE: The aim of the study was to evaluate the effectiveness of fentanyl pectin nasal spray (FPNS) in controlling procedural breakthrough cancer pain (BTCP) in advanced cancer patients undergoing radiotherapy.MATERIALS AND METHODS: This study involved 62 advanced cancer patients, with well-controlled background pain, who presented BTCP associated to routine radiotherapy procedures, treated with FPNS according to our protocol of administration. The BPE intensity was measured using a visual analog scale (VAS).RESULTS: The BTCP was triggered during the computed tomography simulation (79.3%) or treatment delivery (20.7%). Patients indicated a mean VAS of 8.8 (range 7-10) when attempting the procedure. After 4.5 min (range 2-10) of the first FPNS dose, the majority of patients (85.5%) indicated a VAS of 4.3 (range 2-6). 15.5% of the patients did not respond after 15 min; requiring a second dose. All these patients responded, reporting a mean VAS of 4.2 (range 4-6) after 3.0 min (range 2-5) of the second dose. None of the patients required a third dose, nor reported an AE after the administration of FPNS.CONCLUSIONS: In our knowledge, our study is the one of highest recruitment, and with the fastest response of BTCP treated with FPNS reported in advanced cancer patients undergoing radiotherapy. FPNS has proven to be highly effective in reducing the intensity of procedural BTCP in a very short period of time.",Excluded
2803,Effects of LSD on receptive fields of single cells in the lateral geniculate nucleus of the cat,Excluded
3171,"Histopathological findings in a surgically resected thalamic cavernous hemangioma 1 year after 40-Gy irradiation. Stereotactic radiosurgery is a controversial treatment modality in the management of cerebral cavernous hemangiomas (CHs), and results vary from center to center. Even the interpretation of treatment failure is controversial. It is suggested that the systematic pathological investigation of irradiated specimens could help to resolve the controversy. A hemorrhagic lesion in the posterior part of the thalamus had been diagnosed as a tumor and was treated with 40-Gy fractionated radiotherapy. One year after this treatment the case was reconsidered based on new imaging evidence, and the lesion was removed by conventional craniotomy. Histopathological examination revealed a CH with postirradiation changes. Compared with nonirradiated control CH tissue samples, there was endothelial cell destruction and marked fibrosis with scar tissue formation in the stroma of the treated lesion. The histopathological findings in this specimen were similar to those described in arteriovenous malformations after gamma knife surgery. The results of light microscopic investigations suggest that the ionizing effect of radiation energy evokes vascular and connective tissue stroma changes in CHs as well.",Excluded
2873,[The early reaction of the neuroendocrine system to irradiation at high doses]. It has been found that in 2 hours after the total gamma irradiation of rats at doses of 20 and 100 Gy the ACTH and glucagon levels in plasma increased by 5-6 and 10-12 times correspondingly. No significant changes in levels of plasma insulin and glucose have been revealed.,Included
3173,"Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Recent studies have suggested that regeneration of non-haematopoietic cell lineages can occur through heterotypic cell fusion with haematopoietic cells of the myeloid lineage. Here we show that lymphocytes also form heterotypic-fusion hybrids with cardiomyocytes, skeletal muscle, hepatocytes and Purkinje neurons. However, through lineage fate-mapping we demonstrate that such in vivo fusion of lymphoid and myeloid blood cells does not occur to an appreciable extent in steady-state adult tissues or during normal development. Rather, fusion of blood cells with different non-haematopoietic cell types is induced by organ-specific injuries or whole-body irradiation, which has been used in previous studies to condition recipients of bone marrow transplants. Our findings demonstrate that blood cells of the lymphoid and myeloid lineages contribute to various non-haematopoietic tissues by forming rare fusion hybrids, but almost exclusively in response to injuries or inflammation.",Excluded
2637,"Characterization of a new rat model of experimental combined neurotrauma. Traumatic brain injury (TBI) is present in two-thirds of patients with multiple injuries and in one-third combined with injuries of the extremities. Studies on interactive effects between central and peripheral injuries are scarce due to the absence of clinically relevant models. To meet the demand for ""more-hit"" models, an experimental model of combined neurotrauma (CNT) incorporating a standardized TBI via lateral fluid percussion (LFP) together with a peripheral bone fracture, i.e., tibia fracture, is introduced. Sprague-Dawley rats were randomized to four experimental groups: controls (n = 10), animals with TBI (n = 30), animals with tibia fracture (n = 30), and animals with CNT (n = 30). Morphological aspects of brain and bone injury were analyzed via standard histopathological procedures and x-ray. Trauma-induced neuromotor dysfunction was assessed using a standardized neuroscore. For interactive effects between injuries, we studied the extent and temporal pattern of circulating interleukin 6 (IL-6) levels via immunoassay and callus formation at fracture sites by means of microradiography. LFP produced an ipsilateral lesion with cortical contusion, hemorrhage, mass shift, and neuronal cell loss (adjacent cortex and hippocampus CA-2/-3), along with contralateral neuromotor dysfunction. X-rays confirmed complete fractures in the middle of the bone shaft. The type of injury (P < 0.001) and time (P = 0.022) were significantly associated with increased IL-6 levels. CNT produced the highest IL-6 plasma levels with a maximum peak at 6 h after trauma (P < 0.001). Similarly, callus formation at fracture sites in CNT was significantly increased versus fracture only (P < 0,01). The CNT model mimics a variety of clinically relevant features known from human multiple injury, including TBI, and offers novel approaches for investigation of interactive mechanisms and therapeutic approaches.",Excluded
2849,"Computational modelling of the cerebral cortical microvasculature: effect of x-ray microbeams versus broad beam irradiation. Microbeam Radiation Therapy is an innovative pre-clinical strategy which uses arrays of parallel, tens of micrometres wide kilo-voltage photon beams to treat tumours. These x-ray beams are typically generated on a synchrotron source. It was shown that these beam geometries allow exceptional normal tissue sparing from radiation damage while still being effective in tumour ablation. A final biological explanation for this enhanced therapeutic ratio has still not been found, some experimental data support an important role of the vasculature. In this work, the effect of microbeams on a normal microvascular network of the cerebral cortex was assessed in computer simulations and compared to the effect of homogeneous, seamless exposures at equal energy absorption. The anatomy of a cerebral microvascular network and the inflicted radiation damage were simulated to closely mimic experimental data using a novel probabilistic model of radiation damage to blood vessels. It was found that the spatial dose fractionation by microbeam arrays significantly decreased the vascular damage. The higher the peak-to-valley dose ratio, the more pronounced the sparing effect. Simulations of the radiation damage as a function of morphological parameters of the vascular network demonstrated that the distribution of blood vessel radii is a key parameter determining both the overall radiation damage of the vasculature and the dose-dependent differential effect of microbeam irradiation.",Excluded
2541,"The dysbacteriosis of extreme states. [Russian]. The study was aimed at investigation of the characteristic features of intestinal dysbacteriosis in man under extreme conditions and development of methods for correcting intestinal microflora for prevention of dysbacteriosis under such conditions. Microbiocenosis of the intestine was investigated in 99 practically healthy persons under model earth conditions and in 34 cosmonauts after space flights of various duration. The following factors influencing intestinal microflora in man under extreme conditions were studied: neuroemotional tension, hypokinesia, increased physical loads, isolation under conditions of altered gaseous environment and microclimate. The study revealed that the above factors participated in development of dysbacteriosis. It was shown that the neuroemotional stress played the main role in development of dysbacteriosis in man under extreme conditions: intestinal microflora responded under extreme conditions by decreased counts of bifidobacteria and lactobacilli participating in maintenance of the intact ecological barrier and colonization resistance. For preventing dysbacteriotic reactions of intestinal microflora it was recommended to use bifidobacterin tablets. Bifidobacterin correction was shown to be efficient in prevention of dysbacteriosis in persons under extreme conditions.",Excluded
2957,"Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. Current knowledge about the molecular mechanisms of NMDA receptor (NMDAR)-independent long-term potentiation (LTP) in the hippocampus and its function for memory formation in the behaving animal is limited. NMDAR-independent LTP in the CA1 region is thought to require activity of postsynaptic L-type voltage-dependent Ca2+ channels (Cav1.x), but the underlying channel isoform remains unknown. We evaluated the function of the Cav1.2 L-type Ca2+ channel for spatial learning, synaptic plasticity, and triggering of learning-associated biochemical processes using a mouse line with an inactivation of the CACNA1C (Cav1.2) gene in the hippocampus and neocortex (Cav1.2(HCKO)). This model shows (1) a selective loss of protein synthesis-dependent NMDAR-independent Schaffer collateral/CA1 late-phase LTP (L-LTP), (2) a severe impairment of hippocampus-dependent spatial memory, and (3) decreased activation of the mitogen-activated protein kinase (MAPK) pathway and reduced cAMP response element (CRE)-dependent transcription in CA1 pyramidal neurons. Our results provide strong evidence for a role of L-type Ca2+ channel-dependent, NMDAR-independent hippocampal L-LTP in the formation of spatial memory in the behaving animal and for a function of the MAPK/CREB (CRE-binding protein) signaling cascade in linking Cav1.2 channel-mediated Ca2+ influx to either process.",Excluded
2588,"Effective long-term local results and prognostic factors after fractionated stereotactic radiotherapy of 257 intracranial meningeoma. Background: The aim of this study was to evaluate the local tumour control and safety of patients with meningioma after fractionated stereotactic radiotherapy. Moreover, we have analysed the overall survival and identified prognostic factors after SRT. Method(s): 233 patients with 257 meningeoma of the skull base (71.2%), falx (12.1%), convexity (14.4%) and meningeomatosis (2.3%) were treated between 01/2002 and 01/2015 at the Erlangen University Hospital. 81.7% (210) of patients received SRT postoperatively and 18.3% (47) as primary treatment. 119 (46.3%) had a WHO grade I, 64 (24.9%) grade II, 16 (6.2%) grade III meningioma. In 58 cases no histology was obtained, whereas 47 (18.3%) of which received SRT alone. SRT was given in 28 or 30 fractions. The lesion (PTV) received a median reference dose of 54.0 (range: 35.50- 66.60) Gy in single fraction of 1.80 Gy. Result(s): The median follow-up at the time of overall survival (OS) analysis was 38.10 (range: 0.46-130.03) months. Local control rate was 97% at 5- and 83% at 10 years. OS rate was 92% at 5- and 90% at 10 years. No radiation associated acute toxicity occurred. In one patient considerable worsening of vision in left eye was observed (opticus left dose: 56.16 Gy). The most common chronic symptoms were headache. The skull base meningioma (vs. other location), female sex and irradiation of primary tumour (vs. reccurence) were a high significant (p = 0.000) prognostic factor for progression-free-survival. Conclusion(s): The SRT was associated with excellent local control of 97% after 5- and 83% after 10 years. It has been shown that local control was significantly associated with the tumour location, irradiation of primary tumour or recurrence and the gender.",Excluded
3548,"Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial. PURPOSE: Neurotoxic effects of brain irradiation include cognitive impairment in 50% to 90% of patients. Prior studies have suggested that donepezil, a neurotransmitter modulator, may improve cognitive function.PATIENTS AND METHODS: A total of 198 adult brain tumor survivors >= 6 months after partial- or whole-brain irradiation were randomly assigned to receive a single daily dose (5 mg for 6 weeks, 10 mg for 18 weeks) of donepezil or placebo. A cognitive test battery assessing memory, attention, language, visuomotor, verbal fluency, and executive functions was administered before random assignment and at 12 and 24 weeks. A cognitive composite score (primary outcome) and individual cognitive domains were evaluated.RESULTS: Of this mostly middle-age, married, non-Hispanic white sample, 66% had primary brain tumors, 27% had brain metastases, and 8% underwent prophylactic cranial irradiation. After 24 weeks of treatment, the composite scores did not differ significantly between groups (P = .48); however, significant differences favoring donepezil were observed for memory (recognition, P = .027; discrimination, P = .007) and motor speed and dexterity (P = .016). Significant interactions between pretreatment cognitive function and treatment were found for cognitive composite (P = .01), immediate recall (P = .05), delayed recall (P = .004), attention (P = .01), visuomotor skills (P = .02), and motor speed and dexterity (P < .001), with the benefits of donepezil greater for those who were more cognitively impaired before study treatment.CONCLUSION: Treatment with donepezil did not significantly improve the overall composite score, but it did result in modest improvements in several cognitive functions, especially among patients with greater pretreatment impairments.",Excluded
3359,"Clinical correlates of true progression versus treatment effect in brain metastases treated with stereotactic radiosurgery. Purpose: A substantial proportion of brain metastases treated with Stereotactic Radiosurgery (SRS) will subsequently grow on imaging, though often transiently. Optimal clinical management in such cases is hampered by an inability to reliably distinguish true progression (TP) from pseudoprogression with conventional imaging. Identifying clinical features associated with TP may aid clinical decision making. Methodology: Patients treated with SRS for brain metastases who subsequently underwent resection of treated lesions at our institution were retrospectively reviewed. Clinical and radiation planning features were fitted into a multivariate logistic regression model to identify significant relationships with pure TP on pathology. Result(s): Seventy-five cases of treated brain metastases across 60 patients (median age: 57 years) met our inclusion criteria (Table 1). Prescribed dose range was 14-25 Gy in 1-5 fractions prescribed to 50-90% isodose line (IDL) with corresponding BED10 of 28-60Gy. Median time from SRS to subsequent resection was 255 days (range: 21-1351). Pathology showed pure TP in 39/75 surgical specimens (52%). Clinical covariates were entered into a multivariate logistic regression model with poorest predictors removed in step-wise fashion. Factors removed due to lesser significance (p > 0.3) included treatment machine, time from SRS, and radiation dose in BED10. For the final multivariate model, statistically significant predictors included small cell lung cancer (SCLC) pathology, infratentorial location, and increasing IDL (Table 2). (Table presented) Conclusion(s): SCLC histology, infratentorial location, and higher prescription IDL predicted for TP while prior WBRT showed a trend for predicting treatment effect in this institutional cohort. These data suggest that SCLC or infratentorial location may reflect a higher probability for local microscopic spread and marginal miss with SRS. The more gradual dose fall off and less centrally ablative dose associated with higher prescription IDLs also seemto correlate with lower rates of radionecrosis and increased odds of progression in this cohort. Validation in large independent datasets is warranted.",Excluded
2726,"Sustained ocular venous fluid shift during spaceflight may contribute to optic disc edema. Purpose : The Spaceflight Associated Neuro-ocular Syndrome (SANS) is characterized by the development of optic disc edema, chorioretinal folds, globe flattening, and/or hyperopic shifts in astronauts during 6-month missions on the International Space Station (ISS). We hypothesize that a weightlessness-induced chronic headward fluid shift within the venous system contributes to these ocular changes. Methods : Astronauts (n=10) were studied before flight (seated and supine posture) and ~150 days into a 6-month mission on the ISS. Ocular and vascular measures included optical coherence tomography (OCT; Spectralis, Heidelberg Engineering) assessments of sub-macular choroid thickness and peripapillary total retinal thickness (TRT; segmented from Bruch's membrane to the internal limiting membrane); ultrasound-derived internal jugular vein (IJV) cross-sectional area (GE VividQ) and non-invasive IJV pressure (Veinpress); and intraocular pressure (IOP; iCare pro pre-flight and TonoPen in-flight). Repeatedmeasures ANOVA with Tukey's post-test was used to determine the mean change between conditions; data are presented as group mean +/- standard deviation. Results : The mean IJV area increased from 9 +/- 6 mm<sup>2</sup> in the seated position to 83 +/- 27 mm<sup>2</sup> in the supine position on Earth and to 64 +/- 31 mm<sup>2</sup> during spaceflight (P<.001). Similarly, mean IJV pressure increased from 4.3 +/- 1.6 mmHg in the seated position to 16.6 +/- 5.6 mmHg in the supine position on Earth and to 14.4 +/- 5.3 mmHg in-flight (P<.001). No significant changes in sub-macular choroid thickness or TRT were detected during the acute preflight posture change, however after 150 days of weightlessness, choroid thickness increased by 50 +/- 37 mum (P<.05) and TRT increased by 26 +/- 32 mum (P=.05) relative to preflight seated values. IOP remained within a normal range in weightlessness, averaging 15.4 +/- 2.1 mmHg after 150 days of spaceflight, compared to 14.8 +/- 2.7 mmHg and 15 +/- 1.1 mmHg pre-flight in the seated and supine positions, respectively. Conclusions : Although a transient posture-induced venous fluid shift has no effect on choroidal or retinal thickness, a sustained, unrelenting cephalad fluid shift during spaceflight results in increased choroidal and retinal thickness. These data suggest that altered venous hemodynamics during spaceflight may contribute to SANS.",Excluded
3134,"Photic and circadian regulation of melatonin production in the Mozambique tilapia Oreochromis mossambicus. Diverse circadian systems related to phylogeny and ecological adaptive strategies are proposed in teleosts. Recently, retinal photoreception was reported to be important for the circadian pacemaking activities of the Nile tilapia Oreochromis niloticus. We aimed to confirm the photic and circadian responsiveness of its close relative-the Mozambique tilapia O. mossambicus. Melatonin production in cannulated or ophthalmectomized fish and its secretion from cultured pineal glands were examined under several light regimes. Melatonin production in the cannulated tilapias was measured at 3-h intervals; it fluctuated daily, with a nocturnal increase and a diurnal decrease. Exposing the cannulated fish to several light intensities (1500-0.1 lx) and to natural light (0.1 and 0.3 lx) suppressed melatonin levels within 30 min. Static pineal gland culture under light-dark and reverse light-dark cycles revealed that melatonin synthesis increased during the dark periods. Rhythmic melatonin synthesis disappeared on pineal gland culture under constant dark and light conditions. After ophthalmectomy, plasma melatonin levels did not vary with light-dark cycles. These results suggest that (1) Mozambique tilapias possess strong photic responsiveness, (2) their pineal glands are sensitive to light but lack circadian pacemaker activity, and (3) they require lateral eyes for rhythmic melatonin secretion from the pineal gland.",Excluded
2995,"Dosimetric feasibility of real-time MRI-guided proton therapy. PURPOSE: Magnetic resonance imaging (MRI) is a prime candidate for image-guided radiotherapy. This study was designed to assess the feasibility of real-time MRI-guided proton therapy by quantifying the dosimetric effects induced by the magnetic field in patients' plans and identifying the associated clinical consequences.METHODS: Monte Carlo dose calculation was performed for nine patients of various treatment sites (lung, liver, prostate, brain, skull-base, and spine) and tissue homogeneities, in the presence of 0.5 and 1.5 T magnetic fields. Dose volume histogram (DVH) parameters such as D95, D5, and V20 as well as equivalent uniform dose were compared for the target and organs at risk, before and after applying the magnetic field. The authors further assessed whether the plans affected by clinically relevant dose distortions could be corrected independent of the planning system.RESULTS: By comparing the resulting dose distributions and analyzing the respective DVHs, it was determined that despite the observed lateral beam deflection, for magnetic fields of up to 0.5 T, neither was the target coverage jeopardized nor was the dose to the nearby organs increased in all cases except for prostate. However, for a 1.5 T magnetic field, the dose distortions were more pronounced and of clinical concern in all cases except for spine. In such circumstances, the target was severely underdosed, as indicated by a decrease in D95 of up to 41% of the prescribed dose compared to the nominal situation (no magnetic field). Sites such as liver and spine were less affected due to higher tissue homogeneity, typically smaller beam range, and the choice of beam directions. Simulations revealed that small modifications to certain plan parameters such as beam isocenter (up to 19 mm) and gantry angle (up to 10degree) are sufficient to compensate for the magnetic field-induced dose disturbances. The authors' observations indicate that the degree of required corrections strongly depends on the beam range and direction relative to the magnetic field. This method was also applicable to more heterogeneous scenarios such as skull-base tumors.CONCLUSIONS: This study confirmed the dosimetric feasibility of real-time MRI-guided proton therapy and delivering a clinically acceptable dose to patients with various tumor locations within magnetic fields of up to 1.5 T. This work could serve as a guide and encouragement for further efforts toward clinical implementation of hybrid MRI-proton gantry systems.",Excluded
3131,"Enhanced binding of the convulsive ligand DMCM to high-energy irradiated benzodiazepine receptors: Evidence of complex receptor structure. <sup>3</sup>H-DMCM apparently binds to benzodiazepine receptors in rat brain (8). Binding of <sup>3</sup>H-DMCM has high affinity for its binding sites (K(D) 0.5-5 nM, with curvilinear Scatchard plot); benzodiazepine receptor ligands have high affinity for <sup>3</sup>H-DMCM binding sites; and GABA reduces specific <sup>3</sup>H-DMCM binding under appropriate conditions. The present preliminary report describes an unexpected increase in <sup>3</sup>H-DMCM binding upon high-energy irradiation of rat cortical membranes.",Included
2830,"Whole-brain radiotherapy and stereotactic radiosurgery in brain metastases: what is the evidence?. The overall local treatment paradigm of brain metastases, which includes whole-brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS), continues to evolve. Local therapies play an important role in the management of brain metastases. The choice of local therapy depends on factors that involve the patient (performance status, expected survival, and age), the prior treatment history, and the tumor (type and subtype, number, size, location of metastases, and extracranial disease status). Multidisciplinary collaboration is required to facilitate an individualized plan to improve the outcome of disease in patients with this life-limiting complication. There has been concern about the neurocognitive effects of WBRT. A number of approaches that mitigate cognitive dysfunction, such as pharmacologic intervention (memantine) or a hippocampal-sparing strategy, have been studied in a prospective manner with WBRT. Although there has been an increase in the use of SRS in the management of brain metastases in recent years, WBRT retains an important therapeutic role.",Excluded
3427,"Noncancerous neurologic manifestations during development of malignant tumors. [French]. The appearance of neurological signs during the course of treatment against cancer is not synonymous with a neoplastic or paraneoplastic lesion of the nervous system. The possibility of an iatrogenic disorder or of a curable pathological disease combination should always be considered during discussion of clinical and paraclinical data. Iatrogenic neurological diseases or benign tumors associated with a cancer have a variable prognosis but nevertheless, their diagnosis demands a specific attitude on the part of the staff treating the patient.",Excluded
3545,"In vivo imaging of endothelial cell adhesion molecule expression after radiosurgery in an animal model of arteriovenous malformation. Focussed radiosurgery may provide a means of inducing molecular changes on the luminal surface of diseased endothelium to allow targeted delivery of novel therapeutic compounds. We investigated the potential of ionizing radiation to induce surface expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on endothelial cells (EC) in vitro and in vivo, to assess their suitability as vascular targets in irradiated arteriovenous malformations (AVMs). Cultured brain microvascular EC were irradiated by linear accelerator at single doses of 0, 5, 15 or 25 Gy and expression of ICAM-1 and VCAM-1 measured by qRT-PCR, Western, ELISA and immunocytochemistry. In vivo, near-infrared (NIR) fluorescence optical imaging using Xenolight 750-conjugated ICAM-1 or VCAM-1 antibodies examined luminal biodistribution over 84 days in a rat AVM model after Gamma Knife surgery at a single 15 Gy dose. ICAM-1 and VCAM-1 were minimally expressed on untreated EC in vitro. Doses of 15 and 25 Gy stimulated expression equally; 5 Gy was not different from the unirradiated. In vivo, normal vessels did not bind or retain the fluorescent probes, however binding was significant in AVM vessels. No additive increases in probe binding were found in response to radiosurgery at a dose of 15 Gy. In summary, radiation induces adhesion molecule expression in vitro but elevated baseline levels in AVM vessels precludes further induction in vivo. These molecules may be suitable targets in irradiated vessels without hemodynamic derangement, but not AVMs. These findings demonstrate the importance of using flow-modulated, pre-clinical animal models for validating candidate proteins for vascular targeting in irradiated AVMs.",Included
3188,"Effect of jump exercise training on long-term head-down bed rest-induced cerebral blood flow responses in arteries and veins. New Findings: What is the central question of this study? What is the effect of an exercise countermeasure on microgravity-induced change in cerebral blood flow? What is the main finding and its importance? Jump exercise training as a countermeasure did not modify the heterogeneous cerebral blood flow response to head-down bed rest, suggesting that this method is effective in preventing cardiovascular system deconditioning but is not good for cerebral haemodynamics. Abstract: This study aimed to examine the effect of an exercise countermeasure on cerebral blood flow (CBF) response to long-term -6degree head-down bed rest (HDBR) in all cerebral arteries and veins. Twenty male volunteers were exposed to HDBR for 60 days with (training group, n = 10) or without (control group, n = 10) jump exercise training as a countermeasure to spaceflight. The blood flow in the neck conduit arteries (internal carotid and vertebral artery; ICA and VA) and veins (internal jugular and vertebral veins; IJV and VV) was measured, using ultrasonography before (baseline) HDBR, on the 30th and 57th day of HDBR. Long-term HDBR causes a heterogeneous CBF response between the anterior and the posterior brain or between arteries and veins. Long-term HDBR decreased anterior cerebral arterial and venous blood flow, while posterior cerebral arterial and venous blood flows were well maintained. However, exercise jump training did not change each arterial and venous CBF responses to HDBR (control vs. training; ICA, P = 0.643; VA, P = 0.542; external carotid artery, P = 0.644; IJV, P = 0.980; VV, P = 0.999). These findings suggest that jump exercise training did not modify the heterogeneous CBF response to long-term HDBR. Copyright Â© 2021 The Authors. Experimental Physiology Â© 2021 The Physiological Society",Excluded
3002,"Experimental and preclinical tools to explore the main neurological impacts of brain irradiation: Current insights and perspectives. Radiation therapy is a powerful tool in the treatment of primary and metastatic cancers of the brain. However, brain tissue tolerance is limited, and radiation doses must be tailored to minimize deleterious effects on the nervous system. Due to improved treatments, including radiotherapy techniques, many patients with brain tumors survive longer, but they experience late effects of radiotherapy, especially cognitive decline, for which no efficient treatment is currently available. Improving the prevention and treatment of radiation-induced neurological defects first needs to better characterize radiation injuries in brain cells and tissues. Rodent models have been widely used for this. Here, observations from patients will be reviewed briefly as an introduction, mainly regarding clinical cognitive defects and anatomical alterations using magnetic resonance imaging (MRI). This limited descriptive clinical knowledge addresses many questions that arise in preclinical models regarding understanding the mechanism of radiation-induced brain dysfunction. From this perspective, we next present methods to characterize radiation-induced neurogenesis alterations in adult mice and then detail how MRI could be used as a powerful tool to explore these alterations. Copyright Â© 2021, Springer Science+Business Media, LLC, part of Springer Nature.",Excluded
3163,"Morphometric analysis of hypothalamic cells showing c-Fos proteins after movement restriction and EHF-irradiation. A morphometric analysis of hypothalamic cells containing c-Fos-like protein detected by an indirect immunoperoxidase method was carried out to clarify the responses to movement restriction and skin electromagnetic high frequency (EHF) irradiation (7.1 mm, 42.2 GHz, 20 mW output power) simultaneously to three acupuncture projection areas. The morphometry of c-Fos-protein positive neurons by their number and type was analyzed. Movement restriction (40 min) induced c-Fos protein expression primarily in cells with 10-50 mum<sup>2</sup> sizes (associative type neurons) only in anterior hypothalamic nucleus and lateral hypothalamic area; while additional EHF-irradiation of acupuncture projection areas (under movement restriction) induced c-Fos expression in all hypothalamic structures and mostly in cells with 70-150 mum<sup>2</sup> sizes (relay type neurons), i.e. changed the pattern of activated cell type distribution. In conclusion, the findings show that modest stress under which experimental animals often are exposed increase c-Fos protein expression in hypothalamic centers and skin EHF-irradiation of acupuncture projection areas seem to increase that. Â© 2008.",Excluded
3177,"Post-treatment imaging changes in primary brain tumors. Discerning between primary brain tumor progression and treatment-related effect is a significant issue and a major challenge in neuro-oncology. The difficulty in differentiating tumor progression from treatment-related effects has important implications for treatment decisions and prognosis, as well as for clinical trial design and results. Conventional MRI is widely used to assess disease status, but cannot reliably distinguish between tumor progression and treatment-related effects. Several advanced imaging techniques are promising, but have yet to be prospectively validated for this use. This review explores two treatment-related effects, pseudoprogression and radiation necrosis, as well as the concept of pseudoresponse, and highlights several advanced imaging modalities and the evidence supporting their use in differentiating tumor progression from treatment-related effect.",Excluded
3308,"Early assessment of normal tissue tolerance of fast neutron beam radiation therapy. Between September 10, 1973 and May 20, 1975, 94 selected patients were treated with fast neutron beams generated by bombarding an ""intermediate"" beryllium target with 21 MeV deuterons. The clinical material included: 58 patients with head and neck cancers; 27 patients with cerebral glioblastoma multiforme; and 9 patients with a variety of other neoplasms. Of the 67 patients treated only with neutron beams, 31 received two increments per week and 36 received three increments per week. The calculated doses in most patients were 1800 rad n gamma (neutrons + gamma components) delivered in 6 weeks. Seventeen patients were treated with two increments of neutron beams and three increments of 60Co photons weekly to calculated total doses of 780-1050 rad n gamma + 3360-3780 rad 60Co gamma delivered over 50-54 days. Ten patients were treated with neutron bean ""boosts"" of 300-900 rad n gamma in three to seven increments over 8-23 days following conventional radiation therapy. Treatment has been well tolerated, with only 9 of 94 patients not completing the anticipated course. In three of these, treatment was dixcontinued because of intercurrent problems. Except for those patients with glioblastoma multiforme, treatment complications have not been dose-related. In four patients, complications probably were related to persistent cancer. Neutron beam irradiaiton may have been a factor in the neurologic deterioration of five patients with glioblastoma multiforme who did not complete treatment.",Excluded
3607,"Ca2+/calmodulin-binding peptides block phototransduction in Limulus ventral photoreceptors: evidence for direct inhibition of phospholipase C. Phototransduction in Limulus photoreceptors involves a G protein-mediated activation of phospholipase C (PLC) and subsequent steps involving InsP3-mediated release of intracellular Ca2+. While exploring the role of calmodulin in this cascade, we found that intracellular injection of Ca2+/calmodulin-binding peptides (CCBPs) strongly inhibited the light response. By chemically exciting the cascade at various stages, we found the primary target of this effect was not in late stages of the cascade but rather at the level of G protein and PLC. That PLCdelta1 contains a calmodulin-like structure raised the possibility that PLC might be directly affected by CCBPs. To test this possibility, in vitro experiments were conducted on purified PLC. The activity of this enzyme was strongly inhibited by CCBPs and also inhibited by calmodulin itself. Our results suggest that the calmodulin-like region of PLC has an important role in regulating this enzyme.",Excluded
3469,"A pertussis toxin-sensitive G-protein mediates the alpha 2-adrenergic receptor inhibition of melatonin release in photoreceptive chick pineal cell cultures. The avian pineal gland is a photoreceptive organ that has been shown to contain postjunctional alpha 2-adrenoceptors that inhibit melatonin synthesis and/or release upon receptor activation. Physiological response and [32P]ADP ribosylation experiments were performed to investigate whether pertussis toxin-sensitive guanine nucleotide-binding proteins (G-proteins) were involved in the transduction of the alpha 2-adrenergic signal. For physiological response studies, the effects of pertussis toxin on melatonin release in dissociated cell cultures exposed to norepinephrine were assessed. Pertussis toxin blocked alpha 2-adrenergic receptor-mediated inhibition in a dose-dependent manner. Pertussis toxin-induced blockade appeared to be noncompetitive. One and 10 ng/ml doses of pertussis toxin partially blocked and a 100 ng/ml dose completely blocked norepinephrine-induced inhibition. Pertussis toxin-catalyzed [32P]ADP ribosylation of G-proteins in chick pineal cell membranes was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. Membranes were prepared from cells that had been pretreated with 0, 1, 10, or 100 ng/ml pertussis toxin. In the absence of pertussis toxin pretreatment, two major proteins of 40K and 41K mol wt (Mr) were labeled by [32P]NAD. Pertussis toxin pretreatment of pineal cells abolished [32P] radiolabeling of the 40K Mr G-protein in a dose-dependent manner. The norepinephrine-induced inhibition of both cAMP efflux and melatonin release, as assessed by RIA of medium samples collected before membrane preparation, was also blocked in a dose-dependent manner by pertussis toxin. Collectively, these results suggest that a pertussis toxin-sensitive 40K Mr G-protein labeled by [32P]NAD may be functionally associated with alpha 2-adrenergic signal transduction in chick pineal cells.",Excluded
3020,"Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. Intracellular proteinaceous inclusions (Lewy bodies and Lewy neurites) of alpha-synuclein are pathological hallmarks of neurodegenerative diseases such as Parkinson's disease, dementia with Lewy bodies (DLB), and multiple systemic atrophy. The molecular mechanisms underlying the aggregation of alpha-synuclein into such filamentous inclusions remain unknown, although many factors have been implicated, including interactions with lipid membranes. To model the effects of membrane fields on alpha-synuclein, we analyzed the structural and fibrillation properties of this protein in mixtures of water with simple and fluorinated alcohols. All solvents that were studied induced folding of alpha-synuclein, with the common first stage being formation of a partially folded intermediate with an enhanced propensity to fibrillate. Protein fibrillation was completely inhibited due to formation of beta-structure-enriched oligomers with high concentrations of methanol, ethanol, and propanol and moderate concentrations of trifluoroethanol (TFE), or because of the appearance of a highly alpha-helical conformation at high TFE and hexafluoro-2-propanol concentrations. At least to some extent, these conformational effects mimic those observed in the presence of phospholipid vesicles, and can explain some of the observed effects of membranes on alpha-synuclein fibrillation.",Excluded
2862,"Long thoracic and spinal accessory nerve injury after an esophagectomy: A unusual case report of scapular winging. Patients or Programs: A 54-year-old right-handed man with a history of esophageal cancer treated with chemotherapy, radiation, and esophagectomy. Program Description: The patient was referred to the clinic by his oncologist for evaluation of bilateral shoulder pain. He had recently undergone esophagectomy with right thoracotomy. Before surgery, the patient had no shoulder pain; after surgery, he developed severe pain and restricted range of motion in the bilateral shoulders, worse on the right side. He had difficulty with overhead reaching and use of his right upper limb in activities of daily living. On examination, he was noted to have significant winging of the right scapula along the medial border when at rest and with a wall pushup, an inability to forward flex the right shoulder past 80degree and abduct past 70degree, atrophy of the right posterior shoulder girdle, and a large well-healed scar along the right lateral scapular border. Setting(s): Outpatient musculoskeletal clinic. Result(s): An electromyography and nerve conduction study was performed and revealed both long thoracic and spinal accessory neuropathy. Subsequent ultrasound imaging of the shoulder revealed a neuroma deep to the scar in the right mid axillary line, suspicious for a laceration of the long thoracic nerve. The patient was referred to the orthotics department to be fitted for a scapulothoracic orthosis. Discussion(s): Although rare, scapular winging can present after surgery due to traumatic, iatrogenic, or idiopathic factors. Prior studies have shown that postoperative scapular winging can have a neurogenic etiology, with isolated injury to the long thoracic, spinal accessory, or dorsal scapular nerve. In this unusual case, the patient developed injury to a combination of nerves, which led his symptoms. Conclusion(s): Postoperative scapular winging can be associated with concomitant long thoracic and spinal accessory nerve injury.",Excluded
3451,"[Changes of Spinal Motor Neurons in Mice after a Space Flight]. The expression of choline acetyltransferase (ChAT), neurofilament (NF) protein 200 kDa, calbindin (CAB) 28 kDa, neuronal NO-synthase (nNOS), caspase 3, Ki-67 was studied in motor neurons from TIII-TV segments of the spinal cord in C57/ BL6 male mice by immunohistochemical methods 12 h after a 30 days-long space flight on the Bion-M1 biosatellite. Mice living under standard vivarium conditions served as a control. The motoneurons of experimental animals demonstrated the reactive changes that were manifested by the increase of their size, decrease in the number of subpopulations expressing ChAT and NF, increase of subpopulations containing CAB, appearance of motor neurons expressing nNOS, caspase-3, and the absence of Ki-67. The lack of proliferating gliocytes, the preservation of nucleolar component indicate the absence of necrobiotic changes characteristic of necrosis. The cytoplasmic vacuolization was observed in thionine-stained CAB-immunoreactive neurons. The disintegration of motor neurons into fragments resembling the apoptotic bodies was observed in single cells that contained caspase-3.",Excluded
3186,"Treatment and prognosis of brain metastases from gynecological cancers. Brain metastases from gynecological cancers were retrospectively investigated in 18 patients who were treated between 1985 and 2006. Six patients received surgical resection followed by radiotherapy, and 12 patients received only radiotherapy. The median survival for all patients was 4.1 months (range 0.7-48.2 months), and the actuarial survival rates were 11% at both 12 months and 24 months. Univariate analysis showed that treatment modality, extracranial disease status, total radiation dose, number of brain metastases, and Karnofsky performance status (KPS) all had statistically significant impacts on survival. Two patients survived for more than 2 years, and both had single brain metastasis, inactive extracranial disease, 90-100% KPS, and were treated with surgical resection followed by radiotherapy. Improvements in neurological symptoms were observed in 10 of the 12 patients treated with palliative radiotherapy, with median duration of 3.1 months (range 1.5-4.5 months). The prognoses for patients with brain metastases from gynecological cancers were generally poor, although selected patients may survive longer with intensive brain tumor treatment. Palliative radiotherapy was effective in improving the quality of the remaining life for patients with unfavorable prognoses.",Excluded
3462,X-ray-induced morphological differentiation of mouse neuroblastoma cells in vitro,Included
2672,[A possible role of neuroimmunoendocrine interactions and development of post-irradiation pathology]. On the basis of the literature a postulate is proposed that the immune system contributes to regulating the intensity and direction of endocrine and nervous system functions in normal conditions and after the effect of ionizing radiation. The role of neuroimmunoendocrine interactions and their impairment in the realization of stochastic and nonstochastic sequelae of irradiation at various levels of radiation affecting the organism under normal conditions and in a combination with other unfavourable factors.,Excluded
2797,"Interstitial brachytherapy for malignant brain tumors. For nearly 20 years, interstitial brachytherapy has been used as adjuvant treatment for malignant brain tumors in both prospective clinical trials and as part of standard therapy. Numerous publications analyzing the results of this treatment seem to indicate an improvement in median survival for highly selected patients. Some newly diagnosed glioblastoma multiforme, recurrent malignant glioma, brain metastases and possibly low grade gliomas seem to benefit. While Iodine-125 (I-125) remains the most popular radionuclide for brachytherapy, there is a recent move away from temporary high-activity implants to permanent low-activity implants. This review article will concentrate on the results from the University of California, San Francisco, as well as recent series published since 1990. In spite of the increased availability of radiosurgery, interstitial brachytherapy still has a place in the management of these difficult tumors. [References: 59]",Excluded
2852,"Feasibility and clinical tolerability of the extendTM relocatable head frame for perfexionTM intra-cranial stereotactic radiotherapy. Purpose: This study aims to identify the challenges in clinical use of the EXTENDTM relocatable head frame (RHF) and to qualitatively report the patient's experience. Materials/Methods: Patients and volunteers enrolled on two prospective clinical trials were fitted, positioned, and immobilized using the RHF. The RHF includes a patient-specific detachable front mouthpiece for dental and hard palate impression. A vacuum is applied to ensure tensionless fixation without the need for active patient cooperation. For positioning, a 1mm action threshold was used. To capture the tolerability of the RHF, subjects were asked to complete a questionnaire immediately after initial fitting, CT simulation, and at the end of their treatment. The questions addressed overall impression and discomfort during the various stages of the procedure. Result(s): Six volunteers completed study procedures without difficulty. Of 21 patients enrolled, one patient was aborted due to geometric constraints of the RHF colliding with his skull, and one patient withdrew from study participation. For the four patients treated on Perfexion the mean difference between CT and PFX position was less than 1mm.Patient anatomy including a high palate, short neck, and broad shoulders were identified as challenges to clinical use of the RHF. Gagging during fitting occurred in six patients and with one patient during positioning. Qualitative review of questionnaires revealed 5 themes: (1) patients have an overall positive impression of the process; (2) most find the dental imprint procedure distressing; (3) positioning was fairly tolerated; (4) overall discomfort during the time of immobilization is none to mild in the hard palate; (5) discomfort to the neck, shoulders and back is mild. Conclusion(s): The study result highlights challenges related to the dental impression procedure, and the importance of a careful patient selection. From the patients perspective the procedure is fairly well tolerated, and may improve by addressing discomforts during the fitting procedure. Positioning within a sub-millimeter accuracy threshold is achievable.",Excluded
2813,"The effect of sequential irradiation with X-rays and fast neutrons on the survival of V79 Chinese hamster cells. V79 Chinese hamster cells have been exposed to X-rays or fast neurons or to the two radiations given sequentially. Cells exposed to a priming dose of X-rays and then exposed immediately to a series of neutron doses regard the X-ray dose as equivalent to a neutron dose giving the same surviving fraction (iso-effective). If the cells are exposed to a neutron dose followed by X-rays the resulting survival is higher than would be obtained if the primary dose had been an iso-effective X-ray dose. However, it is lower than would be expected if the two radiations acted independently. The results imply that there is interaction between the damage caused by X-rays and fast neurons. If the two radiations are given 3 hours apart they act independently.",Included
3269,"Modulation of feeding and drinking by dopamine in caudate and accumbens nuclei in rats. Injection of dopamine (DA) into accumbens and caudate nuclei facilitates a dose-dependent increase in food and water intake, whereas administration of spiperone (SP), a central D2-receptor antagonist suppresses DA-facilitated food and water intake. Bilateral lesions of nucleus accumbens and caudatus result in a sustained and significant decrease in food and water intake. The results suggest that DA is a neurotransmitter involved in feeding and drinking behavior in accumbens and caudate nuclei and this effect is mediated by central D2 receptors.",Excluded
2622,"Stochastic growth pattern of untreated human glioblastomas predicts the survival time for patients. Glioblastomas are highly malignant brain tumors. Knowledge of growth rates and growth patterns is useful for understanding tumor biology and planning treatment logistics. Based on untreated human glioblastoma data collected in Trondheim, Norway, we first fit the average growth to a Gompertz curve, then find a best fitted white noise term for the growth rate variance. Combining these two fits, we obtain a new type of Gompertz diffusion dynamics, which is a stochastic differential equation (SDE). Newly collected untreated human glioblastoma data in Seattle, US, re-verify our model. Instead of growth curves predicted by deterministic models, our SDE model predicts a band with a center curve as the tumor size average and its width as the tumor size variance over time. Given the glioblastoma size in a patient, our model can predict the patient survival time with a prescribed probability. The survival time is approximately a normal random variable with simple formulas for its mean and variance in terms of tumor sizes. Our model can be applied to studies of tumor treatments. As a demonstration, we numerically investigate different protocols of surgical resection using our model and provide possible theoretical strategies.",Excluded
3196,"Evaluation of gamma thalamotomy for parkinsonian and other tremors: Survival of neurons adjacent to the thalamic lesion after gamma thalamotomy. Object. The effects of gamma thalamotomy for parkinsonian and other kinds of tremor were evaluated. Methods. Thirty-six thalamotomies were performed in 31 patients by using a 4-mm collimator. The maximum dose was 150 Gy in the initial six cases, which was reduced to 130 Gy thereafter. The longest follow-up period was 6 years. The target was determined on T<inf>2</inf>-weighted and proton magnetic resonance (MR) images. The point chosen was in the lateral-most part of the thalamic ventralis intermedius nucleus. This is in keeping with open thalamotomy as practiced at the authors' institution. In 15 cases, gamma thalamotomy was the first surgical procedure. In other cases, previous therapeutic or vascular lesions were visible to facilitate targeting. Two types of tissue reaction were onserved on MR imaging: a simple oval shape and a complex irregular shape. Neither of these changes affected the clinical course. In the majority of cases, the tremor subsided after a latent interval of approximately 1 year after irradiation. The earliest response was demonstrated at 3 months. In five cases the tremor remained. In four of these cases, a second radiation session was administered. One of these four patients as well as another patient with an unsatisfactory result underwent open thalamotomy with microrecording. In both cases, depth recording adjacent to the necrotic area revealed normal neuronal activity, including the rhythmic discharge of tremor. Minor coagulation was performed and resulted in immediate and complete arrest of the remaining tremor. Conclusions. Gamma thalamotomy for Parkinson's disease seems to be an alternative useful method in selected cases.",Excluded
3345,"Supportive care for brain cancer patients and their families: from research to resource. Aim: The first aim of the project was to identify the needs and preference for service delivery within the target population (people diagnosed with brain cancer and their families). The second aim was to translate these research findings into the development of resources that would be available to people regardless of where they live. Method(s): Qualitative methods were used to identify the needs of the target population [focus group, N = 20 (n = 8 patients, n = 12 carers/family members)]. These needs were subsequently used to inform an online survey [N = 25, n = 10 patients, n = 12 carers/family members). In addition to need assessment, the online survey also sought information in regard to resource delivery preferences. Result(s): The qualitative data indicated a need for information on the following: types of cancer; treatments and side-effects; practical issues; dealing with changes in personality and behaviour; palliative care; communication strategies. Preferred pathways for information included both video and online material, and a central contact person within the health system. These issues were subsequently used to inform the online survey. This data revealed that the top 5 most endorsed needs were information relating to: diagnosis; symptoms and side effects (seizures, fatigue); managing personality and behavioural changes; current research and advances in treatment; staying fit (diet, nutrition). The most popular type of service delivery was online (videos, information on the internet), followed by postal (booklet, DVD). Outcome(s): Needs and service delivery information was used to inform the development of resources. These resources included the development of a website and the production of video modules addressing various issues across the cancer journey (diagnosis; radiotherapy; palliative care). The modules included information from health care professionals (e.g., neurosurgeons, radiation and medical oncologists) in addition to perspectives from people diagnosed with brain cancer and their families.",Excluded
2631,"Precision dosimetry for narrow photon beams used in radiosurgery-determination of Gamma Knife output factors. Treatment units for radiosurgery, like Leksell Gamma Knife and adapted, or dedicated, linear accelerators use small circular beams of ionizing radiation down to 4 mm in diameter at the isocenter. By cross-firing, these beams generate a high dose region at the isocenter together with steep dose gradients of up to 30% per mm. These units are used to treat small complex shaped lesions, often located close to critical structures within the brain, by superimposing several single high dose regions. In order to commission such treatment units for stereotactic irradiations, to carry out quality assurance and to simulate treatment conditions, as well as to collect input data for treatment planning, a precise dosimetric system is necessary. Commercially available radiation dosimeters only partially meet the requirements for narrow photon beams and small field sizes as used in stereotactic treatment modalities. The aim of this study was the experimental determination of the output factors for the field defining collimators used in Gamma Knife radiosurgery, in particular for the smallest, the 4 mm collimator helmet. For output factor measurements a pin point air ionization chamber, a liquid ionization chamber, a diode detector, a diamond detector, TLD microcubes and microrods, alanine pellets, and radiochromic films were used. In total, more than 1000 measurements were performed with these different detection systems, at the sites in Munich and Zurich. Our results show a resultant output factor for the 4 mm collimator helmet of 0.8741 +/- 0.0202, which is in good agreement with recently published results and demonstrates the feasibility of such measurements. The measured output factors for the 8 mm and 14 mm collimator helmets are 0.9578 +/- 0.0057 and 0.9870 +/- 0.0086, respectively.",Excluded
3117,"Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study. BACKGROUND: The treatment for brain metastases in small cell lung cancer (SCLC) is still controversial. The purpose of this study was to compare different brain radiotherapy treatments on SCLC patients with brain metastases.METHODS: In this multi-center retrospective study, SCLC patients who had undergone whole brain radiation therapy (WBRT) or stereotactic radiosurgery (SRS) for brain metastases from January 2012 to December 2018 were retrospectively screened.RESULTS: A total of 263 eligible SCLC patients were included in this study, among whom, 73 were women and 190 were men. According to accepted brain radiotherapy, the remaining patients were divided into WBRT plus focal radiation boost (WBRT+boost), WBRT, and SRS groups. In pairwise comparisons of the overall survival (OS), WBRT+boost group led to longer survival than did WBRT both in all patients (17.9 vs 8.7 months; P < 0.001) and 140 matched patients (17.9 vs 11.7 months; P = 0.045). There were no significant differences in OS between WBRT+boost and SRS groups in all patients (17.9 vs 14.5 months; P = 0.432). Among 74 matched patients between WBRT+boost and SRS groups, however, patients who received WBRT+boost led to a longer survival than did SRS alone (21.8 vs 12.9 months; P = 0.040). In pairwise comparison of the intracranial progression-free survival time (iPFS), WBRT+boost group also showed survival advantages over WBRT (10.8 vs 6.5 months; P = 0.005) and SRS groups (10.8 vs 7.5 months; P = 0.032).CONCLUSION: Due to the SCLC-derived multiple brain metastases and better survival time, focal radiation boost combined with adjuvant WBRT may be a preferred strategy for SCLC patients with brain metastases.",Excluded
2954,"Radiation therapy for the treatment of tumours in small companion animals. Radiation is becoming widely available to treat tumours in veterinary patients. Orthovoltage machines capable of delivering low energy external beam radiation are less versatile than linear accelerators and cobalt-60 machines that deliver megavoltage radiation. In addition, electron beam capabilities that are available with some linear accelerators allow more targeted treatment in smaller patients. Acute effects of radiation are to be expected, but in nearly all cases such side effects resolve without limiting protocols. In contrast, late effects of radiation are dose limiting and are more likely with higher doses per treatment fraction. Protocols that use smaller doses per fraction have a lower risk of late effects thereby allowing higher total doses to be delivered which leads to higher tumour control rates. It is possible to provide long-term tumour control in cats and dogs using radiation therapy, particularly for mast cell tumours, soft tissue sarcomas, oral tumours and brain tumours in dogs and soft tissue sarcomas and skin tumours in cats. Individualization of treatments for tumours based on tumour staging and proliferative fraction should be considered, rather than making blanket assumptions about the behaviour of histologically determined tumour types. Â© 2002 Elsevier Science Ltd. All rights reserved.",Excluded
2905,"Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone. BACKGROUND: The objective of this study was to test the efficacy of an individualized uncertainty management intervention delivered by telephone to Caucasian and African-American men with localized prostate carcinoma and directed at managing the uncertainties of their disease and treatment.METHODS: The authors delivered a psychoeducational intervention by phone to men with prostate carcinoma, with or without supplemented delivery to a close family member, that was directed at managing uncertainty and improving symptom control. One hundred thirty-four Caucasian men and 105 African-American men were assigned randomly to one of two approaches to delivering the intervention or to the control condition. Men entered the study immediately after surgical treatment or in the first 3 weeks of radiation therapy. Trained nurses delivered the intervention through weekly phone calls for 8 weeks.RESULTS: The authors found that the majority of intervention effects were from baseline to 4 months postbaseline, when treatment side effects are most intense. Both Caucasian men and African-American men who received either one of the two approaches for delivering the intervention improved in the two uncertainty management methods of cognitive reframing and problem solving. Similarly, when the intervention groups were combined, men who received the intervention also improved significantly in control of incontinence by 4 months postbaseline. Decreases in the number of treatment side effects differed by time and treatment/ ethnic group interactions as did satisfaction with sexual functioning.CONCLUSIONS: This is one of the first tests of a psychoeducational intervention among men with prostate carcinoma and was the first test that included a sufficient number of African-American men to test by ethnic group. Therefore, replication of these findings is advised.",Excluded
2420,"Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in forebrain. Previous studies of acrylamide (ACR) neuropathy in rat PNS [Toxicol. Appl. Pharmacol. (1998) 151:211-221] and in spinal cord, brainstem and cerebellum [NeuroToxicology (2002a) 23:397-414; NeuroToxicology (2002b) 23:415-429] have suggested that axon degeneration was not a primary effect and was, therefore, of unclear neurotoxicological significance. To conclude our studies of neurodegeneration in rat CNS during ACR neurotoxicity, a cupric silver stain method was used to define spatiotemporal characteristics of nerve cell body, dendrite, axon and terminal argyrophilia in forebrain regions and nuclei. Rats were exposed to ACR at a dose-rate of either 50 mg/kg per day (i.p.) or 21 mg/kg per day (p.o.) and at selected times brains were removed and processed for silver staining. Results show that intoxication at either ACR dose-rate produced a terminalopathy, i.e. nerve terminal degeneration and swelling were present in the absence of significant argyrophilic changes in neuronal cell bodies, dendrites or axons. Exposure to the higher ACR dose-rate caused early onset (day 5), widespread nerve terminal degeneration in most of the major forebrain areas, e.g. cerebral cortex, thalamus, hypothalamus and basal ganglia. At the lower dose-rate, nerve terminal degeneration in the forebrain developed early (day 7) but exhibited a relatively limited spatial distribution, i.e. anteroventral thalamic nucleus and the pars reticulata of the substantia nigra. Several hippocampal regions were affected at a later time point (day 28), i.e. CA1 field and subicular complex. At both dose-rates, argyrophilic changes in forebrain nerve terminals developed prior to the onset of significant gait abnormalities. Thus, in forebrain, ACR intoxication produced a pure terminalopathy that developed prior to the onset of significant neurological changes and progressed as a function of exposure. Neither dose-rate used in this study was associated with axon degeneration in any forebrain region. Our findings indicate that nerve terminals were selectively affected in forebrain areas and, therefore, might be primary sites of ACR action.",Excluded
3376,"Mobile Lower Body Negative Pressure Suit as an Integrative Countermeasure for Spaceflight. BACKGROUND: Persistent headward fluid shift and mechanical unloading cause neuro-ocular, cardiovascular, and musculoskeletal deconditioning during long-term spaceflight. Lower body negative pressure (LBNP) reintroduces footward fluid shift and mechanical loading. METHOD(S): We designed, built, and tested a wearable, mobile, and flexible LBNP device (GravitySuit) consisting of pressurized trousers with built-in shoes to support ground reaction forces (GRF) and a thoracic vest to distribute load to the entire axial length of the body. In eight healthy subjects we recorded GRF under the feet and over the shoulders (Tekscan) while assessing cardiovascular response (Nexfin) and footward fluid shift from internal jugular venous cross-sectional area (IJVa) using ultrasound (Terason). RESULT(S): Relative to normal bodyweight (BW) when standing upright, increments of 10 mmHg LBNP from 0 to 40 mmHg while supine induced axial loading corresponding to 0%, 13 +/- 3%, 41 +/- 5%, 75 +/- 11%, and 125 +/- 22% BW, respectively. Furthermore, LBNP reduced IJVa from 1.12 +/- 0.3 cm2 to 0.67 +/- 0.2, 0.50 +/- 0.1, 0.35 +/- 0.1, and 0.31 +/- 0.1 cm2, respectively. LBNP of 30 and 40 mmHg reduced cardiac stroke volume and increased heart rate while cardiac output and mean arterial pressure were unaffected. During 2 h of supine rest at 20 mmHg LBNP, temperature and humidity inside the suit were unchanged (23 +/- 1degreeC; 47 +/- 3%, respectively).DISCUSSION: The flexible GravitySuit at 20 mmHg LBNP comfortably induced mechanical loading and desired fluid displacement while maintaining the mobility of hips and knee joints. The GravitySuit may provide a feasible method to apply low-level, long-term LBNP without interfering with daily activity during spaceflight to provide an integrative countermeasure.Petersen LG, Hargens A, Bird EM, Ashari N, Saalfeld J, Petersen JCG. Mobile lower body negative pressure suit as an integrative countermeasure for spaceflight. Aerosp Med Hum Perform. 2019; 90(12):993-999.",Excluded
2702,Tumor relapse or radionecrosis after radiosurgery: single-photon emission computed tomography for differential diagnosis. In regard to Blonigen et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. (Int J Radiat Oncol Biol Phys 2010;77:996-1001),Excluded
3179,"Determining elemental tissue composition from dual energy cone-beam CT using principal component analysis and a shallow neural network. Purpose: Due to the use of kV photon beams in small animal radiotherapy, the dose deposition is strongly dependent on the elemental tissue composition. We present a novel method to extract continuous elemental tissue compositions from dual energy CBCT (DE-CBCT) images. Method(s): We use principal component analysis (PCA) to reduce the dimensionality of the material space. For each DE-CBCT image, we first classify individual voxels as air, soft tissue, or bone through a support vector machine. In a next step, a shallow neural network determines the weights of the principal components. All images were acquired on the Small Animal Radiation Research Platform (XStrahl Ltd). The DE-CBCT imaging protocol was optimised over a range of energy and tin filter combinations. The model is calibrated on a mousesized solid water phantom with 10 tissue-equivalent material inserts with known elemental composition. We validate the model on a second phantom with 6 different tissue-equivalent inserts, and compare the predictions to a conventional PCA method with a linear regression model. We additionally apply the new method to a mouse DE-CBCT. Result(s): The material composition in the 6 inserts of the validation phantom was extracted with a mean squared error of 1%, averaged over all inserts. This is an improvement over conventional PCA methods without a neural network (3% average mean squared error), especially for bony tissues. While no ground truth is available for the mouse tissues, we found good agreement with the composition from the material database, for instance within 3% for the mouse brain. Conclusion(s): We presented a novel method to extract the elemental tissue composition from DE-CBCT images. The continuous assignment of materials is expected to reduce discretisation errors in dose calculations compared to current approaches, where only 4 to 7 materials are used.",Excluded
3619,"Acute tongue necrosis: A case report. Necrosis of the tongue can have many causes, but is relatively rare because of the excellent blood supply. These include malignant tumours, ergotismus, previous radiation to the neck, emboli, intra-arterial drug injections, calciphylaxis, severe haemorrhage, infections, cardiac arrest, and giant cell arteritis. We report the original case of a 71-year-old woman who presented an acute tongue necrosis during treatment with dihydroergotamine, prednisolone, pregabalin and amphotericin B. This woman was treated with dihydroergotamine since a few years. Her medical history included acoustic neurinoma, Parkinson's disease and depression. She began receiving prednisolone, pregabalin and amphotericin B in November 2010. A few days later, she presented a villous black tongue with macroglossia. This patient developed acute tongue necrosis of the right side. A surgical act was realized, biopsy was negative and Horton's disease was excluded. The treatment with prednisolone, pregabalin and amphotericin B was discontinued and a treatment with fluconazole was intaured. Evolution was favourable. In our case, it was not found any etiological element. Treatments with dihydroergoamine and prednisolone and infection would have been able to favour acute tongue necrosis.",Excluded
3591,"Octopamine modulates photoreceptor function in the Limulus lateral eye. Activity at night in efferent nerve fibers from a central circadian clock produces changes in photoreceptor function in the lateral compound eye of Limulus: the response to light is increased; membrane potential fluctuations (bumps) occurring in the dark are suppressed; and the duration of bumps occurring both in the dark and under dim illumination is increased (Barlow et al., 1977; Kaplan & Barlow, 1980; Barlow, 1983; Barlow et al., 1985). Efferent nerve terminals release octopamine when activated (Battelle et al., 1982; Battelle & Evans, 1984, 1986); exogenous octopamine in vitro produces some of the changes resulting from efferent nerve activity in vivo (Kass et al., 1988). We report here that the increase in both on-transient and steady-state response to light induced by octopamine in the lateral eye in vitro are concentration dependent with threshold at or below 100 nM, saturation at or above 100 microM, and half-maximal increase in the range 1-10 microM. Octopamine also reduces bump activity in the dark in a concentration-dependent way. Unlike the increase in light response, the dependence of this effect on octopamine concentration is extremely variable from specimen to specimen. The effects of exogenous octopamine on light response and bump activity can sometimes be reversed by removing octopamine from the medium bathing the in vitro preparation. Octopamine also increases bump duration, apparently in a concentration-dependent manner. We have not succeeded in reversing this increase in bump duration. The concentration dependence of changes in photoreceptor response described here agrees qualitatively with the dependence of cAMP levels on octopamine in Limulus photoreceptors (Kaupp et al., 1982), lending further support to the idea that cAMP acts as a second messenger in the circadian control of photoreceptor function. Our results also suggest that the changes induced in the transient and steady-state response to light by both efferent nerve activity and exogenous octopamine have a common origin, which may differ from that responsible for the modulation of bump activity.",Excluded
2623,"Successful prevention from acute rejection in human hand allograft. [Chinese]. Aim: To explore the prevention of acute rejection in human band allograft. Method(s): Two male patients underwent right hand allograft in the Nanfang Hospital of Southern Medical University on 21st September 1999. In the two patients, the right hand of one was exploded when exploding the fish and underwent initially fitting; the right wrist of the other was carved by steel-wire and underwent fitting after the failure replantation two years ago. On 26th September 2000, another patient with traumatic both forearms amputation underwent the hand allograft, whose both forearms were injured in explosion one year ago, with deletion in 1/3 middle and lower of the right forearm and 1/3 middle and upper of the left forearm. The 3 patients had normal psychological and immune state without systemic disease, and their disabled limb condition was better, which requested urgently hand allograft. Three brain-dead donors were matched respectively to ABO- and Rh-compatible, HIA-half compatible. After removed the marrow of ulnar and radial bone by scraping, two of the donor's arms was irrigated with 8 Gy X-ray; The artery, vein and nerve of the patients were anastomosed under microscope combined with immunosuppressants. T-lymphocyte subsets and cytokine were dynamically detected. Result(s):(1) General condition, transplanted hand skin and histopathologic examination of the patients: After transplantation, the vital signs were stable, and the circulation of the transplanted hands was satisfactory. No bacteria, virus or fungal infection were found. The skin healing was fused with the replanted limb, all the grafted hands survived. No acute rejection reaction was found in the clinical symptoms, physical signs and skin pathologic examination.(2) Dynamic detection of cytokine in peripheral blood: The level of serum interleukin 2 (IL-2), tumor necrosis factor ot(TNF-alpha) and interferon gamma(IFN-gamma) were descent quickly within the first post-transplantation week and returned at induction period of inummosuppressive agent, but remained at low level. Conclusion(s): Tissue matching with donor, reasonable handle of donor limbs, individualized inummosupressants, refined and exact microsurgical technology, and effective infection prevention can prevent acute rejection. Monitoring of serum IL-2, TNF-alpha and IFN-gamma in the peripheral blood of patients is helpful to judge the occurrence of acute rejection.",Excluded
2625,"A quantitative study of MRI-based treatment planning for the percutaneous radiation therapy of brain tumors. [German]. This study examined to which extent treatment plans for brain tumors can be constructed with a commercial treatment planning system (TPS) based on MRI data only. Cad-Plan 6.4.7 was used as TPS. In particular, differences between MRT-based and conventional CT-based plans were examined systematically. The quantification of the retrospective evaluation was carried out by the point-wise dose difference and the gamma-distribution. In this study the gamma-distribution did not appear advantageous over the dose difference for the tolerance range (point-wise dose difference <3%, distance criterion LLL 5 mm). The calculated dose distribution showed large differences (up to 103%) at the boundary of the treatment fields, in the regions of the head contour, and in areas with air inclusions and significant bone structures. The inner parts of the fields, and therefore the actual target volume, revealed only small deviations in the range of -2% in the homogeneous distribution.",Excluded
2401,"Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model. Gliomas are primary brain tumors associated with a poor prognosis partly due to resistance to conventional therapies. To overcome this problem, we investigated the combined effects of gamma knife radiosurgery (GKS) and an antiangiogenic agent, thalidomide (THD), or a chemotherapeutic agent, temozolomide (TMZ), on a rat glioma model. GKS (20 Gy single dose) alone and/or drugs (for 3 days) were delivered 14 or 18 days after stereotactic implantation of C6/LacZ glioma cells into the brains of Sprague-Dawley rats. A group of animals treated with or without drugs for 3 days was irradiated on day 18 and sacrificed at 24 h after GKS to evaluate cell proliferation, apoptosis and microvessel density. The other group of animals was irradiated on day 14 and sacrificed at day 5 after GKS for the measurement of tumor volume. Apoptosis of endothelial cells in the tumor beds was only observed in the early period after GKS. Decreased cell proliferation and increased tumor cell apoptosis were observed in rat gliomas treated with GKS and THD or TMZ. The combination treatments with GKS and THD or GKS and TMZ also decreased microvessel density, i.e. angiogenesis, more effectively compared with GKS treatment alone. The combination of GKS and THD was the most effective regimen, resulting in a significant decrease of tumor volume. We suggest that the antitumor effect of GKS on glioma is enhanced by the addition of THD. Therefore, combined therapy with GKS and THD might be a favorable treatment for gliomas.",Excluded
2921,"Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve. PURPOSE: To investigate technical feasibilities of noncoplanar proton-beam therapy (PBT) on dose reduction to critical organs.MATERIAL AND METHODS: The degree of mechanical precision, rotational limitations of the gantry and the treatment couch were evaluated, and dose-volume histograms were compared for noncoplanar and coplanar PBT. Following these studies, three patients with tumors proximal to the optic nerve underwent noncoplanar PBT.RESULTS: Noncoplanar PBT offered advantage in dose reduction to the optic nerve when compared to coplanar therapy. This advantage was more significant if the tumor reduced in size during treatment. None experienced radiation injury to the optic nerve during a short follow-up time of 7-12 months.CONCLUSION: Noncoplanar PBT appears to reduce doses to organs at risk.",Excluded
3398,"Pion radiation for high grade astrocytoma: results of a randomized study. PURPOSE: This study attempted to compare within a randomized study the outcome of pion radiation therapy vs. conventional photon irradiation for the treatment of high-grade astrocytomas.METHODS AND MATERIALS: Eighty-four patients were randomized to pion therapy (33-34.5 Gy pi), or conventional photon irradiation (60 Gy). Entry criteria included astrocytoma (modified Kernohan high Grade 3 or Grade 4), age 18-70, Karnofsky performance status (KPS) > or = 50, ability to start irradiation within 30 days of surgery, unifocal tumor, and treatment volume < 850 cc. The high-dose volume in both arms was computed tomography enhancement plus a 2-cm margin. The study was designed with the power to detect a twofold difference between arms.RESULTS: Eighty-one eligible patients were equally balanced for all known prognostic variables. Pion patients started radiation 7 days earlier on average than photon patients, but other treatment-related variables did not differ. There were no significant differences for either early or late radiation toxicity between treatment arms. Actuarial survival analysis shows no differences in terms of time to local recurrence or overall survival where median survival was 10 months in both arms (p = 0.22). The physician-assessed KPS and patient-assessed quality of life (QOL) measurements were generally maintained within 10 percentage points until shortly before tumor recurrence. There was no apparent difference in the serial KPS or QOL scores between treatment arms.CONCLUSION: In contrast to high linear energy transfer (LET) therapy for central nervous system tumors, such as neutron or neon therapy, the safety of pion therapy, which is of intermediate LET, has been reaffirmed. However, this study has demonstrated no therapeutic gain for pion therapy of glioblastoma.",Excluded
2772,"Effects on the photoresponse of calcium buffers and cyclic GMP incorporated into the cytoplasm of retinal rods. It is generally accepted that the light response in retinal rods involves a reduction of ionic permeability (predominantly to Na+) in the plasma membrane of the outer segment and that this is mediated by an internal messenger which diffuses between the disk and plasma membranes. There is controversy, however, over the identity of the diffusible substance; two alternative schemes have received widespread support (for review see refs 1,2). According to the 'calcium hypothesis', light stimulates the release into the cytoplasm of calcium, leading to the blockage of channels which are normally open in darkness, whereas based on the 'cyclic nucleotide hypothesis', cyclic GMP causes the opening of channels in the dark, but is hydrolysed by a light-activated phosphodiesterase. We report here effects of introducing calcium buffers and cyclic GMP into the rod cytoplasm by means of a patch pipette, which seem to be inconsistent with the calcium hypothesis.",Excluded
2487,"Microglial trogocytosis and the complement system regulate axonal pruning in vivo. Partial phagocytosis-called trogocytosis-of axons by microglia has been documented in ex vivo preparations but has not been directly observed in vivo. The mechanisms that modulate microglial trogocytosis of axons and its function in neural circuit development remain poorly understood. Here, we directly observe axon trogocytosis by microglia in vivo in the developing Xenopus laevis retinotectal circuit. We show that microglia regulate pruning of retinal ganglion cell axons and are important for proper behavioral response to dark and bright looming stimuli. Using bioinformatics, we identify amphibian regulator of complement activation 3, a homolog of human CD46, as a neuronally expressed synapse-associated complement inhibitory molecule that inhibits trogocytosis and axonal pruning. Using a membrane-bound complement C3 fusion protein, we demonstrate that enhancing complement activity enhances axonal pruning. Our results support the model that microglia remodel axons via trogocytosis and that neurons can control this process through expression of complement inhibitory proteins. Copyright Â© Lim and Ruthazer.",Excluded
2738,"The role and limitations of Gamma knife radiosurgery. [Japanese]. The primary role of Gamma knife radiosurgery is to control small, benign or metastatic brain tumors while preserving critical neuronal functions. Controlling functional disorders is another role of Gamma knife radiosurgery. It can provide high-quality radiosurgery as it is based on 40-years of treatment history and it has a high level of maneuverability. On the other hand, the limitations of Gamma knife radiosurgery include a difficulty to control large lesions or malignant tumors, a relatively slow treatment effect, a risk of radiation injury to the optic nerve, and a limit of treatable range. Extra long-term results of more than 20 years also have to be clarified in the future.",Excluded
3169,"Secondary Brain Neoplasm after Stereotactic Radiosurgery in Patients with Metastatic Non-small Cell Lung Cancer. Stereotactic radiosurgery (SRS) using the Gamma Knife (GK) is now being increasingly utilized for the treatment of brain metastases. However, there are a few reported cases of SRS-induced brain neoplasms. We herein report the case of a Japanese woman with metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor (EGFR)-mutations who was treated four times with a GK for brain metastases. She developed glioblastoma 5.7 years after the initial GK surgery. Radiation-induced secondary neoplasms generally appear after a latency period of several years. Advances in cancer therapy have improved the survival of patients with NSCLC, providing enough time for secondary neoplasms to appear after SRS.",Excluded
2994,"The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. AIM: Radiation-induced mucositis is an early effect of head and neck radiotherapy. Mucositis can cause ulcers, and patients may experience pain and dysphasia which need treatment. The aim of this study is to evaluate the effect of pure natural honey on radiation induced mucositis.METHODS AND MATERIALS: In this randomized single blind (examiner blind) clinical trial 40 patients with head and neck cancer requiring radiation to the oropharyngeal mucosa were randomly assigned to two groups. Twenty patients assigned to the study group received honey, while both the study and control groups received standard head and neck radiation therapy based on a standard protocol. In the study group patients were instructed to take 20 ml of honey 15 minutes before radiation therapy, then again at intervals of 15 minutes and six hours after radiation. In the control group patients were instructed to rinse with 20 ml of saline before and after radiation. Patients were evaluated weekly for progression of mucositis using the Oral Mucositis Assessing Scale (OMAS). Data were analyzed using the independent t-test, Mann-Whitney, and Friedman tests.RESULTS: A significant reduction in mucositis among honey-received patients compared with controls (p=0.000) occurred.CONCLUSION: Within the limits of this study the results showed the application of natural honey is effective in managing radiation induced mucositis.CLINICAL SIGNIFICANCE: Natural honey is a product with rich nutritional qualities that could be a pleasant, simple, and economic modality for the management of radiation mucositis.",Excluded
2502,"Maintenance of multi-domain neurocognitive functions in patients with newly-diagnosed primary CNS lymphoma after primary cranial radiotherapy combined with methotrexate-based chemotherapy: A preliminary case-series study. Conventional treatment for treating primary central nervous system lymphoma (PCNSL) has consisted of either whole-brain radiotherapy (WBRT) or methotrexate (MTX)-based combined modality therapy. However, delayed cognitive sequelae have emerged as a significant debilitating complication in PCNSL patients. A prospective observational case-series study with prospective assessments of neurocognitive functions (NCFs), neuroimaging, and activities of daily living in newly-diagnosed PCNSL patients was undertaken. A battery of neuropsychological measures, used to evaluate NCFs, is composed of ten standardized NCF tests, representing four domains sensitive to disease and treatment effects (executive function, attention, verbal memory, psychomotor speed), and activities of daily living. A total of 15 patients with newly-diagnosed PCNSL were consecutively enrolled in this study. Comparing the NCF scores between the baseline (before WBRT) and post-treatment (after combined chemoradiation therapy) intervals (Mean=122.33days, SD=34.49, range = 77-196), neurobehavioral outcomes consistently remained improving or stable in almost each domain of NCF. Specifically, the scores on Paced Auditory Serial Addition Test-Revised (PASAT-R) were significantly improved between the baseline and post-chemoradiation assessment. Under the multidisciplinary treatment guidelines for treating patients with newly-diagnosed PCNSL, multi-domain NCF become stabilized and even improved after the course of conformal WBRT combined with or without MTX-based chemotherapy.",Excluded
2697,"Monitoring of mental performance during spaceflight. Mental performance of astronauts during spaceflight may suffer from both direct effects of microgravity on perceptual, cognitive, and psychomotor processes, and unspecific stress effects on these functions due to high workload sleep disturbances, or the general burden of adapting to the extreme living conditions in space. Early detection of any signs of mental performance impairments seems to be essential for mission success and to prevent obvious performance decrements in critical mission tasks. One possible approach to this problem is to assess the astronaut's performance on specific screening tests repeatedly during a space mission and to compare the results with a self-referenced baseline established pre-flight. The selection of screening tests for this purpose should be guided by three different criteria: 1) their reliability; 2) their sensitivity (i.e., their power to reveal subtle mental performance changes induced by internal or external stressors during spaceflight); and 3) their diagnosticity (i.e., their capability to reveal the underlying processes that lead to these performance deficits). Based on a discussion of these theoretical issues, first attempts to monitor mental performance of astronauts during spaceflight by means of short-term laboratory tasks are reviewed. The results of these studies suggest that, in particular, perceptual-motor tasks (tracking) and tasks placing comparatively high demands on attentional processes (e.g., dual-tasks) represent sensitive monitoring measures. First studies on the diagnositicity of tracking performance decrements during spaceflight suggest that they reflect both microgravity-related changes in the sensory-motor system as well as unspecific stress-effects, with the former factor reflected primarily in tracking performance decrements during early adaptation to the microgravity environment. [References: 43]",Excluded
2462,"Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles. BACKGROUND: Near-IR fluorescence (NIRF) imaging is becoming a promising approach in preclinical tumor detection and clinical image-guided oncological surgery. While heptamethine cyanine dye IR780 has excellent tumor targeting and imaging potential, its hydrophobic property limits its clinical use. In this study, we developed nanoparticle formulations to facilitate the use of IR780 for fluorescent imaging of malignant brain tumor.METHODS: Self-assembled IR780-liposomes and IR780-phospholipid micelles were prepared and their NIRF properties were characterized. The intracellular accumulation of IR780-nanoparticles in glioma cells were determined using confocal microscopy. The in vivo brain tumor targeting and NIRF imaging capacity of IR780-nanoparticles were evaluated using U87MG glioma ectopic and orthotopic xenograft models and a spontaneous glioma mouse model driven by RAS/RTK activation.RESULTS: The loading of IR780 into liposomes or phospholipid micelles was efficient. The particle diameter of IR780-liposomes and IR780-phospholipid micelles were 95 and 26 nm, respectively. While stock solutions of each preparation were maintained at ready-to-use condition, the IR780-phospholipid micelles were more stable. In tissue culture cells, IR780-nanoparticles prepared by either method accumulated in mitochondria, however, in animals the IR780-phospholipid micelles showed enhanced intra-tumoral accumulation in U87MG ectopic tumors. Moreover, IR780-phospholipid micelles also showed preferred intracranial tumor accumulation and potent NIRF signal intensity in glioma orthotopic models at a real-time, non-invasive manner.CONCLUSION: The IR780-phospholipid micelles demonstrated tumor-specific NIRF imaging capacity in glioma preclinical mouse models, providing great potential for clinical imaging and image-guided surgery of brain tumors.",Excluded
3500,"Effects of 1800-MHz radiofrequency fields on circadian rhythm of plasma melatonin and testosterone in male rats. Radiofrequency fields (RF) at 1800 MHz are known to affect melatonin (MEL) and testosterone in male rats, but it remains to be determined whether RF affected circadian rhythm of these plasma hormones. Male Sprague-Dawley rats were exposed to 1800-MHz RF at 208 muw/cm2 power density (SAR: 0.5762 W/kg) at different zeitgeber (ZT) periods of the day, including 0 (ZT0), 4 (ZT4), 8 (ZT8), 12 (ZT12), 16 (ZT16), and 20 (ZT20) h. RF exposure was 2 h/d for 32 d. From each rat, the concentrations of plasma MEL and testosterone were determined in plasma after RF exposure and compared with controls. The results confirmed the existence of circadian rhythms in the synthesis of MEL and testosterone, but revealed an inverse relationship in peak phase of these rhythms. These rhythms were disturbed after exposure to RF, with the effect being more pronounced on MEL than testosterone. The most pronounced effect of RF exposure on MEL and testosterone appears to be in rats exposed to RF at ZT 16 and ZT0 h, respectively. Data suggest that regulation of testosterone is controlled by MEL and that MEL is more sensitive to RF exposure.",Excluded
3326,"Temporomandibular disorder in head and neck cancer patients undergoing radiotherapy: Clinical findings and patient-reported symptoms. BACKGROUND: The aim of this study was to investigate how common temporomandibular disorder (TMD) symptoms are among head and neck cancer (HNC) patients before and after oncological treatment.METHODS: Eighty-nine patients with HNC receiving radiotherapy were enrolled in the study. Patients were examined before radiotherapy and at 6 and 12 months after radiotherapy to evaluate the function and tenderness of the temporomandibular jaw and the muscles of mastication as well as the patient-reported symptoms.RESULTS: At 6 months after radiotherapy, there was a large increase in the number of patients reporting problems with opening their mouth, fatigue, stiffness, and pain of the jaw. Sixty-eight percent of the patients had symptoms of TMD before oncological treatment and 94% and 81% had symptoms at the 6- and 12-month follow-up, respectively.CONCLUSION: The signs and symptoms of TMD escalate after radiotherapy, with symptoms peaking at 6 months after radiotherapy. Most commonly, patients suffer from restricted mouth opening, stiffness, fatigue, and pain of the jaw.",Excluded
3494,"Improved survival for elderly married glioblastoma patients : Better treatment delivery, less toxicity, and fewer disease complications. OBJECTIVES: Marital status is a well-described prognostic factor in patients with gliomas but the observed survival difference is unexplained in the available population-based studies.METHODS: A series of 57 elderly glioblastoma patients (>=70 years) were analyzed retrospectively. Patients received radiotherapy or chemoradiation with temozolomide. The prognostic significance of marital status was assessed. Disease complications, toxicity, and treatment delivery were evaluated in detail.RESULTS: Overall survival was significantly higher in married than in unmarried patients (median, 7.9 vs. 4.0 months; p = 0.006). The prognostic significance of marital status was preserved in the multivariate analysis (HR, 0.41; p = 0.011). Married patients could receive significantly higher daily temozolomide doses (mean, 53.7 mg/m2 vs. 33.1 mg/m2; p = 0.020), were more likely to receive maintenance temozolomide (45.7 % vs. 11.8 %; p = 0.016), and had to be hospitalized less frequently during radiotherapy (55.0 % vs. 88.2 %; p = 0.016). Of the patients receiving temozolomide, married patients showed significantly lower rates of hematologic and liver toxicity. Most complications were infectious or neurologic in nature. Complications of any grade were more frequent in unmarried patients (58.8 % vs. 30.0 %; p = 0.041) with the incidence of grade 3-5 complications being particularly elevated (47.1 % vs. 15.0 %; p = 0.004).CONCLUSION: We found poorer treatment delivery as well as an unexpected severe increase in toxicity and disease complications in elderly unmarried glioblastoma patients. Marital status may be an important predictive factor for clinical decision-making and should be addressed in further studies.",Excluded
2744,Effect of hypothalamic stimulation on lactate- and malate dehydrogenase activities in rat cardiac muscle. [Russian]. The activity of lactic and malic dehydrogenases was examined in the rat heart after stimulation of the hypothalamus. The activity of LDG and MDG was increased after stimulation of the paraventricular nuclei of the hypothalamus and decreased after stimulation of the ventromedial nuclei. Both effects were abolished by preliminary injection of actinomycin D. This finding suggests an important role of heart cells' genetic apparatus in the neurohormonal regulation of the heart metabolism.,Excluded
2686,"Effects of microgravity and other space stressors in immunosuppression and viral reactivation with potential nervous system involvement. Space exploration exposes astronauts to a variety of gravitational stresses. Exposure to a reduced gravity environment affects human anatomy and physiology. Countermeasures to restore homeostatic states within the human body have begun. The pathophysiological effects of exposure to microgravity, on the neurological system, are, however, still not clear. NASA has scheduled deep space exploration of extraterrestrial locations such as the Moon and Mars in the 2030s. Adverse health effects related to the human exposure to microgravity from previous, relatively shorter missions have been documented. A lengthy deep space travel to Mars could be overburdened by significant adverse health effects. Astronauts demonstrate a significant increase in the number of many types of circulating white blood cells (neutrophils, monocytes, T-helper cells, and B-cells) but a decrease in natural killer cells. It is unclear whether these changes are due to increased production or decreased clearance of these cells. In this review, viral reactivation in astronauts will be discussed, including the occurrence of clinical cases before, during, or after spaceflight and their management during and after flight. Studies on models used in spaceflight studies such as the AKATA cells (an immortalized B-cell line derived from a Japanese patient with Burkitt's lymphoma, a tumor induced by Epstein-Barr virus) and other cell lines which shed these latent viruses, will be reviewed with specific reference to gravitational changes, radiation, and spaceflight-induced immune suppression.",Excluded
3275,"Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. The mechanism by which genotoxic stress induces IRF-1 and the signalling components upstream of this anti-oncogenic transcription factor during the response to DNA damage are not known. We demonstrate that IRF-1 and the tumour suppressor protein p53 are coordinately up-regulated during the response to DNA damage in an ATM-dependent manner. Induction of IRF-1 protein by either ionizing radiation (IR) or etoposide occurs through a concerted mechanism involving increased IRF-1 expression/synthesis and an increase in the half-life of the IRF-1 protein. A striking defect in the induction of both IRF-1 mRNA and IRF-1 protein was observed in ATM deficient cells. Although ATM deficient cells failed to increase IRF-1 in response to genotoxic stress, the induction of IRF-1 in response to viral mimetics remained intact. Re-expression of the ATM kinase in AT cells restored the DNA damage inducibility of IRF-1, whilst the PI-3 kinase inhibitor wortmannin inhibited IRF-1 induction by DNA damage in ATM-positive cells. The data highlight a role for the ATM kinase in orchestrating the coordinated induction and transcriptional cooperation of IRF-1 and p53 to regulate p21 expression. Thus, IRF-1 is controlled by two distinct signalling pathways; a JAK/STAT-signalling pathway in viral infected cells and an ATM-signalling pathway in DNA damaged cells.",Excluded
2610,"RNA-Seeded Functional Amyloids Balance Growth and Survival. In this issue of Developmental Cell, Audas et al. (2016) report non-membrane-enclosed amyloid bodies (ABs) assembled in the nuclei of cells exposed to heat and low pH. Remarkably, ABs form not by liquid-to-liquid phase separation, implicated in RNA-seeded granule assembly, but by an amyloidogenic process that promotes a liquid-to-solid transition. Copyright Â© 2016",Excluded
3424,"The analysis of I125 brachytherapy complications in cases of uveal melanoma. [Polish]. PURPOSE: Analysis of type and frequency of complications after brachytherapy 1125 between 1-12 months after treatment and during the following controls. MATERIALS AND METHODS: 147 persons (76 men and 71 women) aged 23-86 years (mean 57 years), were treated in our clinic in 1998-2001. In 43% of the cases the thickness of the tumor was more than 8 mm and in 94% the maximum diameter was bigger than 8.1 mm. The irradiation dose was 80-120 Gy, mean 100 Gy. RESULT(S): Regression and stabilization of the tumor was achieved in 84.3% of all cases. Complications of different type and intensity associated with brachytherapy I125 were observed in majority of the cases. The complications observed were: radiation retinopathy (52%), radiation maculopathy (33.6%), radiation optic neuropathy (25.3%), vitreous hemorrhage (8.8%), glaucoma (20.5%) and cataract (18.5%). CONCLUSION(S): 125I brachytherapy yields good results in cases of uveal melanoma, however it's associated with post radiation complications.",Excluded
3474,"Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of biological transitions in mouse nuclei. Cre-responsive dual-fluorescent alleles allow in situ marking of cell lineages or genetically modified cells. Here we report a dual-fluorescent allele, ROSA <sup>nT-nG</sup> , which directs nuclear accumulation of tdTomato in Cre-naive lineages. Cre converts the allele to ROSA <sup>nG</sup> , which drives nuclear EGFP accumulation. Conditions were established for analyzing marked nuclei by flow cytometry on the basis of red-green fluorescence and ploidy, with a particular focus on liver nuclei. Hydrodynamic delivery of a Cre-expression plasmid was used to time-stamp arbitrary hepatocytes for lineage tracing. The distinct green fluorescence of nuclei from Cre-exposed lineages facilitated analyses of ploidy transitions within clones. To assess developmental transitions in liver nuclei, ROSA <sup>nT-nG</sup> was combined with the hepatocyte-specific AlbCre transgene, facilitating discrimination between hepatocyte and nonhepatocyte nuclei. Nuclei extracted from postnatal day 2 (P2) livers were 41 % green and 59 % red and reached a stable level of 84 % green by P22. Until P20, green nuclei were >98 % diploid (2N); at P40 they were ~56 % 2N, 43 % 4N, and <1 % 8N; and by P70 they reached a stable distribution of ~46 % 2N, 45 % 4N, and 9 % 8N. In conclusion, ROSA <sup>nT-nG</sup> will facilitate in vivo and ex vivo studies on liver and will likely be valuable for studies on tissues like muscle, kidney, or brain in which cells are refractory to whole-cell flow cytometry, or like trophectoderm derivatives or cancers in which cells undergo ploidy transitions.",Excluded
3440,"Cone beam computed tomography number errors and consequences for radiotherapy planning: An investigation of correction methods. Purpose: The potential of keV cone beam computed tomography (CBCT) for guiding adaptive replanning is well-known. There are impediments to this, one being CBCT number accuracy. The purpose of this study was to investigate CBCT number correction methods and the affect of residual inaccuracies on dose deposition. Four different correction strategies were applied to the same patient data to compare performance and the sophistication of correction-method needed for acceptable dose errors. Methods and Materials: Planning CT and CBCT reconstructions were used for 12 patients (6 brain, 3 prostate, and 3 bladder cancer patients). All patients were treated using Elekta linear accelerators and XVI imaging systems. Two of the CBCT number correction methods investigated were based on an algorithm previously proposed by the authors but only previously applied to phantoms. Two further methods, based on an approach previously suggested in the research literature, were also examined. Dose calculations were performed using scans of a ""worst"" subset of patients using the Pinnacle<sup>3</sup> version 9.0 treatment planning system and the patients' clinical plans. Result(s): All mean errors in CBCT number were <50 HU, and all correction methods performed well or adequately in dose calculations. The worst single dose discrepancy identified for any of the examined methods or patients was 3.0%. Mean errors in the doses to treatment volumes or organs at risk were negatively correlated with the mean error in CT number. That is, a mean CT number that was too large, averaged over the entire CBCT volume, implied an underdosing in a volume-of-interest and vice versa. Conclusion(s): Results suggest that (1) the correction of CBCT numbers to within a mean error of 50 HU in the scan volume provides acceptable discrepancies in dose (<3%) and (2) this is achievable with even quite unsophisticated correction methods. Â© 2012 Elsevier Inc. All rights reserved.",Excluded
3246,"Effects of radiation dose reduction in Volume Perfusion CT imaging of acute ischemic stroke. PURPOSE: To examine the influence of radiation dose reduction on image quality and sensitivity of Volume Perfusion CT (VPCT) maps regarding the detection of ischemic brain lesions.METHODS AND MATERIALS: VPCT data of 20 patients with suspected ischemic stroke acquired at 80 kV and 180 mAs were included. Using realistic reduced-dose simulation, low-dose VPCT datasets with 144 mAs, 108 mAs, 72 mAs and 36 mAs (80 %, 60 %, 40 % and 20 % of the original levels) were generated, resulting in a total of 100 datasets. Perfusion maps were created and signal-to-noise-ratio (SNR) measurements were performed. Qualitative analyses were conducted by two blinded readers, who also assessed the presence/absence of ischemic lesions and scored CBV and CBF maps using a modified ASPECTS-score.RESULTS: SNR of all low-dose datasets were significantly lower than those of the original datasets (p < .05). All datasets down to 72 mAs (40 %) yielded sufficient image quality and high sensitivity with excellent inter-observer-agreements, whereas 36 mAs datasets (20 %) yielded poor image quality in 15 % of the cases with lower sensitivity and inter-observer-agreements.CONCLUSION: Low-dose VPCT using decreased tube currents down to 72 mAs (40 % of original radiation dose) produces sufficient perfusion maps for the detection of ischemic brain lesions.KEY POINTS: * Perfusion CT is highly accurate for the detection of ischemic brain lesions * Perfusion CT results in high radiation exposure, therefore low-dose protocols are required * Reduction of tube current down to 72 mAs produces sufficient perfusion maps.",Excluded
3390,"Comparison of different radiation types and irradiation geometries in stereotactic radiosurgery. Recent interest in stereotactic radiosurgery of intracranial lesions, and the development of stereotactic irradiation techniques has led to the need for a systematic and complete comparison of these methods. A method for conducting these comparisons is proposed and is applied to a set of currently-used stereotactic radiosurgical techniques. Three-dimensional treatment planning calculations are used to compare dose distributions for several different radiation types and irradiation geometries. Calculations were performed using charged particles (H, He, C, and Ne ions) and the irradiation geometry currently used at Lawrence Berkeley Laboratory. Photons in the Gamma Knife configuration and the Heidelberg Linac arc method are used. The 3-dimensional dose distributions were evaluated by means of dose-volume histograms and integral doses to the target volume and to normal brain. The effects of target volume, shape and location are studied. The charged particle dose distributions are more favorable than those of the photon methods. The differences between charged particles and photons increase with increasing target volume. The differences between different charged particle species are small, as are the effects of target shape and location.",Excluded
3125,Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases: regarding Kondziolka et al. IJROBP 1999;45:427-434,Excluded
3582,"Use of 2-deoxy-D[1-11C]glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects. The deoxyglucose technique for the measurement of local cerebral glucose metabolism (LCMRgl) has been widely applied in animals utilizing 14C-deoxyglucose and in humans employing 18F-fluorodeoxyglucose. Repeat studies in humans over a relatively brief period of time have not been possible because of the 110-min half-life of fluorine-18. With the synthesis of 11C-deoxyglucose it has now become possible to utilize this short-lived (20 min) tracer for the measurement of LCMRgl and to determine its variability within subjects over a 2-h period. The kinetic rate constants for 11C-deoxyglucose were determined for gray and white matter and found to be very similar to those for 18F-fluorodeoxyglucose, suggesting that these two analogues of glucose have similar affinities for the facilitated transport system and are similar substrates for hexokinase in the brain. The coefficient of variation of repeated measurements of LCMRgl in a series of six normal subjects was 5.5% to 8.7% for various gray matter structures and 9.7% and 14.0% for white matter structures. The pattern of cerebral metabolic rates is relatively constant in a given individual when the conditions of the study are unchanged. The ability to make repeat measurements in the same subject reduces the variance due to between-subject differences, allowing smaller changes in LCMRgl to be detected with confidence.",Excluded
2894,"Target delineation and optimal radiosurgical dose for pituitary tumors. Stereotactic radiosurgery (SRS) delivered as either single-fraction or multi-fraction SRS (2-5 fractions) is frequently employed in patients with residual or recurrent pituitary adenoma. The most common delivery systems used for SRS include the cobalt-60 system Gamma Knife, the CyberKnife (CK) robotic radiosurgery system, or a modified conventional radiotherapy machine (linear accelerator, LINAC). Tumor control and normalization of hormone hypersecretion have been reported in 75-100 % and 25-80 % of patients, respectively. Hypopituitarism is the most commonly reported late complication of radiation treatment, whereas other toxicities occur less frequently. We have provided an overview of the recent available literature on SRS in patients with a pituitary adenoma. Critical aspects of pituitary irradiation, including target delineation and doses to organs at risk, optimal radiation dose, as well as the long-term efficacy and toxicity of SRS for either nonfunctioning or secreting pituitary adenomas are discussed. Single-fraction SRS represents an effective treatment for patients with a pituitary adenoma; however, caution should be used for lesions > 2.5-3 cm in size and/or involving the anterior optic pathway. Future studies will be necessary to optimize target doses and critical organ dose constrains in order to reduce the long-term toxicity of treatments while maintaining high efficacy.",Excluded
3285,"Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cells derived from individuals with ataxia telangiectasia (AT) show enhanced spontaneous levels of chromosomal abnormalities and are sensitive to ionizing radiations and radiomimetic drugs, as evidenced by decreased survival and increased chromosome aberration frequencies at mitosis when compared with normal cell lines. The higher base line frequencies of chromosome aberrations in part involve chromosome end-to-end associations as seen at metaphase. Since telomeres of tumor cells and aging tissues are often reduced in length, chromosome end associations may be due to loss of telomeric repeats. We studied the chromosome behavior and telomeres of two ataxia telangiectasia lymphoblastoid cell lines compared to two normal control cell lines. The ataxia telangiectasia cell lines showed higher frequencies of chromosome end associations both at metaphase and in interphase, determined in prematurely condensed chromosomes of G1 and G2 cells. They also showed higher frequencies of chromosomal breaks at metaphase and fewer telomeric signals determined using fluorescent in situ hybridization with a (TTAGGG)n probe. The frequency of telomeric repeats was variable in the ataxia telangiectasia cell lines (4.3 and 8.2 kb) compared to the normal cell lines (9.6 and 12 kb) and an inverse correlation between telomere length and chromosome end associations was observed. Both ataxia telangiectasia cell lines showed more robust telomerase activity than the normal cell lines, precluding defective enzymatic capacity as the basis for the chromosome end associations. It is possible that chromatin structure in the form of telomere-nuclear matrix interactions are variant in ataxia telangiectasia cells negatively influencing telomerase function and contributing to telomere associations.",Excluded
3575,"Theranostic trial of well differentiated neuroendocrine tumors (NETs) with 68GA-OPS201 and 177LU-OPS201. Background: Radiolabeled somatostatin receptor 2 (sstr2) antagonists have shown higher tumor uptake than agonists in preclinical models. We performed a phase I study to evaluate the safety and dosimetry of the sstr2 antagonists 68Ga-OPS201 and 177Lu-OPS201 (68Ga/177Lu-DOTA-JR11) in patients with metastatic well differentiated NETs (NCT02609737). Method(s): Patients with RECIST disease progression underwent a 68Ga-OPS202 PET/CT to confirm in-vivo binding of the sstr2 antagonists and if positive, underwent treatment with 3 doses of 177Lu-OPS201. The first dose of 50 mCi 177Lu-OPS201was used to calculate tumor and normal organ radiation doses. Dosimetry was then calculated to administer 177Lu-OPS201 in divided doses for the 2nd and 3rd fractions, 8-10 weeks apart. Result(s): 19 patients enrolled (1 lung, 7 small bowel, 8 pancreatic, 1 gastric, 1 rectal, 1 kidney). Average age was 55 y (22-73 y), 52% female; mean number of prior treatments was 3. All patients received 1 therapeutic dose of 177Lu-OPS201, 7 patients received 2 doses.With the exception of the kidneys and bladder, no organ demonstrated uptake of 68Ga-OPS201 above background. Tumor radiation doses ranged from 0.15 Gy/mCi to 0.48 Gy/mCi. Subacute hematologic toxicity after cycle 1 was mild-moderate (G3 2/19 leukopenia that reversed before cycle 2). 4/7 (57%) patients that received the second dose of 177Lu-OPS201had G4 hematological toxicities, which occurred 4-6 weeks after administration. G 3/4 toxicities in the four patients have resolved to G2 or lower; none of these patients demonstrated fever, infection, bleeding, or renal toxicity. Substantial efficacy was observed: 1 patient achieved a CR (1/19, 5%), 32% PR (6/19), 47% SD (9/19), and 16% POD (3/19). Median PFS has not yet been reached. Conclusion(s): In this trial of treated NETs, preliminary data are promising for the use of 68Ga-OPS201/177Lu-OPS201 as a theranostic combination for imaging and therapy. Additional studies are planned to determine an optimal therapeutic dose and schedule.",Excluded
2705,"Multisession radiosurgery for sellar and parasellar benign meningiomas: Long-term tumor growth control and visual outcome. BACKGROUND: Concern about radiation-induced optic neuropathy (RION) has governed recent thinking about the role of radiation therapy in the treatment of meningiomas involving the anterior optic pathways. Despite this concern, during the last few years, the use of radiosurgery for such lesions has increased steadily. OBJECTIVE(S): To define both the tumor control rate and the risk of RION over a long-term follow-up period in a large cohort of patients treated with multisession radiosurgery. METHOD(S): The local control and visual outcome of 143 patients who underwent multisession radiosurgery (mRS) were evaluated. Neurological outcome was also analyzed. The data for the present study were obtained from a prospectively maintained database. RESULT(S): The mean follow-up was 44 months (range, 12-113 months). All patients underwent mRS. The median prescription dose was 25 Gy delivered in 3 to 5 fractions. The prescription isodose, which typically encompassed at least 95% of the tumor, ranged from 65% to 86% (median, 80%). The mean tumor volume was 11.0 cm 3 (range, 0.1-126.3 cm 3; median, 8 cm 3). The progression-free survival at 3, 5, and 8 years was 100%, 93%, and 90%, respectively. Compared with baseline, visual function improved in 36% of patients, whereas 7.4% experienced a worsening in visual function (5.1% excluding the patients with progressive disease). CONCLUSION(S): Good local control rate and a low risk of RION indicate that mRS is a safe and effective treatment option in cases of large meningiomas. ABBREVIATIONS: AOP, anterior optic pathway AVP, anterior visual pathway mRS, multisession radiosurgery PD, progressive disease RION, radiation-induced optic neuropathy sRS, stereotactic radiosurgery. Copyright Â© 2015 by the Congress of Neurological Surgeons.",Excluded
3299,"Mortality among pilots and cabin crew in Greece, 1990-1997. Background. Specific health hazards, among them radiation of cosmic origin, have caused some concern among aircrew in civil aviation in recent years. Several cohort studies in Northern countries have investigated mortality and cancer incidence among aircrew. Our goal was to study the pattern of mortality among Greek commercial airline cockpit and cabin crew. Methods. We performed a retrospective cohort study including 843 Olympic Airways cockpit crew and 1835 cabin attendants. Standardized mortality ratios (SMR) were calculated based on death rates of the Greek population. Duration of employment as a proxy for occupational exposure was used to stratify the cohort. Results. For cockpit crew, the overall SMR was 0.7 (n = 65, 95% CI: 0.5-0.9). The SMR for all cancers was also significantly decreased (n = 17; SMR = 0.6; 95% CI: 0.3-0.9). Most of this reduction was due to a large deficit in lung cancer deaths (SMR = 0.1; 95% CI: 0.0-0.5). Slight but non-significant increases were noted for brain and liver cancer. The SMR for cardiovascular death was close to unity. Among female cabin attendants the SMR for all causes was 0.8 (95% CI: 0.4-1.3). The SMR for all cancers was 0.8 (95% CI: 0.3-1.7). Mortality from breast cancer was not increased. Among male cabin crew, SMR for all causes was 0.5 (95% CI: 0.3-0.9). Analyses according to duration of employment showed no pattern. Conclusions. In this first-ever occupational cohort study in Greece, Greek aircrew had a low overall and cancer mortality. Due to the small number of events, the strength of our study is limited. The Greek data will be included in a pooled analysis of European studies.",Included
3621,"Moderated <sup>252</sup>Cf neutron energy spectra in brain tissue and calculated boron neutron capture dose. While there is significant clinical experience using both low- and high-dose <sup>252</sup>Cf brachytherapy, combination therapy using <sup>10</sup>B for neutron capture therapy-enhanced <sup>252</sup>Cf brachytherapy has not been performed. Monte Carlo calculations were performed in a brain phantom (ICRU 44 brain tissue) to evaluate the dose enhancement predicted for a range of <sup>10</sup>B concentrations over a range of distances from a clinical <sup>252</sup>Cf source. These results were compared to experimental measurements and calculations published in the literature. For <sup>10</sup>B concentrations <=50mug/g, the <sup>10</sup>B neutron capture dose enhancement was small in comparison to the <sup>252</sup>Cf fast neutron dose. Â© 2004 Elsevier Ltd. All rights reserved.",Excluded
3547,"Morphologic comparisons between rhodopsin-mediated and short-wavelength classes of retinal light damage. The histologic manifestations of rhodopsin-mediated versus short-wavelength classes of retinal phototoxicity were compared after spectral exposures of the albino rat retina. Animals were exposed to wave-bands of light centered at the peak of rhodopsin absorbance (green, 500 nm) or in the ultraviolet A (UVA; 360 nm). Intensity-damage curves generated for each wave-band indicated that UVA light was 50-80 times more effective than green light at causing photoreceptor cell losses. Examination of early ultrastructural changes in rod inner segments, outer segments, and retinal pigment epithelium revealed a remarkable degree of similarity between UVA and green light-induced damage. Furthermore, the two classes of damage were indistinguishable in terms of post-exposure recovery from threshold damage and regional distribution of photoreceptor cell loss along the vertical meridian. The finding of essentially identical histologic manifestations for the two classes of damage raises the possibility that they share a common biochemical etiology or pathway of cell destruction.",Excluded
3495,Scanning electron microscopic study of the damages induced by continuous illumination on the eye of albino rat II. The photoreceptors,Excluded
3307,"Blocking GABAA neurotransmission in the interposed nuclei: effects on conditioned and unconditioned eyeblinks. The interposed nuclei (IN) of the intermediate cerebellum are critical components of the circuits that control associative learning of eyeblinks and other defensive reflexes in mammals. The IN, which represent the sole output of the intermediate cerebellum, receive massive GABAergic input from Purkinje cells of the cerebellar cortex and are thought to contribute to the acquisition and performance of classically conditioned eyeblinks. The specific role of deep cerebellar nuclei and the cerebellar cortex in eyeblink conditioning are not well understood. One group of studies reported that blocking GABA(A) neurotransmission in the IN altered the time profile of conditioned responses (CRs), suggesting that the main function of the cerebellar cortex is to shape the timing of CRs. Other studies reported that blocking GABA(A) neurotransmission in the IN abolished CRs, indicating a more fundamental involvement of the cerebellar cortex in CR generation. When examining this controversy, we hypothesized that the behavioral effect of GABA(A) blockers could be dose-dependent. The IN of classically conditioned rabbits were injected with high and low doses of picrotoxin and gabazine. Both GABA(A) blockers produced tonic eyelid closure. A high dose of both drugs abolished CRs, whereas a less complete block of GABA(A)-mediated inputs with substantially smaller drug doses shortened CR latencies. In addition, low doses of picrotoxin facilitated the expression of unconditioned eyeblinks evoked by trigeminal stimulation. These results suggest that the intermediate cerebellum regulates both associative and non-associative components of the eyeblink reflex, and that behavioral effects of blocking Purkinje cell action on IN neurons are related to collective changes in cerebellar signals and in the excitability of extra-cerebellar eyeblink circuits.",Excluded
2746,"Out come of glioblastoma multiforme in adults. Purpose: Glioblastoma multiforme (GBM) is the most common and most malignant primary intracranial tumor. The prognosis of Glioblastoma Multiforme (GBM) remains very poor despite aggressive treatment with surgery, radiation, chemotherapy and novel therapeutic strategies. The aim of this study was to analyze the prognostic factors & survival of GBM patients treated at our institution. Materials: The SKMCH & RC Cancer Registry was accessed and 51 patients of GBM treated in our institution were identified between Jan 2006 to May 2010. Surgery was performed in 49 patients (8 gross total resection and 41 subtotal resection) while 2 patients were surgically unresectable. All patients received radiotherapy (8 patients were given conventional radiotherapy 60Gy/30 fractions at 2Gy per fraction over a period of 6 weeks while 43 patients treated with hypofractionated regimen 48Gy/16 fractions at 3Gy per fraction over a period of 3 weeks. Result(s): Median age at diagnosis was 47 Years (Range 18-73) and Male to female ratio was 3:1. ECOG performance status 0, I, II was 24%, 16% and 11% respectively. Radiological response was 64% (Partial response 34% and stable disease in 30%) and 36% had progressive disease on MRI which was done 3 months following completion of radiotherapy. On Univariate analysis ECOG performance status, extent of surgical resection and response following radiotherapy were significant prognostic factors (P=0.003, P=0.01 and 0.002 respectively). Median over all survival for all patients was 8 months. Conclusion(s): The outcome of GBM remains poor despite adequate surgical resection and good radiotherapy techniques. Extent of surgery and the performance status were the most important prognostic factors. Improved outcome with the use of temozolamide is a step forward in this regard.",Excluded
2478,"Delayed radiation necrosis of the brain. A report of two cases. [Chinese]. A clinico-pathological report of 2 cases of delayed radiation necrosis of the brain following radiation therapy for acromegaly in one and for nasopharyngeal carcinoma in another is presented. The diagnoses were confirmed surgically and pathologically. The intervals between the termination of radiation therapy and the onset of symptoms were 17 months and 32 months, respectively. The clinical features consisted of progressive headache, visual disturbances, mental abnormality, aphasia and hemiparesis. The echoencephalogram revealed midecho shifting to the contralateral side. Focal delta slowing and phase reversion were observed in EEG in one case. Cerebral angiograms of both cases showed a left temporal avascular space occupying lesion. The histories and clinical findings were quite characteristic of delayed radiation necrosis of the brain. Surgical resection led to clinical improvement in both cases. Specimens for pathologic diagnoses were also obtained from the resection. The problems of diagnosis, pathogenesis, treatment and prevention have been discussed.",Excluded
2853,"White matter microstructure abnormalities in patients with dominant optic atrophy and OPA1 mutations. Introduction: Aim of this study was to assess abnormalities of white matter (WM) microstructure in patients affected by dominant optic atrophy (DOA) linked to OPA1 gene mutations, using tract-based spatial statistics (TBSS) analysis. Method(s): Using a 3.0 Tesla scanner, dual-echo and diffusion tensor (DT) MRI images were derived from 19 patients with DOA (10 females, mean age = 43 years, range = 22-64) and 20 sex- and agematched controls. A complete neurological and neuro-ophthalmologic examination was obtained in all patients. TBSS analysis was performed using FMRIB's Diffusion Toolbox. Result(s): Visual acuity was reduced in almost all patients, whereas none of the patients had extra-ocular neurological complications. Focal lesions in the brain WM were identified in ten patients. Three patients presented hyperintense optic nerve lesions on T2 weighted scans. Optic nerve and chiasm atrophy were detected in twelve patients. TBSS analysis showed that compared to controls, patients with DOA had significant lower mean diffusivity, axial and radial diffusivity in WM of the cerebellum, brainstem, thalamus, frontooccipital- temporal lobes, including the cingulum, corpus callosum, corticospinal tract and optic radiation bilaterally. No abnormalities of fractional anisotropy were detected. DT MRI measures were correlate with ganglion cell complex thickness. Conclusion(s): Patients with DOA linked to OPA1 gene mutations present diffuse WM microstructural abnormalities. Clinical expression of DOA could be influenced by the level of mithocondrial impairment and potential compensatory mechanisms, such as increased protein expression. Restricted water diffusion might be explained by a higher macromolecular water binding, due to increased molecular crowding and microviscosity.",Excluded
3217,"Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. OBJECTIVE: To assess the efficacy and safety of a preradiation chemotherapy regimen in patients with primary CNS lymphoma (PCNSL), with emphasis on long-term outcomes.METHODS: In this prospective phase II trial, patients with a new diagnosis of PCNSL received two cycles of intrathecal (12 mg) and IV (1 g/m2) methotrexate (MTX), thiotepa (30 mg/m2), and procarbazine (75 mg/m2), prior to whole-brain radiotherapy (RT).RESULTS: Seventeen patients were enrolled (ages 26 to 71, median 53). Median Karnofsky performance scale score was 70. After chemotherapy, 7 patients (41%) had a complete response (CR) and 7 (41%) a partial response (PR). After RT, 13 (76%) patients achieved a CR, 2 (12%) a PR, and 2 (12%) had disease progression. Relapse occurred in 7 (41%) patients; median disease-free survival was 18 months. Fifteen (88%) patients have died: 8 (47%) from PCNSL, 5 (29%) from neurotoxicity, and 2 (12%) from unknown causes. Median overall survival was 32 months. Two patients (12%) are alive and disease free at 12 years follow-up. Nephrotoxicity was a minor complication, but grades 3 and 4 myelosuppression were found in 5 (29%) patients.CONCLUSIONS: This regimen resulted in an efficacy and toxicity profile comparable to other combined modality treatments, despite the relatively low dose of methotrexate. It may be a useful option in patients unable to tolerate higher doses. Procarbazine and thiotepa are potential candidates for incorporation into chemotherapy regimens aiming to decrease the incidence of neurotoxicity. First relapse and neurotoxicity within 2 years of diagnosis seem to be critical for predicting long-term outcomes.",Excluded
2597,Radiosurgery vs radiation therapy for brain metastases: A waning controversy,Excluded
3497,"Possible fractionated regimens for image-guided intensity-modulated radiation therapy of large arteriovenous malformations. The aim of this study was to estimate a plausible alpha/beta ratio for arteriovenous malformations (AVMs) based on reported clinical data, and to design possible fractionation regimens suitable for image-guided intensity-modulated radiation therapy (IG-IMRT) for large AVMs based on the newly obtained alpha/beta ratio. The commonly used obliteration rate (OR) for AVMs with a three year angiographic follow-up from many institutes was fitted to linear-quadratic (LQ) formalism and the Poisson OR model. The determined parameters were then used to calculate possible fractionation regimens for IG-IMRT based on the concept of a biologically effective dose (BED) and an equivalent uniform dose (EUD). The radiobiological analysis yields a alpha/beta ratio of 2.2 +/- 1.6 Gy for AVMs. Three sets of possible fractionated schemes were designed to achieve equal or better biological effectiveness than the single-fraction treatments while maintaining the same probability of normal brain complications. A plausible alpha/beta ratio was derived for AVMs and possible fractionation regimens that may be suitable for IG-IMRT for large AVM treatment are proposed. The sensitivity of parameters on the calculation was also studied. The information may be useful to design new clinical trials that use IG-IMRT for the treatment of large AVMs. Â© 2007 IOP Publishing Ltd.",Excluded
3283,"Circadian light input in plants, flies and mammals. The rotation of our planet results in daily changes in light and darkness, as well as seasons with characteristic photoperiods. Adaptation to these daily and seasonal changes in light properties (and associated changes in the environment) is important to the sustained survival of higher life forms on our planet. Many organisms use their intrinsic circadian oscillator or clock to orchestrate daily rhythms in behaviour and physiology to adapt to diurnal changes. Some higher organisms use the same oscillator to monitor day length in selecting the appropriate season for reproductive behaviour. Organisms have developed irradiance measurement mechanisms to ignore photic noise (lightning, moonlight), and use the light of dusk and dawn for circadian photoentrainment. They have also devised multiple photoreceptors and signalling cascades to buffer against changes in the spectral composition of natural light. The interaction of the clock with ambient light is, therefore, quite intricate. [References: 31]",Excluded
2739,"Differential longitudinal decline of white matter integrity in frontotemporal lobar degeneration and alzheimer's disease. Objective: To identify imaging biomarkers of disease progression in frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD) that can be used in longitudinal assessments. Background(s): Recent years have witnessed the emergence of treatment trials for FTLD and AD, creating a need for sensitive biomarkers of disease progression. Cross-sectional studies have shown that white matter integrity, measured via diffusion tensor imaging (DTI), is affected by both AD and FTLD. Few studies have quantified or compared the rates of change in white matter integrity in these disorders. Method(s): Diffusion weighted 3T MRIs from a cohort of 60 FTLD patients (27 behavioral-variant, 19 semantic-variant, 14 progressive non-fluent aphasia), 19 AD, and 69 healthy age-matched controls were acquired at baseline and 1-year on average follow up. Images were processed using a longitudinal DTI pipeline implemented in SPM12 to identify annualized changes in fractional anisotropy (FA). Result(s): Compared to controls, FTLD showed more reduction in FA over 1-year in the corpus callosum (CC), superior longitudinal fasciculus, inferior longitudinal fasciculus, the uncinate, and anterior portions of the internal capsule and corona radiata. In AD, FA reductions were seen in the splenium and posterior portions of the thalamic radiation. Rates of decline were -0.028 FA units per year in FTLD in the genu of the CC, and -0.017 FA units per year in AD in splenium of the CC. Conclusion(s): Decline in white matter integrity in FTLD and AD is measurable over 1 year and reflects established patterns of brain pathology in these two disorders. This suggests that changes in white matter integrity can provide a viable surrogate marker in both FTLD and AD for future clinical trials. In addition, similar to previous clinical and volumetric studies, white matter is shown to degrade nearly twice as rapidly in FLTD compared to AD.",Excluded
2967,"Fragments of ATM which have dominant-negative or complementing activity. The ATM protein has been implicated in pathways controlling cell cycle checkpoints, radiosensitivity, genetic instability, and aging. Expression of ATM fragments containing a leucine zipper motif in a human tumor cell line abrogated the S-phase checkpoint after ionizing irradiation and enhanced radiosensitivity and chromosomal breakage. These fragments did not abrogate irradiation-induced G1 or G2 checkpoints, suggesting that cell cycle checkpoint defects alone cannot account for chromosomal instability in ataxia telangiectasia (AT) cells. Expression of the carboxy-terminal portion of ATM, which contains the PI-3 kinase domain, complemented radiosensitivity and the S-phase checkpoint and reduced chromosomal breakage after irradiation in AT cells. These observations suggest that ATM function is dependent on interactions with itself or other proteins through the leucine zipper region and that the PI-3 kinase domain contains much of the significant activity of ATM.",Excluded
3237,"Autophagy in normal tissues of camel (Camelus dromedarius) with focus on immunoexpression of LC3 and LC3B. Autophagy is a highly regulated intracellular pathway for degradation and recycling of cytoplasmic protein aggregates and entire organelles. The autophagic pathway is stimulated by nutrient starvation, which prompted us to study the desert camel. Various organs of the camel undergo ecological and physiological stress due to food and water deprivation, dehydration and long exposure to solar radiation. We investigated the immunohistochemical expression of specific biomarkers of autophagy under normal conditions as a baseline for later work on stressed individuals. The autophagy-specific biomarkers, microtubule-associated protein1 light chain 3 (LC3), and its cleaved variant, LC3B, were strongly expressed in the cytosol of all tissues examined. The cytosolic immunoreactivity of LC3 was relatively weak, diffuse and vacuolar, while that of LC3B was stronger, punctate and at lower levels. LC3 appears to be associated with the autophagosomal membranes, either free or lysosome-bounded. LC3B is specific for the autophagosome-lysosome complexes and their degraded, granular contents. Autophagy was strongly expressed in CNS neurons and intestinal neural elements, which suggests a protective function for the nervous system. Autophagic markers also were seen in deformed immune-competent cells with fragmented nuclei in lymph nodes, spleen and gut-associated lymphoid tissue (GALT), which suggests a ""suicidal"" activity of eliminating unneeded cells. Autophagy, as measured by LC3 and LC3B expression, may participate in a general regulatory mechanism in tissues of the desert camel.",Excluded
3490,"Low-Dose and Limited-Volume Radiotherapy Alone for Primary Dural Marginal Zone Lymphoma: Treatment Approach and Review of Published Data. Purpose: Primary dural lymphoma is a rare intracranial lymphoma that almost always has a marginal zone histologic type and immunophenotype and often remains localized and is thus potentially curable with radiotherapy (RT) alone. The unusual location and histologic type of primary dural marginal zone lymphoma (PDMZL) distinguish it from primary central nervous system lymphoma and poses treatment dilemmas of technique, volume, and dose that have not been well addressed. We set out to analyze our recent experience in treating PDMZL and reviewed the limited published data available. Methods and Materials: Between 2002 and 2006, we treated 5 patients with localized PDMZL. Of these 5 patients, 3 had unilateral and 2 had bilateral/multifocal involvement, and 3 underwent subtotal tumor resection and 2 biopsy only. Whole brain RT was given before involved-field RT (IFRT) in 4 patients and 1 received IFRT alone. The median whole brain RT, IFRT, and total RT dose was 20, 12, and 30 Gy, respectively. The planning computed tomography scan was always fused with the post-gadolinium magnetic resonance imaging scan to assist in the IFRT volume determination. We also analyzed the published data from 27 additional patients. Result(s): The median follow-up was 34 months (range, 31-52). All obtained lasting local control. One patient developed a relapse in the soft tissue of the flank and additional systemic progression but no central nervous system recurrence. At last follow-up, no significant treatment-related neurotoxicity was detected. Conclusion(s): The results of our study have demonstrated that a combination of whole brain RT/IFRT or even low-dose IFRT alone provides excellent durable local control of PDMZL. This approach is potentially curative, possibly without significant neurotoxicity. Additional study and longer follow-up are needed to determine the appropriate RT dose and volume parameters for this rare, debilitating, and yet potentially curable lymphoma. Â© 2008 Elsevier Inc. All rights reserved.",Excluded
2693,"Controlled E-field gradient coils. Peripheral neural stimulation is a major problem in current gradient coil designs. Induced current problems in patients relate directly to gradient strength and modulation frequency. Current designs of gradient coil tend to limit ultra-high-speed imaging methods such as echo-planar imaging through the effect of induced currents which produce tingling sensations and involuntary muscle twitch. Neural stimulation could also trigger epileptic fits and/or cardiac fibrillation. For reduction of induced currents, an important aspect is the coil geometry. It is desirable to design the gradient coil in such a way as to prevent closed loop circulating currents within the body. Preliminary results using a four-sector gradient coil with rectangular geometry, operating in a low mutual coupling mode, indicate significant reduction in the E-field within the subject volume of the coil. Reduction in induced currents in the patient allows safer operation at higher magnetic field strengths together with faster scans currently prohibited through neural stimulation effects in standard coil geometries.",Excluded
3387,"[Repermeabilization of the laryngeal pathway using the laser]. Based on results in 48 cases, the principal indications and the place of laser in the repermeabilization of the glottic tract are discussed. Results on the cord adhesions were fair, whereas they were more constant with respect to regain of function in stenosis, paralysis and laryngeal edema. Laser can be used as single therapy by the endoscopic route for ankylosis or diplegia of the larynx, but should also act as a complement to a surgical or radiotherapeutic action.",Excluded
2812,"Idiopathic occipital neuralgia a rare cause of debilitating headache. LEARNING OBJECTIVE #1: Identify the presentation of occipital neuralgia LEARNING OBJECTIVE #2: Judicious use of diagnostic tools and treatment CASE: A 27-year-old female presented to the ER with episodes of severe intermittent headache over the past 3 weeks. Prior to her presentation at admission she reported 2 episodes of intermittent pain on the right occipital region. She promptly followed with her primary care physician who prescribed her oral steroids. The 2 weeks following the initial episodes were symptom free. On the day of admission she was watching television when she experienced a recurrence of the 10/10 right sided occipital headache with radiation over her vertex. Initial vital signs were unremarkable, however, physical exam was significant for tenderness over the right occipital region of the scalp. Labs were within normal limits. MRI did not reveal any abnormality. A consultation to neurology was obtained and the patient was started on carbamazepine, gabapentin and narcotics, which provided little relief. The patient's distribution of pain in the greater occipital area in addition to ruling out secondary causes of headache made ON the likely diagnosis. Pain management was consulted and greater occipital nerve block was performed which provided complete resolution of her symptoms. She was discharged home with carbamazepine the following morning and continued to be symptom free at follow up. DISCUSSION: Occipital neuralgia is usually defined as paroxysmal stabbing pain in the greater or lesser occipital nerve distribution. Although there is no published data to suggest the incidence of occipital neuralgia (ON), it is generally considered a very rare cause of headache. ON is a rare cause of headache that has no published data on incidence. Since this is a rare disorder there is limited evidence in the literature to support the full understanding of its physiology and treatment. Currently, the diagnosis ismade by history, characteristics described in the International Headache Society, exclusion of referred pain by CT/MRI and anesthetic block of the occipital nerve. Patients with severe symptoms can continue to have a debilitating headache despite conservative management. The best treatment in the acute setting is the same intervention for diagnosis, which is an occipital nerve block. Patients with recurrent ON symptoms despite steroid injections benefit from botulinium injections and pulsed radiofrequency. This case illustrates the detailed diagnostic evaluation and the need for high suspicion by the primary physicians to consider ON. It is often challenging to diagnose, yet it is critical to do so as early diagnosis and treatment can maximize recovery.",Excluded
3025,"Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. OBJECTIVE: The objective of the present study was prospective evaluation of the potential efficacy and safety of the intraoperative photodynamic therapy (PDT) using talaporfin sodium and irradiation with 664-nm semiconductor laser in patients with primary malignant parenchymal brain tumors. METHOD(S): In 27 patients with suspected newly diagnosed or recurrent primary malignant parenchymal brain tumors a single intravenous injection of talaporfin sodium (40 mg/m2) was administered one day before surgical resection of the neoplasm. Next day after completion of the tumor removal the residual lesion and/or resection cavity were irradiated with 664-nmsemiconductor laser with a radiation power density of 150 mW/cm2 and radiation energy density of 27 J/cm2. The procedure was performed at 22-27 hours after drug administration. The study cohort included 22 patients with histopathologically confirmed diagnosis of primary malignant parenchymal brain tumor. Thirteen of these neoplasms (59%) were newly diagnosed glioblastoma multiforme (GBM). RESULT(S): Among all 22 patients included into study cohort the 12-month overall survival (OS), 6-month progression-free survival (PFS), and 6-months local PFS rates after surgery and PDT were 95.5%, 91%, and 91%, respectively. Among patients with newly diagnosed GBM all these parameters were 100%. Side effects on the skin, which could be attributable to administration of talaporfin sodium, were noted in 7% of patients and included rush (2 cases), blister (1 case), and erythema (1 case). Skin photosensitivity test results were relatively mild and fully disappeared within 15 days after administration of photosensitizer in all patients. CONCLUSION(S): Intraoperative PDT using talaporfin sodium and semiconductor laser may be considered as potentially effective and sufficiently safe option for adjuvant management of primary malignant parenchymal brain tumors. Its inclusion in combined treatment strategy may have a positive impact on OS and local tumor control, particularly in patients with newly diagnosed GBM.",Excluded
3320,"Comparison of Whole Heart Computed Tomography Scanners for Image Quality Lower Radiation Dosing in Coronary Computed Tomography Angiography: The CONVERGE Registry. RATIONALE AND OBJECTIVES: Novel technology in coronary computed tomographic angiography allows assessment of coronary artery disease with high image quality (IQ). There are currently two wide detector ""whole heart"" coverage scanners available, which avoid misregistration artifacts. However, there are no data directly comparing IQ between the two scanners. The aim of the current study is to investigate if IQ is different between the most scanners of GE and Toshiba broad detector scanners.MATERIALS AND METHODS: Prospective, observational, multicenter international cohort study comparing 236 consecutive patients who underwent coronary computed tomographic angiography using whole-heart scanners; 126 patients on scanner S1 ( Aquilion ONE Vision, Toshiba), and 110 patients on scanner S2 (Revolution CT, GE Healthcare). Hounsfield units were measured using regions of interest in the descending aorta at 6 points (cranial slice, level of the visualized first, second, third, and fourth spines, and the caudal slice). We also compared the coverage length (z-axis) of the full width field of view between a single rotation of the two scanners.RESULTS: Evaluating mean CT attenuation values Hounsfield units through the scan range, are progressively reduced across the descending aorta in the S1 group, resulting in the larger difference of contrast brightness between the cranial and caudal slices compared to the S2 group (absolute difference: S2 13.0 +/- 4.4 vs S1 141.9 +/- 16.4, p < 0.0001; Percent difference: 19.3 +/- 2.1 vs -3.4 +/- 1.2, <0.0001). The standard deviation (SD) is similar at the cranial slice between the two scanners, however, the S1 group demonstrated higher SD-differential from cranial to caudal than S2 group. Median radiation exposure was significantly lower for the S2 scanner 1.50 +/- 0.75 mSv vs the S1 system 1.9 mSv (IQR 1.7-2.7 mSv) (p=0.01). Z-axis coverage was larger for the S2 scanner 152.5 mm (244 slices x 0.625 mm/slice) than 133 mm for S1 (266 slices x 0.5 mm/slice).CONCLUSION: Although both ""volume"" scanners cover the whole heart z-axis with one beat, scans using the S1 scanner have a larger variability in attenuation values throughout the scan range, resulting in 20% increase in nonuniformity from cranial to caudal slice. Additionally, SD variation across the field of view, a metric of noise, is larger when using the S1 scanner vs the S2 scanner. These results indicate that the GE Revolution CT has more uniform contrast enhancement and more coverage, lower radiation and lower image noise compared to the Toshiba Aquilion ONE Vision system.",Excluded
2816,"Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. OBJECTIVE: Radiation necrosis is a well-known complication of radiotherapy for malignant brain tumors. Although surgery was once considered the mainstay of treatment, no recent reports have evaluated the use of intraoperative magnetic resonance imaging (IOMRI) and frameless stereotaxis during surgical resection of radiation necrosis. In this retrospective review, we evaluate the effectiveness of surgical resection using frameless stereotaxis and IOMRI for the treatment of radiation necrosis.METHODS: From October 1999 through February 2002, 11 patients who had malignant brain tumors underwent surgery for radiation necrosis. The diagnosis of radiation necrosis was based primarily on MRI and clinical suspicion. Frameless stereotaxis was used in all patients and IOMRI was used in nine. All patients underwent at least one radiation treatment before surgery and nine patients had multiple treatments. Patient outcome was based on changes in steroid dose, Karnofsky Performance Score (KPS), and neurologic deficit.RESULTS: Optimal resection as confirmed by IOMRI was achieved in all patients by the use of frameless stereotaxis alone; no additional resection was performed in any patient. For nine patients taking steroids (mean preoperative dose 24 mg/day) before treatment of necrosis, all had a substantial reduction in steroid dosage (mean postoperative dose 8 mg/day) after surgical treatment. Postoperatively, KPS improved in four patients, remained stable in four, and worsened in three. Three complications that resulted from surgery included wound infection, asymptomatic carotid dissection, and pulmonary embolism; thus, overall morbidity including both surgical complications and neurologic deterioration was 54%.CONCLUSIONS: In this review, frameless stereotaxis was helpful in guiding the surgeon; however, IOMRI did not provide any additional benefit for the surgical treatment of radiation necrosis. Surgical treatment of radiation necrosis was associated with high risks of complication or neurologic deficit. Given the success of medical therapies, including hyperbaric oxygen, we believe that surgical treatment of radiation necrosis should be reserved for symptomatic patients in whom medical therapy has failed.",Excluded
2508,"Pyruvate kinase and aspartate-glutamate carrier distributions reveal key metabolic links between neurons and glia in retina. Symbiotic relationships between neurons and glia must adapt to structures, functions, and metabolic roles of the tissues they are in. We show here that Muller glia in retinas have specific enzyme deficiencies that can enhance their ability to synthesize Gln. The metabolic cost of these deficiencies is that they impair the Muller cell's ability to metabolize Glc. We show here that the cells can compensate for this deficiency by using metabolites produced by neurons. Muller glia are deficient for pyruvate kinase (PK) and for aspartate/glutamate carrier 1 (AGC1), a key component of the malate-aspartate shuttle. In contrast, photoreceptor neurons express AGC1 and the M2 isoform of pyruvate kinase, which is commonly associated with aerobic glycolysis in tumors, proliferating cells, and some other cell types. Our findings reveal a previously unidentified type of metabolic relationship between neurons and glia. Muller glia compensate for their unique metabolic adaptations by using lactate and aspartate from neurons as surrogates for their missing PK and AGC1.",Excluded
2981,"Randomised phase III trial of fotemustine versus fotemustine plus whole brain irradiation in cerebral metastases of melanoma. [French]. Purpose. - The main objective of this prospective multicenter randomised phase III study was to compare a combined regimen of fotemustine plus whole brain irradiation versus fotemustine alone in terms of cerebral response and time to cerebral progression in patients with melanoma brain metastases. Patients and methods. - Seventy-six patients (instead of the 106 planned patients; study was stopped after the interim analysis) were randomised receiving either fotemustine (arm A, n = 39) or fotemustine and whole brain irradiation (arm B, n = 37). Fotemustine was administered intravenously at 100 mg m<sup>-2</sup> on day 1, 8 and 15, followed by a 5-week rest period, then every 3 weeks in non-progressive patients. In arm B, a concomitant whole brain irradiation was performed at the total dose of 37.5 Gy (2.5 Gy/d<sup>-1</sup>, days 1-5, 3 consecutive weeks). Results. - Although patients who received fotemustine alone had worse prognostic factors, there was no significant difference in brain response (arm A: 7.4%, B: 10.0%) or control rates (objective response plus stable disease) after seven weeks (arm A: 30%, B: 47%) and overall survival (arm A: 86d, B: 105d). However, there was a significant difference in favour of arm B for the time to brain progression (p = 0.028, Wilcoxon test). Conclusion. - Fotemustine plus whole brain irradiation delayed the time to brain progression of melanoma cerebral metastases compared to fotemustine alone but without a significant improvement in terms of objective control or overall survival. Â© 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.",Excluded
3143,"Posterior decompression and posterior stabilization for the metastatic spinal tumor. [Japanese]. We report the clinical results of the surgical treatment for metastatic spinal tumors. Radiation therapy is one of the primary options for the metastatic spinal tumor with neurological deficit. However, when conservative treatment is failed, an early surgical intervention for the spinal metastasis presenting paraplegia or intolerable pain is the another beneficial procedure to improve patients' ability of life.",Excluded
2619,"Effects of neuro-immuno-modulation on healing of wound combined with local radiation injury in rats. PURPOSE: To investigate effects of neuro-immuno-modulation on wound healing by observing changes of cytokines and hypothalamic-pituitary-adrenal (HPA) axis hormones in acute stress reaction in rats with wound and combined local radiation injury.METHODS: Sixty female Wistar rats (weighting 200 +/- 20 g) were randomly divided into normal control group, wound group and combined wound-local radiation (CWR) group (25 Gy local radiation post wound), 20 rats in each group. Contents of IL-1beta, IL-6 and IFN-gamma and IL-4 in serum were measured and changes of adrenocorticotropic hormone (ACTH) and glucocorticoid (GC) in serum were analyzed by using enzyme-linked immunosorbent assay and radioimmunologic assay, respectively at different time points post wound and radiation.RESULTS: (1) The level of IFN-gamma, one of the Th1 cell cytokines increased significantly at 14 d post CWR, which was markedly higher than that in control group and wound group. However, the level of IL-4, IL-1beta and IL-6, one of the Th2 cell cytokines, did not show obvious change. (2) Ratio of Th1/Th2 (IFN-gamma/IL-4) in wound group and CWR group increased significantly at 7 d after wound and radiation, which suggested that Th1/Th2 balance drifted to Th1 immune response. The ratio of Th1/Th2 in wound group returned to the normal level up to 14 d after the wound and radiation, while the Th1/Th2 ratio in CWR group increased persistently and was much higher than that in control and wound groups. (3) Level of serous ACTH and GC in CWR group increased at 3 d post wound and radiation, and among them, level of GC showed statistically significant increase, which was much higher than that in control and wound groups.CONCLUSION: Level of serous neurohormone GC in rats increased significantly immediately after wound and radiation; while the level of IFN-gamma showed significant increase only up to 14 d after wound and radiation, and the Th1/Th2 imbalance sustained till 28 d post wound and radiation. In order to reduce acute damage caused by CWR, organic immune system and nerve system showed up a marked regulate effects simultaneously and mutually. Nonetheless, the excessive stress induced by CWR causes disturbance of immunoregulation, which is one of the key reasons for delayed wound healing in CWR.",Included
2644,"Carcinomatous meningitis: are surgeryand gamma knife radiosurgery treatment risk factors?. OBJECT: The purpose of this study was to identify possible risk factors leading to carcinomatous meningitis in patients with a known brain metastasis and who were treated with gamma knife radiosurgery (GKS).METHODS: Two hundred eighty lesions in 101 patients were treated during 121 GKS procedures. The clinical and neuroimaging history, tumor histology, and follow-up studies were reviewed for all patients. Evidence as demonstrated by magnetic resonance imaging criteria and/or cerebrospinal fluid (CSF) cytology of carcinomatous meningitis was evaluated. The data were then analyzed to identify potential risk factors for the development of CSF dissemination.CONCLUSIONS: It appears that carcinomatous meningitis is exclusively identified in patients with adenocarcinoma, in particular with primary lung cancer. Furthermore, the incidence is higher if surgery is performed and the interval to subsequent GKS is prolonged.",Excluded
3485,"[Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain]. The treatment of neuropathic pain is a medical challenge. The responsiveness to the different classes of drugs is often unsatisfactory and frequently associated to a wide range of side effects. International guidelines suggest for the ""localized"" neuropathic pain the topical treatment with 5% lidocaine medicated plaster, alone or associated to systemic drugs, as the first choice since its favorable efficacy and tolerability profile. Many clinical experiences support the rationale for using 5% lidocaine medicated plaster in different kinds of localized neuropathic pain, such as postherpetic and trigeminal neuralgia, compressive syndromes, painful diabetic polyneuropathy and pain secondary to trauma or surgical interventions. This paper reports a series of clinical cases whose heterogeneity suggests the wide burden of applicability of the topical 5% lidocaine, either alone and associated to systemic drugs. All the described conditions were characterized by a highly intense pain, not adequately controlled by actual medications, which improved after the use of topical lidocaine. The good response to lidocaine allowed the reduction, of even the withdrawal, of concurrent drugs and improved the patients' quality of life.",Excluded
3185,"[Contractile properties of skeletal muscles of rats after flight on ""Kosmos-1887""]. Contractile properties of skeletal muscles of rats were investigated using glycerinated muscle preparations that were obtained from Cosmos-1887 animals flown for 13 days (plus 2 days on the ground) and from rats that remained hypokinetic for 13 days on the ground. In the flow rats, the absolute mass of postural muscles remained unchanged while their relative mass increased; this may be attributed to their enhanced hydration which developed during the first 2 days after landing. Strength losses of the postural muscles were less significant than after previous flights. Comparison of the Cosmos-1887 and hypokinesia control data has shown that even 2-day exposure to 1 G after 13-day flight can modify drastically flight-induced changes.",Included
2743,"Fictive swimming motor patterns in wild type and mutant larval zebrafish. Larval zebrafish provide a unique model for investigating the mechanisms involved in generating rhythmic patterns of behavior, such as swimming, due to the array of techniques available including genetics, optical imaging, and conventional electrophysiology. Because electrophysiological and imaging studies of rhythmic motor behaviors in paralyzed preparations depend on the ability to monitor the central motor pattern, we developed a fictive preparation in which the activity of axial motor neurons was monitored using extracellular recordings from peripheral nerves. We examined spontaneous and light induced fictive motor patterns in wild type and mutant larval zebrafish (4-6 days post-fertilization) paralyzed with curare. All spontaneous and light-induced preparations produced alternation of motor activity from side-to-side (mean contralateral phase = 50.7 +/- 7.0%; mean burst frequency = 35.6 +/- 4.7 Hz) and a progression of activity from head-to-tail (mean ipsilateral rostrocaudal delay = 0.8 +/- 0.5 ms per segment), consistent with lateral undulation and forward propulsion during swimming, respectively. The basic properties of the motor pattern were similar in spontaneous and light-induced swimming. This fictive preparation can be used in combination with conventional electrophysiological and imaging methods to investigate normal circuit function as well as to elucidate functional deficits in mutant lines. Toward this end, we show that two accordion class mutants, accordion and bandoneon, have alternating activity on opposite sides of the body, contradicting the hypothesis that their deficit results from the absence of the reciprocal glycinergic inhibition that is typically found in the spinal cord of swimming vertebrates.",Excluded
2966,"Autofluorescence spectroscopy as a proxy for chronic white matter pathology. Background: The balance of tissue injury and repair ultimately determines outcomes of chronic neurological disorders, such as progressive multiple sclerosis (MS). However, the extent of pathology can be difficult to detect, particularly when it is insidious and/or offset by tissue regeneration. Objective(s): The objective of this research is to evaluate whether tissue autofluorescence-typically a source of contamination-provides a surrogate marker of white matter injury. Method(s): Tissue autofluorescence in autopsied specimens both experimental and clinical was characterized by spectral confocal microscopy and correlated to severity and chronicity as determined by standard histopathology. Result(s): Months after cuprizone (CPZ)-induced demyelination, despite robust remyelination, autofluorescent deposits progressively accumulated in regions of prior pathology. Autofluorescent deposits (likely reflecting myelin debris remnants) were conspicuously localized to white matter, proportional to lesion severity, and displayed differential fluorescence over time. Strikingly, similar features were apparent also in autopsied MS tissue. Conclusion(s): Autofluorescence spectroscopy illuminates prior and ongoing white matter injury. The accumulation of autofluorescence in proportion to the extent of progressive atrophy, despite robust remyelination in the CPZ brain, provides important proof-of-concept of a phenomenon (insidious ongoing damage masked by mechanisms of tissue repair) that we hypothesize is highly relevant to the progressive phase of MS. Copyright Â© The Author(s), 2020.",Excluded
2570,"Optical clearing potential of immersion-based agents applied to thick mouse brain sections. We have previously demonstrated that the use of a commercially-available immersion-based optical clearing agent (OCA) enables, within 3-6 hours, three-dimensional visualization of subsurface exogenous fluorescent and absorbing markers of vascular architecture and neurodegenerative disease in thick (0.5-1.0mm) mouse brain sections. Nonetheless, the relative performance of immersion-based OCAs has remained unknown. Here, we show that immersion of brain sections in specific OCAs (FocusClear, RIMS, sRIMS, or ScaleSQ) affects both their transparency and volume; the optical clearing effect occurs over the entire visible spectrum and is reversible; and that ScaleSQ had the highest optical clearing potential and increase in imaging depth of the four evaluated OCAs, albeit with the largest change in sample volume and a concomitant decrease in apparent microvascular density of the sample. These results suggest a rational, quantitative framework for screening and characterization of the impact of optical clearing, to streamline experimental design and enable a cost-benefit assessment.",Excluded
2569,"Symptom control trials: a 20-year experience. Symptoms related to cancer and/or cancer therapy are a prominent consideration in cancer patients; multiple options have been proposed to alleviate these problems. The US National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) has mandated that CCOP participant institutions be involved with cancer control trials in addition to cancer treatment trials. Through such efforts, scientifically sound symptom control clinical trials are being conducted to determine the effectiveness of promising agents. In this article, the authors provide an update of clinical trial outcomes regarding 13 symptom and symptom complexes related to cancer and/or cancer therapy, emphasizing that publication of both positive and negative study results is important to separate what works from what does not. [References: 72]",Excluded
2951,"Postoperative and postradiation head and neck: Role of magnetic resonance imaging. Interpretation of head and neck imaging after treatment for malignancy poses a challenge even for the experienced neuroradiologist. While computed tomography is often the preferred modality for assessment of the head and neck due to its faster acquisition, magnetic resonance imaging (MRI) is superior in the evaluation of nasopharyngeal, sinonasal and skull base tumors. In this article, we review pretherapy imaging protocols, common surgical approaches and reconstructions, postsurgical and postradiation MRI appearance and complications, MRI criteria for tumor recurrence and clinical applications of advanced MRI techniques as applicable to head and neck tumors. Copyright Â© 2015 Wolters Kluwer Health, Inc. All rights reserved.",Excluded
2998,"Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer. OBJECTIVE: Neoadjuvant therapy followed by surgery has been the standard treatment for advanced esophageal cancer. Severe toxicities may influence body composition, including skeletal muscle mass, and increase postoperative complications. The purpose of this study was to evaluate the influence of sarcopenia, changes in body composition, and adverse events during neoadjuvant chemotherapy (NACT) on postoperative complications in esophageal cancer patients.METHODS: A total of 83 patients with esophageal cancer undergoing NACT followed by esophagectomy were included. Body composition was assessed before chemotherapy and before esophagectomy. The relationships between postoperative infectious complications and sarcopenia, changes in body composition, and adverse events during NACT were investigated.RESULTS: Univariate analysis revealed that skeletal muscle loss during NACT, but not preoperative sarcopenia, was significantly higher in the complication (+) group. Febrile neutropenia tended to occur frequently in the complication (+) group. Multivariate analysis demonstrated that skeletal muscle loss was the only factor significantly associated with infectious complications (p = 0.029). Among adverse events, febrile neutropenia was significantly associated with a decrease in skeletal muscle mass.CONCLUSION: Loss of skeletal muscle mass during NACT was a significant risk factor for postoperative infectious complications in patients with esophageal cancer. Prevention of severe adverse events may reduce postoperative infectious complications.",Excluded
2427,"Gamma unit facility: Concept genesis, architectural design and practical realization. The physical creation of a gamma unit facility requires the development of a broad-perspective multidisciplinary plan. The primary goal is radiosurgicaI treatment of intracranial lesions in a functional environment. The practical realization of a facility optimally designed for patient treatment is dependent on factors which include the facility setting, architectural goals, radiation safety requirements, and patient and medical team needs. This necessitates combined intellectual resources from neurosurgery, radiation oncology and physics, anesthesia, radiology, nursing, administration, and architectural and engineering teams. We undertook the development of a gamma unit facility which optimized the ergonomics and efficiency of patient evaluation, care and treatment, given the instrument requirements. This general plan based on our experience can be used for the development of other gamma unit facilities.",Excluded
3240,"Radiation effects of iridium-192 implants in the cat brain. The radiation effects of <sup>192</sup>Ir permanent implants into the cat brain were studied with respect to morphological changes, blood flow, brain water and electrolytes. <sup>192</sup>Ir wires (10 animals) and non-radioactive silver wires (5 control animals) were placed stereotactically into the left internal capsule. Activity of <sup>192</sup>Ir was 0.31 mCi, the accumulated dose at 5 mm distance was 3060 rad after 21 days and 4680 rad after 35 days, respectively. None of the animals presented a neurological deficit, and the EEG recording was without significant changes. Histological damage which could be attributed to the radiation was not observed. Serum proteins, however, were detected immunohistochemically in reactive astrocytes (3 x), in macrophages (2 x) and as diffuse perivascular accumulation. Brain water in the white matter near the implantation site increased from 68.6 to 73.2%, corresponding to a volume increase of about 17%. There was no change in the grey matter or the opposite hemisphere. Cerebral blood flow decreased slightly but there was no relationship with the development of edema. The findings suggest that low dose rate topical irradiation of the brain produces primarily membrane-dependent changes, resulting in local brain-edema.",Included
3021,Radiation induced intracranial meningiomas,Included
3152,"Radiosurgery for re-irradiation of brain metastasis: Results in 54 patients. Purpose: To evaluate in terms of probabilities of local-regional control and survival, as well as of treatment-related toxicity, results of radiosurgery for brain metastasis arising in previously irradiated territory. Patients and Methods: Between January 1994 and March 2000, 54 consecutive patients presenting with 97 metastases relapsing after whole brain radiotherapy (WBRT) were treated with stereotactic radiotherapy. Median interval between the end of WBRT and radiosurgery was 9 months (range 2-70). Median age was 53 years (24-80), and median Karnofski performance status (KPS) 70 (60-100). Forty-seven patients had one radiosurgery, five had two and two had three. Median metastasis diameter and volume were 21 mm (6-59) and 1.2 cc (0.1-95.2), respectively. A Leksell stereotactic head frame (Leksell Model G, Elektra, Instrument, Tucker, GA) was applied under local anesthesia. Irradiation was delivered by a gantry mounted linear accelerator (linacs) (Saturne, General Electric). Median minimal dose delivered to the gross disease was 16.2 Gy (11.8-23), and median maximal dose 21.2 Gy (14- 42). Result(s): Median follow-up was 9 months (1-57). Five metastases recurred. One- and 2-year metastasis local control rates were 91.3 and 84% and 1- and 2-year brain control rates were 65 and 57%, respectively. Six patients died of brain metastasis evolution, and three of leptomeningeal carcinomatosis. One- and 2-year overall survival rates were 31 and 28%, respectively. According to univariate analysis, KPS, RPA class, SIR score and interval between WBRT and radiosurgery were prognostic factors of overall survival and brain free-disease survival. According to multivariate analysis, RPA was an independent factor of overall survival and brain free-disease survival, and the interval between WBRT and radiosurgery longer than 14 months was associated with longer brain free-disease survival. Side effects were minimal, with only two cases of headaches and two of grade 2 alopecia. Conclusion(s): Salvage radiosurgery of metastasis recurring after whole brain irradiation is an effective and accurate treatment which could be proposed to patients with a KPS > 70 and a primary tumour controlled or indolent. We recommend that a dose not exceeding 14 Gy should be delivered to an isodose representing 70% of the maximal dose since local control observed rate was similar to that previously published in literature with upper dose and side effects were minimal. Â© 2001 Elsevier Science Ireland Ltd.",Excluded
2677,"Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum induced by high-LET 56Fe particle irradiation. Cerebellum is a vital organ responsible for the motor coordination and recently it has been reported to be involved in cognitive function. Reactive oxygen species are implicated in neurodegeneration and cognitive disorders because of higher vulnerability of neuronal tissues. Therefore, the present study aimed at investigating the role of melatonin against high-LET (linear energy transfer) (56)Fe particle irradiation-induced oxidative damage and apoptosis in the mouse cerebellum. Radiation-induced oxidative damage was examined using a neuronal-specific terminal deoxynucleotidyl transferase-mediated nick end-labeling (TUNEL), quantitative histopathology, DNA damage (comet assay), carbonyl content and 4-HAE + MDA (4-hydroxyalkenal + malondialdehyde) status of the cerebellum. Radiation exposure augmented the number of TUNEL positive cell, DNA migration in the comet tail and carbonyl and 4-HAE + MDA level in the cerebellum. Melatonin pretreatment significantly inhibited the oxidative damage to biomolecules as well as cerebellar apoptosis. Melatonin-treated irradiated mice showed higher counts of intact Purkinje cells as compared to vehicle-treated irradiated mice. In addition, radiation induced augmentation of 8-hydroxy-2'-deoxyguanosine (8-OHdG) and a decline in the total antioxidant capacity in serum; these changes were also ameliorated by melatonin pretreatment. The present results provide evidence supporting the antioxidant and neuroprotective function of melatonin.",Included
3438,A comparison between the distinct inward currents activated in rat cultured dorsal root ganglion neurones by intracellular flash photolysis of two forms of caged cyclic guanosine monophosphate. Whole cell inward currents activated by intracellular photorelease of cyclic guanosine monophosphate (cGMP) were investigated in cultured dorsal root ganglion (DRG) neurones. The actions of two distinct types of caged cGMP (NPE-caged cGMP and a highly water-soluble caged cGMP) were compared. Rapidly activating inward currents were evoked by cGMP in a subpopulation (12.5%) of neurones and these currents may be due to activity of cyclic nucleotide-gated channels. In contrast in 52% of DRG neurones intracellular photorelease of cGMP activated a delayed Ca(2+)-dependent inward current through the generation of cyclic ADPribose and mobilisation of Ca(2+) from ryanodine sensitive intracellular stores. Similar delayed inward currents were activated by both caged compounds but only NPE-caged cGMP evoked rapidly activating currents. Cyclic GMP appears to increase excitability in some DRG neurones by diverse mechanisms.,Excluded
3558,Pituitary ablation for diabetic retinopathy. II. Results of yttrium 90 implantation in the pituitary gland,Included
2974,"InterCardioRisk: a novel online tool for estimating doses of ionising radiation to occupationally-exposed medical staff and their associated health risks. Those working in interventional cardiology and related medical procedures are potentially subject to considerable exposure to x-rays. Two types of tissue of particular concern that may receive considerable doses during such procedures are the lens of the eye and the brain. Ocular radiation exposure results in lens changes that, with time, may progress to partial or total lens opacification (cataracts). In the early stages, such opacities do not result in visual disability; the severity of such changes tends to increase progressively with dose and time until vision is impaired and cataract surgery is required. Scattered radiation doses to the eye lens of an interventional cardiologist in typical working conditions can exceed 34 muGy min<sup>-1</sup> in high-dose fluoroscopy modes and 3 muGy per image during image acquisition (instantaneous rate values) when radiation protection tools are not used. A causal relation between exposure to ionising radiation and increased risk of brain and central nervous system tumours has been shown in a number of studies. Although absorbed doses to the brain in interventional cardiology procedures are lower than those to the eye lens by a factor between 3.40 and 8.08 according to our simulations, doses to both tissues are among the highest occupational radiation doses documented for medical staff whose work involves exposures to x-rays. We present InterCardioRisk, a tool featuring an easy-to-use web interface that provides a general estimation of both cumulated absorbed doses experienced by medical staff exposed in the interventional cardiology setting and their estimated associated health risks. The tool is available at http://intercardiorisk.creal.cat.",Excluded
2713,"Extracellular currents alter gap junction intercellular communication in synovial fibroblasts. We studied the effect of extremely low frequency (ELF) currents on gap junction intercellular communication (GJIC) mediated by connexin43 protein. Confluent monolayers of synovial fibroblasts (HIG-82) and neuroblastoma cells (5Y) were exposed in bath solution to 0-75 mA/m(2) (0-56 mV/m), 60 Hz. Single channel conductance, cell membrane current-voltage (I-V) curves, and Ca(2+) influx were measured using the nystatin single and double patch methods. The conductances of the closed and open states of the gap junction channel in HIG-82 cells were each significantly reduced (by 0.76 and 0.39 pA, respectively) in cells exposed to 20 mA/m(2). Current densities as low as 10 mA/m(2) significantly increased Ca(2+) influx in HIG-82 cells. No effects were seen in 5Y cells. The I-V curves of the plasma membranes of both types of cells were independent of 60 Hz electric fields and current densities, 0-75 mA/m(2), indicating that the effect of the 60 Hz fields on GJIC in HIG-82 cells was not mediated by a change in membrane potential. We conclude that ELF electric fields can alter GJIC in synovial cells via a mechanism that does not depend on changes in membrane potential, but may depend on Ca(2+) influx. The results open the possibility that GJIC mediated responses in synovial cells, such as for example, their secretory responses to proinflammatory cytokines, could be antagonized by the application of ELF electric fields.",Excluded
3560,"Effect of different photoperiods on the diurnal rhythm of 5-methoxytryptamine in the pineal gland of golden hamsters (Mesocricetus auratus). This study tested the photo-dependency of the rhythmic synthesis of 5-methoxytryptamine (5-MT) in the pineal gland of golden hamsters. After pargyline administration, pineal 5-methoxytryptamine and melatonin were measured by HPLC in male golden hamsters kept under short and long photoperiod. In both photoperiodic regimes, a clear 5-MT rhythm was observed which fitted a sinusoidal function with high values occurring during the daytime and low values occurring during the night-time. The duration of the low night-time levels was clearly proportional to the length of the dark phase. A marked rhythm of melatonin synthesis was also seen with low daytime levels and high night-time values. An inverse relationship between 5-MT and melatonin levels was observed. Thus, after pargyline administration, the rhythms of 5-MT and melatonin in the pineal gland of golden hamsters are photoperiod-dependent and show a reciprocal relationship.",Excluded
2575,[Some forensic viewpoints on radiation induced late reactions of the nervous system from the neurologic view],Excluded
2667,"Effect of Exposure to Gadodiamide and Brain Irradiation on T<inf>1</inf>-Weighted Images and ADC Maps of the Dentate Nucleus. Background: Brain irradiation is considered a cofactor influencing the dentate nucleus (DN) signal intensity (SI) on unenhanced T<inf>1</inf>-weighted images in patients exposed to gadolinium-based contrast agents (GBCAs). Purpose(s): To assess the effect of gadodiamide and whole-brain radiation therapy (WBRT) on T<inf>1</inf>-weighted images and on apparent diffusion coefficient (ADC) maps of DN. Study Type: Single-center retrospective. Population: In all, 125 patients who underwent brain MRIs were classified into four groups: 1) patients who did neither receive intravenous GBCAs injections nor irradiation (controls); 2) patients having >=3 GBCAs-enhanced scans and no WBRT; 3) patients having WBRT and < 3 GBCAs-enhanced scans; and 4) patients having WBRT and >= 3 GBCAs-enhanced scans. Field Strength/Sequence: 1.5T magnet, echo-planar diffusion weighted imaging (DWI) and unenhanced T<inf>1</inf>-weighted sequences. Assessment: The DN-to-pons SI ratio on unenhanced T<inf>1</inf>-weighted images and ADC values of the DN were calculated. Values were compared between groups and relative to the cumulative gadolinium dose and to the time delay after WBRT. Statistical Tests: Statistical analysis included the Mann-Whitney U-test and Spearman's rank-order correlation. Result(s): DN ADC values were not significantly different (P = 0.34) between patients exposed to gadodiamide (0.81 +/- 0.06) and controls (0.83 +/- 0.07). There were no differences in DN ADC values (P = 0.28) and DN-to-pons SI ratios (P = 0.42) between patients exposed to WBRT (ADC values: 0.85 +/- 0.09; SI ratio: 1.11 +/- 0.10) and controls (ADC values: 0.83 +/- 0.06; SI ratio: 1.09 +/- 0.06). There was a significant negative correlation between DN ADC values and the time (days) since the end of WBRT (r = - 0.33; 95% confidence interval [CI]: -0.55, -0.06; P < 0.05). Data Conclusion(s): We did not find changes suggestive of gadolinium-related tissue microstructural damage of the DN. The ADC values of the DN are associated with the time from WBRT. Level of Evidence: 3. Technical Efficacy Stage: 5. Copyright Â© 2020 International Society for Magnetic Resonance in Medicine",Included
3190,"Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control. In this study, we assessed the efficacy of salvage stereotactic radiotherapy (SRT) for recurrent glioma. From August 2008 to December 2012, 30 patients with recurrent glioma underwent salvage SRT. The initial histological diagnoses were World Health Organization (WHO) grades II, III, and IV in 6, 9, and 15 patients, respectively. Morphologically, the type of recurrence was classified as diffuse or other. Two methods of clinical target delineation were used: A, a contrast-enhancing tumor; or B, a contrast-enhancing tumor with a 3-10-mm margin and/or surrounding fluid attenuation inversion recovery (FLAIR) high-intensity areas. The prescribed dose was 22.5-35 Gy delivered in five fractions at an isocenter using a dynamic conformal arc technique. The overall survival (OS) and local control probability (LCP) after SRT were calculated using the Kaplan-Meier method. A univariate analysis was used to test the effect of clinical variables on OS/LCP. The median follow-up period was 272 days after SRT. The OS and LCP were 83% and 56% at 6 months after SRT, respectively. Morphologically, the tumor type correlated significantly with both OS and LCP (P = 0.006 and <0.001, respectively). The method of target delineation also had a significant influence on LCP (P = 0.016). Grade 3 radiation necrosis was observed in two patients according to Common Terminology Criteria for Adverse Events, version 3. Salvage SRT was safe and effective for recurrent glioma, especially non-diffuse recurrences. Improved local control might be obtained by adding a margin to contrast-enhancing tumors or including increased FLAIR high-intensity areas.",Excluded
3126,Effects of radiotherapy and chemotherapy on sensory deficits from spinal cord damage,Excluded
3097,"Significance of histology in determining management of lesions regrowing after radiosurgery. Brain metastases treated with stereotactic radiosurgery may show delayed enlargement on post-treatment imaging that is of ambiguous etiology. Histopathologic interpretation of brain specimens is often challenging due to the presence of significant radiation effects admixed with irradiated residual tumor of indeterminate viability. The purpose of this study was to assess the impact of histologic findings on clinical outcomes following resection of these lesions. Between 2004 and 2010, 690 patients with brain metastases were enrolled in a prospective gamma knife data repository, and lesions requiring excision were identified. Tissue specimens were divided into four groups based on the ratio of treatment related inflammatory changes (TRIC) to tumor cells, and subsequently patient outcomes were assessed. Of 2,583 metastases treated, 36 were excised due to symptomatic enlargement. Only TRIC, without residual evidence of tumor, was seen in 36 % (13/36) of specimens. Resection of these lesions resulted in 100 % local control in follow-up. Of the remaining 23 lesions that contained any viable-appearing tumor within the resected specimen, 8 recurred after resection. Lesions that enlarged in the first 6 months were more likely to contain higher amounts of residual tumor cells. Patients with even <2 % tumors cells on excision had significantly worse local control (75 vs. 100 %, p = 0.024) and survival (HR 0.27, p = 0.029) compared with those patients with exclusively TRIC. In summary, our findings underscore the importance of surgically obtaining tissue in a method that facilitates complete lesional interpretive histology in order to accurately guide ongoing patient management.",Excluded
3259,"Effects of the coenzyme Q10 against radiationinduced acute renal and liver injuries in rats. Objective: Coenzyme Q10 (CoQ10), which is one of the main cofactors of oxidative phosphorylation in mitochondria, is known to have anti-oxidative effects and used in certain diseases such as heart failure, Parkinson's disease and Alzheimer's disease for this purpose. Oxidative stress-induced acute toxic effects seen in some tissues and organs after radiation therapy. In previous studies, CoQ10 was shown to be protective against oxidative stress particularly in organs such as heart, liver and kidney. In this study the effects of the coenzyme Q10 on acute oxidative renal and liver injuries in radiation induced rats were investigated. Material(s) and Method(s): The rats were randomly divided into four groups and each group included 10 rats; group 1 (Control group), group 2 (intraperitoneally CoQ10 administered), group 3 (radiation applied) and group 4 (both radiation applied and intraperitoneally CoQ10 administered). Rats were administered dose of 10mg/kg/day CoQ10 intraperitoneally, and underwent radiation therapy through a posterior portal covering the thorax and the abdomen. Malondialdehyde (MDA) and CoQ10 levels and activities of superoxide dismutase, glutathione peroxidase, catalase enzymes in renal tissue were studied. Result(s): MDA levels significantly increased and CoQ10 levels significantly decreased in the liver and kidney tissues of the radiation applied group as compared to the control group (p <0.05). Conclusion(s): These results show that CoQ10 has not adequate protective and antioxidant effects on acute renal and liver tissue injuries in radiation induced rats.",Included
3441,"Intraoperative radiotherapy and reconstructive operations in the treatment of locally spread tumors of oral cavity. Aim: to improve the results of the treatment of patients with locally spread oral cavity tumors, spreading on to neighboring anatomic structures, including skull base. Material(s) and Method(s): we proposed the variant of combined treatment of patients with head and neck tumors, including expanded operations, intraoperative radiotherapy and reconstruction-at-once in the case of primary and recurrent tumors after surgical, radiation, combined, complex treatment, just as their repeated coalition. We accumulated experience of 55 patients' treatment, for whom block resections were conducted, together with intraoperative radiotherapy in radiation doze 15 Gray (52 patients) and in radiation doze 25 Gray in the conditions of gas hypoxia (3 patients). For all the patients the spread of tumor process corresponded to T4 symbol. In 32 cases for reconstruction-at-once we used the method of microsurgical tissue autotransplantation, in 23 observations locally-relocated flaps were used. Result(s): the complications appeared in 41,2% of cases, the complications predominated in the group of patients with intracranial expansion of a tumor. Total survival rate was for 3 years - 23,3+/-6,3%; for 5 years - 14,8+/-7,0%. At the same time, there was observed reliable difference in the survival rate of patients with recurrent and primary tumors. 3 year survival rate with recurrent tumors was 15,6 +/-2,3%; with primary tumors - 39,7 +/-1,7%; 5 year survival rate - 10,41 +/- 5% and 23,8 +/- 1,4% correspondingly.",Excluded
3075,"Glioma invasiveness responds variably to irradiation in a co-culture model. PURPOSE: We developed a co-culture system to quantitate the growth and invasion of human malignant gliomas into a background of confluent normal human astrocytes, then used this assay to assess independently the effects of irradiating both cell types on glioma invasion.METHODS AND MATERIALS: Enhanced green fluorescent protein (EGFP)-labeled immortalized human astrocytes, human malignant glioma cells, or transformed human astrocytes were focally plated onto a confluent layer of normal human astrocytes, and the invasiveness of EGFP-labeled cells was scored after 96 h. To address the consequences of irradiation on glioma invasion, the invasiveness of irradiated glioma cell lines and irradiated astrocytic backgrounds was assessed. Fluorescence-activated cell sorting was used to quantitate the total number of EGFP-labeled cells.RESULTS: Growth in the co-culture assay consistently reflected transformation states of the plated cells. Immortalized, but untransformed human astrocytes failed even to establish growth on confluent normal human astrocytes. In contrast, all malignant human glioma cell lines and transformed human astrocytes demonstrated various degrees of infiltration into the astrocytic bed. Irradiation failed to alter the invasiveness of U87, A172, and U373. A 1-Gy dose slightly reduced the invasiveness of U251 MG by 75% (p < 0.05 by one-way analysis of variance and post hoc Neuman-Keuls), without reducing total cell numbers. Independently irradiating the human astrocytic bed did not alter the invasiveness of nonirradiated U251, whereas the matrix metalloproteinase (MMP) inhibitor GM6001 reduced U251 invasiveness in the co-culture assay.CONCLUSIONS: Growth in the co-culture assay reflects the transformation status and provides a useful in vitro model for assessing invasiveness. Human glioma invasiveness in the co-culture model responds variably to single low-dose fractions. MMP activity promotes invasiveness in the co-culture model. Reduced invasiveness in irradiated U251 appears to be mediated by MMP-independent mechanisms.",Included
2419,"The response of ataxia telangiectasia cells to bleomycin. The autosomal recessive disorder, ataxia telangiectasia (AT) is characterised by cellular sensitivity to ionizing radiation. The molecular basis of this radiosensitivity is the subject of controversy. We report here that cultured fibroblasts from AT patients are also sensitive to the lethal effects of bleomycin. As with ionizing radiation, no defect has been observed in the overall rejoining of single or double-strand breaks produced by bleomycin. Since, however, only apyrimidinic (and to a lesser extent apurinic) sites and strand breaks are known to be produced by bleomycin, we tentatively suggest that AT cells are unable to rejoin a very small fraction of the total strand breaks. We attribute our inability to detect such unrejoined strand breaks to the relative insensitivity of the sucrose gradient procedures normally used to detect strand breaks.",Excluded
2499,"Genetic analysis of dTSPO, an outer mitochondrial membrane protein, reveals its functions in apoptosis, longevity, and Ab42-induced neurodegeneration. The outer mitochondrial membrane (OMM) protein, the translocator protein 18 kDa (TSPO), formerly named the peripheral benzodiazepine receptor (PBR), has been proposed to participate in the pathogenesis of neurodegenerative diseases. To clarify the TSPO function, we identified the Drosophila homolog, CG2789/dTSPO, and studied the effects of its inactivation by P-element insertion, RNAi knockdown, and inhibition by ligands (PK11195, Ro5-4864). Inhibition of dTSPO inhibited wing disk apoptosis in response to gamma-irradiation or H2O2 exposure, as well as extended male fly lifespan and inhibited Abeta42-induced neurodegeneration in association with decreased caspase activation. Therefore, dTSPO is an essential mediator of apoptosis in Drosophila and plays a central role in controlling longevity and neurodegenerative disease, making it a promising drug target.",Excluded
2703,"Space missions: psychological and psychopathological issues. Exploring space is one of the most attractive goals that humanity ever set, notwithstanding, there are some psychological and psychopathological risks that should be considered. Several studies identified some possible hazards of space travels and related physical and psychological consequences on astronauts. If some psychological reactions are obviously inherent to the characteristics of the spaceships (habitability, confinement, psychological, and interpersonal relationships), other (disturbances of sleep-wake cycle, personality changes, depression, anxiety, apathy, psychosomatic symptoms, neurovestibular problems, alterations in cognitive function, and sensory perception) represent a clear warning of possible central nervous system (CNS) alterations, possibly due to microgravity and cosmic radiation. Such conditions and eventual CNS changes might compromise the success of missions and the ability to cope with unexpected events and may lead to individual and long-term impairments. Therefore, further studies are needed, perhaps, requiring the birth of a novel branch of psychology/psychiatry that should not only consider the risks related to space exploration, but the implementation of targeted strategies to prevent them.",Excluded
2850,"Repair of large defects of the dome of the skull by means of cranial homografts sterilised by gamma radiation. [French]. Twenty eight patients with large defects of the dome of the skull underwent reconstruction by means of a cranial homograft sterilised by gamma radiation. These cases were followed clinically, radiologially and by isotope examinations, with a follow-up of 2 to 6 years (from 1979 to 1983). This procedure appears to be useful in major reconstructions of the dome of the skull when autografts cannot be used. A good aesthetic result is obtained by means of a single piece of bone prepared according to the site and dimensions of the skull defect. Because homografts are able to induce renewed osteogenesis, it seems preferable to use these grafts rather than non-biological materials.",Excluded
2729,"Early and transient effects of neutron irradiation on dopamine receptors in the adult rat brain. The early neurochemical effects of neutron-gamma radiation exposures were studied through ligand dopamine D1, D2 receptors binding experiments. The parameters of binding were investigated on crude preparations from striatum at different delays (from 2 to 72 hours) after irradiation. An early and transient increase in the total number of sites was seen after exposure, even at infra-lethal dose. This 'radiosensitivity' was higher for D1 than for D2 receptor. It is assumed that these modifications could participate in the early neuro-vegetative syndrome observed in irradiated persons.",Included
3184,"Impact of therapy and disease-related symptoms on health-related quality of life in patients with follicular lymphoma: results of the population-based PHAROS-registry. OBJECTIVES: The increasing number of longer living patients with follicular lymphoma (FL) and serious side effects of treatment urged us to study the health-related quality of life (HRQoL) and persistent (treatment-related) symptoms in unselected patients after different treatment modalities and compare HRQoL of patients with a normative population.METHODS: The population-based Eindhoven Cancer Registry was used to select patients diagnosed with FL during 2004-2010. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) was completed twice, with a 1-yr interval. This questionnaire was also completed by an age- and sex-matched normative population (N = 580). Detailed data on treatment were extracted from the cancer registry and Population-based HAematological Registry for Observational Studies (PHAROS).RESULTS: Of the 181 patients who were invited, 148 responded (82%, T1). Patients treated with immunochemotherapy reported clinically relevant higher mean fatigue scores than those who underwent radiotherapy (P = 0.02). No differences were observed on the other HRQoL scales between treatment groups. Mean HRQoL scores were worse for FL patients treated with immunochemotherapy compared with a normative population (P < 0.01). A quarter to 50% of patients persistently reported to be slowed down, lethargic, or persistently worried about future health or was limited in social activities. Subsequently, patients reporting these symptoms/worries had a lower global health status/HRQoL.CONCLUSION: Alertness for persistent symptoms that occur during and after treatment of FL patients is needed and may help to avoid lasting negative influence on their HRQoL.",Excluded
2935,Neuromuscular toxicity of therapy. The peripheral nervous system is frequently impaired in patients who have cancer. This impairment often results from toxicity of treatment but may also be due to direct invasion by tumor or may be part of a paraneoplastic syndrome. This review summarizes the recent literature regarding peripheral neuropathies and myopathies that are seen in patients with cancer. Highlights include the neuromuscular toxicity of some of the newer chemotherapeutic agents and immune mediators such as taxol and interleukin-2; a discussion of some of the agents being investigated for chemoprotection and rescue; an assessment of the evidence supporting the concept of motor neuron disease as a paraneoplastic disorder; and an interesting case report of megakaryoblastic leukemia invading peripheral nerves. Also summarized are some nice reviews and prospective studies of the toxicity of more conventional treatments. [References: 27],Excluded
2711,[Stereotactic radiation treatment of patients with cerebral arteriovenous malformations],Included
2465,"Lesser Known Facts of Small Cell Lung Cancer. Until recently, the treatment of small cell lung cancer (SCLC), a malignancy classically described as having a robust response to first-line therapy with near-universal recurrence, has remained relatively unchanged. Advancements in the management of SCLC have lagged behind those seen for non-small cell lung cancers. As the era of precision medicine and targeted immunotherapy evolves, radiologists must be familiar with the modern treatment paradigms of SCLC and associated imaging patterns, including classic and nonclassic appearances of treatment complications. Copyright Â© 2019 Wolters Kluwer Health, Inc. All rights reserved.",Excluded
2731,"Influence of a complex magnetic field application in rats upon thermal nociceptive thresholds: the importance of polarity and timing. The application of a weak (1 microTesla) complex magnetic field pattern with a relevant electrophysiological signature produced an analgesic response in rats to thermal stimuli when the pattern was presented once every 4 sec for 30 min through iron-core solenoids. In one experiment, the burst-firing pattern was presented once every 4 s for 30 min and restricted to the positive polarity, negative polarity or a bipolar equivalent. The strongest analgesia occurred when the burst-firing pattern was presented with positive polarity or as the typical bipolar signal. Administrations of the burst-firing pattern once per week for four consecutive weeks produced analgesia that was clearly evident during the first, third, and fourth weeks but not during the second week of treatment. A telephone sensor coil (that can be readily obtained from local electronic shops) was then used instead of the solenoids along with an audio (.wav) file to generate the magnetic field; the analgesia was still apparent. However, when the magnetic pattern was generated from a compact disc source the analgesia was not evoked. The current results suggest that these fields can be generated through simple commercial devices controlled by available computer software.",Excluded
3515,"An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer. BACKGROUND/AIM: For treatment personalization in elderly cancer patients, survival prognoses should be considered. We developed an instrument to estimate survival of elderly patients with brain metastasis from gynecological cancer.PATIENTS AND METHODS: In 15 patients, whole-brain radiotherapy regimen, tumor site, age, Karnofsky performance score (KPS), number of brain metastases, extra-cerebral metastases and interval from diagnosis of gynecological cancer until radiotherapy were retrospectively evaluated for survival. Characteristics found significant on multivariate analysis were used for the instrument.RESULTS: In the multivariate analysis, KPS >=70% (hazard ratio=3.71, p=0.0499) and an interval >=28 months (hazard ratio=3.71, p=0.030) were significantly associated with better survival. Based on these characteristics, patients received 0 (n=6), 1 (n=3) or 2 points (n=6). Six-month survival rates of the groups 0-1 and 2 points were 0% and 50%, respectively (p=0.007).CONCLUSION: This instrument helps estimating survival in elderly patients with brain metastases from gynecological cancer and contributes to personalization of their treatment.",Excluded
3429,"[Rules of application and mode of action of transcranial direct current stimulation in neurorehabilitation: primary motor cortex]. Transcranial direct current stimulation (tDCS) is an emerging technique of non-invasive brain stimulation that has been found useful in facilitating treatment of various neurological disorders, especially stroke. Currently available criteria for single application of several minutes-long stimulation at 1-2 mA have been considered safe. However, knowledge regarding safety parameters of repeated and long-term electrical stimulation is so far limited. Studies on the use of tDCS focus predominantly on the motor cortex. They demonstrate that weak direct current is capable of eliciting cortical excitability changes which occur during and after stimulation. The nature of these changes is specific for current polarity - anodal stimulation enhances excitability, and cathodal reduces it. Studies indicate that tDCS effects are generated by polarity-driven alterations of membrane potentials and efficacy modulations of specific neuronal receptors. According to interhemispheric competition models, possible mechanisms underlying functional improvements due to stimulation in patients with stroke are attributed to tDCS-induced modification of inappropriate interhemispheric inhibition. [References: 50]",Excluded
3478,"Transcription coupled repair deficiency results in increased chromosomal aberrations and apoptotic death in the UV61 cell line, the Chinese hamster homologue of Cockayne's syndrome B. Transcription coupled repair (TCR), a special sub-pathway of nucleotide excision repair (NER), removes transcription blocking lesions rapidly from the transcribing strand of active genes. In this study, we have evaluated the importance of the TCR pathway in the induction of chromosomal aberrations and apoptosis in isogenic Chinese hamster cell lines, which differ in TCR efficiency. AA8 is the parental cell line, which is proficient in the genome overall repair of UV-C radiation induced 6-4 photoproducts (6-4 PP) and the repair of cyclobutane pyrimidine dimer (CPD) from the transcribing strand of active genes. UV61 cells (hamster homologue of human Cockayne's syndrome (CS) group B cells) originally isolated from AA8, exhibit proficient repair of 6-4 PP but are deficient in CPD removal by the TCR pathway. Upon UV-C irradiation of cells in G1-phase, UV61 showed a dramatic increase in apoptotic response as compared to AA8 cells. Abolition of TCR by treatment with alpha-amanitin (an inhibitor of RNA polymerase II) in AA8 cells also resulted in an elevated apoptotic response like that observed in UV61 cells treated with UV alone. This suggests that the lack of TCR is largely responsible for increased apoptotic response in UV61 cells. Furthermore, the chromosomal aberrations and sister chromatid exchange (SCE) induced by UV were also found to be higher in UV61 cells than in TCR proficient AA8 cells. This study shows that the increased chromosomal aberrations and apoptotic death in UV61 cells is due to their inability to remove CPD from the transcribing strand of active genes and suggests a protective role for TCR in the prevention of both chromosomal aberrations and apoptosis induced by DNA damage. Furthermore, flow cytometry analysis and time-course appearance of apoptotic cells suggest that the conversion of UV-DNA damage into chromosomal aberrations precedes and determines the apoptotic process.",Excluded
3316,"The reaction of Helix photosensitive neurons to light and cyclic GMP. The effect of light and cyclic nucleotides (cGMP and cAMP) on a group of identified photosensitive neurons in Helix pomatia left parietal ganglion was examined. The onset of light induces in these cells a slow inward current shift associated with decrement of slope conductance. The reversal potential (Erev) of the light induced current (IL) and its changes due to altered extracellular concentration of potassium support the assumption that (IL) is due to suppression of K+ conductance. Elevation of intracellular concentration of cyclic GMP by adding 8-bromo-cGMP into the bathing solution or by injecting the nucleotide into the cell mimics, in all cases, the effect of light: it produces an inward current accompanied by decrement of slope conductance. The effect of elevation of cAMP was inconsistent. The I-V relations of IL and IcGMP follow a similar course and have a common Erev. The assumption that 3',5'-cyclic GMP is increased by light is also supported by comparing the effect of light and the cyclic nucleotide on the action potential. Both light and 8-bromo-cGMP broaden the action potential by increasing the voltage-dependent Ca2+ current.",Excluded
3382,"Fractional anisotropy dose-response relationship of the corpus callosum. Purpose or Objective: Diffusion tensor magnetic resonance imaging (DTI) is a non-invasive modality for determination of water diffusion properties. Fractional anisotropy (FA) quantifies the extent of directionality of water diffusion. We investigated absorbed dose as a predictor of FA change in the corpus callosum (CC) following radiation therapy for high grade glioma. Material(s) and Method(s): Fifteen patients with high-grade glioma underwent DTI scans before, and ten months after radiation therapy to 59.4-60 Gy. Diffusion data were acquired on a 3T MRI scanner. Using an automated white matter fiber tracking technique, 23 fiber tracts were segmented on the baseline and follow-up DTI images. The CT images used for treatment planning and both DTI image sets were aligned using non-linear registration. This way, the baseline FA, the follow-up FA, and the absorbed dose could be determined for each voxel in all 15 patients. For each voxel in the CC, we calculated the FA change as FA follow-up /FA baseline and dichotomized the data into a binary outcome variable using 0.5 as cutoff. For all 15 patients, logistic regression was used to determine dose-response curve parameters (D50 and g50) and their confidence intervals (CIs). We used the area under the receiver-operating characteristics curve (AUC) to evaluate the discriminative ability of the voxel dose. Then, we estimated dose-response curve parameters and calculated the AUC for each patient individually. Result(s): The median age was 59 (range: 40-85) years. The average CC volume and average CC mean absorbed dose was 62+/-8 cm3 and 26+/-14 Gy (1 SD), respectively. Using data from 99 691 voxels, the estimated parameters for the doseresponse curve for all patients (upper panel in Figure 1) were D50=88.0+/-0.1 Gy and gamma50=0.80+/-0.01 (95% CIs). The AUC was 0.71 indicating good discriminative ability. For nine out of 15 patients, the individual AUC was >=0.60, indicating that higher absorbed dose is associated with higher probability of FA change >=0.5. Dose -response curves for those patients are shown in the lower panel in Figure 1 and their estimated parameter values in Table 1. Individual D50s varied between 41.3 and 125.9 Gy. Conclusion(s): Absorbed dose was a significant predictor of FA change in the CC. This was the case both when all patients were pooled for analysis, and in nine out of 15 patients when analyzed separately. More detailed analyses are needed to better understand the effect radiation has on water diffusion in brain white matter. (Figure Presented).",Excluded
